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This thesis is concerned with microbially derived cis-3,5-cyclohexadiene-1,2-
dihydroxy-1-carboxylic acid and its iron tricarbonyl derivatives as precursors for 
the efficient and practical synthesis of useful products.  
The opening chapter consists of a review of the biocatalytic cis-dihydroxylation 
process including its mechanism and applications in synthesis.  
In a Chapter 2 the utility of cyclohexadiene iron tricarbonyl complexes to date is 
outlined, with particular focus on their preparation and reactivity. Synthetic routes 
towards the synthesis of the natural products gabaculine and carbazole alkaloids 
are described, followed by the preparation of tamiflu and general methods of 
decomplexation.  
Chapter 3 presents the synthesis of novel iron tricarbonyl complexes and studies 
on their reactivity are disclosed. (Figure A.) 
 
 
 Figure A. 
 
Chapter 4 describes the formation of a new rearrangement product of the 
acetonide protected iron tricarbonyl complexes. In order to validate this process, 
independent studies with labelled compounds have been employed. Following 
Myers’ procedure for microbial oxidation of p-deutero-benzoic acid, quantities of 
a novel deutero-diol product were successfully prepared and used to elucidate 
the mechanism of the rearrangement process. (Figure B) 
 
 






In Chapter 5 the formation of the η5 cyclohexadienyl complexes is discussed 





Chapter 7 provides detailed specific and general procedures for the synthesis of 
the compounds described within this thesis, along with their characterisation 
data. The appendices provide analytical support to this thesis and list of 
publications. 
Each chapter includes a separate discussion of the results and Chapter 6 
provides an overall summary and suggestions for possible future work.
iii                                                    iv 
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Chapter 1. INTRODUCTION 
 
Iron, element 26 in the periodic table, is the fourth most abundant element and 
the second most abundant metal after aluminium in the earth’s crust. Metal ions 
can serve in biological systems in many different ways depending on the 
distance between them and their oxidation state – one example is as sites at 
which enzyme catalysis occurs.1 It is certain that billions of years ago the 
environment was anaerobic and sulphur and iron could form the first ever 
catalysts provided by Nature, proteins containing iron-sulphur (Fe−S) clusters.2 
 
1.1 Rieske non-heme iron oxygenases 
 
These enzymes are classified according to the properties of their electron 
transfer components, and it has been shown that the catalytic sites (α−subunits) 
of all Rieske non-heme iron oxygenases are very similar as a consequence of 
their evolution. In general the classification is correlated to the substrates 
oxidized by the members. The family of Benzoate oxygenases consists of 
enzymes that oxidize aromatic carboxylic acids (benzoate, 2-chlorobenzoate, 
toluate, anthranilate, isopropylbenzoate, trichlophenoxyacetate).3 
 
1.2 Arene cis-dihydroxylation 
 
It has been found that aromatic hydrocarbons can be utilized as the sole carbon 
source by certain bacteria under aerobic conditions. Biodegradation is initiated by 
bacterial Rieske non-heme iron dioxygenases (RO) with molecular oxygen, 
yielding the corresponding cis-diols, which are subsequently oxidized by catechol 
dioxygenases. Therefore organisms expressing Rieske dioxygenases can play 
an important role in bioremediation of serious environmental pollutants.3,4,5,6 
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The most studied dioxygenases are toluene dioxygenase (TDO), benzene 
dioxygenase (BDO), naphthalene 1,2-dioxygenase (NDO), phthalate 
dioxygenase (PDO), anthranilate 1,2-dioxygenase (ADO), and benzoate 1,2-
dioxygenase (BZDO).7 
 
The first crystal structure of an arene dioxygenase to be reported was for NDO, 
which was solved in 1998. The Rieske dioxygenases are an α3 or α3β3 hexamers. 
It is believed that in some cases beta subunits stabilized the alpha subunits. In 
most examples, the enzyme consists of three components (a) a flavoprotein 
reductase containing iron-sulphur cluster; (b) a Rieske [2Fe−2S] ferrodoxin; (c) 
an oxygenase component accommodating a Rieske [2Fe−2S] cluster 
coordinated by Cys-81, Cys-101, His-83, and His-104 and a mononuclear iron(II) 
centre which is coordinated by His-208, His-213, Asp-362 and a water 
molecule.8,9 This model is illustrated in Figure 1. 
 
 







1.3 Mechanism of cis-dihydroxylation 
 
The redox centres are located on the α-subunit of the oxygenase. The initial 
steps are not fully understood but involve movement of electrons from NAD(P)H, 
which are removed by the reductase and transferred to the ferredoxin. Then 
electrons are transferred from the ferredoxin to the Rieske domain of the 
oxygenase, and then molecular oxygen is bound in the active site of the catalytic 
domain followed by complexation of an aromatic substrate. Electrons are 
transferred from the oxygenase Rieske domain to the catalytic mononuclear iron 
and cis-dihydoxylated product is formed.10,11,12 The proposed mechanism is 
depicted in Scheme 1.  
In addition to naphthalene NDO is known to oxidize over 30 different aromatic 
compounds, and the majority of the products are enantiomerically pure. One 
major focus of Rieske arene dioxygenase research is generation of chiral cis-





Scheme 1 Proposed Catalytic Cycle for Naphthalene cis-Dihydroxylation. 
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Dihydroxylation catalyzed by Naphthalene Dioxygenase. Image shows NADH-dependent 
ferredoxin reductase component in biphenyl dioxygenase (Protein Data Bank no. 1F3P), biphenyl 
reductase ferredoxin (Protein Data Bank no. 1FQT), and naphthalene dioxygenase (Protein Data 
Bank no. 1NDO).  Symbol 2 means 18O-labelled oxygen. 
 
The Rieske dioxygenases have a mononuclear iron active site coordinated to a 
“2-Histidine-1-carboxylate facial triad”, and a few researchers have employed N-
acylated dipyridin-2-ylmethylamine ligands (R-DPAH)13 and tetraalkylcyclam 
complexes14 to mimic the action of the NDO active site.15,16 
 
1.4 Non-enzymatic approaches to arene dihydroxylation 
 
1,2-syn diols are very common motifs in natural products and important 
intermediates in organic synthesis. Arene dioxygenases are selective towards a 
small range of aromatic hydrocarbons, which is the major problem in their 
applicability. Also, biotransformations are often difficult to control with low 
accessibility to the microorganisms and low selectivity throughout substrates. In 
response several research groups have address the problem of an alternative 
method of arene dihydroxylation able to mimic natural enzymes. 
Very recently (2009) Que et al. have reported the first non-heme iron complex 
that catalyses the cis-dihydroxylation of naphthalene.15 Scheme 2. 
 
 
Scheme 2 Dihydroxylation of naphthalene with iron catalyst. 





Napthalene was oxidised in the presence of catalyst A and hydrogen peroxide in 
CH3CN, albeit the yield was very low. 18O labelling studies have shown that the 
water-assisted mechanism is highly possible with initial formation of low spin 
FeIII-OOH species, further cleaved by water to the reactive cis-HO-FeV=O oxidant 
responsible for cis-dihydroxylation of naphthalene.15 
 
Motherwell et al. have also looked at alternative dihydroxylations of aromatic 
compounds.17 Their work was based on prior reports from Kochi and Wallis.18 
Catalytic photoinduced charge transfer osmylation of benzene in the presence of 
sodium bromate or barium chlorate followed by treatment with acetic anhydride 




Scheme 3 Catalytic photoinduced charge-transfer osmylation of benzene.  
Reagents and Conditions. (a) OsO4 (cat.), hν, NaBrO3 (0.22 M), 45 °C; (b) AcOH, Ac 2O, (5) 
7,7%, 6:7, 5:11, 18.8%, 8:9, 1:5, 2.3%. 
 
 
Scheme 4 Catalytic photoinduced charge-transfer osmylation of toluene. 
Reagents and Conditions. (a) OsO4 (cat.), hν, Ba(ClO3)2 (0.22 M); (b) Ac2O, Et3N, DMAP; 




The overall yield of catalytic osmylation of toluene was achieved in 13% without 
cleavage of the carbocyclic ring. The proposed mechanism involves formation an 
ion pair 17 under photochemically induced charge transfer conditions, from 
benzene to OsO4, which subsequently collapses to the mixture of osmate ester 
of benzene diol 18; this is osmylated further to give polymeric anti thermal 






















































Scheme 5 Proposed mechanism of catalytic photoinduced charge-transfer osmylation 
 (adapted from reference17). 
 
1.5 Degradation of benzoate 
 
Many microorganisms can utilize aromatic compounds as a source of carbon. 
The microbial degradation of aromatic compounds has tremendous practical 
significance. The aromatic ring structure is degraded and the products are 
converted to compounds that can enter central metabolic pathways to provide a 
carbon source and energy. Most soil bacteria can further degrade the cis-diol 
products of arene dioxygenases with dihydrodiol dehydrogenases to yield ring 
opened products.20,21,22 
 
The β-ketoadipate pathway is widely spread among taxonomically diverse 
bacteria and fungi. It plays an important role in the degradation of environmental 
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pollutants and naturally occurring aromatic compounds, e.g. those derived from 
lignins.23  
In the specific case of R. eutrophus B9, the organism central to the work in this 
thesis, benzoate is degraded via the ortho-cleavage pathway to yield 1,2-
dihydroxybenzoate 22, which is converted to catechol 23 by a DHD 
dehydrogenase. This compound is then degraded with catechol-1,2-dioxygenase 
to cis,cis-muconate 24. After several sequential inductions (each enzyme in the 
pathway is inducible by its specific substrate) succinyl-CoA and acetyl CoA are 
delivered (Scheme 6). It is important to point out that wild-type organism utilizes 
benzoate by the β-ketoadipate pathway fully, whereas the blocked B9 mutant has 
an inactivated DHD dehydrogenase and so can be easily cultured to provide 




Scheme 6 The β–ketoadipate pathway (the ortho-cleavage pathway) for the degradation of 
benzoate in R. eutrophus 






1.5.1 Boyd’s Model 
 
Boyd et al. have derived a very useful method to predict the outcome of 
dihydroxylation of mono- and 1,4-disubstituted benzene substrates and in most 
cases the obtained product is an enantiometrically pure cis-2,3-diol.25 
In monosubstitued arenes (RS = H) good facial selectivity for the dioxygenase-
mediated dihydroxylation is observed, with e.e. ≈ 100%, since all RL substituents 
were significantly larger than a hydrogen atom. The notable exception, where a 
significant decrease in the e.e. value was observed, was for fluorobenzene. 
For 1,4-disubstituted arenes, the size of the substituents is again the major factor 
in the prediction of which product will be formed.26 In instances where the two 
substituents are of similar size, the e.e. values are eroded. 
 
 
Figure 2 Boyd’s model for predicting the regio- and stereochemical outcome of microbial 
oxidation of monocyclic aromatics. 
 
 
1.6 Diversity of metabolites 
 
Since the first investigation of the arene dioxygenase by Gibson in the late 
1960s27,3 the reaction has been intensively studied.28,3,29,30,30,31,32,33-36  
Certain strains of the common bacterium Pseudomonas putida are able to 
synthesize cis-3,5-cyclohexadiene-1,2-diol (DHCD) 31 from benzene by 
oxidation with toluene dioxygenase (TDO) and recently this enzyme was 





Scheme 7 Microbial oxidation of benzene with P. putida. 
 
The ortho-meta dihydroxylation is by far the most common regiochemical 
outcome in most arene-metabolising bacteria and relays very well onto Boyd’s 
model to deliver cis-configured dihydrodiols.  
 
In 1971, Reiner and Hegeman isolated a mutant strain of Ralstonia eutrophus 
(strain B9, formerly known as Alcaligenes eutrophus) that oxidized benzoic acid 
32 to (1S,2R)-1,2-dihydroxycyclohexa-3,5-diene-1-carboxylic acid (DHCDC) 33.38 
In contrast this is a rare example of ipso-ortho oxidation, also with a reversed 
sense of absolute enantioinduction. 
 
 
Scheme 8 Microbial oxidation of benzoic acid with R.eutrophus B9. 
 
In order to avoid complete degradation of the DHCDC product 33, this mutant 
microorganism lacks a working version of the enzyme dihydroxydiol 
dehydrogenase. Myers et al. have demonstrated that modification of the original 
procedure reported by Reiner et al. can deliver DHCDC 33 on a multihundred 
gram scale (and as a single enantiomer).39 
 
Mono- and disubstituted benzoic acids have been found to be acceptable 
substrates for benzoate 1,2-dioxygenase. It was found that meta- substituted 
benzoic acids have comparatively high turnover rates, whereas the ortho- and 





In 1987, Ribbons and Williams showed that mutant Pseudomonas putida JT103, 
could also oxidize benzoic acid and its derivatives to the corresponding vicinal 
cis-diols such as DHCDC.42 Furthermore, P. putida KTSY01 showed the ability to 
oxidize benzoate to DHCDC.43 In 1995, Widdowson and coworkers reported the 
synthesis of 33 with P. putida U103.44 Also they assigned for the first time the 
stereochemistry and absolute configuration of cis-diol acid 33 (1S,2R), by X-Ray 





Scheme 9 Formation of p-bromobenzoylmethyl 
ester of 34. 
Reagents and Conditions: (a) 33, Et3N (2.15 
mmol), acetone, p-bromobenzoyl methyl bromide 
in acetone (1.2 equiv.), 3 h, rt., 68%. 
 
Figure 3 Crystal structure of 34 
 
The benzoate 1,2-dioxygenase systems (BZDO) from Pseudomonas putida mt-2 
and Acinetobacter sp. Strain ADP1 have also been purified and 
characterised.45,46 
 
As a representative example of the diversity of metabolites, in 2012, D. R. Boyd 
and coworkers investigated microbial oxidations (P. putida UV4) of 
benzo[b]thiophenes to give product 36.47 Sylvestre et al. demonstrated that the 
scope of the biooxidation by biphenyl dioxygenases of mutant strains can be 
expanded to various substrates for example to dibenzofuran.48 However, P. 
Putida UV4 was not so effective during oxidation of 4-chloroquinoline compared 
with Sphingomonas yanoikuyae B8/36.49,50 Dihydroxylation of phthalate 41 was 
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1.7 Application in synthesis 
 
Microbial 2,3-dihydroxylation products (DHCD) have been used systematically in 
the synthesis of metalloorganic intermediates, inositols and many natural 
products.39,52,53,54 
 
Diol acid 33 has seen isolated previous reports of use in organic synthesis. In 
2005, Myers and coworkers reported syntheses of important natural and 
unnatural tetracycline antibiotics.55,56 A few years later Parker et al. have 
provided an efficient synthesis of carba-β-L-fructopyranose in seven steps from 
33.57 In contrast Mihovilovic et al. have published the results of a study on 
intramolecular Diels–Alder derivatives of 33.58,59 In 2011, Hudlický reported the 
synthesis of idesolide in just five steps from benzoic acid.60 Recently Lewis and 
coworkers have demonstrated the use of microbial diol acid 33 in syntheses of 
natural product zeylenols and zeylenones as well as (+)-grandifloracin61,62, the 






































































Figure 4 Novel products delivered from microbial oxidation cis-diol 33. 
 
In recent years, the more common microbially derived cis-2,3-diols were 
exhaustively explored in order to access natural and unnatural cyclitols, 
conduramines, inositols, carbohydrates, and the anti-HIV agent 
indinavir.26,65,66,67,50,68,69,70,71 
 
Specifically highlighted examples include oseltamivir along with codeine 62, 
balanol (59) and 7-deoxypancratistatin (57) and epibatidine (56), hexacyclinol 
(58),72 connatusin A (61),73 narseronine (63)74 which were obtained from 






Figure 5 Syntheses of 7-deoxypancratistatin, balanol, codeine, oseltamivir, epibatidine, 
hexacyclinol, connatusin A, and narseronine. 
 
There have been many other applications to use dioxygenases in organic 
chemistry.78 The most unusual is the oxidation of indole 64 to the blue jean dye 
indigo 67 by Pseudomonas indoloxidans.79,80,81 
 
 
Scheme 11 Oxidation of indole by Naphthalene Dioxygenase, the remaining reactions occur 
spontaneously in air. 
 
This process was later optimized to an industrial-scale fermentation. 
 
Novel methods into production of polymers under environmentally friendly 
conditions have been intensively studied.82,83 In 1988, Ballard et al., have 
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developed polymerization process using derivatives of cis-dihydrocatechols 
(DHDC) obtained from microbial fermentation of benzene.84 The yield was only 
60% but Xu et al., have prepared conducting polymer polyparaphenylene (PPP) 
by Ballard et al.’s method from purified monomer 31.85 Scheme 12 
 
 
Scheme 12 Synthesis of PPP from cis-dihydrocatechol 31.  
Reagents and conditions: (a) DHDC, acetic anhydride, −10 °C, 2 h then warm up, 92% after 
distillation; (b) DHDC-DA (51.0 mmol), AIBN (0.03 mmol), THF, 70 °C, 72 h; (c) P(DHDC-
DA), 270 °C to 300 °C with 10 °C interval for 1 h u nder N2. 
 
1.8 Isolation of cis-dihydrodiols 
 
Most cis-dihydrodiols are highly water-soluble and, in many cases, inherently 
unstable. Therefore, the isolation process of microbial oxidation products (cis-
DHDC) can be problematic. Usually the cis-dihydrodiols are extracted several 
times with ethyl acetate, and after concentration they can be stored at −78 °C 
without traces of  phenols or acids, which can catalytically lead to rearomatization 
products.  
One approach to long term storage is that of Herbert et al., who have applied the 
method of formation of unsoluble phenylboronate complexes, which can be 
hydrolysed and reused again after recrystalization.83,64,86 
 
 




Some methods of purification of dihydroxylation products required use of 
charcoal or zeolite and after binding DHCD successively passing through the 
column an aqueous solution to remove water soluble components (DNA, 
proteins) followed by e.g. methanol.87   
It must be kept in mind that 33 itself is unstable upon prolonged exposure to air 
and moisture at room temperature, which leads to rearomatization products 
phenol 73 and salicylic acid 74. 
 
 





In this chapter I have described the production of microbial diols from aromatic 
precursors by different types of dioxygenases, including mechanistic 
investigations of bio-oxidation process. I have added information about theirs 
applications towards syntheses of several natural products and polymers. More 
work must be done in order to recover microbial oxidation products and strain 




CHAPTER 2. CYCLOHEXADIENYL 




CHAPTER 2. CYCLOHEXADIENYL 
COMPLEXES IN ORGANIC SYNTHESIS 
 
The chemistry of organoiron complexation dates back to 1930, when Reihlen and 
co-workers88 described for the first time the isolation of an acyclic (η4-buta-1,3-
diene)tricarbonyliron(0) complex, when iron pentacarbonyl reacts with butadiene 
in an autoclave. Several years later after the discovery of ferrocene89,90,91, the 
synthesis of butadiene-iron tricarbonyl was reinvestigated.92 
In 1958, Hallam and Pauson prepared92 (η4-cyclohexa-1,3-diene)tricarbonyl 77, 
by direct reaction of Fe(CO)5 with cyclohexa-1,3-diene as shown in Scheme 15. 
 
 
Scheme 15 Hallam and Pauson synthesis of (η4-cyclohexa-1,3-diene)tricarbonyl complex. 
Reagents and Conditions. (a) FeCO5, autoclave, 135 °C, 24 h. 
 
The scope of this complexation was improved by Arnet and Pettit93, when they 
discovered that non-conjugated 1,4-dienes (e.g. 76) react with pentacarbonyliron 
resulting in formation of conjugated tricarbonyl complexes. Since then a variety of 
substituted 1,4-cyclohexadiene ligands were delivered by Birch reduction of the 
corresponding aromatic precursors.94,95  
Usually coordination of iron tricarbonyl moiety is achieved under thermal or 
photochemical conditions with iron pentacarbonyl, diiron nonacarbonyl or 
triirondodecacarbonyl in moderate yield (30%-50%). Iron tricarbonyl complexes 
are usually stable towards air and moisture and can be stored for several months 
without any significant decomposition. 
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Knӧlker et al. achieved complexation of 1,3-cyclohexadiene under mild 
conditions by using a catalytic amount of tricarbonyliron transfer reagent 78 in 
98% yield96 as shown in Scheme 16. 
 
 
Scheme 16 Complexation of 1,3-cyclohexadiene with tricarbonyl transfer reagent 78. 
Reagents and Conditions. (a) 78 (0.125 eq), Fe2(CO)9 (1.5 equiv. based on iron), DME, 85 
°C, 16.5 h, 98%.  
 
It must be mentioned that chiral enantiopure (η4-1-aza-1,3-butadiene)tricarbonyl 
complexes can act as asymmetric catalysts and deliver enantiopure tricarbonyl 
iron complexes. Knӧlker et al. described the first asymmetric complexation of 
prochiral ligands with chiral camphor derivatives of 1-azabutadienes.97 
 
 
2.1 Preparation of η5-cyclohexadienyl cationic complexes 
 
In 1960, Fischer and Fischer reported for the first time formation of a cationic iron 
tricabonyl complex by hydride abstraction from a neutral complex using trityl 
tetrafluoroborate.98 Various methods are available to access η5-
cyclohexedienyliron tricarbonyl intermediates from the corresponding 
cyclohexadieneiron tricarbonyl complexes. The most common procedure used is 
direct hydride abstraction from neutral (η4-cyclohexadiene) with trityl 
hexafluorophosphate or trityl tetrafluoroborate99,100,98,101,102,95 in dichloromethane.  
As regards regioselectivity, for 2-substituted cyclohexadiene complexes, if R is 
an EDG e.g. -OMe, the major product is delivered in 94% yield (isomer 84) 





Scheme 17 Formation of cationic intermediates by trityl cation. 
 
However, the outcome of these hydride abstraction reactions also depends on 
the steric effects of the starting material.103 When a substituent is present at the 
C-5 carbon and anti to the metal, the abstraction generally does not occur. An 
example is shown below, wherein the complex 86, when subjected to this 
methodology, failed to produce cation 87.104 
 
 
Scheme 18 Attempted formation of cationic intermediate.  
Reagents and conditions: (a) trityl tetrafluoroborate, DCM, 30 min. 
 
It is possible that the methyl group “exo- to” the iron tricarbonyl moiety is 
effectively blocking the approach of the bulky trityl cation as required for hydride 
abstraction at C-6. A rare exception is the report from Yeh and Wang of hydride 
abstraction of the most hindered endo C-5 hydrogen in complex 88 by 
triphenylcarbenium hexafluorophosphate in acetonitrile to give a air stable cation 





Scheme 19 Formation of cationic intermediate 89 by abstraction of hindered endo hydrogen. 
Reagents and conditions: (a) 88, triphenylcarbenium hexafluorophosphate (1.5 equiv.) 
acetonitrile, 25 °C, N 2, 8 h, 84%. 
 
 Asymmetric hydride abstraction from meso 1,4-dialkoxycyclohexadienyl iron 
carbonyl complexes by a chiral trityl cation 93 was reported by Pettus and co-
workers in moderate enantioselectivities (43-53% e.e.). 106,107 
 
 
Scheme 20 Desymmetrisation of a meso iron carbonyl complex. 
 
To avoid the problem of steric inhibition of hydride abstraction, several alternative 
methods were developed, such as oxidation of neutral 1-OMe, 2-OMe iron 
tricarbonyl complexes with thallium(III) tris(trifluoroacetate) at rt or activated 
DDQ-HBF4 at −78 °C. 108 Stephenson et al. have applied thallium (III) oxidation to 
synthesis of (±)-carvone 96 and (±)-sylvecarvone 97.109 
 
 





Figure 6 Structures of (±)-carvone and (±)-sylvecarvone. 
 
Another method of preparation of η5-cyclohexadienyl salts is by treatment of the 
corresponding 1- or 2-substituted hydroxy or methoxy irontricarbonyl complexes 
with acid.110  
 
 
Scheme 22 Formation of cationic intermediate 79 under acidic conditions. 
 
Stephenson and co-workers have examined111 formation of complexes under 
acidic conditions.28,112 It must be mentioned that these microbial diene diols were 
for the first time used for Fe(CO)3 complexation. An arene 1,2-cis dihydrodiol (99, 
100 or 101) in acetic anhydride reacted with hexafluorophosphoric acid to give 
cation 102 or 103, depending on the electronic nature of the substituent R. For 
instance, methoxy- and chloro- substituents predominantly lead to 102 and 104 
complexes in a ratio 2:1, and 7:2 respectively, as shown in Scheme 23. On the 
other hand, a trifluoromethyl substituent gave 106 as the sole product. 
 
 
Scheme 23 Formation of monosubstituted cationic intermediates.  




The mechanisms of the formation of cationic species were investigated widely for 
acyclic and cyclic products.113 On treatment of a mixture of 107 and 108 with 
deuterated trifluoroacetic acid (TFA-d1), a mixture of 109-d2 and 111-d2 was 
produced, which was separated by column chromatography on alumina. Both 
products were subsequently subjected to hydride abstraction by reaction with 
trityl tetrafluoborate. 
Interestingly, in both cases, hydride was lost and two different products were 
produced (Scheme 24). 
 
 
Scheme 24 Labelling studies of the formation of cationic species. 
 
In view of the above results the hydride abstraction by triphenylcarbenium cation 
is presumably affected by steric hindrance due to the phenyl group, and therefore 








The (η5)-cationic cyclohexadienyl complexes are very reactive electrophiles and 
they react regio- and stereospecifically upon treatment with nucleophiles. The 
outcome of the reaction is determined by the arrangement of any substituents 
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and by iron tricarbonyl tripod, in which the nucleophilic addition typically proceeds 
by approach to the diene face anti to the metal due to both steric and electronic 
effects.  
 
Birch et al. defined this strategy as “superimposed lateral control of reactivity, 
stereochemistry and structure”.114,115 
This can be demonstrated by the reaction of η5-methoxy iron cation 84 with a 
nucleophile to deliver neutral iron complex 82, which can behave differently 
under subsequent demetallation and dehydrogenation giving p-substituted 




Scheme 25 An example of superimposed lateral control of reactivity. 
 
A wide variety of reagents have been used in nucleophilic additions to cationic 
(η4-cyclohexadienyl)Fe(CO)3 complexes, and this reaction has proved to be of 
great value in synthesis. This is a very powerful tool to carry out C-C, C-X (X=N, 
O, S etc.) bond formation under very mild conditions.116  
The salts readily react with a wide variety of nucleophiles such as hydroxide and 
alkoxyanions117, amines, enamines102 and ketones as enols, thiocyanate, 
selenocyanate and cyanate ions, halide ions, nitrite ions, azide and 
dithiocarbamates.118 Alkylation with dialkylzinc, dialkylcadmium, lithium alkyls 





Scheme 26 Nucleophilic addition to η5-cyclohexadienyl cations. 
 
Table 1 Examples of nucleophilic addition into (η5)-cyclohexadienyliron complexes; “-“ yield 
not reported although product was obtained. 
Nucleophile R1,R2 Product Nu= Yield 
NaBH4 H,H H 23%123 
MeLi H,H Me 87%116 
Me2CuLi H,H Me 80%119 
(CH2=CHCH2)2Zn H,H CH2=CHCH2 82%123  
KCN H,H CN 59123,52%94 
NaOMe H,H OMe 53123,57%94 
HOSi(CH3)3 H,H OSi(CH3)3 42%117  
KOPh H,H OPh 64%117 
 
MeO,H Ph 60%124,125 
 
MeO,H p-MeO-Ph 61%125 
MeLi MeO,H Me 94%116 







NaBH4 MeO,H H 65%104,88%99, 
50%114 
NaCH(CO2Et)2 MeO,Me CH(CO2Et)2 89%128,129 
NaHCO3/H2O MeO,Me OH 90%99 
O(CH2CH2)2NH MeO,Me O(CH2CH2)2N 65%99 
NaHCO3/H2O H,H OH 75%94 
 
H,H C4H8N 82%94 
O(CH2CH2)2NH 
Morpholine 























(CH2=CHCH2)2Zn Me,H CH2=CHCH2 50%132 
(Me2CH)2Zn Me,H CH2=CHCH2 50%132 
KI H,H I 9%133 
NH2Boc H,H NHBoc 83%101 
AgNO2 H,H NO2 -118 
KCH(CO2Et)2 MeO,Et CH(CO2Et)2 96%123 
NH4SCN H,H SCN -118 
 
 
Limited applications in surface functionalisation have also been reported in the 
literature, where cationic cyclohexadiene complexes are attached to a 
polystyrene surface in order to introduce novel polymers as new chiral stationary 
phases.134,135 
There are a few examples in the literature of direct fluorination of a cationic 
cationic (η5-dienyl)iron tricarbonyl complex. Attempted introduction of fluoride ion, 
for the purposes of forming a C-F bond was investigated by Powell and 
Horvath.136 The reaction was carried out under rigorously anhydrous conditions 
with KF/18-crown-6 and 79 in acetonitrile. The fluoride ion was captured to give 






Scheme 27 An attempted introduction of fluoride nucleophile to cationic 79. 
Reagents and conditions: (a) KF/18-crown-6 or [(Me2N)3S]-[Me3SiF2], CD2Cl2. 
 
Also, formation of a C-C dimer has been observed upon reaction of 79 with oxy 
anions such as hydroxide117 and with iodide.133 
Both neutral and cationic complexes are valuable as intermediates in organic 
synthesis, although η5-cyclohexadienyls are more reactive and are capable of 
efficent reactions with a wide variety of nucleophiles, and of SEAr reactions with 
aromatic ring systems. 
Methoxsubsituted cyclohexadieneiron complexes can react with strong acids 
(TFA), followed by anion exchange with ammonium hexafluorophosphate to 
provide the corresponding salts, which can be isolated. The reactivity of the 2-
methoxycyclohexadienyl cation complex has been widely studied, and 
nucleophilic attack takes place at the C-5 position. In addition, increasing the 
steric congestion at C-5 on the dienyl dooes not change the preference for this 
carbon being attacked.103 
Interestingly, in 2010, Adejoro et al. developed the reaction of pyridines and 
pyridine derivatives with the organometallic complexes 79 and 84 giving novel 
pyridino(1,4-η-2-methoxycyclohexa-1,3-diene) derivatives of iron tricarbonyl 
complexes, as shown in Scheme 28.137  
The reactions were performed with freshly distilled reagents before use and the 
reaction mixture allowed to stand at room temperature for 10 min, in acetonitrile. 
After solvent evaporation and several washes with petroleum ether, twelve new 





Scheme 28 Preparation of novel iron complexes with pyridines and pyridine derivatives. 
 
Cationic iron intermediates were also applied in the derivatization of galactosides 
at the C3-position, which could be useful in the preparation of new carbohydrate 
derivatives of biological interest.138 
 
McCague and Potter have developed a novel methodology employing 2-methoxy 
substituted cyclohexadieneiron complexes with low-order organocopper 
complexes to produce an anticancer drug candidate, an analogue of tamoxifen 
which they refer to as tamandron.139 Scheme 29 
Moreover, the same authors have reported synthesis of N2-arylated nucleosides 
directly from the corresponding non-protected 2’-deoxyguanosine in just three 
steps by treatment with tricarbonyl(η5-cyclohexadienylium)iron or tricarbonyl[η5-2-
(n-butyl)cyclohexadienylium]iron cations.140 Scheme 30 
 
 





Scheme 30 Synthesis of N2-arylated nucleosides.  
Reagents and conditions: (a) 2,6-di-tert-butyl-4-methylpyridine, MeCN, 20 °C; (b), Me 3NO, 
MeCONMe2, 90 °C; (c),(MeCN) 2PdCl2, Et3N, MeCONMe2, 80 °C 
 
Interestingly, the caesium salt of phthalimide reacts with chiral complex 130, 
prepared from p-(1S,2R,5S)-menthoxytoluene, to give the product 131 after 
nucleophilic addition ipso to the methyl substituent at the C-5 position.141 This 
strategy may be applied to the synthesis of 4-methoxycyclohexadienones, 
important intermediates in the synthesis of the A-ring of steroid hormones, 
potential lead compounds for treatment of hormone-dependent cancers. 
 
 
Scheme 31 Nucleophilic addition of caesium phthalimide into cationic salts at 20 °C. 
 
Pearson et al. have shown the tricarbonyl(4-methoxy-1-
methylcyclohexadienylium)iron hexafluorophosphate 123 reacts at the 
methylated dienyl terminus with the potassium enolate of methyl 2-
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oxocyclopentanecarboxylate in a regio- and stereospecific fashion, leading to two 
diastereoisomers, which were further converted to 12,13-epoxy-14-
methoxytrichothecenes of potential biological interest.142,143,144 Since the 12,13-
epoxide is essential for pharmaceutical activity, any active synthetic analogues 
must contain this functionality. This methodology opens the way to a wide range 
of trichothecene derivatives, such as (±)-trichodiene, (±)-12,13-epoxytrichothec-
9-ene, and (±)-trichodermol.145,146 




Scheme 32 Synthesis of aphidicolin and trichtocene derivative. 
 
 
2.3 Reactivity of Irontricarbonyl Cyclohexadienone Complexes 
 
Cyclohexadienyl complexes show considerable promise as synthetic 
intermediates for organic synthesis. The cationic forms of methoxysubstituted 
complexes react with nucleophiles at the para-position. A cyclohexadienone 
coordinated to the iron tricarbonyl moiety is stable and tautomerization to phenol 
or Diels-Alder addition are not possible, in contrast to the uncomplexed form. 
These complexes react with a limited number of nucleophiles. This 
cyclohexenone γ-cation equivalent has been used in the synthesis of natural 






Scheme 33 Cyclohexadienyl complex as a γ-cyclohexanone as an intermediate to the 
alkaloids aspidospermine and limaspermine. 
 
The most common method of decomplaxation of the Fe(CO)3 fragment from the 
diene ligand is by oxidation. Hovewer, there are rare examples of oxidation of the 
diene ligand without decomplexation, e.g. to access cyclohexadienones. 
Reboul et al have reported150 preparation of novel 4-substituted-tricarbonyl(η4-
cyclohexa-2,4-dien-1-one)iron complexes 144-147 in moderate yields (12%-60%) 
(from 1-substituted-tricarbonyl(η4-4-methoxy-cyclohexa-1,3-diene)iron complex 
140-143 using thallium(III) trifluoroacetate or nitrate in methanol, or ethanol as 
depicted in Scheme 34.  
 
 
Scheme 34 Cyclohexadienyl complexes as a γ-cyclohexanone.  
Reagents and conditions: Tl(CF3CO2)3, EtOH, MeOH, 10 min, −10 °C. 
 
When acyclic tosylhydrazones of tricarbonyliron complexes fragment at high 






Scheme 35 Preparation of cyclohexadienone from acyclic tosylhydrazone. 
Reagents and conditions: NaH, mesitylene, CO, 20 °C  to 110 °C, 20 min. 
 
Interestingly, Narasaka et al have developed a method for the regioselective 
formation of meta-acyl phenols by reaction of alkyl cuprates and organoiron 




Scheme 36 Reaction of cyclohexadienone iron complexes 152 with higher order methyl 
cuprate. 
 
The removal of the iron scaffold was accomplished at room temperature with 
TMANO in N,N-dimethylacetamide for 1 h. 
One year later, the same authors have employed (in a similar manner) iron 
tricarbonyl oximes and higher order cuprates followed by treatment with acetic 
anhydride and carbon monoxide leading to m-acylaniline derivatives in good 
yields after demetallation by oxidation with cerium(IV) ammonium nitrate.153 Also, 




1-Substituted complexes are accessible by modification of an original procedure 
described by Birch, later developed by Stephenson et al.155 They have 
demonstrated a powerful method of changing phenyl regiocontrol preference to 
the far end of (π)–system (C-5) by the use of the methoxy group at C-4 directing 
to the C-1 position at the η4-cyclohexadiene. 
 
 
Figure 7 Demonstration of change of regioselectivity of methoxyl- and phenyl groups of η4-
cyclohexadiene complexes. 
 
This novel approach is mediated by two nucleophilic additions with the anti 
stereochemistry to the metal as demonstrated in Scheme 37. 
 
 
Scheme 37 Demonstration of regioselectivity of alkoxy- and phenyl groups of η4-
cyclohexadiene complexes. 
 
Anson et al. have demonstrated multiple use of iron tricarbonyl moiety as 
directing group to complete synthesis of highly enatiopure product (“auxiliary 





Scheme 38 Demonstration of regiodirecting effects of phenyl and methoxy groups of η4-
cyclohexadiene complexes. 
 
Hudson et al. have reported the combination of hydroalumination/BF3 activation 
as a practical method for elaboration of irontricarbonyl cyclohexadienone 
complexes.157 
Hydroalumination of propargyl esters provided an organoaluminium nucleophile 
which upon direct treatment with dienone 168, gave only starting material. Tsuda 
et al.158 employed Lewis acid to enhance the electrophilicity, and the reaction 
with an excess of boron trifluoride etherate was employed, giving the C-C bond 
formation successfully 171 in 61% yield. It was also possible to convert product 













The substituted cationic (η5-cyclohexadiene)iron complexe undergoes reactions 
with a wide range of anions, and the outcome of the reaction depends on the 
nature of the substituents. For instance with 1-CO2Me or 2-OMe monosubstituted 
(η5)-salts the nucleophilic attack occurs preferentially at the C-5 position (Scheme 
26, Entry 2, Scheme 28 and 31), except when very reactive anions are used.116 
Nevertheless, a weakly deactivating 2-Me group directs exclusively to C-5. 
(Scheme 26, Entry 4) 
The preparation of 2-OMe cation 84 proceeds directly from the corresponding 2-
OMe neutral complex, by hydride abstraction process. To access 1-OMe and 3-
OMe salts the reaction is not straightforward as previously mentioned, because 
(η5)-1-OMe is not stable in water during isolation and yields cyclohexadienone 
complex.159,160 
Desired 3-OMe cationic product 173 can be accessed by treatment of 172 with 
strong acids (Pathway A) by OMe loss or from the cyclohexadienone 174, 
NaBH4 reduction followed by hexafluorophosphoric acid as an alternative 
pathway B as shown in Scheme 40. 
 
 
Scheme 40 Preparation of the 3-OMe cationic product. 
Reagents and Conditions: (a) H2SO4, (80%); (b) trifluoroacetic acid at 0 °C (100%); ( c) 
NaBH4, dry 1,2-dimethoxyethane, 0 °C, 12 h, isolation th en propionic anhydride HPF6 aq., 15 
min, 39%. 
 






2.5 ARYL CYCLOHEXADIENE REACTIVITY 
 
The cyclohexadiene ligand structure has been the most studied and was first 
prepared by Fischer in 1960. As described above, the reactivity of the 
corresponding stabilized cyclic η5 cations with nucleophiles is wide in scope, 
including electron rich aromatic rings creating a new carbon-carbon bond.  
There has been extensive research done employing 1-CO2Me and 2-OMe 
groups in electrophilic cyclic iron complexes to direct substitution with a 
representative range of nucleophiles into to the distal end of the π-system (ω-
directing). However, only a few research groups explored the formation and 
reactivity of aryl substituted electrophiles.162,163,164,165,127, 
Monosubstituted 1-aryl cyclohexadienyl iron complex 163 was prepared from the 
1-OEt corresponding complex 161 by treatment with phenyllithium, to give 
unstable intermediate 162 which upon treatment with acid and precipitation with 
NH4PF6 furnished 163 in 96% yield. The 1-Ar and 2-Ar monosubstituted products 
have shown strong ω-directing effects with a series of nucleophiles 
(NaCH(CO2Me)2, NaBH4, Me2CuLi).163 However, the ipso position was 
accessible with more electrophilic Ar examples (4’-CF3) and with stabilized 
enolates as nucleophiles.  
 
 
Scheme 41 Preparation of 1-Phenyl cationic product 163 followed by nucleophilic addition. 
Reagents and Conditions: (a) PhLi, DCM, rt, 15-30 min, (67%); (b) trifluoroacetic acid; (c) 




Some groups in substituent cyclohexadienyl complexes direct to the same diene 




Stephenson et al.163 
 
 
Figure 8 Some examples of the “mutually reinforcing effect”. 
 
As can be seen from the previous examples, cationic cyclohexadienyl complexes 
are very reactive towards nucleophilic additions, and these reactions are usually 
chemoselective, (the CO ligand typically does not undergo nucleophilic addition), 
highly regioselective (for complexes substituted with an EWG, cyclohexadienyl 
addition occurs into the ω position), and stereoselective (typically anti-addition to 
the metal).  
Many monosubstituted cyclohexadienyl ligands are available, bearing at C1 
electron donating or electron withdrawing groups. Directing effect of the 2-OMe 
group forces nucleophiles to attack into the ω-position (C-5) at the terminus of the 
diene system. The situation is more complicated for an ethoxy group which 





Figure 9 Directing effect of C1-substituted cyclohexadienyl cations. 
 
2.6 The reactivity of 1-ethoxycyclohexadienyl salt  
 
In 1997, Stephenson and co-workers reported167 for the first time the preparation 
of alkyne-substituted tricarbonyl complex 190 and its reactivity. The methodology 
they used employed 1-ethoxycyclohexadienyl complex 161 and the aryl lithium 
reagent which attacks the ipso position as demonstrated in Scheme 42.  
A series of nucleophiles were tested for addition to alkynyl cyclohexadienol 
cation 190 and surprisingly the reaction is highly regioselective to give ω-addition 
products in good yields. The same regioselectivity (ω) is observed with electron 
withdrawing groups like CO2Me and CN, but in the PhC≡C case the outcome 
depends on steric effects rather than electronic ones. The conclusion can be 





Scheme 42 Preparation of 1-alkynyl substituted tricarbonyl(cyclohexadienyl)iron complex 190 
followed by nucleophilic addition reactions. 
Reagents and Conditions: (a) PhC≡CLi, (67%); (b) HPF6, acetic anhydride, 70%; (c) 
NaCH(CO2Me)2, THF, 0 °C, 79%; NaBH 4, CH3CN, 0 °C, 81%; Me 2CuLi, THF, 0 °C, 48%; 
nBuLi, THF, 0 °C, 62%; KCN(aq.) CH 3CN/H2O -two products. 
 
Ferrocenes have been extensively investigated as organometallic donors in 
donor-π-acceptor second order NLO chromophores. Hendrix et al.168 for the first 
time investigated cationic η5-cyclohexadiene iron complex 196 with dipolar 




complex reacted with lithiated acetylene 195 to 
give 196 in 79% yield. The product was subsequently treated with 
hexafluorophosphoric acid to afford cationic salt (η5)-ferrocenylethyne-substituted 
cyclohexadienyl complex 198 in 71% yield. The same reaction sequence was 
repeated for 1,4-dimethoxy-substituted elecrophile 123, but yields were lower.168 
Scheme 43 
 
Scheme 43 Preparation of the bimetallic monocation iron complexes with a single alkyne 
spacer.  




Significant result has been reported in the field of cross-coupling: (η4-
chlorodiene)FeCO3 cyclohexadiene complex 200 underwent smooth coupling 
with terminal alkynes with 5 mol% of PdCl2(PPh3)/CuI at 60 °C in high yields. 
Complexation with the Fe(CO)3 moiety clearly activates the vinylic C-Cl bond 
toward Pd(0) insertion allowing Sonogashira coupling (and also Heck coupling) to 
proceed smoothly under mild conditions.169 Vinyl chlorides are generally 
unreactive in such cross-coupling processes. 
 
 
Scheme 44 The Sonogashira coupling of complex 200.  
Reagents and Conditions: (a) PdCl2(PPh3)2 5 mol%, CuI (5 mol%), Et3N, 60 °C, 3 h.   
 
 
2.7 APPLICATIONS IN NATURAL PRODUCT SYNTHESIS 
 
2.7.1 Natural products from the arylcyclohexadienyliron precursors 
 
The use of organoiron electrophiles with mutually reinforcing groups is well 
understood.163,170,171 Aryl substituents on tricarbonyl(cyclohexadienyl)iron 
complexes usually direct nucleophiles to the ω-position. However when the effect 
of an alkoxy substituent reinforces that of an arene substituent, there is a 
stronger directing effect favouring ipso addition of nucleophiles ω- to the arene 
and proximal to the alkoxy group.172 The combination of a C(1)-OMe with the ω-
directing group ensures nucleophile addition at C1 of η5-cationic complex 123.165 
Subsequent treatment with an acid173, such as TFA or HPF6, induces the 




Scheme 45 Preparation of (1-arylcyclohexadienyl)iron complexes. 
 
Stephenson et al. described a unified strategy to access both 1- and 2-
arylcyclohexadienyl iron complexes.165 When two sequential nucleophilic attacks 
take place at the same carbon atom (ipso to the aryl group) the strategy is 
referred to as a “1,1-strategy”, giving a product with one quaternary centre.165,174 
When the addition take place at adjacent positions, two stereogenic quaternary 
centres are formed (“1,2-strategy”).165,171 This methodology offers access to a 
“C12-building block strategy” for the synthesis of alkaloids such as 
mesembrine175, O-methyljoubertiamine171, hippeastrine127, martidine174,176 and 
lycorine125, as well as various flavonoids177. Interestingly, highly substituted 
organic natural products i.e. lycoramine174,178,179 could also be accessed by a 
related “C13-central building block strategy”165. 
 
 
Figure 10 Example of a retrosynthetic analysis for O-methyljoubertiamine using the 1,1 




The Sceletium alkaloid (±)-mesembrine is a serotonin uptake inhibitor, and was 
prepared from 221 in just four steps by aforementioned “C12-building block 
strategy”.175 To establish a quaternary centre through C-C bond formation 3,4-
dimethoxyphenyllithium was employed as a nucleophile to react with prochiral 
tricarbonyl-(η4-1,4-dimethoxycyclohexadiene)iron(0) to give 220 in 66% yield. 
Subsequently, acid mediated transformation gave η5 salt 221 in over 80% yield. 
After generation of an enolate from 2-trimethylsilylethyl cyanoethanoate, and 
reaction with 221, the reaction was quenched with TBAF, and heated at reflux for 
3 h giving 222 in 77% yield in the one pot reaction. 
 
 
Scheme 46 Preparation of (±)-mesembrine. 
Reagents and Conditions: (a) (3,4-OMe)2C6H3Li, DCM, ether, −78 °C, 2.5 h, 66%; (b) 1. HPF6 
aq., Ac2O, 2. NH4PF6 aq., 0 °C, rt., 30 min, 83%; (c) Na(Me 3SiCH2CH2O2CCHCN), THF, 0 °C, 
1 h, then TBAF, THF, reflux, 3 h, 77%; (d) DIBAL-H, DCM, −78 °C, 2 h then 0 °C, 1 h, then 
NH4Br in MeOH, then MeNH2 in MeOH, NaBH4 in MeOH, rt., 2 h, then aq HCl, then NaOH, 
79%; (e) Me3NO, acetone, rt, 16 h, then (CO2H)2.2H2O, MeOH, rt., 3 h, then NaOH aq. 20 
min, 52%. 
 
Reduction with DIBAL-H, and addition of ammonium bromide and methyl amine 
in methanol followed by sodium borohydride delivered secondary amine 223 by 
reductive amination in 79% yield.  
Demetallation was accomplished with TMANO in acetone followed by quenching 
with oxalic acid, and simple work up furnished target product 224 (±)-
mesembrine in 52% yield.175 Using the same methodology, the same authors 
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have also reported a new class of tricyclic η4-dieneiron complexes possessing a 
fused cyclopentane ring system.180 
 
Biologically active natural products of the Amaryllidaceae group show potent 
antitumor and antiviral activity. In 2008, Studer et al. reported181 the first total 
synthesis of one natural product of this class, trans-dihydronarciclasine 228 
which has shown activity against selected human cancer cell lines. The synthesis 
was accomplished in 17 steps, starting from commercially available o-vanilin 225 
in 5.6% overall yield. A key step of the synthesis was a nitroso-Diels−Alder 
reaction.181 (Scheme 47) 
 
 
Scheme 47 Synthesis of (+)−trans-dihydronarciclasine. 
Reagents and Conditions: (a) nBuLi, THF, −78 °C; (b) CAN, acetone, 0 °C. 
 
In 2010, Stephenson and co-workers extended this methodology, employing 
irontricarbonyl diene complexes, in a novel tandem decomplexation-nitroso 
Diels−Alder (NDA) reaction. The resultant cycloadducts are formed with correct 





In 1959 Schmutz et al. were the first to describe183 a naturally occurring 
carbazole olivacine, which was isolated from Aspidosperma olivaceum. Later, 
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from a small Indian tree -Murraya koenigii, commonly known as the curry-leaf 
tree, isolation of another novel carbazole alkaloid was reported and named 
murrayanine.184 
Carbazomycins belong to a group of rare microbial quinone antibiotics which 
contain a carbazole nucleus and represent a novel class of antifungal, 
antimicrobial and also potential anti-tuberculosis drug candidates.185,186  
 
An iron mediated carbazole synthesis may be achieved by C-C bond formation 
between the aryl amine 229 with iron tricarbonyl cation 79 (or its methoxy 
analogue 84) which proceeds via electrophilic substitution, and then C-N bond 
formation is accomplished by an oxidative cyclization with manganese dioxide, 
followed by demetallation with TMANO and methylation to provide Carbazomycin 
A, and Carbazomycin D.187,188    
 
 
Scheme 48 Synthesis of Carbazomycin A and D. 
 
Starting from the appropriate aryl amine, a similar sequence of events provided 



































































































































































































































Several further applications of the iron-mediated methodology were applied in the 
synthesis of carbazole alkaloids, Hyellazole and 6-chlorohyellazole,199 
murrayanine, koenoline, murrayafoline A200, anhydrolycorinone, hippadine201, 





Birch et al. employed203 cyclohexadiene-tricarbonyliron complex 276 to prepare 
(-)-gabaculine 279 a naturally occurring amino acid, which is a potent inhibitor of 
GABA-T catabolising enzyme. Gabaculine could potentially be useful for the 
treatment of Parkinsons, epilepsy and schizophrenia, because inhibition of 4-
aminobutyrate:2-oxo-glutarate animotransferase increases the level of gamma-
aminobutyric acid (GABA) in the brain. 
Birch reduction of methyl benzoate followed by complexation of 272 under 
thermal conditions with iron pentacarbonyl provided (±)−2-
carbomethoxycyclohexadiene-Fe(CO)3 complex 273. (Scheme 49) 
Isomerisation was carried out in methanolic sulphuric acid at reflux over 24h, 
leading to 274 in 90-95% yield. Complex 274 was resolved through the 1-
phenylethyl ammonium salt, and after several recrystallisations followed by acidic 
hydrolysis provided pure (−)-acid 274. This was subjected to methylation with 
diazomethane leading to corresponding ester 275 in quantitative yield. To a 
solution of trityl hexafluorophosphate in DCM was added 275 in hexane and after 
standing for 3 h, an orange precipitate was collected and purified by precipitation 





Scheme 49 Syntheses of (−)-gabaculine and (−)-methyl shikimate.  
Reagents and conditions: (a) KOH, dimethyl sulphate, 30 min at rt.→reflux for 5 h, then 
Fe(CO)5, heat; (b) sulfuric acid, MeOH, reflux, 24 h, then H2O, reflux, 30 h, 95%, then 
resolution with (−)-1-Phenylethylamine; (c) CH2N2, Et2O, rt., 30 min, quantitative; (d) 
Ph3CPF6, DCM, 73%; (e) H2NCO2-t-Bu (2.2 equiv), Hünig’s base, DCM, 0 °C, 5 min, 81 %; (f) 
Me3NO, CH3CONMe2, −15 °C, 3 h, then 0 °C, 16 h, 80%; (g) NaOH, MeOH, H2O, 66% (h) 3 
M HCl, MeOH, ion-exchange column; (i) NaHCO3/aqueous CH3CN, 95%; (j) CrO3, pyridine, 
DCM, 85%; (k) NaBH4, ZnCl2, Et2O, 98%; (l) TBDMS triflate, DMF, Hünig’s base; 83%; (m) 
Me3NO, benzene, 82%; (n) 1 equiv. OsO4/acetone, 67%; (o) (nBu)4NF/THF, 85%. 
 
Nucleophilic addition of tert-butyl carbamate in DCM, in the presence of 
diisopropylamine delivered 277 in 81% yield after column chromatography on 
silica. Demetallation with TMANO overnight and subsequent hydrolysis of the 
crude diene ester with 2 M NaOH in methanol provided pure acid 278 which was 
isolated after recrystallization from hexane-ether in 66% yield. This underwent 
Boc deprotection hydrolysis in MeOH with 3 M HCl, leading to (−)-gabaculine 279 
after purification on ion-exchange column.203 
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In addition, in 1988, the same authors reported a synthesis of the natural 
enantiomer of (−)-methyl shikimate 284204 starting from the same resolved iron 
cations 276 as depicted in Scheme 49.205 
 
 
2.8 SPIROCOMPOUNDS  
 
In 1975, Green and co-workers206 reported a new reaction with 
tetrafluoroethylene in which iron complex 77 under U.V. irradiation affords a π-
allyl product 285 where the new C-C bond is formed at the less substituted end 
of the diene. 
 
 
Scheme 50 Reaction of cyclohexadiene with C2F4 under photochemical conditions. 
 
This has led to the development of methods for intramolecular cyclocoupling 
reactions, suitable for the construction of quaternary centres through C-C bond 
formation.207  
The most useful substrates are allylic amide derivatives which under thermal 
conditions generate spirocyclic products. Additional substituents on the pendant 
olefin have the effect of decreasing the yield, which is attributed to steric 
hindrance. Under  photothermal conditions allylic ester and allylic thioester 





Scheme 51 Intramolecular coupling of olefin with diene-Fe(CO)3 moiety. 
Reagents and conditions: (a) n-Bu2O, reflux, CO, 12 h; (b) n-Bu2O, reflux, CO, 6.5 h, 85%.  
 
The overall cyclization reactions of allylic thioester derivatives of cyclohexadiene 
iron tricarbonyl systems is similar to [6pi+2pi] ene reaction, leading to the 
formation of spiro thialactone derivatives.208 This intramolecular iron tricarbonyl-
promoted all-carbon [6+2] ene type spirocyclisation likely proceeds via a 
mechanism similar to the carbonyl-ene type of spirocyclisation.  
Pearson expanded the scope of this spirocyclisation reaction with a pendant 
carbonyl group promoted by iron to afford products with a functionalisable 
hydroxyl group at C4.209  (Scheme 52) 
 
 
Scheme 52 Carbonyl-ene-type of spirocyclisation.  
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Reagents and conditions: (a) MsCl, DIEA, CH2Cl2, 0 °C, 1 h, followed by ethyl 2-
(phenylamino)acetate 296, 24 h, 40 °C, 77%; (b) DIBAL-H (1.5M in toluene), DCM, −78 °C, 1 
h, 75%; (c) toluene, 350 nm, 12 h, 100 °C.  
 
Introduction of a methoxy group at the C-3 position of the diene moiety controls 




Scheme 53 All-carbon cyclization via ketone intermediate. 
Reagents and conditions: (a) MsCl, Et3N, CH2Cl2, 0 °C, 85%; (b) Et 2O, 3-butenylmagnesium 
bromide (0.67 mL, 1.1 M in Et2O), 72%; (c) n-Bu2O, CO, 5 h, 142 °C, 90%, 1:1 mixture 
separated by preparative TLC purification (1:4/EtOAc:Hex); (d) Me3NO (36.0 eq.), benzene, 
rt., 16 h, Ar; (e) MeOH, oxalic acid in water (15.5 eq.), rt., 12 h, 75%.  
 
This chemistry can be applied to the total synthesis of 18-deoxycytochalasin H 
309, a natural product that is a potent HIV-1 protease inhibitor. A preliminary 






Figure 11 A Possible Approach to 18-Deoxycytochalasin H. 
 
Ong et al. have reported a very useful (2+1) cycloaddition reaction between 
tricarbonyl[(1-4-η)-2-methoxy-5-methylene-cyclohexa-1,3-diene]iron 313 with a 
carbene for the rapid preparation of a spiro[2,5]octane system.214 Interestingly, 
their first attempt with chlorocarbene did not undergo (2+1)cycloaddition, but 
dichlorocarbene gave a mixture of two diastereomers as a 9:1 mixture of 314 and 
315, estimated from the accurate integrated 1H NMR spectra. Reaction with 
dibromocarbene provided a single diastereoisomer: the endo cyclopropanation 
did not occur, due to steric hindrance. As depicted in Scheme 54. 
 
 
Scheme 54 Possible approach of carbene to 313 from the exo and endo face. 
Reagents and conditions: (a) CHCl3, t-BuOK, pentane, 0 °C. 
 
Knӧlker et al. described a method of diastereoselective spiroannelation of 
arylamines with cationic cyclohexadiene salts which is dependent on the reaction 
temperature. Formation of 317 is favoured over 316 at low temperatures.202 
Dimethyl aminomalonate reacts with 318 overnight at room temperature to 
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deliver the tricarbonyliron-coordinated 2-azaspiro[4.5]decane 319 exclusively.215 
Demetallation of 319 with anhydrous TMANO in acetone at 23 °C was 
accomplished in 83% yield, and Diels-Alder reaction was attempted between iron 
free product and 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD). Scheme 55 
 
 
Scheme 55 Iron-mediated spiroannelation of arylamines and dimethyl aminomalonate 
followed by Diels-Alder reaction of the spirycyclohexa-1,3-diene 320. 
Reagents and conditions: (a) ArNH2, MeCN, 82 °C, 2 h (53–93%); (b) 2 equiv. of dimeth yl 
aminomalonate, MeCN, 25 °C, 14 h (98%); (c) Me3NO, acetone, 25 °C, 3h, (83%); (d) PTAD, 
CH2Cl2, −30 °C to −10 °C, 1h, (68%); 
 
 
2.9 Double Cyclization 
2.9.1 Bicyclic Molecules by Rearrangement-Cyclization 
 
The methodology described in Section 2.8 was extended to amides, in an 
attempted preparation of six-membered lactams. The synthesis began with 
amide complex 323, which was prepared from acid 322 and N-benzylallyl amine. 
As previously mentioned, the cyclization reaction proceeds via coordination of 
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Scheme 56 Iron-mediated [6+2]-ene-type cyclization. 
Reagents and conditions: (a) (COCl)2, pyridine, MS, CH2Cl2; (b) pyridine, N-benzylallylamine 
(90%); (c) n-Bu2O, reflux, CO. 
 
The same authors also reported a one pot cyclization to produce bicyclic 
architectures starting from 1,4-dihydrobenzoic acid, followed by amidation and 
complexation in the presence of Fe(CO)5, under a CO atmosphere in refluxing di-
n-butyl ether (0.02 mol/L). Compound 325 has a bicyclic framework and 
stereochemistry identical with a natural product gelsemine 327, and this 
methodology is a promising approach to its derivatives.216 (Figure 12) 
 
 
Figure 12 Retrosynthetic analysis of gelsemine. 
 
If an appended 1,3-diene is used, a complex tricyclic molecule 333 can be 
obtained by tandem double cyclization.216 (Scheme 57). 
Removal of the iron tricarbonyl scaffold leads to formation of tricyclic organic 
structures 336. When 331 was treated with 2.2 equiv of TMANO added in four 
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portions at room temperature over 12 h, the cyclooctadiene 334 was formed as a 
single stereoisomer in quantitative yield.217 This ring system is found in natural 
product structures such as ophiobolins C and F. 
 
 
Scheme 57 Iron-mediated double cyclization of pendant dienes. 
Reagents and conditions: (a) n-Bu2O, 142 °C, CO; (b) Me 3NO; (c) 2.2 equiv Me3NO in four 





Many records showed that human influenza and the avian flu (H5N1) have 
caused numerous deaths in many countries.218,219 Oseltamivir phosphate is a 
potent neuraminidase inhibitor and the most widely used anti-influenza drug: only 
this drug was approved as an orally bioavailable drug for both treatment 
prophylaxis of flu.220 Considering the worldwide demand for Tamiflu, improved 
production methods are needed.  
Nowadays, the procedure developed by F. Hoffman-La Roche, has been use 
commercially, utilising naturally occurring shikimic acid as a starting point, which 
is a limited resource subject to fluctuations in supply.221,222 
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In contrast to the current process route Corey’s route using a catalytic 
asymmetric Diels-Alder reaction is very attractive because no expensive starting 
material and no hard-to-deal-with azide reagent were needed.223 
In 2008, the shortest synthesis of (−)-oseltamivir 60 (8 steps from commercially 
available materials, overall yield 30%) was reported by Trost and co-workers.224 
(Scheme 58) 
Commercially available racemic lactone 337 was opened using [(η3-C3H5PdCl)2],  
and the Trost ligand (R,R)-346 as the catalyst, and with TMS-phthalimide as a 
nucleophile to give TMS-caboxylate further converted in situ to 338 in 84% yield 
and 98% e.e in one pot. Treatment of 338 with fresh KHMDS in THF at −78 °C 
for 6 h, followed by PhSSO2Ph  afforded an approximate 1:1 diasteromeric 
mixture of α-thioester 339 in 94% yield. 
Oxidation of 339 with 70% m-CPBA in toluene formed the corresponding 
sulfoxide intermediate, which provided an elimination product 340 as 10:1 
regioisomeric mixture after purification by silica gel column in 85% yield. The 
mixture was carried on into the next step of selective aziridination reaction with 
PhI(OPiv)2 and SESNH2, followed by the catalyst [Rh2(esp)2] and base MgO, the 






Scheme 58 Synthesis of (−)-oseltamivir by Torst et al.  
Reagents and conditions: (a) 2.5 mol% [(η3-C3H5PdCl)2], 7.5 mol% (R,R)-344, 
trimethylsilylphthalimide (1.5 equiv.), THF, 40 °C,  then TsOH·H2O, EtOH, reflux, 84%, 98% 
e.e.; (b) KHMDS (1.5 equiv.), PhSSO2Ph (1.8 equiv.), THF, −78 °C to rt., 94%; (c) m-CPBA 
(1.0 equiv.), NaHCO3 (2.0 equiv.), 0 °C, then DBU (1.0 equiv.), 60 °C, toluene, 85%; (d) 2 
mol% 343, SESNH2 (1.1 equiv.), PHI-(O2CCMe3)2 (1.3 equiv.), MgO (2.3 equiv.), PhCl, 0 °C 
to rt., 86%; (e) BF3·Et2O (1.5 equiv.), 3-pentanol, 75 °C, 65%; (f) DMAP (2 .0 equiv.), pyridine 
(20.0 equiv.), Ac2O, MW, 150 °C, 1 h, 84%; (g) TBAF (2.0 equiv.), THF , rt., 95%; (h) NH2NH2 
(5.0 equiv.), EtOH, 68 °C, quant. 
 
Then aziridine 341 was opened with BF3·Et2O in 3-pentanol at 75 °C to afford 
342 in 65% yield. Subsequent treatment of 342 with DMAP in Ac2O and pyridine  
was subjected to microwave heating at 150 °C for 1 hr and after purification by 
column chromatography yielded 343 (84%). Removal of the SES protecting 
group was accomplished in 95% yield, after treatment of 343 with 1 M solution of 
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TBAF. Then after reaction of 344 with hot ethanolic hydrazine for 10 h  delivered 
the final product (−)-oseltamivir 60 in quantitative yield.  
 
The synthesis of oseltamivir phosphate based on cationic iron carbonyl chemistry 
was reported by Kann et al. in 2007.225 (Scheme 59) 
The starting point of the synthesis was cyclohexadienoic acid ethyl ester 347 
which was converted to (±)-iron tricarbonyl complex 348, after treatment with 
diiron nonacarbonyl in toluene at 55 °C overnight, in 86% yield after column 
chromatography. A resolution was performed on corresponding cationic mixture 
of enantiomers 349 provided by hydride abstraction with trityl cation - after 
nucleophilic addition of (−)-(1R,2S)-trans-2-phenylcyclohexanol a mixture of 
separable diastereomers 350 and 351 were formed in 75% yield. Subsequent 
treatment with hexafluorophosphoric acid of both chiral ethers provided 
enantiopure salts (−)-352 and (+)-352 in high yield, which where then employed 
in a second nucleophilic addition with Boc-amine in the presence of Hünig’s 
base, an approach which has some similarity with the procedure of the synthesis 
of (±)- and (−)-gabaculine reported by Birch et al.203 The reaction was carried out 
with very slow addition of base, which improved the yield up to 86% for both 
products. Demetallation was achieved with hydrogen peroxide in aqueous 
sodium hydroxide to afford two enantiomers in 95% yield. Selective epoxidation 
of (−)-354 with m-CPBA resulted in the formation of (+)-355 also in 95% yield 
based on the crude, followed by ring opening with sodium azide to the 
corresponding azido alcohol 356 in 95% yield and then mesylation and 
purification to give (±)-357 in 68% yield. Addition of triphenylphosphine followed 
by Et3N into a solution of (±)-357 in THF/H2O at room temperature gave aziridine, 
which was then acetylated in situ leading to (±)-358 in an overall yield of 65% 
after purification by column chromatography. The final stage of the synthesis of 
Tamiflu 60 was aziridine ring opening by treatment with Cu(OTf)2 catalyst as 
depicted in Scheme 59. This novel synthesis which utilized cationic iron 
intermediates was accomplished in a total 12 steps from cyclohexadienoic acid 
Introduction 
 59 
ethyl ester (347). Final product 60 (Tamiflu) was formed after Boc group 
deprotection and salt formation with phosphoric acid in ethanol.  
 
 
Scheme 59 Synthesis of (−)-oseltamivir by Kann et al.  
Reagents and conditions: (a) Fe2(CO)9, toluene, 55 °C, 86%; (b) Ph 3CPF6, DCM, rt., 94%; (c) 
Hünig’s base, (−)-(1R,2S)-trans-2-phenylcyclohexanol, DCM, 0 °C, 5 min, 75% , HPLC 
separation; (d) HPF6, Et2O, 0 °C, 94%; (e) Boc-NH 2, Hünig’s base, DCM, 0 °C, 86%; (f) H 2O2, 
NaOH, EtOH, 0 °C, 95%; (g) m-CPBA, DCM, −70 °C to rt., 95%; (h) NaN3, DME/EtOH, H2O, 
NH4Cl, 0 °C, 95%; (i) MsCl, Et 3N, DCM, 0 °C, 68%; (j) PPh 3, Et3N, THF/H2O, rt.; (k) Ac2O, 
pyridine, DCM, 0 °C, 65% after two steps; (l) Cu(OT f)2, 3-pentanol, 0 °C, 48%; (m) H 3PO4, 





Decomplexation of tricarbonyl iron complexes is usually achieved by oxidation, 
resulting in liberation of ligand without structural changes. The most common 
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reagent introduced in 1974 by Shvo and Hazum is trimethylamine-N-oxide 
(TMANO).226 To a lesser extent copper(II) chloride227, FeCl3228, cerium 
ammonium nitrate (CAN)229, Pb(OAc)4230,231, H2O2/NaOH232, MnO2231,104 and 
pyridinium chlorochromate233 have also been used for this purpose. 
Demetallation of acyclic tricarbonyliron dienes was also accomplished by 
treatment with freshly prepared Raney nickel.234 
The optimal method of demetallation depends on the structure and the reactivity 





Iron tricarbonyl complexes imparted novel reactivity and selectivity to their attached 
organic ligands such as microbial diols thus providing unique opportunities to construct 
various organic molecules and natural products. 










CHAPTER 3: Iron complexation 
 
As described in Chapter 1, microbial oxidation of benzoic acid by Ralstonia 
eutrophus B9, is very effective to provide the corresponding (1S,2R)-diol 33 in 
high e.e.(>95%): this can undergo several novel synthetic transformations.39 
However, 33 had not been used in organometallic chemistry prior to the current 
work. We decided to explore the viability of forming iron carbonyl complexes of 
33 and its derivatives.  
In order to do so, we used commercially available homoleptic binuclear Fe2(CO)9, 
which is more reactive and less toxic than Fe(CO)5 (as it is a solid as opposed to 
a liquid). It was the first ever binuclear transition metal carbonyl synthesized.235 It 
is made by photolysis of Fe(CO)5 in acetic acid initiated by direct sunlight or a 
medium pressure mercury lamp.236 
 
Scheme 60 
Another preparation by Braye and Hubel was reported under the name diiron 
enneacarbonyl.237 The reactivity of this compound is very important in 
organometallic chemistry.  




Cotton et al. reported that when complexation reactions were carried out in THF 
with diironnonacarbonyl, very reactive intermediates are formed.240 
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In the first instance, we employed the microbial diol acid 33 in attempted 
reactions with various carbonyliron species coordinated with various solvents, but 
these attempts were unsuccessful and the product mixtures became very 
complicated leading to intractable mixtures. We needed to keep in mind that 33 
itself is unstable upon prolonged exposure to air and moisture at room 
temperature which leads to rearomatization products phenol and salicylic acid. 
(Chapter 1, Scheme 14) In addition, the highly polar nature of the functional 
groups present (carboxylic acid, diol) rendered purification by silica 
chromatography impractical. 
 
An alternative procedure was therefore sought. Thus esterification of the 
microbial diol acid to the corresponding methyl ester was investigated as a 
starting point of our endeavour. The reaction with (trimethylsilyl)diazomethane in 
benzene/MeOH under nitrogen can offer a swift method of methyl ester 
synthesis.241,242 As hoped, the reaction mixture was converted to 360 in 
quantitative yield, after flash column chromatography. 
From a safety point of view, use of TMS-diazomethane is preferable to 
diazomethane due to a reduced risk of explosion, but it is nevertheless just as 
toxic by inhalation. 
  
A further drawback to use of (trimethylsilyl)diazomethane is cost. Thus, other 
procedures were attempted. Initial attempts to perform an esterification reaction 
with methyl iodide in DMF at room temperature resulted in formation of methyl 
ester 360 in poor 8% yield after purification on a silica gel column. Although the 
optimisation of this reaction was pursued, the yield did not increase significantly. 
In order to circumvent this problem, and increase the yield, we decided to search 
the literature for other applicable esterification methods. Sato et al. reported a 
practical CsF-promoted esterification of carboxylic acids at room temperature, 
although the use of long reaction times is required.243 The (1S,2R)-diol 33 
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reacted smoothly under mild conditions at room temperature, and the desired 
product 360 was furnished in a good yield of 72% after purification.  
 
 
Scheme 62 Preparation of methyl ester 360. 
Reagents and conditions: (a) TMSCHN2, rt., Benzene-MeOH (1:1), rt, N2, 1 h, 100%; (b) MeI, 
DMF,NEt3, N2, rt., 23 h, 8%; (c) CsF (1.5 equiv), rt., DMF, MeI, N2, 24 h, 72%. 
 
The mechanism of this reaction remains unclear, but is possible that CsF acts as 
a base, and the hydrogen bonding is essential in the transformation of free acids 
into esters.  
 
To the best of our knowledge, there are no prior reports of the use of an 
enantiomerically pure nonannelated cyclohexadiene ligand 33 possessing a 
quaternary centre for complexation with Fe2(CO)9. A relevant precedent dates 
from the late seventies, when Barton et al. reported diastereoselective 
complexation of ergosteryl acetate, giving the complex 362 in 69%. The iron 
tricarbonyl moiety was effectively protecting the diene in ring B of this steroid 
during hydrogenation of the C22-C23 double bond elsewhere in the structure 
(Scheme 63). Multiple ergosteryl iron complexes (acetate and benzoate) were 
obtained, but stereochemical assignment was not undertaken.244,245 
In a similar vein, the same group has demonstrated applications of this 
methodology in the formation of calciferol analogues. In this case stereochemical 
assignment of the iron complexes was by inference from the similar existing 





Scheme 63 Complexation of ergosteryl acetate 
Reagents and conditions: (a) [Fe(CO)3(bza)], ˟bza=benzylideneacetone, toluene, 90 °C 24 h, 
69%. 
 
Results reported by Stephenson et al. constitute a very important precedent, 
where several cyclohexadienyl diols were obtained by direct biooxidation of 
toluene and further elaborated to iron tricarbonyl complex 366, possessing di-
endo stereochemistry,247 illustrating the effect of a hydroxyl group on facial 
selectivity. At the same time Stephenson has also reported a preparation of 
homochiral derivatives of toluene via microbial oxidation248 and complexation to 
the iron tricarbonyl scaffold endo to the methyl ether (Scheme 64).247,249  
 
 
Scheme 64 Microbial oxidation of toluene and complexation of 365. 
Reagents and conditions: (a) MeI, KOH, 80%; (b) Fe2(CO)9, Et2O, 34 °C, 16 h,  53%. 
 
Later Pearson et al. reported bio-oxidation of analogues of toluene to give 
(trifluoromethyl)cyclohexadienedienol products, and their manipulation towards  
novel enantiopure iron complexes; again, complete endo selectivity was 
observed.112 
 
When employing acetophenone substrate, an anomalous monooxidation was 
observed to give unstable 368 manipulated in situ with diiron nonacarbonyl to 
give single diastereoisomer 369 after purification. In order to verify the 
stereochemistry of this product, additional steps were carried out to obtain well 
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known complex 371, by reaction with HPF6 in acetic anhydride, giving cationic 
stable complex 370 in 86% yield after crystallization. Addition of an aqueous 
solution of sodium hydrogen carbonate, provided alcohol 371 as a 
diastereoisomer of 369 in 52% yield.250 
 
 
Scheme 65 Preparation of alcohol 371 
Reagents and conditions: (a) Fe2(CO)9, THF, yield not reported; (b) HPF6, Ac2O, 86%; (c) 
NaHCO3, H2O, 52%. 
 
Most recently, in 2011, Stephenson et al. reported the synthesis of an 
enantiopure aryl-substituted organoiron complex 374 via microbial oxidation (P. 
putida UV4 mutant) of biphenyl, which was directly used for complexation in THF 
over 5 days. The yield was not reported. (Scheme 66) The absolute 
stereochemistry of (1R,2S,3S)-stereoisomer was assigned by X-ray analysis 
where the irontricarbonyl moiety was on the same side as the cis diol.251 
 
 
Scheme 66 Formation of organoiron complex 374 
Reagents and conditions: (a) Fe2(CO)9, 5 days, THF, yield not reported.  
 
 
Suemune and co-workers reported252 for the first time formation of chiral iron 
complex (R,R)-376 without diastereoface selectivity because of the C2 symmetry 





Scheme 67 Formation of chiral iron complex (R,R)-376 
Reagents and conditions: (a) Fe2(CO)9, THF, reflux, 2 h, 64%, 95% e.e.  
 
The reaction conditions were optimized and only the reaction over 2 h in THF 
with diiron nonacarbonyl (3.00 equiv) gave satisfactory results in the formation of 
(5,6-bis(benzyloxy)cyclohexa-1,3-diene)iron tricarbonyl complex in 64% yield. 
Surprisingly, prolonged reaction time decreased the e.e. of the complex 376, 
probably due to the presence of acidic Lewis species from the Fe2(CO)9 source. 
 
The same author, also reported further advances of this chemistry in the 
synthesis of novel optically active ligands 7,8-bis(benzyloxy)bicyclo[2.2.2]octa-




Reagents and conditions: (a) dimethyl acetylenedicarboxylate, benzene, reflux, 4 h, 93% for 
R=Ac, DCM, rt., 4 d, 90% for R=Bn; (b) Fe2(CO)9, THF, rt., Ar atmosphere, 4 h, 34%. 
 
The corresponding tricarbonyliron complexes have also been synthesized in 
enantiomerically pure form. Reaction of (R,R)-377 in basic conditions afforded 




In addition to the previously disscused results for chiral cyclohexadiene ligands in 
organoiron chemistry, more examples are known in the literature for non 
cyclohexadiene ring systems reported by Schmaltz et al.254,255 
There are numerous examples existing in the literature of chiral iron tricarbonyl 
complexes obtained by direct nucleophilic addition to the cationic intermediates. 
 
3.1 FACIAL STEREOSELECTIVITY 
 
Berchtold and Ashworth reported the synthesis of iron complex 382 as a single 
isomer in 45% yield. The reaction was carried out in benzene at 55 °C with 
methoxyacetate 381 and (3-penten-2-one)iron tricarbonyl (vide infra).256 
 
 
Scheme 69 Synthesis of single isomer 382. 
Reagents and conditions: (a) (3-penten-2-one)iron tricarbonyl, benzene, 55 °C, 45%. 
 
The importance of this result is that it is the only prior literature example showing 
the directing selectivity in a “competition ligand” (i.e. one in which both faces of 
the ring have Lewis basic groups). Other workers have reported that a methyl 
ester257,95 could coordinate iron tetracarbonyl species to deliver endo-product 
after complexation on the same part of the molecule as the ester. In Berchtold’s 
case, the acetoxy group is a stronger directing group. 
 
In our case, the thermally instable 33 scaffold possessing a quaternary centre, 
after esterification, was submitted to the complexation reaction of 360 with diiron 
nonacarbonyl in THF under nitrogen atmosphere at room temperature. After 
prolonged reaction it was transformed into the corresponding single isomer 383 
in 55% yield after two steps. The iron carbonyl moiety approaches the same face 
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as the 1,2-diol to give product 383, the structure of which was confirmed by X-ray 
crystallography (Appendix 1). Similar attempts conducted in Et2O provided 
desired product 383, albeit in disappointing yield of 26%. This can be explained 
in terms of dissociation of diiron nonacarbonyl and the formation of THF−adducts 
with ironpentacarbonyl. We have searched for the best solvent but only THF 
seemed to give a satisfactory result. 
 
 
Scheme 70 Complexation of 360 
Reagents and conditions: (a) Fe2(CO)9, THF, rt., 16 days, N2, 55% over two steps. 
 
We postulate that the mechanism involves the formation of an iron tetracarbonyl 
species 384 coordinated to the lone pair of oxygen either at the carbon C1 or C2, 
respectively, on the opposite side of the ring from the methyl ester. Unstable 
intermediates undergo decarbonylation to deliver final product 383. This result 





Figure 13 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 383. 
 
The crystal structure of 383 is shown in Figure 13. The crystallographic data are 
summarized in Appendix 1. The metal-ligand bonding arrangement conforms 
closely to that observed in other (1,3-cyclohexadiene)tricarbonyliron 
derivatives.258 The iron atom is closer to the inner carbon atoms (C5-
Fe=2.0628(18) Å, C6-Fe=2.0459(18) Å) than the outer ones (C7-Fe=2.0813(17) 
Å, C4-Fe=2.1037(17) Å), and the inner C5-C6 bond (1.406(3) Å) is shorter than 
the outer C8-C9 (1.564(2) Å), C7-C8 (1.526(2) Å) bonds.  
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The three CO groups are not equivalent, with one CO group lying over the “open” 
side of the cis-C4-C5-C6-C7 chain, while the other two lie over the outer C-C 
bonds. The mean Fe-C(carbonyl) distance of 1.79(8) Å is comparable to the 
many reported values (1.75-1.80 Å).259 To within experimental error the four-
atom diene set C4-C5-C6-C7 is accurately planar. In contrast, the C7-C8-C9-C4 
set is slightly but significantly aplanar with a torsion angle of −2.94(19)º.  The 
dihedral angle between the sets C8-C9 [44.9º] is larger than has been reported to 
date [36.3-40.6º], and [41.7-43.4º], respectively. The methoxycarbonyl set C11, 
O6, C10, O5 is planar and lies through the set. The hydroxyl substituent bonded 
to participates in a C8 hydrogen bond contact with the second hydroxyl-group 
O4-H4a-O7. 
 
With the intention of increasing the yield of the reaction with TMS-diazomethane, 
the crude methyl esters were used directly for complexation, and surprisingly the 
formation of a second silylated co-product iron scaffold 388 was isolated in 22% 
yield. This was determined by the X-ray crystallographic structure of 388 
(Appendix 1).  
 
 
Scheme 71 Formation of silylated co-product 388 
Reagents and conditions: (a) Fe2(CO)9, THF, rt., 14 days, N2, 22%. 
 
Precoordination of iron species plays an important role to deliver either endo or 
exo iron tricarbonyl complexes. In this case only the C1-hydroxy group was 




Even after precomplexation of the tetracarbonyliron fragment the single available 
tertiary hydroxyl group still showed a stronger directing endo effect and overrode 
the effect of the ester. 
 
 
Figure 14 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 388. 
 
 
3.2 ELECTRONIC EFFECTS 
 
Intrigued by these results of iron tricarbonyl complexes 383 and 388, we decided 
to examine the scope of this chemistry further. 
Herein, we report the synthesis of enantiopure scaffold, either bearing an 






Reagents and conditions: (a) Ac2O, pyridine, −10 °C, 18 h, N 2, 91% 389; (b) TFAA, DCM, 
pyridine, −10 °C, 23 h, N 2, 81%, 390. 
 
Treatment of complex 383 with acetic anhydride at −10 °C in pyridine as a 
reaction medium, afforded compound 389 after 18 hours of stirring in high yield 
91%. A similar reaction was carried out, but with trifluoroacetic anhydride (TFAA) 
in DCM as a solvent, resulting in formation of 390 in 81% yield, which underwent 
spontaneous decomposition on silica gel column. Examination of the scope of 
these iron complexes towards nucleophilic addition reactions, through iterative 
η4-η5+-η4 complex formation is described in Chapter 5.  
 
Further attempts to manipulate complex 383 towards direct introduction of new 
groups at C2 under Mitsunobu conditions, were unsuccessful. These reactions 
should invert the stereochemistry at the C2 carbon atom.  
 
The Mitsunobu reaction was performed with DEAD (diethylazodicarboxylate) as a 
coupling agent, and triphenylphosphine in THF, followed by addition of iron 
complex 383 and phthalimide in THF. In an analogous fashion, replacing 
pthalimide with benzyl alcohol did not change the outcome of these attempts, 
and starting material was recovered in both attempts, instead of the desired 
product depicted in Scheme 73.  
 
 
Scheme 73 Attempted Mitsunobu reaction 
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Reagents and conditions: (a) DEAD, phthalimide, 0 °C, 24 h, N2, THF; (b) DEAD, benzyl 
alcohol, PPh3, 0 °C, 24 h, N 2, THF. 
 
Those results persuaded us to find a new route to afford the desired product by 
formation of cationic iron frameworks described in detail in Chapter 5.  
 
3.3 OXIDATIONS  
3.3.1 Synthesis of iron tircarbonyl cyclohexadienone 398 
 
We next turned to an approach that the conversion of iron tricarbonyl methyl 
ester diol 383 to the corresponding ketone 396, which would lead to a novel 
cyclohexadienone ligand not accessible by other means. Myers et al.39 reported 
transformation of secondary alcohol of microbially derived methyl ester 393 by 
oxidation with Dess-Martin periodinane260 in quantitive yield, after flash column 
chromatography. In the original paper, the authors were not able to oxidise the 
free diol 360 directly without decomposition, thus several protecting group 
stretegies were employed, where the –BOM ether (via multisep route) could 
deliver protected cyclohexadienone 394. However, spontaneous Diels−Alder 
dimerization occurs at room temperature (t1/2 = 4h), as shown in Scheme 74. 
 
 
Scheme 74 Diels−Alder dimerization of 394 
Reagents and conditions: (a) DMP, pyr, DCM, rt, quantitive; (b) 23 °C, ( t1/2 ) 4 h, initial 
concentration 0.6 M, CDCl3. 
 
Therefore it was desirable to find an alternative route to the synthesis of 
cyclohexadienone 396 which resembles that of 383, but its dimerisation would be 
unable to take place due to it bearing an iron tricarbonyl moiety. Also, additional 
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protection of 1,2-diol was not required, and after demetallation a novel 
cyclohexadienone ligand would be readily accessible. Scheme 75. 
 
Nevertheless, our first choice of oxidant (Dess–Martin periodinane)260 was not 
successful, and only starting material was recovered. Various reaction times, 
temperatures and quench procedures were carried out, for selective oxidation of 
383, but only a few were successful. Importantly, the oxidant must be 
chemoselective, because in most cases oxidation will liberate the ligand without 
structural changes (demetallation). In our case the oxidation should provided iron 
cyclohexanone 396 without cleavage of metal. 
 
 
Scheme 75 Selective oxidation of iron complex 383 
Reagents and conditions: (a) Ph3CBF4, DCM, 26% (b) CrO3, DCM, 2.5 h, rt, 9%; (c) PCC, 
DCM, 5 h, rt, 12%; (d) MnO2, DCM, 24 h, r.t., 4 Å MS, 58%. 
 
Triphenylcarbenium tetrafluoroborate is an oxidising agent which acts by hydride 
abstraction.112 Attempted selective oxidation of the diol 383 was capricious, and 
furnished desired product 396 in yield 26%, after purification on silica gel column 
chromatography. Also, the trityl cation can act as dehydroxylating agent by 
coordinating to an alcohol, but for steric reasons (iron tricarbonyl moiety blocks 
approach of the bulky trityl cation) we did not noticed this process here.  
The relatively low yield is tentatively attributed to demetallation, leading to the 
microbial methyl ester 360, even with additional amounts of Cs2CO3. It was 
hoped that addition to the reaction mixture of DABCO (a base) would give the 
corresponding ketone 396, but those attempts were also fruitless, and the 
starting material was recovered.  
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Therefore, other potential oxidations were examined, such as: TEMPO261, and 
Swern262. No desired product was detected under any of these conditions. 
Attempts with Parikh-Doering oxidation263 were low yielding (7%). Chromium(VI) 
compounds are highly toxic, and we decided not to pursue further with 
optimisations of those reactions.  
 
Intriguingly, activated MnO2 was demonstrated to be very effective264 in the 
oxidation of diol 383, leading to the corresponding iron ketone 396 in a 
repeatable yield of 58%, the structure of which was confirmed by X-ray 
crystallography (Fig. 15, Appendix 1). During the oxidation small quantities of 
water are produced and this could deactivate the surface of the MnO2, therefore 
addition of active 4 Å MS was necessary.265 
A long reaction time was required, and this was found to be beneficial. We have 
observed full conversion by monitoring the reaction by 1H NMR, but the 
comparatively low isolated yield could be attributed to loss of product 396 on 
Celite® during purification and probably also on the surface of the excess of 
MnO2 particles. The yield could perhaps be further improved by a reaction 
conducted with ionic liquids266 and under sonication over prolonged time; this is 
currently under investigations in our lab.  
Herein we report for the first time the oxidation of a cyclohexadienyl iron complex 
without decomplexation by manganese dioxide. In the literature only a few 
examples are known where MnO2 was used for demetallation of the iron 
tricarbonyl fragment,197 oxidation of acyclic dienes,267 and of cyclobutadiene 
complexes.264 In applications of organic chemistry it is used for the oxidations of 
allylic, benzylic and propargylic alcohols into the corresponding ketones or 
aldehydes (Ball-Goodwin-Morton reaction).268 The iron complex 383 substrate 




Figure 15 ORTEP diagram (50% probability factor for thermal ellipsoid) for 396. 
3.4 Reactivity of scaffold iron tricarbonyl-ketone 396 
 
3.4.1 Reduction and PMB-derivatives 
 
With 396 in hand, we turned our attention to obtaining cis-diol 383 by means of a 
direct reduction step. Initials attempts with L-Selectride,269 followed by TLC 
monitoring, showed incomplete consumption of starting material and hence 
proved futile. Several new spots appeared but we were unable to unambiguously 
identify the products formed. Attempts to convert 396 to 383 using sodium 
borohydride also met with failure resulting in complete loss of material. 
Additionally, decomposition occurred when 396 was treated with acetic acid, 
followed by addition of PMB-amine and treated with sodium 
triacetoxyborohydride overnight at room temperature and then heating to reflux; 





Scheme 76 Attempted reduction of iron ketone 396 
Reagents and conditions: (a) L-Selectride (1M in THF), −78 °C, THF, 9  h, N2; (b) 
NaBH4, MeOH, N2, rt, 5 h; (c) AcOH (1.0 equiv), THF, PMB-amine (2.00 equiv), (AcO)3BHNa 
(2.00 equiv), N2, rt→80 °C, 24 h. 
 
The aim of this experiment was to form an imine that subsequently could be 
reduced to the amine and demetallation would provide an amino alcohol.  
 
It was interesting to note that the reaction between PMB-amine and iron ketone 
396 in diethyl ether, at room temperature, with a catalytic amount of pTSA 
delivered a new product 401.  The reaction was stirred overnight and indicated 
only starting material in the reaction mixture by 1H NMR. Thus, it was left to stir 
for an additional 9 days with activated 4 Å MS, following it by TLC. Subsequent 
purification on a silica gel column surprisingly led to isolation of novel iron 
































Scheme 77 Formation of PMB-derivative product 401. 





It is believed, that an ɑ-lactone 399 is produced by methoxy group elimination 
after hydroxy group (C1-OH) attacking protonated carbonyl group of methyl ester 
398 to form an intermediate with three-membered ring of a cyclic ester 399, 
which upon treatment with PMB-amine 400 undergoes ring opening to deliver 
final product 401.270,271,272 
 
3.4.2 Preparation of Meerwein’s salts 
 
Encouraged by the preliminary results obtained using pTSA we wished to extend 
the scope of this methodology through to an alkylation with trimethyloxonium 
tetrafluoroborate,273,274 as this would allow the preparation of more stable cationic 























Scheme 78 Formation of methoxy substituted intermediate with Meerwein’s reagent.  
Reagents and conditions: (a) Me3OBF4, Ac2O, −10 °C, N 2, 1 h, (b) NaOMe, MeOH, 24 h, −10 
°C →rt, (83%) over two steps. 
 
It was possible that the conversion of the iron ketone 396, by direct treatment 
with trimethyloxonium tetrafluoroborate in Ac2O at −10 °C, could be achieved, 
leading to 402, which underwent nucleophilic attack upon treatment with sodium 
methoxide in MeOH, and subsequent hydrolysis to provide 404 in 83% yield over 
two steps.  
Iron complexation 
 80 
The putative intermediate 402 could not be isolated, but this pathway is feasible, 
and this reaction sequence might be useful in formation of acetylated 
cyclohexadienyl ligands at C1 carbon atom.  
 
Encouraged by the formation of possible cationic species of 402, we decided to 




Reagents and conditions: (a) Ac2O, −12 °C, HBF 4-OEt2, N2, 1 h; (b) aqueous work up, 96% 
(c) NaSPh, 0 °C, THF, 2 h, 64% ( aqueous work up). 
 
A solution of iron ketone 396 in acetic anhydride was treated with HBF4-OEt2 at 
−12 °C, followed by aqueous work up, and provided a cetylated product 404 in 
high yield (96%). The reaction was attempted in a similar fashion, leading to 
cationic intermediate 405, which upon treatment with sodium thiophenolate gave 
the same acetylated product 404 in 64% yield after column chromatography. 
Aqueous work up of the reaction mixture or some traces of water caused the 
hydrolysis of the cationic intermediate 405, scheme 79.  
 The unexpected product 404 is not accessible by straight forward acetylation of 
neutral complex 396, thus cationic intermediate step is essential to furnish it. 
 
To prove the use of this approach additional studies were conducted, and the 
attempted synthesis of 404 was carried out in a manner similar to that used 
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previously, but trimethyloxonium tetrafluoroborate or acid were not introduced at 
any stage. With this change of approach, the reaction did not lead to the required 
product, and starting material was recovered (vide infra). In this case, the only 
method of the acetylation of C1-OH is achieved through formation of η5-
cyclohexadienyl intermediates (402 or 405) followed by hydrolysis, (scheme 80). 
 
 
Scheme 80 Attempted acetylation of complex 396 at C1.  
Reagents and conditions: (a) Ac2O, −10 °C, N 2, 1h. 
 
Faced with this setback, we decided to perform the O-alkylation reactions on the 
more stable acetylated scaffold 404. However, the attempted introduction of a 
phenyl or methyl group was unsuccessful, giving recovered starting material in all 
cases, as depicted in scheme 81. 
It could therefore be concluded that the presence of the ketone group plays a 
significant role on the electronic effect of the whole molecule 404, but a detailed 
understanding of these observations is still lacking. 
 
 
Scheme 81 Attempted O-alkylation of methoxy-intermediate 402.  
Reagents and conditions: (a) Me3OBF4, CH3CN, −10 °C, 1 h; (b) PhLi, DCM, 2h, −78 °C; (c) 





3.4.3 Attempted demetallation reactions of iron tricarbonyl 
cyclohexadienone 396 and 404 
 
Various attempts to deprotect irontricarbonyl ketones 396 and 404 failed, such as 
use of CuCl2 in EtOH or TMANO in acetone; only for 404 conditions employing 
CAN (10.0 equiv.) in acetone afforded dimerisation product 411. This was 
observed by analysis of mass spectrometry confirming formation of the required 
product (m/z HRMS (+ve ESI-TOF) m/z calcd for (C16H17O8)+, 337.0923; found 
337.0897, for (C16H16O8Na)+, 359.0748; found 359.0722), but unfortunately it was 
unstable during purification by flash column on silica gel chromatography. In our 
lab, we were unable to cleanly deliver demetallated cyclohexanone 411. 
 
 
Scheme 82 Attempted demetallation of irontricarbonyl acetylated ketone complex 404.  
Reagents and conditions: (a) CAN (10.00 equiv), acetone, 0 °C →rt, 23 h. 
 
 
In contrast to the ketone complex, upon addition of the diol methyl ester complex 
383 to a solution of TMANO in benzene, then stirring for 24 h at room 
temperature, the desired product 360 was afforded in 54% yield after purification.  
 
 
Scheme 83 Demetallation with TMANO or CAN iron tricarbonyl scaffold 383. 
Reagents and conditions: (a) TMANO (6.00 equiv), benzene, rt, 24 h, 54%. (b) 




Also, treatment of 383 with CAN in acetone for 15 min gave 360 as a white 





To summarize our results, we have shown the utility of the complexation reaction 
towards enantiomerically pure microbially-derived cyclohexadiene ligands 
possessing a quaternary centre and their modification post-complexation to give 
derivatives.  
Additional investigations of silylated cyclohexadiene ligands to prevent the 
formation of the endo metallated  product proved unsuccessful. 
 
Regrettably, several attempts to access a dienone with various oxidising agents 
proved unsuccessful, however the successful oxidation with activated MnO2 led 
to stable irontricarbonyl ketone 396 in good yield. Nevertheless 396 proved to be 
unreactive in most subsequent transformations. 
Subsequent X-ray crystallographic studies confirmed the structures and 
stereochemical assignment of 383 and 396. 
The demetallation could be achieved on both complexes, although only the 
Diels–Alder dimer was detected after decomplexation of irontricarbonyl ketone.  
 









CHAPTER 4: REARRANGEMENT  
 
 
Having successfully synthesised the diol-containing complex 383 where the iron 
tricarbonyl moiety was endo, the focus of our efforts shifted to the synthesis of a 
complex where diol was exo, by protecting the diol as an acetonide. We 
assumed that the additional steric hindrance of the lower face would disfavour 
the formation of a precoordinated iron intermediate and iron would undergo top 
face coordination.  
As depicted in Scheme 84, protected acetonide 413 was prepared in just two 
steps, either by direct conversion into the corresponding methyl ester 360, further 
exposed to the catalytic amount of p-toluenesulfonic acid and 2,2-
dimethoxypropane in acetone, or by reversing the order of addition of the 
substrates, to furnish desired product 413 in high yield. 
 
 
Scheme 84 Synthesis of acetonide protected 413. 
Reagents and conditions: (a) PTSA (cat.), DMP, acetone, rt, 2 h; (b) TMSCHN2, rt, Benzene-
MeOH(1:1), rt, 1 h, 100%. 
 
Reaction with a slight excess of diironnonacarbonyl in THF at ambient 
temperature for 7 days resulted in the generation of a complex mixture of starting 
material and two products, which were purified by a silica gel column 
chromatography. It was fascinating to note that indeed the exo product 414 
(29%) was formed, along with the novel, unexpected rearrangement product 415, 
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in 26% yield, (Scheme 85). The structures were confirmed by X-ray 















Scheme 85 Formation of unexpected rearrangement product 415. 
Reagents and conditions: (a) Fe2(CO)9 (1.09 equiv.), THF, rt, 7 d. 
 
 
Figure 16 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 





Figure 17 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 415. 
 
When the reaction was repeated with 1.00 equivalents of diironnonacarbonyl it 
did not give rise to the rearrangement product, but endo iron complex 416 was 
isolated in a very low yield of 4% in addition to exo complex 414 (29%).  
The reaction was capricious, sometimes leading to conjugated product 415.  
 
 
Scheme 86 Iron complexation of acetonide protected 413 
Reagents and conditions: (a) Fe2(CO)9 (1.00 equiv.), THF, rt, 7 d. 
 
Reversing the order of events by effecting complexation of the acetonide 
protected free acid 412 (with subsequent esterification) did not improve the yield 
of the reaction. Interestingly, however, it resulted in the formation of all three 
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products including the rearrangement product 415 every time. Also other 
conditions were investigated, such as reversing the order of addition of starting 


















412 414 415 416
 
Scheme 87 Iron complexation of acetonide protected acid 412 followed by esterification 
Reagents and conditions: (a) Fe2(CO)9 (1.00 equiv.), THF, rt, 8 d; (b) TMSCHN2, rt, 
Benzene/MeOH (1:1), rt, 1 h.  
 
4.1 Mechanism  
 
We postulated that rearrangement of 414, was occurring by way of “clockwise” 
migration of the acetonide protecting group rather than “anticlockwise” migration 
of the carboxymethyl group. 
To probe the mechanism of formation of the novel rearrangement product, 
studies with labelled compounds were employed. Commencing from p-
chlorobenzoic acid, dehalogenation with deuterium gas proceeded smoothly to 
give 418 in a reasonable yield of 77%.275 
Following Myers’ procedure for the microbial oxidation39, but employing p-
deuterobenzoic acid 418 as substrate gave 419 in a yield of 19%.  
 
 
Scheme 88 Synthesis of labelled acetonide protected microbial diol acid 420 
Reagents and conditions: (a) 10% Pd/C, D2O, Et3N, rt, 48 h, 77%; (b) pTSA (cat.), DMP, 




With a supply of 419 in hand, we proceeded as shown in schemes 88 and 89. 
Conversion of 419 to acetonide 420 was accomplished with DMP and pTSA in 
75% yield, followed by direct esterification of the crude with TMS-diazomethane. 
Then the product was treated with diiron nonacarbonyl in THF for 8 days, giving 
a mixture of three different components (421-423) after further purification on a 
silica gel column.  
 
 
Scheme 89 Synthesis of labelled rearrangement product 423 
Reagents and conditions: (a) Fe2(CO)9 (2.17 equiv.), THF, rt, 9 d; (b) TMSCHN2, rt, 
Benzene/MeOH( 1:1), rt, 50 min.  
 
Variations in chemical shift are observed upon comparison of the rearranged 
(423) and non-rearranged complex (421). Shifts in the conjugated olefinic system 
C-H5 signal from 6.13 ppm to 5.71 ppm and C-H6 from 5.81 ppm to 6.36 ppm in 
the 1H NMR spectrum confirmed successful synthesis of the desired rearranged 
2H-labelled methyl ester 423. Moreover, an analysis of the splitting pattern for C-
H5 and C-H3 in the labelled product 423 showed separate doublets instead of a 
triplet, and doublet of doublets, respectively. Also, most tellingly, in the 
deuterated cyclohexadiene system C-H4 is absent, whereas in the non-
deuterated system it is observed as a doublet of doublets at 3.11 ppm (vide 
infra). From an above analysis the formation of a second product 424, after the 






Figure 18 1H NMR spectrum for deuterated product 423. 
 




These studies strongly suggested that the rearrangement was taking place by an 
“anticlockwise acetonide migration” mechanism and not a “clockwise ester 
migration” mechanism. 
 
The mechanism we propose invokes cationic η5 intermediates in order to furnish 
conjugated product 415. We believe that an unknown Lewis acid is present 
(perhaps a coordinatively unsaturated iron species) and is a key factor to form 
more stable 426 due to steric strain relief upon rehybridisation of C1 from sp3 to 
sp2 where the methyl ester group is coplanar with the dienyl system. The 
Pathway A was taking place rather than Pathway B, because the structure 415 
was found to be not racemic (vide infra), whose identity was established by X-ray 
crystallographic analysis. (Appendix 1). If Pathway B was operative, it would 
result in racemisation of the starting material 414 (and hence give a racemic 
product 414) because cation 428 is achiral. 
 
 
Scheme 90 Proposed mechanism for iron mediated isomerisation by Lewis acid. 
 
Hence, we sought an alternative method to obtain the conjugated product 415 in 
higher yield. Since the proposed mechanism is catalysed by a Lewis acid, we 
believed that addition of Brønsted acid would improve the yield significantly, thus 
an attempt at a one-pot complexation/rearrangement with addition of pTSA into 
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the reaction mixture. The reaction was conducted in THF and diironnonacarbonyl 
for 12 d, and then followed by addition of 40 mol% of pTSA for 7 days, as shown 
in scheme 91. This attempt, met with failure and rearrangement product 415 was 

















Scheme 91 Attempted synthesis of conjugated complex 415  
Reagents and conditions: (a) Fe2(CO)9 (1.50 equiv.), THF, rt, 12 d, then pTSA (40 mol%), 
additional 7 d. 
 
Finally, the last example, where the compound 432 was furnished, after iron 
complexation of 412, could conceivably be an autocatalytic process, proceeding 
by the formation of kinetic η3-allyliron product 431. A plausible alternative 
mechanism accompanying isomerisation, could take place through the 
protonation of the Fe(CO)3 tripod, and formation of kinetically stable product 431, 
which would allow for the unusual acetonide group migration by nucleophilic 
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Scheme 92 Proposed mechanism for a autocatalytic acetonide migration inducted by acid. 
 
To the best of our knowledge we are not aware of any such example where 
acetonide migration is mediated by an iron tricarbonyl tripod in the literature. 
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There are some known examples where a cobalt Cp complexes can induce such 
a rearrangement277 (Scheme 93). It was found, that standard oxidative 
demetallation of 433 gave desired product 435 (27%) but also rearrangement 



















Scheme 93 Demetallation of cobalt Cp complex 433.  
Reagents and conditions: (a) CuCl2·H2O, 5 equiv., Et3N (2.0 equiv.), 1,2-


















                    
Scheme 94 Cobalt mediated [2+2+2]cycloaddition of 436.  
Reagents and conditions: (a) BTMSA (5 equiv.), toluene, 23 °C, CpCo (C 2H4)2, providing 437 
(8%) and 438 (25%). 
 
Volhard et al278 have reported cobalt mediated [2+2+2]cycloaddition of 436 with 
solvent bis(trimethylsilyl)acetylene providing a series of rearrangement products, 
(Scheme 94). 
 
4.2 Determination of e.e. 
 
The determination of e.e. of the rearrangement product 415 was required in view 
of the potential for erosion of e.e. via “Pathway B” (vide supra). Many methods of 
determining of e.e. values are known such as GC or HPLC with a chiral column 
chromatography and NMR techniques. 
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Currently a widely used method is Mosher’s procedure279,280,281 for alcohols and 
amines that employes MPTA. The applicability of both 1H and 19F NMR to the 
products is an advantage as it increases the likelihood of finding a diagnostic 
resonance to integrate. 
With 415 in our hand as obtained previously, demetallatation was conducted 
using TMANO in benzene at room temperature to deliver uncomplexed 439 in 














Scheme 95 Demetallation and reduction of 424 complex.  
Reagents and conditions: (a) TMANO, benzene, rt, 5 h (73%); (b) LiAlH4, Et2O, 15 min at −84 
°C →rt 30 min, then Rochelle’s salt, 1 h, rt, (29%). 
 
Upon subjection of 439 to LiAlH4 reduction, primary alcohol 440 was isolated 
(29%), followed by direct treatment of the resultant alcohol 440 with (+)-MTPA, 





















Scheme 96 Preparation of Mosher’s esters.  
Reagents and conditions: (a) (2R)-3,3,3-trifluoro-2-methoxy-2-phenylpropionate (Aldrich 
#155268, 99% e.e.), (2.00 equiv.), DIC (2.00 equiv.), DMAP (0.15 equiv.), DCM, rt, 17 h, 
(72%); (b) (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropionate (Aldrich #155616, 95% e.e.), 
(2.00 equiv.), DIC (2.00 equiv.), DMAP (0.09 equiv.). DCM, rt, 17 h, (87%). 
 
From the NMR investigation of the both products the 19F-NMR of the derived 
MTPA esters 441 and 442 showed a single resonance at −7.51 ppm. However, 
the 1H-NMR spectrum was much more useful, as the diastereotopic methylene 
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phenylpropionate (Aldrich #155268, 99% e.e.) 
(2S)-3,3,3-trifluoro-2-methoxy-2-
phenylpropionate (Aldrich #155616, 95% e.e.) 
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From the above spectra, it can be discerned that the e.e. of 415 is >95% and 
therefore racemisation by “Pathway B” in Scheme 90 is minor. 
 
4.2.1 Deprotection of acetonide 
 
We wished to explore the feasibility of removing the acetonide and unmasking 
the free diol in 439. Initial experiments were carried out using catalytic AcOH or 
Dowex® 50WX8 but were unproductive, resulting in the formation of an aromatic 
product 444. However, partial success was obtained in an attempt by treatment 
of the solution containing 439 with I2 in CD3OD in a Young’s NMR tube, and 
heated up to 50 °C resulting in direct product form ation (Scheme 97).282,283 1H-
NMR spectra were acquired at five minute intervals revealing formation of the 
product 443. Unfortunately before all acetonide removal had occurred, 




Scheme 97 Formation of (2S,3R)-methyl 2,3-dihydroxycyclohexa-4,6-dienecarboxylate 443 
observed by 1H-NMR.  














t = 0 min 
t = 95 min 
t = 70 min 





4.2.2 The importance of discovery 
 
The microbial oxidation of methyl benzoate gives (2R,3S)-446 diol in accordance 
with Boyd’s model. In our studies, we have accessed the opposite enantiomer 




Scheme 98 Bio-oxidation of methyl benzoate 445 
 
The microbial oxidation of arene diols provides only one enantiomeric series, 
previously this restricted the use of bio-oxidation in synthesis, but the iron 
rearrangement method allows the other enantiomeric series to be used for more 
natural products to be synthesised.  
The acetonide protected cis-dihydrodiol metabolite 447 from methyl benzoate 
has been used as a synthetic precursor of carba-β-L-galactopyranose (450), 
carba-β-L-talopyranose (448) and carba-α-L-talopyranose (449).284 (Figure 23) 
 
 
Figure 23 Variable carbasugars from methyl benzoate cis-dihydrodiol metabolite. 
 
Also, further elaboration of the methyl ester will provide access to wide variety of 




     4.3 Variable temperature spectra 
 
The motivation to carry out variable temperature NMR studies was to determine 
whether there is a restricted tripod rotation at low temperature indicated by a split 
in the metal carbonyl signal in the 13C NMR spectrum. 
Variable temperature NMR spectra measurements were possible thanks to the 
use of the NMR probe, which allows experiments down to 120 K. 
13C-{1H} NMR measurements for rearrangement product 415 did not show the 
Fe(CO)3 carbonyl signal at approx. 210 ppm in the 13C spectrum that all the other 
complexes exhibited. The calculations below were performed by Dr John Lowe, 
University of Bath. 
 
The spectroscopic simulation shows that a very good agreement between 
experimental and simulated spectra of  415 was achieved (Figure 25). 
The explanation for this phenomenon is restricted rotation of the iron tricarbonyl 
tripod and the use of variable temperature NMR allowed us to calculate the 
barrier to rotation. 
Usually, η5-(cyclohexadienyl)CO3 iron complexes show a preference for 
“staggered”  geometry (Figure 24, complexes 415a&c). 
Better understanding of the factors influencing the tripod orientation and 






Figure 24 Possible conformations staggered and eclipsed of complex 415  
 
Simulations were carried out using the D−NMR program within Brüker 
TOPSPIN3.1, where the rate constant and, where appropriate, chemical shifts 
were iteratively altered until the simulated spectra gave the closest match to the 
real spectra. The rate constants given in Figure 25 were derived from the best fit 
of the simulated spectrum to the real spectrum at each temperature. 
The rate constants, k, obtained from the simulations (Figure 25) were used in 





Thermodynamic properties such as activation energy (Ea), entropy of activation 
(∆S‡), enthalpy of activation (∆H‡) and Gibbs energy of activation (∆G‡) were 
determined by Arrhenius and Eyring plots (Figure 26) and using eqn (1) and (2) 
 
ln k = Ea /RT + ln A      eqn (1) 
ln (k/T) = − (∆H‡)/RT + ln (kB/h) + ∆S‡/R   eqn (2) 
where R = gas constant, h = Planck’s constant, kB = Boltzmann constant 
 
The variable temperature spectra of complex 415 allowed derivation of the 
activation parameters for the exchange process of Ea = 46.8 ± 1.7 kJ mol−1, 
∆H‡(298) = 44.4 ± 1.6 kJ mol−1, ∆S‡ = −22.8 ± 5.2 J K−1 mol −1 and ∆G‡(298) = 51.2 ± 
3.1 kJ mol−1. 
 
Figure 25 Experimental (left) and simulated (right) variable temperature 13C-{1H}  spectra of 
complex 415, at 100.6 MHz in toluene-d8, showing the iron carbonyl region only. 
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The present study has primarily led to a novel rearrangement product in very 
high e.e. From labelling studies it appears that formation of this product is 
through acetonide migration rather than methyl ester group migration. We have 
proposed a plausible mechanism of formation of this product. Understanding this 
process is of high importance in cyclohexadiene iron complex chemistry, and will 







As an application of this methodology we are able to access arene 2,3-diol 
derivatives of non natural configuration not obtainable by bio-oxidation. 
 










CHAPTER 5: NUCLEOPHILIC ADDITION 
 
5.1 Optimisation of Cationic products formation 
 
Whilst examining synthetic routes to cationic η5 products from iron tricarbonyl 
complex 383, it was noted that the reaction of iron tricarbonyl complex 383 in 
acetic anhydride in the presence of tetrafluoroboric acid-diethyl etherate stood 
out as a potentially useful protocol from which a general methodology could be 
developed. This method for the preparation of cationic iron complexes, was 
previously established by Pearson et al. with HBF4 in acetic anhydride. The 
acetic anhydride plays three roles. Not only is it the solvent, but it also serves to 
acetylate the alcohol function groups in situ, as it has been shown that η5 
cyclohexadienyl complexes that have an unprotected alcohol rapidly decompose 
by aromatisation.256 Finally, the acetic anhydride acts as a desiccant, removing 
the water formed upon dehydroxylation of the complex as well as any water 
present in the added acid. 
 
 
Scheme 99 Preparation of cationic complexes 451 and 452  
Reagents and conditions: (a) HX (X = ΘBF4, ΘPF6, ΘOTf) (10.0 equiv.), Ac2O, −10 °C, 1h, N 2. 
 
A proposed mechanism for the reaction is outlined below (Scheme 99). The first 
stage involves protonation of hydroxyl groups by the acidic species, to form 
cationic intermediates 453 and 454. Subsequent elimination of water and 
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acetylation yielded the two acetylated intermediates. Water free work up resulted 
in the isolation of products 451 and 452, which in turn were found to be very 
reactive in the presence of nucleophiles.  
 
Originally we had attempted formation of the cationic η5 iron salts using a known 
procedure, triflic acid in DCM, but to no avail. Treatment of complex 383 with 
triflic acid in a more polar solvent such as MeCN, followed by treatment with 
aqueous 1M NaOH provided disappointing results, as mostly SM was recovered. 
Work up and purification failed to isolate the desired product.  
 
It seemed that the solvent was an important key factor for the preparation of the 
stable iron intermediate. We proposed that this problem might be surmounted by 
acetylation of the hydroxyl group by simply running the reaction in acetic 
anhydride at −10 °C followed by addition of acid HX (X = ΘBF4, ΘPF6, ΘOTf, 
CF3CO2Θ).  
 
At this point we saw the potential for the incorporation of nucleophiles within this 
route. We envisaged that if successful with a range of chosen nucleophiles, the 
scope of this reaction could be extended further in order to produce a range of 
functionalized cyclohexadiene derivatives. This iron-mediated diene 
rearrangement would represent a new route to dihydroarene 2-cis, 3-trans 
derivatives not possible to access via direct bio-oxidation. A vast array of 
nucleophiles can be envisioned such as C, O, N, P, S or H.287 





Scheme 100 Formation of thiophenolate adducts 
Reagents and conditions: (a) Acid (TFA, HOTf, HPF6, HBF4, HBF4.(OEt)2) (10.0 equiv.), 
Ac2O, −10 °C, 1 h; (b) NaSPh (4.28 equiv.), THF or MeCN, Ac2O, 0 °C, 1 h. 
 
In order to optimise conditions for the addition reaction, the representative 
nucleophile (NaSPh) was chosen, with which we have tried many different 
conditions.  
A wide range of conditions were studied in order to optimise the reaction of 
cationic salt formation, and these are summarised in Table 3 below. 
Consequently, several experiments were conducted using a variety of acids and 
solvents. This helped to determine whether the acid had a significant role to play 
in terms of yield during formation of cationic salts.    
The equivalents a sodium thiophenolate (~4.28 equiv.) and acid was held 
constant, while a range of solvents were investigated at the same temperature 
(−10 °C) over and the same reaction time (1  h). 
 
 
Table 3 10.0 eq. acid, Ac2O, –10 °C, 1 h, then precipitation, filtration, sol vation in alternative 
solvent, 4.3 eq. NaSPh, 0 °C, 1 h. [ ٭] 8% of a byproduct 470 was also obtained. 
Entry acid Solvent 
for step b 
Yield of (±)-
465 (%) 
Yield of 466 
(%) 
1 TFA THF 25 4 
2 TFA MeCN 20 3 
3 TFA Ac2O - 
4 HOTf THF 36 3 
5 HOTf MeCN 38 6 
6 HOTf Ac2O - 
7٭ HPF6 THF 45 6 
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8 HPF6 MeCN 23 0 
9 HPF6 Ac2O - 
10 HBF4 THF 14 4 
11 HBF4 MeCN 13 5 
12 HBF4 Ac2O - 
13 HBF4.OEt2 THF 57 0 
14 HBF4.OEt2 MeCN 34 0 
15 HBF4.OEt2 Ac2O - 
 
 
As will be seen, this study was not without surprises. The reaction with 
hexafluorophosphoric acid, followed by nucleophilic addition of sodium 
thiophenolate in THF, did not proceed cleanly and gave two products 455 and 
456 in 45% and 6% respectively (Entry 7). These yields were slightly lower than 
those obtained with HBF4-ether (Entry 13). Uniquely with HPF6 the formation of 
second nucleophilic product was noticed 460. The explanation of this result is an 
involvement of a novel cationic intermediate 458, which subsequently underwent 
nucleophilic addition with sodium thiophenolate giving a novel product 460, in 8% 


































Scheme 101 Formation of product 460.  
Reagents and conditions: (a) HPF6 (10.0 equiv.), Ac2O, −10 °C, 1 h; (b) NaSPh (4.28 equiv.), 




                          
Figure 27 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 455. 
 
 
We concluded from these studies, that the most effective conditions were with 
tetrafluoroboric acid diethyl etherate and in THF. At this stage, we optimised the 
work up conditions for this reaction by several recrystallisations with TBME and 
cold diethyl ether. 
Having developed a set of successful conditions for formation and isolation of the 
cations, we looked to expand the scope of the methodology by exploring the 
addition of diverse nucleophiles 
 
5.2 Nucleophilic addition reactions 
 
The results for a mixture of cationic intermediates 451 and 452, shown in Table 
3, indicate a general preference for nucleophile addition to C-2/C-6 and C-3, 
respectively. During our initial attempts to form addition products, several 
Nucleophilic addition 
 110 
solvents were studied. However, only acetonitrile or the mixture 2:1 in THF were 
found to give promising results. Moreover, we found that the reaction is not 
dependent on the amount of acid used. Subsequent experiments demonstrated 
that varying the amount of HBF4−ether from 10.0 equivalents to 4.0 equivalents 
resulted in the same addition products in the same yields.  
 
 
Scheme 102 Synthesis of wide variety of nucleophilic addition products. 
Reagents and conditions: (a) HBF4.(OEt)2 (10.0 equiv.), Ac2O, −10 °C, 1 h; (b) NuΘ (5.00 
equiv.) THF or MeCN, 0 °C, 1 h. 
 
In general, the attack of nucleophilic species proceeded in high yields and takes 
place regioselectively, at the terminus of the co-ordinated dienyl system (Davies–
Green–Mingos rules)288 and also stereoselectively anti to the tricarbonyliron 
fragment.288  
Based on the established stereo- and regioselectivity, we also invoked several 
other reagents for nucleophilic addition to these cationic intermediates.  
The first step reactions were carried out for 1 hr in acetic anhydride, which after 
work up gave a mixture of cationic intermediates which subsequently, underwent 



























































0.1M NaOH A  
















Condition A: CH3CN, 0 °C→rt, 1 h 
Condition B: THF, −78 °C→rt, 1 h 
Condition C: THF (10 mL) CH3CN (0.5 mL), 1 h 
 
 The most noteworthy observation is that the reaction with PhSNa and NaBH4 
which gave (±)-455 (45%) and (±)-461 (31%), respectively showing an improved 
yield (Entry 2). Reactions using lithiated dimethyl malonate gave the poorest 
results (Entry 5). Several attempts were conducted to obtain (±)-trans-diol 465. 
Addition of 0.1M solution of sodium hydroxide to a mixture of cationic iron 
tricarbonyl complexes in acetonitrile induced formation of desired products, which 
were isolated as (±)-465 and 466 in 25%, and 10%, respectively (Entry 4). It was 
intended that this route would furnish trans-addition products in better overall 
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yield. After several attempts, we were unable to improve the yields for those 
reactions.  
Lowering the amount of acid and/or increasing the equivalents of the nucleophilic 
species had no effect on the reaction. 
We were pleased that the deacetylation stage of the reaction with sodium 
methoxide was found to have gone to completion after reaction time of 24 h at 
ambient temperature yielding product 468, Scheme 103. 
 
 
Scheme 103 Deacetylation of (±)-465 
Reagents and conditions: (a) NaOMe (20.00 equiv.) MeOH, 24 h, rt, (quantitative). 
 
The structure of (±)-461, and (±)-468, were further confirmed by X-ray 




                                 
Figure 28 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for (±)-461. 
                               
Figure 29 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 




The overall yields after two steps in some entries were not high enough for 
addition reactions towards cationic salts. We therefore set out to develop an 
approach to the efficient and stereocontrolled synthesis of iron complexes, 




Reagents and conditions: (a) pyridine, −10 °C for 1 h, then rt for 18 h, (91%); (b) HBF4−ether, 
THF, −10 °C, 1 h, PhSNa, −78 °C, 1 h.  
 
In order to be able to modify and improve the synthesis of the nucleophilic 
addition products, it was imperative that we thoroughly understood this reaction. 
Here, an alternative synthetic approach towards nucleophilic addition products 
has been examined. This acetylation of the hydroxy group was completed at C-2 
only giving product 389, which was subsequently treated with the acid without 
any acetic anhydride. Surprisingly two nucleophilic addition products 455 and 
456 were delivered in 13% and 24% yield respectively.  
One likely explanation which would account for this observation involves 
reversible reaction of acetylation at C2 position of 452. Consequently, the release 
of favourable and more stable product 451 is observed, which was reacted 




5.3 Details of NMR studies 
 
We have investigated further the reaction with acid in order to explore the 
possible pathway and mechanism of this reaction. The reaction conditions 
employed used compound 383, HBF4-etherate (50 µL) in acetic anhydride at 
room temperature. The reaction was monitored by 1H−NMR, and the change in 
integration of various resonances was observed. Interestingly, 1H−NMR 
spectroscopic analysis showed that the mixture of products had been formed as  
451 and 452 in a 3:1 ratio in 1 h. 
 
 
Figure 30 1H-NMR stacked spectra showing real-time formation of 451 and 452. 





















Surprisingly after prolonged time, the ratio of cationic product 451 possessing C2 
symmetry plane drastically increased whereas the level of product 452 become 
very low. The explanation of this phenomenon could be drawn based on the 
better stability of 451 since the electron withdrawing ester is not conjugated to 
the electron-deficient pi-system, whereas the cationic complex 452 is destabilised 
by conjugation to the ester. The formation of kinetically stable product 451 shifts 
the equilibrium to the right. Figure 31 
 
 
Figure 31 Double effect of stabilisation of symmetrical product 452. 
 
The presence of activating (-OAc) and deactivating group (-COOMe) on the 
same carbon atom (C1) can stabilized positive charge in the cyclohexadienyl ring 
system more effectively due to breaking down the conjugation between methyl 
ester group and diene.  
 
5.4 Demetallation of novel cyclohexadiene iron complexes. 
 
In order to demonstrate the potential applications of this chemistry in organic 
synthesis, demetallated compounds must be readily available. Two particular 
demetallation procedures have been used. The reaction with anhydrous 
trimethylamine N-oxide in benzene (Method A) was less effective than the 







Scheme 105 Demetallation of complexes with CAN and TMANO. 
 





















































































































Method A: Me3NO, 36.00 equiv., dry benzene, rt, 24 h 
Method B: (1) (NH4)2Ce(NO3)6 , 3.00 equiv., acetone, 0 °C, 5 min, rt,  
25 min (Entry 4), 3 h (Entry 7), 4 h (Entry 3), 50 min (Entry 6) 
“-“ reaction not performed at all. 
 
 
In some cases after removing iron tricarbonyl moiety with TMANO from 
cyclohexadiene ring system, some aromatics were detected along with a rather 
complex mixture of products (Entry 1, Method A and Entry 2, Method B). In order 
to establish the viability of detachment of the metal from the tricarbonyl(η4-
cyclohexadiene)iron complex, the adduct (±)-455 was converted to the aromatic 
derivative 479 using Me3NO for 24 h in benzene, Scheme 106. 
Demetallation of (±)-455 gave desired product, but solutions slowly decompose 
in the presence of air. Successfully demetallation of the adduct (±)-455 gave  








Gratifyingly, demetallation of azide (±)-463 with CAN preceeded uneventfully 
providing (±)-473 in 64% yield, (Entry 7). However, no improvement in yield was 
forthcoming after several conducted attempts. 
Hydride product (±)-472 was also synthesized (Entry 2), although only this ligand 
undergoes E2 elimination, where two hydrogen atoms are removed from adjacent 
carbon atoms (θ ≈ 180°) proved difficult to isolate it after silica gel column 
chromatography. This result could potentially be explained by the protonation of 
the acetylated group and formation of aromatic product after the trans-elimination 
step, Scheme 107. 
 
 
Scheme 107 Formation of hydride product (±)-472 
 
We had already demonstrated that demetallation of novel iron complexes was 
productive. (Table 5) However, in our hands when the reaction was attempted 
with 1,2-hydride iron complex (±)-461 with TMANO, this unfortunately failed, 
resulting in complete loss of material.  
The synthesis on a very small scale (~5mg) of novel trans-diol 480 was 
accomplished in two steps from (±)-465, after reaction with sodium methoxide 
(20.00 equiv.) in MeOH for 24 hr, further purified and treated with CAN in 
acetone for 25 min, furnished the desired product (±)-480 however it proved to be 





Scheme 108 Formation of (±)-trans-diol 480 
Reagents and conditions: (a) NaOMe (20.00 equiv.), MeOH, N2, 24 h, rt, (quantitative).  
5.5 Determination of e.e. 
 
All racemic (455, 461, 463, 465) iron complexes were examined on a chiral 
HPLC column packed with Chiracel OD using Hex:IPA (95/5) as eluent. 
Attempted resolution of the rearrangement nucleophilic addition (456, 462, 464, 
466) products using the same conditions as above showed a single peak in each 
case.  
However, in the absence of racemic material for comparison, we could not 
exclude the possibility that enantiomers were co-eluting, unlikely though this 
seemed given that baseline separation was achieved for all the structurally 
similar racemic “1,2” adducts. 
 
To further investigate the enantiopurity of the “2,3” products, we decided to 
employ a procedure reported by Bull and James,  which utilises a simple three 
component chiral derivatisation to allow determination of e.e. by 1H−NMR 
spectroscopic analysis.289-295 This procedure works for both amines and for diols. 
Thus, several attempts to reduce 2,3-azide complex 464 were carried out with 
DIBAL-H, but were unproductive, giving a complex mixture of inseparable 
products. 
 
Scheme 109 Attempted reduction of iron complex 464.  




Faced with this setback, we turned back to the literature to see if racemic 
syntheses had been reported for any of the “2,3” adducts or their demetallated 
derivatives. In fact these were all previously unreported. However, a derivative 
(peracetate) was known: (±)-482 which is an excellent reference point for our iron 
complexes, and after employing it on chiral stationery phase, this could provide 
further a value for the enantiopurity of the “2,3” rearrangement products. 
 
In order to verify this, it was decided to apply compound 478 after further 
protection of hydroxyl group. This product was examined later by CHIRALCEL® 
OD−I column Scheme 110, Figure 32. 
 
 
Scheme 110 Synthesis of peracetate 482 
Reagents and conditions: (a) (NH4)2Ce(NO3)6 , 3.00 equiv., acetone, 0 °C, 5 min, rt, 25 min; 
(b) Ac2O, (2.20 equiv.), DCM, Et3N, 0 °C →rt, 24 h. 
 
When 478 was treated with acetic anhydride (2.20 equiv.) in DCM, followed by 
Et3N peracetate 482 was obtained in 63% yield. The reaction appeared to be 




Scheme 111 Attempted Diels-Alder reaction between furan and acrylic acid 
Reagents and conditions: (a) BH3−THF (0.01 equiv.) over 30 min, 2 °C, 18 h, (b) 




To access the corresponding racemate (±)-482 by independent synthesis initially 
we attempted the conditions reported by Suami et al. for the Diels–Alder reaction 
using commercially available furan 483, and acrylic acid 484,296 Scheme 111. 
Despite exploring several cycloaddition reactions the adduct 486 was not 
obtained directly from acrylic acid. For example, a neat mixture of acrylic acid 
and furan with added hydroquinone, after 75 days (as reported!) gave a complex 
mixture, as did the catalysed reaction with BH3−THF which gave a mixture of 
starting materials. We speculate that HOMO−LUMO interactions and reagent 
purity are at least partially responsible for the difficulties associated with this 
reaction. The failure of acrylic acid to undergo clean cycloaddition as reported led 
us to search for an alternate route.  
 
Thus we decided to attempt to carry out a similar reaction starting with methyl 
acrylate 487 instead, following a procedure published by Kotsuki et al.297 
Although, the cycloaddition was not completely satisfactory, sufficient amounts of 





Scheme 112 Ogawa’s synthesis of (±)-482 
Reagents and conditions: (a) BH3.OEt2 (0.1 equiv.) over 30 min, −20 °C, 18 h; (b) 1 M NaOH, 
23 h, rt; (c) Br2, NaHCO3/H2O, 1 h; (d) HBr, HOAc, 2 days, 80 °C; (e) TMSCHN 2, 
MeOH:Benzene (1:1); (f) Zn (powder), AcOH, 1 h, 70 °C; (g) NBS (2.00 equiv.) AIBN, CCl 4, 
reflux, 2 h; (h) Zn (powder, 4.00 equiv.), AcOH, 2.5 h. 
 
The target Diels–Alder products 488 and 489 were obtained from commercially 
available furan and methyl acrylate when treated with the Lewis acid BH3.OEt2 
(0.1 equiv) at −20 °C for 18 h, and after silica gel chromatography led to (±)-489, 
albeit in low yield 6%. 
Upon treatment of (±)-489 with 1M NaOH at ambient temperature the free acid 
(±)-486 was obtained in 89% yield.298 
The acid (±)-486 was treated with bromine in NaHCO3/H2O and stirred for 1 h, 





Reacting (±)-490 in a sealed tube at 80 °C with 33% hydrogen bromid e and 
glacial acetic acid for 2 days afforded (±)-491 in 42%.300 Then (±)-491 was 
subjected to a esterification reaction using (trimethylsilyl)diazomethane (2.0 M 
solution in hexanes) to furnish (±)-492 in quantitative yield. Analytical data 
agreed with literature values. This product (±)-492 was easily converted into (±)-
493 in 81%, using zinc powder and acetic acid at 70 °C  for 1 h. Further 
conversion to the dibromide (±)-494 was attempted using a mixture of (±)-493, 
and NBS (2.00 equiv.) in the presence of substoichiometric amount of AIBN in 
CCl4, at reflux temperature for 2 h resulted in formation of a major compound (±)-
494 along with many other bromides, but after purification by chromatography on 
silica gel it was isolated in 26% yield301 Scheme 112. 
 
With (±)-494 now available, the debromination reaction was attempted employing 
zinc powder (4.00 equiv.) in AcOH which lead to the final racemic diene (±)-482 
in 64%. Intriguingly, the reaction was completed in 2.5 h at room temperature as 
monitored by TLC, whereas only 10 min was required for zinc dust according to 





Figure 32 Chromatograms for 452 
HPLC: CHIRALCEL® OD−I  column, Hex:IPA = 95/5, 1.0 mL/min., λ = 254 nm, tR1 = 10.50 
min (11.06 min), tR2 = 12.40 min 
 
The key finding: the material produced by the iron route is >99% e.e. and 






5.6 The scope of second nucleophilic additions 
 
Next we began our studies on a possible second nucleophilic addition reaction 
on (±)-461 by addition of trityl tetrafluoroborate followed by treatment with acetic 
acid , gave a cationic intermediate which reacted with PhSNa, Scheme 113.  
Intriguingly novel iron complex (±)-497 was isolated in low yield (27%). The 
formation of (±)-497 could be explained on the basis of the bulky trityl cation 
effecting deacetoxylation instead of hydride abstraction. This implied formation of 
η5-cyclohexadiene intermediate (±)-496 followed by the nucleophilic addition of 




Scheme 113 Synthesis of second nucleophilic addition product (±)-497 
Reagents and conditions: (a) CPh3BF4, (1.05 equiv.), DCM, rt, 1 h, then HOAc (1.00 equiv.), 
−12 °C, 1 h, PhSNa (2.00 equiv.), 0 °C, 1 h. 
 
Encouraged by the results obtained using tricarbonyl complex (±)-461, which 
demonstrated the viability of a second nucleophile addition, we wished to extend 
the scope of this methodology to an ethyl ester complex, as this would allow us 
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to demonstrate the usefulness of this methodology by the preparation of 
oseltamivir intermediates.  
 
5.6.1 Oseltamivir intermediates 
 
The practical industrial routes for the synthesis of oseltamivir were developed by 
F.Hoffman-La Roche Ltd. and Gilead Sciences, Inc, which are still in use today. 
The major starting material according to Roche in oseltamivir production is 
shikimic acid. It was originally derived from star anise, an herb grown in China 
and Vietnam. Innovation in oseltamivir synthesis could further drive down prices. 
While current demand for seasonal influenza treatment and pandemic stockpiling 
are being met, it is important to find an alternative way to have secure supply of 
oseltamivir.  
There are many researchers interested in syntheses of Tamiflu.302  Several 
groups have made oseltamivir from an arene diol (Hudlický75,303,304,305, 
Banwell306,307, Fang308) but nobody has reported the use of 1,2-cis microbial diol 
33 in its synthesis. 
We wanted to develop methodology which used starting materials which are 
cheap and readily available, thus benzoic acid could be a possible choice. It was 
clear that the use of a micriobial derivied diol 33 could lead to iron carbonyl 
intermediate salt 349 after esterification, complexation and dehydroxylation, all 





Scheme 114 Synthesis of Trost’s key intermediate (±)-505 
Reagents and conditions: (a) EtI (1.10 equiv.) Et3N (1.10 equiv.) acetone, rt, 24 h; (b) CsF 
(1.5 equiv.) DMF, EtI, N2, rt, 23 h; (c) Fe2(CO)9, THF, 5 d, rt, argon, (61%); (d) + (e) 
HBF4.ether (10.00 equiv.), Ac2O, −10 °C, 1 h, then NaBH 4 (5.00 equiv.) 0 °C, 1 h, CH 3CN; (f) 
HBF4.ether (1.50 equiv), DCM, −12 °C, 1 h; (g) Potassium phthalimide (3.00 equiv.), DCM, 0 
°C, DIPEA (1.10 equiv.), 30 min at 0 °C →rt, 1 h; (h) H2O2 30%, 0 °C, 1M NaOH, 5 min; (i) 
HBF4.ether (1.50 equiv.), DCM,  1 h, 0 °C, tert-butyl carbamate, 30 min at 0 °C →rt, aqueous 
w-up, (80%). 
 
Preparation of an intermediate in Trost’s synthesis 505 of oseltamivir started from 
microbial diol 33 delivered from benzoic acid. Acid 33 was reacted with EtI and 
Et3N to afford ethyl ester in 22% yield. Ethyl ester 498 was also synthesized 
using CsF243 in an improved yield of 69%. We have not optimized the conditions 
of this reaction. Upon treatment of 498 with diironnonacarbonyl for 5 days at 
room temperature the iron complex 499 was afforded in 61% yield which was 
now ready for the nucleophilic addition reaction. After 2 steps, reaction of 499 
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with HBF4−etherate, followed by treatment of cationic products with NaBH4 in 
MeCN for 1 h, gave the expected compounds (±)-502 and 503 in 42% and 5% 
yield respectively. Then the racemic mixture of (±)-502 was treated with acid to 
afford salt (±)-349 in quantitative yield, which upon treatment with potassium 
phthalimide and Hünig’s base furnished (±)-504 in moderate yield (73%). 
Finally, (±)-504 underwent demetallation upon treatment with an aqueous 
solution of H2O2 (30%), and 1M NaOH to provide Trost’s key intermediate (±)-
505 in good yield (77%), Scheme 114. 
Our formal synthesis was not very high yielding (9.9%) due to the moderate 
yielding intermediate steps. Nevertheless, our route did not require any toxic and 
unstable azide complexes, in contrast to the originally reported route. 
A further advantage of our method is that it allows the formation of (±)-505 as a 
racemic mixture of a single regioisomer, rather than a regioisomeric mixture 
(10:1) as was reported by Trost et al.,224,309 which was carried through as a 
mixture to the next step in their synthesis.  
 
 
Scheme 115 Synthesis of Kann’s key intermediate (±)-353, Corey’s (±)-354, and (±)-
gabaculine 279 
Reagents and conditions: (a) HBF4.ether (1.50 equiv), DCM, −12 °C, 1 h; (b) tert-butyl 
carbamate (2.00 equiv.) DCM, 0 °C, DIPEA (1.50 equi v.), 30 min at 0 °C →rt, 1 h; (c) H2O2 




With hydride (±)-502 in hand, we envisioned that the preparation of Corey’s 
oseltamivir intermediate would be achievable by a similar route.  
The synthetic sequence for the formation of cationic iron complex (±)-349 was 
optimized before. Then (±)-349 was subjected to a nucleophilic addition with tert-
butyl carbamate and DIPEA, and product (±)-353 was formed and then 
demetallated as previously described with an aqueous solution of H2O2 (30%), 
and 1M NaOH to give (±)-354 the key intermediate in Corey’s route to oseltamivir 
in a very good yield of 82%, Scheme 115. 
Surprisingly, when the reaction was performed without isolation of cationic 
intermediate (±)-349 and treated with tert-butyl carbamate, the reaction led to the 
novel (±)-506 complex which was obtained after aqueous work up. The formation 
of (±)-513 was circumvented by isolation of cationic (±)-349 intermediate, before 
addition of any nucleophile. We did not undertake further resolution of the 
cationic racemic iron complex (±)-349.  
At this point we had in hand an intermediate (±)-354 and only 2 steps away from 
a natural product – gabaculine 279. The ethyl ester (±)-354 was hydrolysed with 
base and the deprotected with 4M HCl in dioxane to give final product 279 in 







In this chapter we have tested various conditions of the formation of cationic η5 
intermediates, and through experimentation have found HBF4−ether was highly 
efficient.  
We have investigated nucleophilic addition reactions towards iron tricarbonyl 
cyclohexadienyl salts. We have rationalised the product distribution and designed 
experiments to obtain a wide range of products after nucleophilic additions and 




The enantiopurity of a derivative of a representative product of our methodology 
was determined using a HPLC CHIRALCEL® OD-I column and by comparison 
with racemic material prepared independently. At the end of this study, we 
prepared Trost’s and Corey’s tamiflu’s intermediates along with gabaculine 279. 
From a synthetic view point, the results are potentially very significant, giving a 
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Chapter 6: Overall summary and future work 
 
The objective of the work presented in this thesis was the use in synthesis of 
microbial arene oxidation products, with the main focus on the synthesis of iron 
tricarbonyl cyclohexadiene ligands possessing a quaternary centre and their 
modification post-complexation to give a variety of useful derivatives.  
 
The first intermediate goal was the construction of the iron tricarbonyl complex 
383 obtained directly from microbially derived diol, and its use towards the 
synthesis of iron cyclohexanone 396 was explored. Despite several attempts with 
a variety of selective oxidants, only MnO2 led to stable irontricarbonyl ketone 396 
in good yield. Parallel studies towards iron ketone derivatives were also explored. 
It is our opinion that further studies on the conversion of iron ketone complex 396 
should be carried out, as it seems possible that formation of a cationic 
intermediate 422 with nucleophiles would eventually succeed. 
 
In Chapter 4 we explored a unique rearrangement product 415. We conducted a 
thorough mechanistic investigation into the formation of this compound. After 
additional labelling studies it appears that formation of this product is through 
acetonide migration rather than methyl ester group migration. 
 
As an application of this methodology we were able to access arene 2,3-diols 
derivatives of non natural configuration not obtainable by bio-oxidation. 
 
In future, we would like to explore the reactivity of the silylated cyclohexadiene 
ligands to prevent the formation of endo iron complexes. Moreover microbial diol 
33 could be also protected as a derivative 507, that will offer the advantage of 
being coordinated followed by spontaneous an iron tricarbonyl inducted 
rearrangement. This sequence, after oxidation and TBAF deprotection reaction in 
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neutral conditions will deliver a diol 443 of opposite stereochemistry, as depicted 
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33
 
Scheme 116 Synthesis of silylated derivatives towards 2,3-diols. 
 
Having successfully generated rearrangement product 415 it would be significant 
to deliver similar iron derivative products without the acetonide protection group. 
Although time constraints prevented us from moving this approach forward.  
 
In Chapter 5 the experimental conditions have been thoroughly investigated, 
including different solvents, as well as a variety of acids for optimisation of 
cationic products. The formation of these products was found to be very effective 
and not dependent on the amount of acid used. We have investigated 
nucleophilic addition reactions towards iron tricarbonyl cyclohexadienyl salts. In 
future, we would like to explore the introduction of a wide variety of nucleophiles 
to cationic intermediates and improved the yields of desired products. 
 
The enantiopurity of a derivative of a representative product of our methodology 
was determined by comparison with racemic material prepared by Ogawa’s 
protocol.  
 
Substantial work has also been completed on an alternative synthetic route to 
Trost’s and Corey’s oseltamivir’s intermediates 505 and 354 along with 
gabaculine 279 from ipso,ortho-diol 33. 
The above results clearly demonstrate that use of iron complexes 383 and 489 is 
a simple and straightforward process towards the synthesis of useful building 
blocks. 
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Our unique formal syntheses of oseltamivir will rise an opportunity to deliver wide 
range of derivatives as depicted in Scheme 117. First treatment with an acid of 
ethyl ester complex 499 will provide a cation 500, which is higly reactive towards 
series of nucleophiles. At this stage, we could create a library of novel products 
(±)-510, and after treatment with acid for a second time cationic intermediates 
(±)-511 followed by potassium phthalimide will deliver products (±)-512, which 
upon oxidation will provide ligands (±)-513. We are interested in exploring this 
methodology which is a very promising tool for moderating the outcome of the 
reactions at any stage of nucleophilic addition. Moreover, our approach can be 
easily applied to the synthesis of a wide range of synthetic analogues of 
oseltamivir for structure-activity studies. 
 
 












Reactions which required the use of anhydrous, inert atmosphere techniques 
were carried out under an atmosphere of nitrogen. In most cases, anhydrous 
acetonitrile, diethyl ether, dichloromethane, hexane, toluene and tetrahydrofuran 
were obtained by passing through anhydrous alumina columns using an 
Innovative Technology Inc. PS-400-7 solvent purification system.310 All other 
commercially available compounds were used as obtained from the chemical 
suppliers. Nonacarbonyldiiron was dispensed in a glovebox. 
 
Analytical thin layer chromatography was carried out using silver backed plates 
precoated with Alugram®SIL G/UV254nm and plates were visualised under UV light 
and/or KMnO4 followed by gentle warming. Organic layers were routinely dried 
with anhydrous MgSO4 and evaporated using a Buchi rotary evaporator, and 
then further drying was facilitated by high vacuum. Flash column chromatography 
was carried out using Davisil LC 60 Å particle size silica gel (35−70 microns) 
purchased from Fisher Scientifics or Celite® 545 from Sigma Aldrich. 
 
NMR spectra were run in CDCl3 (unless otherwise specified) on a Brüker Avance 
250, 300, 400 MHz instruments at 298K (250, 300, 400 MHz) or Brüker Avance 
500 (500 MHz) instrument and recorded at the following frequencies: proton (1H - 
250/300 MHz), carbon (13C - 62.9/75.4). The following abbreviations are used: s, 
singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; m, multiplet and 
br, broad. Chemical shifts δ are quoted in parts per million and are referenced to 




Variable temperature experiments for the kinetic studies in Chapter 4 were 
carried out on a Brüker AV400 spectrometer operating at 100.62 MHz for 13C. 
Spectra were acquired in the range 232.1 − 377.4 K using a standard 13C{1H} 
pulse sequence, and each spectrum was acquired in the probe for at least 15 
minutes at each temperature prior to data acquisition. The probe temperature 
was calibrated in a separate experiment by using a sample of 4% methanol in 
methanol-d4.311 
 
IR spectra were recorded on Perkin Elmer Spectrum 100 FTIR with diamond 
ATR spectrometer with only selected absorbances quoted as ν in cm-1.  
 
Mass spectra were recorded on a Bruker Daltonics  micrOTOF mass 
spectrometer (Brüker Daltonik GmbH, Bremen, Germany) with electrospray time-
of-flight (ESI-TOF) using either positive or negative electrospray ionisation (ESI) 
as stated. this was coupled to an Agilent 1200 LC system (Agilent Technologies, 
Waldbronn, Germany). The LC system was used as an autosampler only. 10µl of 
sample was injected into a 30:70 flow of water:acetonitrile at 0.6mL/min to the 
mass spectrometer. For each acquisition 10µL of calibrant of 5mM sodium 
formate was injected after the sample. The observed mass and isotope pattern 
matched the corresponding theoretical values as calculated from the expected 
elemental formula.  
 
Optical rotations were recorded on an Optical Activity, AA −10 Automatic 
polarimeter with a path length of 1dm. Concentrations (c) are quoted in g/100mL. 
 
X-Ray data were collected on a Nonius KappaCCD diffractometer with Mo-Kα 
radiation (λ=0.71074 Ǻ). All structures were solvent by direct methods and 




All capillary melting points were recorded using a Buchi 535 melting point 
apparatus. The readings were taken from a mercury-in-glass thermometer and 
were reported uncorrected as the meniscus point. Elemental analysis was 
performed using an Exeter Analytical CE 440 analyzer. 
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The conversion of benzoic acid to 1,2-dihydroxycyclohexa-3,5-diene-1-carboxylic 
acid was effected by R. eutrophus B9 according to the literature procedure 
reported by Myers et al.39 [α]D25 −106 (c 0.5 in EtOH) [lit.38, (Na+salt) −123.8 (c 
1.78 in H2O); δH (270 MHz, CDCl3 + [2H6]-DMSO); 5.4 (1H, br m, 3-H), 5.2 (1H, d 
m, 6-H), 5.2 (2H, br d, 4-H, 5-H), 4.1 (1H, br s, 2-H);44 
 





Method A:  
To 1.11 g (7.09 mmol, 1.00 equiv) of 33 was added benzene-MeOH (1:1, 100 
mL). The resultant solution was stirred at room temperature, and 
(trimethylsilyl)diazomethane (2.0M solution in hexanes) was added dropwise via 
syringe over 15 min until effervescence ceased and a yellow colour persisted 
(6.5 mL). The reaction mixture was stirred for 2 h and then concentrated under 
reduced pressure, dried in vacuo to give the crude ester 360, sufficiently pure to 
be used without further purification (1.21 g, 100%), as a white crystalline solid, 
mp = 51.5 – 52.5 °C 31, [α]D20 − 75 °C ±2 (c 0.5 in EtOH),44 δH (300 MHz, CDCl3): 
6.13 (1H, dd, J 9.5, 5.5 Hz, H-6), 5.98 (1H, ddd, J 3.0, 2.5, 1.0 Hz, H-5), 5.97-
5.93 (1H, m, H-4), 5.83 (1H, ddd, J 10.0, 1.0 Hz, H-3), 5.73 (1H, dd, J 9.5, 1.0 
Hz, C2-OH), 4.85 (1H, s, C1-OH), 3.88 (3H, s, -O-CH3); δC (100 MHz, CDCl3) 
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175.6, 132.1, 127.0, 124.8, 122.9, 74.1, 71.2, 54.0; νmax (film) 3444, 3041, 1735, 
1436, 1256, 1087, 1038 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C8H10Na1O4)+, 
193.0477; found, 193.0472. 
 
Method B:  
This was performed in accordance with a literature procedure.243  
A mixture of microbial diol acid 33 (0.108 g, 0.694 mmol, 1.00 equiv), CsF (0.158 
g, 1.041 mmol, 1.50 equiv) in DMF (0.8 mL) at room temperature was stirred for 
2 min, followed by addition of MeI (86.4 µL, 1.388 mmol, 2.0 equiv) under 
nitrogen atmosphere, and stirred for 23 h at this temperature. The reaction 
mixture was combined with aqueous NaHCO3 (15 mL), and extracted with EtOAc 
(3 × 20 mL). The organic layer was dried (Na2SO4) and evaporated. Column 
chromatography on silica gel (50:50 petrol-EtOAc) gave methyl ester 360 as light 
yellow oil (85 mg, 72%). 
 
Method C:  
This was performed in accordance with a literature procedure.39 To a solution of 
(1S,2R)-1,2-dihydroxycyclohexa-3,5-diene-1-carboxylic acid 33 (6.15 g, 39.4 
mmol, 1.00 equiv) in DMF (65 mL dry), NEt3 (5.4 mL, 1.00 equiv) and MeI (2.4 
mL, 1.00 equiv) were added via a syringe under nitrogen atmosphere. The 
reaction mixture was stirred at room temperature for 6 h. Then the reaction 
mixture was transferred to a separating funnel, diluted with EtOAc (200 mL) and 
extracted with sat. LiCl(aq) (2 × 100 mL), resulting in slow phase separation. 
Organic phase was dried over MgSO4 and concentrated under reduced pressure 
without heating and purified by column chromatography [60:40 EtOAc-petroleum 
[(b.p. 40-60 °C)] to give (1S,2R)-1,2-dihydroxycyclohexa-3,5-diene-1-methyl 
ester 360 as a light yellow oil; Rf 0.42 [70:30 EtOAc-petroleum [(b.p. 40-60 °C)] 









To a flask containing 360 (1.21 g, 7.08 mmol, 1.00 equiv) in a glovebox was 
added nonacarbonyldiiron (2.79 g, 7.67 mmol, 1.08 equiv). THF (100 mL) was 
added and the reaction mixture was stirred at room temperature for 7 days, then 
concentrated under reduced pressure (Care! Toxic pentacarbonyliron distilled 
over at this point). The crude product was purified by chromatography [40:60 
EtOAc-petroleum (b.p. 40 − 60 °C)] to give tricarbonyl[(1S, 2R)- methyl 1,2-
dihydroxycyclohexa-3,5-dienecarboxylate]iron of 383 (1.37 g, 55%). Crystals 
suitable for X-ray diffraction were grown from DCM/petroleum Rf 0.74 [70% 
EtOAc-petroleum (b.p. 40-60 °C)]; mp 130-132 °C; [ α]D25 −190 (c 0.1, CH2Cl2); δH 
(300 MHz, CDCl3) 5.39 (1H, dddd, J 6.0, 4.0, 1.5, 1.0 Hz, H-4), 5.35 (1H, ddd, J 
6.0, 4.5, 2.0 Hz, H-5), 3.91-3.88 (1H, m, H-2), 3.88 (1H, s, C1-OH), 3.74 (3H, s, -
OCH3), 3.21 (1H, dt, J 6.5, 2.0 Hz, H-3), 3.17 (1H, d, J 7.0 Hz, C2-OH)  2.84 (1H, 
dd, J 6.0, 2.0 Hz, H-6); δC (75.4 MHz, CDCl3) 210.2 (3 × Fe(CO)3), 174.9 (-
COOCH3), 84.6 (C-5), 84.3 (C-4), 77.3 (C-1), 72.1 (C-2), 67.4 (C-3), 64.5 (C-6), 
53.5 (-COOCH3); νmax (film) 3417, 3007, 2957, 2202, 2176, 2049, 1958, 1723, 
1436, 1381, 1236, 1172, 1135, 1062, 1020, 981, 940, 911, 869, 831, 794, 754, 
732, 614 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C11H10FeO7+Na)+, 332.9674; 
found 332.9657. (Found: C, 43.0; H, 3.22. C11H10FeO7 requires C, 42.6; H, 3.25 
%); X-ray crystal data C11H10FeO7, M=310.04, Monoclinic, P212121, a = 
8.0220(1)Å α = 90o b = 8.1780(1)Å β = 90o c = 18.1270(3)Å γ = 90o, 
V=1189.20(3) Å3, Z=4, Dc=1.732 Mg/m3, µ(Cu-Kα)=1.295 mm-1, T=150(2) K, 
25065 independent measured reflections, 2889 independent observed 




The crude of methyl ester 387 obtained by the Method A, was found to give 
silylated byproduct of (−)-(3S)-tricarbonyl(η4-1S,2S)-methyl 1-hydroxy-2-
trimethylsiloxycyclohexa-3,5-dienecarboxylate)iron(0), (388) at the secondary 




388 (1.254 g, 22%), Rf 0.27 [ 8:92 EtOAc-hexane] m.p. = 68 − 70 °C, [ α]D25 −183 
(c 0.1, CH2Cl2); δH (300 MHz, CDCl3); 5.33 (2H, s, H), 4.12 (2H, d, J 7.0 MHz), 
3.69 (3H, s, -COOMe), 3.06 (1H, s, H), 2.92 (1H, s, H), 0.15 (9H, s, (CH3)3Si); δC 
(75.4 MHz, CDCl3) 210.4 (3 × Fe(CO)3),174.3, 85.0, 84.3, 72.6, 67.0, 65.8, 52.8; 
νmax (film) 2963, 2054, 1978, 1733, 1245, 1087, 844, 620, 605 cm-1; HRMS (+ve 
ESI-TOF) m/z calcd for (C14H18FeO7Na1O7Si)+, 405.0064; found 405.0146. X-ray 
crystal data C14H18Fe O7Si, M=382.22, Monoclinic, P 21, a = 11.7832(2)Å α = 90o 
b = 6.61340(10))Å β = 101.4370(10)o c = 22.3223(5)Å γ = 90o, V=1704.97(5)Å3, 
Z=4, Dc=1.489 Mg/m3, µ(Cu-Kα)=0.985 mm-1, T=150(2) K, 30516 independent 
measured reflections, 7382 independent observed reflections, 447 parameters. 
 





To a solution of iron complex 383 (283.5 mg, 0.914 mmol, 1.00 equiv) in pyridine 
(20 mL) at −10 °C, Ac 2O (10 mL) was slowly added. Stirring was continued for 18 
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h, at room temperature, then the reaction was quenched with H2O (15 mL) at 0 
°C, stirred for 5 min, and extracted with EtOAc (3 × 50 mL). The organic layer 
was dried (MgSO4), concentrated in vacuo, to afford yellow foam of 389 (293 mg, 
91%), sufficiently pure to be used without further purification, Rf 0.23 [ 20:80 
EtOAc-hexane] [α]D25 −220 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3); 5.44 (1H, t, J 
4.5, H-4), 5.35 (1H, t, J 5.0, H-5), 4.76 (1H, d, J 2.0, H-2), 3.76 (3H, s, -COOMe), 
3.58 (1H, s, H), 3.05 (1H, d, J 6.5, H-3), 2.83 (1H, d, J 6.0, H-6), 2.09 (3H, s, 
OAc); δC (75.4 MHz, CDCl3) 209.8 (3 × Fe(CO)3), 174.5, 171.5, 77.3, 84.2, 84.16, 
69.9, 65.7, 61.2, 53.5, 20.5; νmax (film) 3505, 2959, 2055, 1964, 1730, 1598, 
1436, 1371, 1235, 1188, 1137, 1120, 1045, 979, 942, 909, 870, 793, 745, 670, 
616 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C15H14FeO9Na1)+, 416.9850; 
found 416.9884. 
 






To a solution of iron complex 383 (13.5 mg, 0.043 mmol, 1.00 equiv.) in acetone 
(2 mL) at room temperature, solid trimethylamine N-oxide (22.3 mg, 6.82 equiv) 
was added, and left to stir for 18h at this temperature.  Then the reaction mixture 
was filtered through a plug of Celite and washed with acetone, concentrated in 
vacuo, purified by column chromatography (50:50 EtOAc-Petroleum) to give 3.2 
mg (43%) of deprotected diol 360 of (1S,2R)- methyl 1,2-dihydroxycyclohexa-3,5-
dienecarboxylate: δH (300 MHz, CDCl3): 6.13 (1H, dd, J 9.5, 5.5 Hz, H-6), 5.98 
(1H, ddd, J 3.0, 2.5, 1.0 Hz, H-5), 5.93 (1H, m, H-4), 5.83 (1H, dt, J 10.0, 1.0 Hz, 
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H-3), 5.73 (1H, dd, J 9.5, 1.0 Hz, C2-OH), 4.85 (1H, s, C1-OH), 3.88 (3H, s, -O-
CH3); δC (100 MHz, CDCl3) 175.6, 132.1, 127.0, 124.8, 122.9, 74.1, 71.2, 54.0; 
νmax (film) 3444, 3041, 1735, 1436, 1256, 1087, 1038 cm-1; HRMS (+ve ESI-TOF) 
m/z calcd for (C8H10Na1O4)+, 193.0477; found, 193.0472. 
Method B:  
To a solution of iron complex 383 (54.0 mg, 0.174 mmol, 1.00 equiv.) in wet 
acetone (2 mL) at 0 °C was added a solution of ceri c ammonium nitrate (3.00 
eq.) in acetone (1 mL) dropwise over 5 mins. The reaction mixture was allowed 
to warm to room temperature and stirred for an additional 10 min. Water was 
added (5 mL) and the solution was extracted with Et2O (3 × 20 mL). The 
combined organic layers were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure and purified by column chromatography 
(50:50 EtOAc-Petroleum) to give 28 mg (90%) of deprotected diol 360. 
 
 





Method A: MnO2 
To 383 (983 mg, 3.17 mmol, 1.00 equiv) activated 4 Å molecular sieves (280 
mg), and MnO2 (5.51 g, 63.4 mmol, 20.00 equiv) were added. The reaction 
mixture was stirred at room temperature for 21 h and then filtered through a plug 
of Celite, washed through with CH2Cl2. The filtrate was concentrated under 
reduced pressure, concentrated in vacuo, and purified by chromatography (8:92 
isopropyl alcohol-hexane) to give 396 as a yellow powder (572 mg, 59%). 
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Crystals suitable for X-ray diffraction were grown from CH2Cl2-petrol at room 
temperature: m.p.=122 °C; compound  Rf 0.13 [8% isopropanol-hexane); [α]D25 
−160 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3) 5.92 (1H, ddd, J 6.0, 5.0, 2.0 Hz, H-4 
or H-5), 5.65 (1H, ddd, J 6.5, 5.0, 1.5 Hz, H4 or H-5), 4.05 (1H, s, -OH), 3.70 (3H, 
s, -CH3), 3.42 (1H, dd, J 6.0, 1.0 Hz, H-3 or H-6), 3.34 (1H, dd, J 6.5, 2.0 Hz, H-
6); δC (75.4 MHz, CDCl3) 207.3 (3 × Fe(CO)3), 188.8 (C2), 170.3 (-C-CO-O-), 
86.6 (C4), 84.7 (C5), 73.1 (C1), 60.7 (C3), 56.9 (C6), 53.3  (-CH3); νmax (film) 
3430, 2957, 2917, 2850, 2261, 2176, 2069 (Fe νCO), 1991(Fe νCO) , 1737 (ester 
νCO), 1667 (ketone νCO) , 1455, 1435, 1364, 1254, 1224, 1130, 1100, 1025, 
978, 943, 871, 801, 733, 615 cm-1; (ESI-TOFMS) m/z calcd for (C11H8FeO7 + H)+, 
308.9697 ; found 308.9702. (Anal. Calcd for C11H8FeO7: Found: C, 43.0; H, 2.60. 
requires C, 42.9; H, 2.62%) 
X-ray crystal data C11H8FeO7, M=308.02, Triclinic, P1, a = 6.6880(3)Å α = 
85.896(1)° b = 6.7010(3)Å β = 85.972(2)° c = 46.634(2)Å γ = 60.254(3)°, 
V=1808.47(15) Å3, Z=6, Dc=1.697 Mg/m3, µ(Cu-Kα)=1.277 mm-1, T=150(2) K, 
14425 independent measured reflections, 8640 independent observed 
reflections, 1177 parameters. 
 
Method B: py*SO3 
To a solution of 383 (80.6 mg, 0.260 mmol, 1.00 equiv) in dry DMSO (9 mL) NEt3 
(236 mg, 2.340 mmol, 9.00 eqiuv) was added dropwise and stirred for 10 minutes 
under nitrogen atmosphere. Separately, a solution of py·SO3 (827 mg, 5.199 
mmol, 20.00 equiv) in dry DMSO (30 mL) was prepared. This was added 
dropwise within 20 minutes by a cannula to the reaction mixture and left to stir for 
an additional 48 h. Then the reaction mixture was diluted with EtOAc (100 mL), 
and washed with H2O (3 × 100 mL) and saturated aq. NaCl (3 × 100 mL) 
portions, 6 in total. The organic layer was dried over MgSO4, and then 
concentrated under reduced pressure to give 396 as yellow oil (5 mg, 7%). 
 
Method C: PCC 
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To a solution of iron complex 383 (17 mg, 0.055 mmol, 1.00 equiv) in CH2Cl2 (5 
mL) at room temperature, solid PCC (31.2 mg, 0.147 mmol, 2.66 equiv) was 
added, and left to stir for 23 h, under nitrogen atmosphere. Then the reaction 
mixture was filtered through a plug of Celite, diluted with Et2O, and extracted with 
H2O (100 mL), and 1M HCl (50 mL). Combined organic phase extracted with H2O 
(50 mL), dried over MgSO4, and concentrated under reduced pressure without 
heating to give crude purified by column chromatography (90% Hexane-
isopropanol) yielding yellow solid of 396 (10 mg, 58%).  
 
Method D: CrO3 
To a solution of 383 (20.3 mg, 0.065 mmol, 1.00 equiv) in CH2Cl2 (8 mL) under 
nitrogen atmosphere, solid CrO3 (38.7 mg, 0.387 mmol, 6.00 equiv) and pyridine 
(310 µL) were added, and stirred for 2.5 hrs. The resulting black reaction mixture 
was filtered through a plug of Celite, diluted with Et2O (20 mL), washed with H2O 
(120 mL), 1M HCl (80 mL) and H2O (100 mL), dried over MgSO4 and 
concentrated under reduced pressure without heating to give further purified by 
column chromatography [80:20 Hexane – isopropanol] to give 396 as a yellow 
solid (1.8 mg, 9%). 
 
Method E: Ph3CBF4 
A solution of 383 (130 mg, 0.420 mmol, 1.00 equiv) in CH2Cl2 (5 mL), was cooled 
to 0 °C and treated with solid triphenylcarbenium t etrafluoroborate (155 mg, 
0.469 mmol, 1.11 equiv), under nitrogen atmosphere, and left to stir for 2 h. Then 
reaction mixture was added dropwise to Et2O (40 mL), concentrated under 
reduced pressure to give crude further purified by column chromatography [60:40 










To the flame dried (25 mL) flask hot MS 4 Å were added. To the flask B were 
added 396 (46.6 mg, 0.151 mmol, 1.00 eguiv) and catalytic amount of and para-
toluenesulfonic acid (5 mg), under nitrogen atmosphere, Et2O (2.5 mL) was 
added and transferred content into flask A via cannula. Reaction mixture was 
stirred at room temperature, and after 40 min, PMB-amine (20 µL, 0.158 mmol, 
1.05 equiv) was added and allowed to stir for 24 h. Reaction was carried out for 9 
days with extra amount of 4Å MS and MgSO4, purified by column 
chromatography (92:8 Hexane-Isopropanol) to give 401 as a light yellow solid 
(5.3 mg, 8%) petroleum Rf 0.82 [20:80 Isopropanol-hexane]; [α]D25 −75 (c 0.1, 
CH2Cl2); δH (300 MHz, CDCl3); 7.13 (2H, d, J 8.5 Hz, MeO-C=C-H), 7.07 (1H, s, 
NH) 6.84 (2H, d, J 8.5 Hz, MeO-C=C-H), 6.02 (1H, ddd, J 11.0, 2.0 Hz, H-4), 
5.64 (1H, t, J 5.0 Hz, H-5), 4.27 (2H, J 5.5 Hz, -CH2-NH-) 4.08 (1H, s, C1-OH), 
3.79 (3H, s, O-CH3) 3.54 (1H, d, J 5.5 Hz, =CH-C=O) 3.29 (1H, dd, 5.0, 2.0 Hz, 
=CH-C-OH); δC (75.4 MHz, CDCl3) 207.6 (3 × Fe(CO)3), 188.15, 169.7; 159.1; 
129.5; 129.0; 114.1; 87.1; 84.8; 73.9; 61.3; 57.2; 55.3; 43.1; νmax (film) 3365, 
2933, 2066, 1992, 1658, 1613, 1513, 1463, 1440, 1359, 1302, 1246, 1177, 1127, 
1097, 1033, 826, 733, 614 cm-1; HRMS (-ve ESI-TOF) m/z calcd for 










To a suspension of 396 (169.4 mg, 0.549 mmol, 1.00 equiv) in CH2Cl2 (6 mL) 
trimethyloxonium tetraflouoroborate (122.3 mg, 1.2 equiv) was added. The 
resulting solution was stirred at −10 °C for 1 h. The reaction mixture was 
concentrated, and dried in vacuo to give crude of 402 as yellow foam (280 mg, 
100 %), used in next step without further purification. To this crude dissolved in 
dry MeOH (30 mL), was added a solution of sodium methoxide (48.20 mg, 1.50 
equiv) in MeOH (3 mL). The reaction left to stir at -10 °C for 1 h, and left to stir at 
room temperature for 24 h. Reaction mixture was concentrated, dried in vacuo 
and purified by silica-gel column chromatography to afford yellow foam of 404 
(159.4 mg, 83%), Rf 0.18 [ 20:80 EtOAc-Petrol]; [α]D25 −10 (c 0.1, CH2Cl2); δH 
(300 MHz, CDCl3); 5.87 (1H, s, H-4), 5.74 (1H, s, H-5), 3.68 (3H, s, -COOMe), 
3.55 (1H, d, J 5.5 MHz, H-3), 3.44 (1H, d, J 4.5 MHz, H-6), 2.20 (3H, s, OAc); δC 
(75.4 MHz, CDCl3) 207.3 (3 × Fe(CO)3), 184.1, 170.0, 167.1, 86.3, 84.9, 77.9, 
77.6, 77.1, 76.7, 62.0, 53.3, 21.0; νmax (film) 2075, 2016, 1995, 1732, 1670, 1435, 
1259, 1234, 1090, 610 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
(C13H10FeO8Na1)+, 372.9620; found 372.9618. 
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7.2 Compounds for Chapter 4 
 
7.2.1 Synthesis of (1S,2R)-1,2-O-Isopropylidene-1,2-dihydroxy-




To microbial acid 33 (1.305 g, 7.677 mmol, 1.00 equiv) and para-toluenesulfonic 
acid (0.048 g, 0.252 mmol, 0.03 equiv) in acetone (50 mL), was added 2,2-
dimethoxypropane (5.947 mL, 48.365 mmol, 6.30 equiv). The reaction mixture 
was stirred at room temperature for 2 h, transferred to a separating funnel, 
washed with brnie then extracted with EtOAc (3 × 40 mL). The organic phase 
was dried over MgSO4 and filtered. The filtrate was concen trated under reduced 
pressure, purified by a silica-gel column chromatography (5:95 MeOH-CH2Cl2) to 
give colourless oil of 412 (1.452 g, 96%); δH (500 MHz, C DCl3) 6.06 (2H, m) 5.92 
(1H, m) 5.70 (1H, dd, J 9.0, 1.5 Hz) 4.85 (1H, dd, J 4.0, 1.0 Hz), 1.39 (3H, s, -
OMe) 1.33 (3H, s, -OMe); δC (125 MHz, CDCl3) 176.9, 124.5, 124.4, 123.9, 
123.8, 107.4, 79.1, 72.8, 26.7, 25.1; νmax (film) 3500, 1736, 1373, 1213, 1165, 
1040 cm-1; HRMS (CI) [M+NH4]+ m/z calcd for (C10H16NO4)+, 214.1079; found 
214.1086. Data in agreement with those reported previously.44 
 








To a stirred solution of 412 (317 mg, 1.00 equiv) in benzene-MeOH (1:1) 100 ml, 
at room temperature was added dropwise (trimethylsilyl)diazomethane (2.20 mL, 
2.0 M in hexanes) until the yellow colour persisted and effervescence ceased. 
The solution was stirred for 50 min, then concentrated under reduced pressure, 
dried in vacuo to give 413 a light yellow oil, sufficiently pure to be used without 
further purification (323 mg, 100%); δH (500 MHz, CDCl3  6.11 (1H, m), 6.02 (1H, 
m), 5.82 (1H, m), 4.97 (1H, d, J, 4.5 MHz), 3.79 (3H, s, -COOMe) 1.44 (3H, s, -C-
CH3), 1.42 (3H, s, -C-CH3); δC (125 MHz, CDCl3) 172.1, 124.7, 124.5, 124.0, 
124.0, 106.7, 79.4, 72.7, 52.9, 26.8, 25.1; νmax (film) 3041, 2977, 2956, 2924, 
1750, 1735, 1453, 1432, 1384, 1368, 1251, 1214, 1166, 1081, 1044, 885, 805, 
710 cm-1; HRMS (CI) [M+NH4]+ m/z calcd for (C11H18NO4)+, 228.1236; found 






To methyl ester 360 (0.967 g, 5.682 mmol, 1.00 equiv) and para-toluenesulfonic 
acid (0.022 g, 0.141 mmol, 0.03 equiv) in acetone (50 mL), was added 2,2-
dimethoxypropane (6.092 mL, 6.30 equiv). The reaction mixture was stirred at 
room temperature for 2 h, transferred to a separating funnel, washed with brnie 
then extracted with EtOAc (3 × 40 mL). The organic phase was dried over 
MgSO4 and filtered. The filtrate was concen trated under reduced pressure, dried 
in vacuo to give 413 a light yellow oil (1.051g, 88%) sufficiently pure to be used 
without further purification. 
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7.2.3 Synthesis of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-methyl 1,2-
isopropylidenedioxy cyclohexa-3,5-dienecarboxylate)iron(0), (414)  
and (−)-(4R)-Tricarbonyl(η4-(1S,2S)-methyl 2,3-isopropylidenedioxy 
cyclohexa-4,6-dienecarboxylate)iron, (415) 
From the Crude Ester: 
 
 
To a flask containing purified 413 (183 mg, 0.872 mmol, 1.00 equiv) in a glove 
box diiron nonacarbonyl (348 mg, 0.957 mmol, 1.09 equiv) was added. THF (100 
mL) was added and the reaction mixture was stirred at room temperature for 7 
days. and then concentrated under reduced pressure (Care! Toxic 
pentacarbonyliron distilled over at this point). The crude brown oil was pre-
adsorbed on silica and purified by chromatography (10% EtOAc-petroleum) to 
give two isomers of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-methyl 1,2-
isopropylidenedioxy cyclohexa-3,5-dienecarboxylate)iron(0) of 414 (88.9 mg, 
29%) as a yellow foam; crystals suitable for x-ray diffraction were grown by slow 
diffusion of acetone of 414; Rf 0.58 [10:90 EtOAc-petroleum (b.p.40-60 °C)]; 
[α]D25 +60 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3) 5.61 (2H, dd, J 3.0, 7.5 Hz, H-4, 
H-5), 5.12 (1H, d, J 4.0 Hz, H-5) 3.80 (3H, s, -COOMe) 3.11 (1H, dd, J 3.0, 5.0 
Hz, H-3)  3.03 (1H, dd, J 4.0, 7.0 Hz, H-6) 1.37 (3H, s, -C-CH3) 1.15 (3H, s, -C-
CH3); δC (75.4 MHz, CDCl3) 209.4 (3 × Fe(CO)3), 171.5 (-COOCH3), 117.0, 87.1, 
85.8, 85.7, 79.9, 57.6, 55.8, 52.8, 28.1, 27.2; νmax (film) 2991, 2936, 2856, 2054, 
1973, 1741, 1456, 1436, 1380, 1371, 1342, 1303, 1256, 1210, 1164, 1135, 1065, 
1030, 988, 966, 937, 893, 863, 820, 792, 761, 647, 622, 613 cm-1; HRMS (+ve 
ESI-TOF) m/z calcd for (C14H14FeO7+Na)+, 372.9986; found 372.9973; 
X-ray crystal data C14H14FeO7, M=350.10, Monoclinic, C2, a = 20.7320(4)Å α = 
90⁰ b = 6.2630(1)Å β = 110.174(1)o c = 12.1540(3)Å γ = 90o, V=1481.31(5) Å3, 
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Z=4, Dc=1.570 Mg/m3, µ(Cu-Kα)=1.050 mm-1, T=150(2) K, 12804 independent 
measured reflections, 3232 independent observed reflections, 219 parameters. 
and 415 (80.4 mg, 26%) as a yellow oil: Rf 0.48 [10% EtOAc-petroleum (b.p.40-
60 °C)]; [ α]D25 −45 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3), 5.41 (1H, t, J 4.5, 10.0 
Hz, H-4), 5.29 (1H, t, J 5.0, 9.5 Hz, H-5), 4.32 (1H, d, J 2.0 Hz, H-2), 3.73 (3H, s, 
-COOMe) 3.34 (1H, d, J 5.0 Hz, H-3), 3.04 (1H, d, J 6.0 Hz, H-6), 1.64 (3H, s, -C-
CH3) 1.16 (3H, s, -C-CH3); δC (75.4 MHz, CDCl3), 210.4 (3 × Fe(CO)3), 174.5 (-
COOCH3), 109.4, 85.7, 85.2, 83.1, 79.5, 64.3, 62.8, 53.1, 25.1, 24.4; νmax (film) 
2991, 2953, 2054, 1972, 1728, 1458, 1435, 1385, 1379, 1339, 1298, 1272, 1251, 
1207, 1171, 1085, 1059, 1032, 1012, 973, 941, 873, 819, 801, 783, 762, 666, 
644, 615 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C14H14FeO7+Na)+, 372.9979; 
found 372.9986 (Found: C, 48.1; H, 4.11. C14H14FeO7 requires C, 48.0; H, 4.03 
%); 
X-ray crystal data C14H14FeO7, M=350.10, Monoclinic, P21, a = 10.1710(4) Å α = 
90⁰ b = 7.2170(4) Å β = 110.426(3)o c = 10.6320(6) Å γ = 90o, V=731.36(6) Å3, 
Z=2, Dc=1.590 Mg/m3, µ(Cu-Kα)=1.063 mm-1, T=150(2) K, 7011 independent 
observed reflections, 203 parameters. 
 
7.2.4 Synthesis of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-methyl 1,2-
isopropylidenedioxy cyclohexa-3,5-dienecarboxylate)iron(0), (414) 
and (−)-(3S)-Tricarbonyl(η4-(1S,2S)-methyl 1,2-isopropylidenedioxy 
cyclohexa-3,5-dienecarboxylate)iron(0), (416) 
 





To a flask containing purified 413 (371 mg, 1.77 mmol, 1.00 equiv) in a glove box 
diiron nonacarbonyl (650 mg, 1.7662 mmol, 1.0 equiv) was added. THF (150 mL) 
was added and the reaction mixture was stirred at room temperature for 8 days, 
and then concentrated under reduced pressure (Care! Toxic pentacarbonyliron 
distilled over at this point) to give crude as a brown oily cake (344 mg), washed 
with DCM, pre-adsorbed on silica and purified by column chromatography [10:90 
EtOAc-petroleum (b.p. 40 − 60 °C)] to give 414 (189 mg, 29%) as a yellow oil, 
partially crystallize in the fridge: Rf 0.58 [10% EtOAc-petroleum (b.p.40-60 ºC)]; 
[α]D25 +60 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3), 5.61 (2H, dd, J 3.0, 7.5 Hz, H-4, 
H-5), 5.12 (1H, d, J 4.0 Hz, H-5), 3.80 (3H, s, -COOMe), 3.11 (1H, dd, J 3.0, 5.0 
Hz, H-3), 3.03 (1H, dd, J 4.0, 7.0 Hz, H-6), 1.37 (3H, s, -C-CH3), 1.15 (3H, s, -C-
CH3); δC (75.4 MHz, CDCl3) 209.4 (3 × Fe(CO)3), 171.5 (-COOCH3), 117.0, 87.1, 
85.8, 85.7, 79.9, 57.6, 55.8, 52.8, 28.1, 27.2; νmax (film) 2991, 2936, 2856, 2054, 
1973, 1741, 1456, 1436, 1380, 1371, 1342, 1303, 1256, 1210, 1164, 1135, 1065, 
1030, 988, 966, 937, 893, 863, 820, 792, 761, 647, 622, 613 cm-1; HRMS (+ve 
ESI-TOF) m/z calcd for (C14H14FeO7+Na)+, 372.9986; found 372.9973; X-ray 
crystal data C14H14FeO7, M=350.10, Monoclinic, C2, a = 20.7320(4)Å α = 90° b = 
6.2630(1)Å β = 110.174(1)° c = 12.1540(3)Å γ = 90°, V=1481.31(5) Å 3, Z=4, 
Dc=1.570 Mg/m3, µ(Cu-Kα)=1.050 mm-1, T=150(2) K, 12804 independent 
measured reflections, 3232 independent observed reflections, 219 parameters. 
And 416 as a yellow oil (30.4 mg, 4%) as a yellow oil: Rf 0.48 [10:90 EtOAc-
petroleum (b.p.40−60 °C)]; [ α]D25 −45 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3), 5.41 
(1H, t, J 4.5, 10.0 Hz, H-4), 5.29 (1H, t, J 5.0, 9.5 Hz, H-5), 4.32 (1H, d, J 2.0 Hz, 
H-2), 3.73 (3H, s, -COOMe) 3.34 (1H, d, J 5.0 Hz, H-3), 3.04 (1H, d, J 6.0 Hz, H-
6), 1.64 (3H, s, -C-CH3) 1.16 (3H, s, -C-CH3); δC (75.4 MHz, CDCl3) 210.4 (3 × 
Fe(CO)3), 174.5 (-COOCH3), 109.4, 85.7, 85.2, 83.1, 79.5, 64.3, 62.8, 53.1, 25.1, 
24.4; νmax (film) 2991, 2953, 2054, 1972, 1728, 1458, 1435, 1385, 1379, 1339, 
1298, 1272, 1251, 1207, 1171, 1085, 1059, 1032, 1012, 973, 941, 873, 819, 801, 
783, 762, 666, 644, 615 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
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(C14H14FeO7+Na)+, 372.9979; found 372.9986 (Found: C, 48.1; H, 4.11. 
C14H14FeO7 requires C, 48.0; H, 4.03 %); 
 
7.2.5 Synthesis of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-methyl 1,2-
isopropylidenedioxy cyclohexa-3,5-dienecarboxylate)iron(0), (423) 
(−)-(3S)-Tricarbonyl(η4-(1S,2S)-methyl 2,3-isopropylidenedioxy 
cyclohexa-4,6-dienecarboxylate)iron, (424) and (−)-(4R)-
Tricarbonyl(η4-(1S,2S)-methyl 1,2-isopropylidenedioxy cyclohexa-3,5-
dienecarboxylate)iron(0), (425) in one pot. 




To a flask containing 412 (742 mg, 3.78 mmol, 1.00 equiv) in a glovebox was 
added nonacarbonyldiiron (1.39 g, 3.78 mmol, 1.00 equiv). THF (350 mL) was 
added and the reaction mixture was stirred at room temperature for 8 days, then 
concentrated under reduced pressure (Care! Toxic pentacarbonyliron distilled 
over at this point) to give brown oily crude used in next step without any 
purification. 
To this crude of acids (1.08 g, 3.23 mmol, 1.00 equiv) benzene/MeOH (1:1) was 
added 100 mL, flushed with nitrogen, and (trimethylsilyl)-diazomethane was 
added dropwise via syringe over 15 min until effervescence ceased and a yellow 
colour persisted (~ 6.5 mL). The reaction mixture was stirred for 2 h and then 
concentrated under reduced pressure, dried in vacuo to give brown oil crude 
esters (221 mg) further purified by column chromatography (10% EtOAc-
Petroleum b.p.40−60) to give 414 (190 mg, 17%) as a yellow oil: Rf 0.58 [10% 
EtOAc-petroleum (b.p.40-60 °C)]; [ α]D25 +60 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3) 
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5.61 (2H, dd, J 3.0, 7.5 Hz, H-4, H-5), 5.12 (1H, d, J 4.0 Hz, H-5) 3.80 (3H, s, -
COOMe) 3.11 (1H, dd, J 3.0, 5.0 Hz, H-3), 3.03 (1H, dd, J 4.0, 7.0 Hz, H-6) 1.37 
(3H, s, -C-CH3) 1.15 (3H, s, -C-CH3); δC (75.4 MHz, CDCl3) 209.4 (3 × Fe(CO)3), 
171.5 (-COOCH3), 117.0, 87.1, 85.8, 85.7, 79.9, 57.6, 55.8, 52.8, 28.1, 27.2; νmax 
(film) 2991, 2936, 2856, 2054, 1973, 1741, 1456, 1436, 1380, 1371, 1342, 1303, 
1256, 1210, 1164, 1135, 1065, 1030, 988, 966, 937, 893, 863, 820, 792, 761, 
647, 622, 613 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C14H14FeO7+Na)+, 
372.9986; found 372.9973; X-ray crystal data C14H14FeO7, M=350.10, 
Monoclinic, C2, a = 20.7320(4)Å α = 90° b = 6.2630(1)Å β = 110.174(1)o c = 
12.1540(3)Å γ = 90o, V=1481.31(5) Å3, Z=4, Dc=1.570 Mg/m3, µ(Cu-Kα)=1.050 
mm-1, T=150(2) K, 12804 independent measured reflections, 3232 independent 
observed reflections, 219 parameters. 
And 416 (182 mg, 16%) as a yellow oil; Rf 0.48 [10:90 EtOAc-petroleum (b.p.40-
60 °C)]; [ α]D25 −45 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3), 5.41 (1H, t, J 4.5, 10.0 
Hz, H-4), 5.29 (1H, t, J 5.0, 9.5 Hz, H-5), 4.32 (1H, d, J 2.0 Hz, H-2), 3.73 (3H, s, 
-COOMe) 3.34 (1H, d, J 5.0 Hz, H-3), 3.04 (1H, d, J 6.0 Hz, H-6), 1.64 (3H, s, -C-
CH3) 1.16 (3H, s, -C-CH3); δC (75.4 MHz, CDCl3) 210.4 (3 × Fe(CO)3), 174.5 (-
COOCH3), 109.4, 85.7, 85.2, 83.1, 79.5, 64.3, 62.8, 53.1, 25.1, 24.4; νmax (film) 
2991, 2953, 2054, 1972, 1728, 1458, 1435, 1385, 1379, 1339, 1298, 1272, 1251, 
1207, 1171, 1085, 1059, 1032, 1012, 973, 941, 873, 819, 801, 783, 762, 666, 
644, 615 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C14H14FeO7+Na)+, 372.9979; 
found 372.9986 (Found: C, 48.1; H, 4.11. C14H14FeO7 requires C, 48.0; H, 4.03 
%); 
and 415 (106 mg, 9%) as a yellow foam: Rf 0.44 [10:90 EtOAc-petroleum 
(b.p.40-60 °C)]; mp 81-84 °C; [ α]D25 +80 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3), 
6.36 (1H, d, J 4.5 Hz, H-6), 5.70 (1H, t, J 5.0, 10.5 Hz, H-5), 5.12 (1H, d, J 8.5 
Hz, H-2), 4.70 (1H, dd, J 3.5, 8.5 Hz, H-3), 3.72 (3H, s, -COOMe), 3.11 (1H, t, J 
4.5, 9. Hz, H-4), 1.34 (3H, s, -C-CH3), 1.22 (3H, s, -C-CH3); δC (100.6 MHz, 
CDCl3) 212.8, 206.6, 204,7 (3 × Fe(CO)3), 171.4, 114.5, 89.8, 86.7, 75.6, 73.9, 
63.3, 59.0, 55.5, 52.3, 31.4, 26.3, 24.6; νmax (film) 2989, 2954, 2252, 2059, 1978, 
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1710, 1460, 1436, 1380, 1372, 1278, 1244, 1204, 1161, 1043, 1006, 961, 916, 
891, 802, 732, 667, 641, 612 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
(C14H14FeO7+H)+, 351.0167; found 351.0164, (C14H14FeO7+Na)+, 372.9986; 
found 372.9979. (Found: C, 47.6; H, 4.03. C14H14FeO7 requires C, 48.0; H, 4.03 
%); X-ray crystal data C14H14FeO7, M=350.10, Monoclinic, P21, a = 10.1710(4) Å 
α = 90° b = 7.2170(4) Å β = 110.426(3)° c = 10.6320(6) Å γ = 90°, V=731.36(6) 
Å3, Z=2, Dc=1.590 Mg/m3, µ(Cu-Kα)=1.063 mm-1, T=150(2) K, 7011 independent 
observed reflections, 203 parameters. 
 
7.2.6 Synthesis of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-methyl 1,2-
isopropylidenedioxy cyclohexa-3,5-dienecarboxylate)iron(0), (414) 





To a flask containing purified 413 (1.309 g, 6.622 mmol, 1.00 equiv) in a glove 
box diiron nonacarbonyl (3.6535 g, 9.934 mmol 1.50 equiv) was added. THF 
(250 mL) was added and the reaction mixture was stirred at room temperature 
for 12 days. Into reaction mixture was added solution of p-toluenesulfonic acid (5 
mg) via syringe in THF (3 mL). The reaction mixture was stirred at room 
temperature for an additional 7 days, and then concentrated under reduced 
pressure (Care! Toxic pentacarbonyliron distilled over at this point). The crude 
brown oil was pre-adsorbed on silica and purified by chromatography (10:90 
EtOAc-petroleum) to give two isomers of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-methyl 
1,2-isopropylidenedioxy cyclohexa-3,5-dienecarboxylate)iron(0), 414 (381 mg, 17 
%) as a yellow oil; Rf 0.58 [10% EtOAc-petroleum (b.p.40-60 °C)]; [ α]D25 +60 (c 
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0.1, CH2Cl2); δH (300 MHz, CDCl3) 5.61 (2H, dd, J 3.0, 7.5 Hz, H-4, H-5), 5.12 
(1H, d, J 4.0 Hz, H-5) 3.80 (3H, s, -COOMe) 3.11 (1H, dd, J 3.0, 5.0 Hz, H-3)  
3.03 (1H, dd, J 4.0, 7.0 Hz, H-6) 1.37 (3H, s, -C-CH3) 1.15 (3H, s, -C-CH3); δC 
(75.4 MHz, CDCl3) 209.4 (3 × Fe(CO)3), 171.5 (-COOCH3), 117.0, 87.1, 85.8, 
85.7, 79.9, 57.6, 55.8, 52.8, 28.1, 27.2; νmax (film) 2991, 2936, 2856, 2054, 1973, 
1741, 1456, 1436, 1380, 1371, 1342, 1303, 1256, 1210, 1164, 1135, 1065, 1030, 
988, 966, 937, 893, 863, 820, 792, 761, 647, 622, 613 cm-1; HRMS (+ve ESI-
TOF) m/z calcd for (C14H14FeO7+Na)+, 372.9986; found 372.9973; X-ray crystal 
data C14H14FeO7, M=350.10, Monoclinic, C2, a = 20.7320(4)Å α = 90° b = 
6.2630(1)Å β = 110.174(1)° c = 12.1540(3)Å γ = 90°, V=1481.31(5) Å 3, Z=4, 
Dc=1.570 Mg/m3, µ(Cu-Kα)=1.050 mm-1, T=150(2) K, 12804 independent 
measured reflections, 3232 independent observed reflections, 219 parameters. 
And 416 (425 mg, 19%)  as a yellow oil: Rf 0.48 [10:90 EtOAc-petroleum (b.p.40-
60 ºC)]; [α]D25 −45 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3), 5.41 (1H, t, J 4.5, 10.0 
Hz, H-4), 5.29 (1H, t, J 5.0, 9.5 Hz, H-5), 4.32 (1H, d, J 2.0 Hz, H-2), 3.73 (3H, s, 
-COOMe) 3.34 (1H, d, J 5.0 Hz, H-3), 3.04 (1H, d, J 6.0 Hz, H-6), 1.64 (3H, s, -C-
CH3) 1.16 (3H, s, -C-CH3); δC (75.4 MHz, CDCl3) 210.4 (3 × Fe(CO)3), 174.5 (-
COOCH3), 109.4, 85.7, 85.2, 83.1, 79.5, 64.3, 62.8, 53.1, 25.1, 24.4; νmax (film) 
2991, 2953, 2054, 1972, 1728, 1458, 1435, 1385, 1379, 1339, 1298, 1272, 1251, 
1207, 1171, 1085, 1059, 1032, 1012, 973, 941, 873, 819, 801, 783, 762, 666, 
644, 615 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C14H14FeO7+Na)+, 372.9979; 
found 372.9986 (Found: C, 48.1; H, 4.11. C14H14FeO7 requires C, 48.0; H, 4.03 
%); 
 
7.2.7 Synthesis of (−)-(4R)-Tricarbonyl(η4-(1S,2S) 1,2-





From crude acid 
 
To a flask containing 412 (658 mg, 3.36 mmol, 1.00 equiv) in a glovebox was 
added nonacarbonyldiiron (1.39 g, 3.78 mmol, 1.00 equiv). THF (200 mL) was 
added and the reaction mixture was stirred at room temperature for 12 days, then 
concentrated under reduced pressure (Care! Toxic pentacarbonyliron distilled 
over at this point) to give brown oily further purified by column chromatography 
(10:90 EtOAc-Petroleum 40-60°) to give mixture of p roducts with major 432 as 
(−)-(4R)-Tricarbonyl(η4-(1S,2S) 1,2-isopropylidenedioxy cyclohexa-3,5-
dienecarboxylic acid)iron(0); δH (300 MHz, CDCl3) 6.36 (1H, d, J 1.0, 3.5 Hz, H-
5), 5.72 (1H, dt, J 1.0, 5.0, 11.0, Hz, H-4), 5.08 (1H, dd, J 1.0, 8.5 Hz, H-1), 4.72 
(1H, dddd, J 1.0, 4.0, 10.0, H-2), 3.16 (1H, ddt, J 1.0, 5.0, 10.0, H-3), 1.35 (3H, s, 
-C-CH3), 1.23 (3H, s, -C-CH3); δC (75.4 MHz, CDCl3) 176.26 (3 × Fe(CO)3), 
115.0, 90.2, 87.0, 76.4, 74.4, 59.2, 56.9, 26.9, 25.4; νmax (film) 2989, 2916, 2850, 
2061, 1980, 1682, 1552, 1463,1406, 1380, 1280, 1251, 1206, 1160, 1098, 1042, 
1010, 959, 940, 895, 866, 812, 760, 732, 652, 613, 603 cm-1; HRMS (+ve ESI-
TOF) m/z calcd for (C13H12FeO7+Na)- 334.9854; found 334.9849; 
7.2.8 Synthesis of (1S,2R)-1,2-dihydroxy-4-deuterocyclohexa-3,5-




A suspension of 10% Pd/C (500 mg) in D2O (100 mL) with 417 were placed in a 
250 mL round-bottom flask, and NEt3 were added (2.81 mL, 31.935 mmol, 1.20 
equiv), and stirred under D2 (balloon) at room temperature for 48 h. The reaction 
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mixture was diluted with Et2O, filtered, and neutralised using 5% NaHSO4 
aqueous solution and extracted with Et2O (3 × 50 mL). Combined organic phase 
was washed successively with water (50 mL) and brnie (50 mL), dried over 
MgSO4, filtered, and concentrated in vacuo to give colourless solid 418 (3.01 g, 
77%).  
The D content was determined by 1H NMR of the corresponding methyl ester on 
the basis of the integration of the methyl protons. Data for methyl ester of [D]-
418: δH (400 MHz, CD3OD): 3.93 (s, 3H), 7.49 (d, J 5.9 Hz, 2 H), 7.62 (m, 0.060 













The conversion of deuterated benzoic acid to (1S,2R)-4-deutero-1,2-
dihydroxycyclohexa-4,6-dienecarboxylic acid, (419) was effected by R. eutrophus 
B9 according to the literature procedure reported by Myers et al.39 
 
Isolated 419 as a cream powder (744 mg, 19%) [α]D25 −90 (c 0.1, CH3OH); δH 
(300 MHz, CD3OD); 6.10 (1H, d, J 7.5, H-5), 5.80-5.78 (2H, m, H-3, H-6), 4.85 
(1H, br s, H-2); δC (75.4 MHz, CD3OD) 177.9, 133.4, 127.2, 127.0, 123.6 (t, 1JCD 
33.0 Hz),75.4, 72.3; νmax (film) 3281, 3060, 2879, 2432, 2229, 2072, 1695, 1576, 
1397, 1357, 1330, 1309, 1267, 1221, 1171, 1150, 1078, 1050, 1008, 976, 912, 
877, 861, 803, 766, 750, 656 cm-1; HRMS (-ve ESI-TOF) m/z calcd for 




7.2.10 Synthesis of (1S,2R)-1,2-O-Isopropylidene-1, 2dihydroxy-4-




To (1S,2R)-4-deutero-1,2-dihydroxycyclohexa-4,6-dienecarboxylic acid 419 
(255mg, 1.622 mmol, 1.00 equiv) and and para-toluenesulphonic acid (8.5 mg, 
0.04 mmol, 0.03 equiv) in acetone (20 mL), was added 2,2-dimethoxypropane 
(0.833 mL, 9.440 mmol, 6.30 equiv). The reaction mixture was stirred at room 
temperature for 2 h, transferred to a separating funnel, washed with brnie then 
extracted with EtOAc (3 × 40 mL). The organic phase was dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure to give colourless 
oil of 420 (241 mg, 75%); [α]D25 −310 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3) 6.13 
(1H, d, J 9.5, H-5), 5.99 (1H, d, J 3.5 H-3),  5.81 (1H, d, J 9.5, H-6) 4.95 (1H, d, J 
4.0, H-2), 1.46 (3H, s, -C-CH3) 1.41 (3H, s, -C-CH3); δC (75.4 MHz, CDCl3) 176.8, 
124.6, 124.5, 124.2, 124.0, 123.9, 123.5, 107.6, 79.4, 77.6, 77.2, 76.7, 73.0, 
31.0, 26.9, 25.3; νmax (film) 2991, 2939, 2256, 1717, 1457, 1376, 1246, 1211, 
1165, 1094, 1042, 966, 909, 867, 822, 780, 728, 667, 647, 631 cm-1; HRMS (-ve 




7.2.11 Synthesis of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-methyl 1,2-
isopropylidenedioxy-4-deuterocyclohexa -3,5-
dienecarboxylate)iron(0), (421) (−)-(3S)-Tricarbonyl(η4-(1S,2S)-methyl 
2,3-isopropylidenedioxy-4-deuterocyclohexa -4,6-
dienecarboxylate)iron(0), (422) and (−)-(4R)-Tricarbonyl(η4-(1S,2S)-
methyl 1,2-isopropylidenedioxy5-deuterocyclohexa -3,5-




To a flask containing acidic acetonide 420 (240 mg, 1.230 mmol, 1.00 equiv) in a 
glovebox was added nonacarbonyldiiron (799 mg, 2.172 mmol, 2.17 equiv). THF 
(100 mL) was added and the reaction mixture was stirred at room temperature 
for 9 days, then concentrated under reduced pressure (Care! Toxic 
pentacarbonyliron distilled over at this point). The crude brown oil was used in 
next step without further purification. To a stirred solution of this crude (410 mg, 
1.00 equiv) in benzene-MeOH (1:1) 100 ml, at room temperature was added 
dropwise (trimethylsilyl)diazomethane (8 mL, 2.0 M in hexanes) until the yellow 
colour persisted and effervescence ceased. The solution was stirred for 50 min 
solvent, then concentrated under reduced pressure, dried in vacuo and pre-
adsorbed on silica and purified by silica-gel column chromatography (10% 
EtOAc-petroleum) to give three isomers of (+)-(3R)-Tricarbonyl(η4-(1S,2S)-
methyl 1,2-isopropylidenedioxy-4-deuterocyclohexa -3,5-
dienecarboxylate)iron(0), 421 (116.5 mg, 29%) as a yellow foam; Rf 0.30 [ 10% 
EtOAc- hexane]; [α]D25 +40 (c 0.1, CH2Cl2);  δH (300 MHz, CDCl3); 5.63 (1H, dd, J 
1.0, 6.0, H-5), 5.13 (1H, d, J 4.0, H-2), 3.82 (3H, s, -COOMe), 3.12 (1H, d, J 6.5, 
H-6), 3.04 (1H, d, J 1.0, 4.0, H-3) 1.38 (3H, s, -C-CH3), 1.16 (3H, s, -C-CH3); δC 
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(75.4 MHz, CDCl3) 210.1 (3 × Fe(CO)3), 174.1, 109.0, 84.8, 82.6, 80.1, 64.0, 
62.3, 52.8, 24.8, 24.0; νmax (film) 2993, 2955, 2053, 1966, 1739, 1457, 1438, 
1380, 1370, 1303, 1255, 1208, 1164, 1060, 1026, 984, 919, 891, 867, 817, 792, 
761 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C14H13DFeO7Na1)+, 374.0050; 
found 374.0047; and  (−)-(3S)-Tricarbonyl(η4-(1S,2S)-methyl 2,3-
isopropylidenedioxy-4-deuterocyclohexa -4,6-dienecarboxylate)iron(0), 422 (37 
mg, 10%) as a yellow oil; Rf 0.20 [ 10% EtOAc- hexane]; [α]D25 −90 (c 0.1, 
CH2Cl2);  δH (300 MHz, CDCl3); 5.30 (1H, dd, J 1.0, 6.5, H-5), 4.43 (1H, d, J 3.0, 
H-2), 3.73 (3H, s, -COOMe), 3.35 (1H, dd, J 1.0, 2.5, H-6), 3.05 (1H, d, J 6.5, H-
3), 1.65 (3H, s, -C-CH3), 1.57 (3H, s, -C-CH3); νmax (film) 2924, 2852, 2054, 1969, 
1729, 1459, 1436, 1378, 1326, 1298, 1249, 1206, 1170, 1115, 1085, 1060, 1031, 
973, 939, 891, 851, 820, 802, 784, 758, 665, 613 cm-1; HRMS (+ve ESI-TOF) 
m/z calcd for (C14H13DFeO7Na1)+, 374.0050; found 374.0055; and (−)-(4R)-
Tricarbonyl(η4-(1S,2S)-methyl 1,2-isopropylidenedioxy5-deuterocyclohexa -3,5-
dienecarboxylate)iron(0), 423 (10.7 mg, 1.8%) as a yellow foam; Rf 0.16 [10% 
EtOAc- hexane]; [α]D25 −70 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3); 6.36 (1H, d, J 
4.0 Hz), 5.71 (1H, d, J 4.5 Hz), 5.13 (1H, d, J 9.0 Hz), 4.71 (1H, d, J 8.5 Hz, H), 
3.73 (3H, s, -COOMe), 1.35 (3H, s, -C-CH3), 1.23 (3H, s, -C-CH3); δC (75.4 MHz, 
CDCl3) 171.4, 115.0, 89.9, 86.9, 74.7, 60.4, 52.1, 27.1, 25.6; νmax (film) 2988, 
2936, 2060, 1982, 1713, 1458, 1437, 1373, 1338, 1318, 1298, 1262, 1244, 1205, 
1160, 1095, 1064, 1012, 961, 905, 878, 814, 661, 632, 612 cm -1; HRMS (+ve 
ESI-TOF) m/z calcd for (C14H13DFeO7Na1)+, 374.0050; found 374.0056. 
 







To 415 (123 mg, 0.350 mmol, 1.0 equiv) and trimethylamine-N-oxide (1.05 g, 
14.0 mmol, 39.9 equiv) under N2 was added benzene (50 mL). The reaction 
mixture was stirred at rt for 5 h. Diethyl ether (50 mL) was then added and 
precipitate was thoroughly dislodged from the flask walls with a spatula. The 
reaction mixture was transferred to a separating funnel and extracted with H2O (2 
× 70 mL). The organic phase was dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure and dried under high vacuum to give (–)-
(2S,3R)-methyl 2,3-isopropylidenedioxycyclohexa-4,6-dienecarboxylate 439 (54 
mg, 73%) as a light brown oil; Rf 0.48 (20% EtOAc-hexane); [α]D25 −108 (c 0.1, 
CH2Cl2); δH (400 MHz, CDCl3, 298 K) 7.14 (1H, d, J 5.0 Hz, H-6), 6.12 (1H, dd, J 
10.0, 2.5 Hz, H-4), 6.09 (1H, dd, J 10.0, 5.0 Hz, H-5), 4.93 (1H, d, J 8.5 Hz, H-2), 
4.87 (1H, dd, J 8.5, 2.5 Hz, H-3), 3.82 (3H, s, -OCH3), 1.46 (3H, s, -CCH3), 1.39 
(3H, s, -CCH3); data in agreement with those reported previously312; δC (75.5 
MHz, CDCl3, 298 K) 166.7 (-COOCH3), 134.0 (C-4), 133.9 (C-6), 126.1 (C-1), 
121.3 (C-5), 105.6 (H3C-C-CH3), 72.5 (C-3), 68.1 (C-2), 52.1 (-OCH3), 26.7 
(-CCH3), 25.1 (-CCH3); νmax (film) 2988, 2921, 1715, 1589, 1437, 1371, 1297, 
1259, 1161, 1108, 1082, 1030, 864, 707 cm-1; HRMS (+ve ESI-TOF) m/z calcd 
for (C11H14O4+Na)+, 233.0790, found 233.0779. 
 
7.2.13 Formation of (2S,3R)-methyl 2,3-dihydroxycyclohexa-4,6-






Isopropylidene 439 (22.0 mg, 0.105 mmol, 1.0 equiv) was dissolved in CD3OD 
(1mL) in a Young’s NMR tube. Iodine (15.4 mg, 0.0607 mmol, 0.58 equiv.) was 
added. The NMR sample was heated to 50 °C and 1H-NMR spectra were 
acquired a five minute intervals. Formation of the diol 443 was observed, but 
subsequently it was converted to an aromatic byproduct 444. 
 





Ester 439 (50 mg, 0.238 mmol, 1.0 equiv) was dissolved in diethyl ether (10 mL) 
under nitrogen atmosphere at −78 °C. Separately, li thium aluminium hydride (9.0 
mg, 0.238 mmol, 1.0 equiv) was dissolved in diethyl ether (3.0 mL) and added 
dropwise via cannula to the reaction mixture. The reaction mixture was stirred for 
15 min, and warm up to room temperature. The reaction mixture was then stirred 
at this temperature for additional 0.5 h, and then a saturated aqueous solution of 
Rochelle’s salt (30 mL) was added dropwise. The biphasic mixture was stirred 
vigorously at room temperature for 1 h, then an additional portion of diethyl ether 
(10 mL) was added and the mixture was transferred to a separating funnel. The 
layers were separated and the aqueous layer was extracted with additional 
portions of diethyl ether (4 × 40 mL). Combined organic phases were dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure and 
purified by chromatography (30% EtOAc-hexane) to give (–)-(2S,3R)-(2,3-
isopropylidenedioxycyclohexa-4,6-dienyl)methanol 440 (12.5 mg, 29%) as a 
colourless oil; Rf 0.21 (30% EtOAc-hexane); [α]D25 −75 (c 0.1, CH2Cl2); δH (400 
MHz, CDCl3, 298 K) 6.03 (1H, dd, J 9.5, 5.5 Hz, H-5), 5.97 (1H, dq, J 5.5, 1.0 Hz, 
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H-6), 5.89 (1H, ddd, J 9.5, 1.5, 1.0 Hz, H-4), 4.73 (1H, d, J 7.5 Hz, H-2 or H-3), 
4.70 (1H, d, J 9.5 Hz, H-2 or H-3), 4.32 (1H, d, J 14.0 Hz, -CHHOH), 4.29 (1H, d, 
J 14.0 Hz, -CHHOH), 2.11 (1H, br s, -OH), 1.41 (3H, s, -C-CH3), 1.41 (3H, s, -C-
CH3); δC (75.5 MHz, CDCl3, 298 K) 136.1 (C-1), 124.6 (C-4), 124.0 (C-5), 119.5 
(C-6), 105.5 (H3C-C-CH3), 71.8 (C-2), 71.0 (C-3), 64.6 (-CH2OH), 26.8 (-CCH3), 
24.8 (-CCH3); νmax (film) 3575, 3416, 3044, 2985, 2930, 1734, 1611, 1541, 1406, 
1371, 1304, 1246, 1207, 1158, 1033, 950, 877, 820, 791, 756, 718, 694 cm-1; 
HRMS (+ve ESI-TOF) m/z calcd for (C10H14O3+Na)+, 205.0841, found 205.0834. 
 






Alcohol 440 (21.2 mg, 0.116 mmol, 1.0 equiv) and (2S)-3,3,3-trifluoro-2-methoxy-
2-phenylpropionate280 (54.5 mg, 0.233 mmol, 2.00 equiv, 95% e.e.) were 
dissolved in CH2Cl2 (0.5 mL) at room temperature. N,N-Dimethylaminopyridine 
(2.5 mg, 0.020 mmol, 0.09 equiv) in CH2Cl2 (0.3 mL) was added by syringe, 
followed by N,N’-diisopropylcarbodiimide (29.4 mg, 0.233 mmol, 2.00 equiv). The 
reaction mixture was stirred at room temperature for 17 h, then concentrated 
under reduced pressure. A 1H−NMR spectrum of the crude was acquired, then 
purification by chromatography (30% EtOAc-hexane) gave 442 (–)-(2’S,3’R)-
(2’,3’-isopropylidenedioxycyclohexa-4’,6’-dienyl)methyl (2S)-3,3,3-trifluoro-2-
methoxy-2-phenylpropionate (40 mg, 87%) as a white gum; Rf 0.68 (30% EtOAc-
hexane); [α]D25 −30 (c 0.1, CH2Cl2); δH (400 MHz, CDCl3, 298 K) 7.53-7.52 (2H, 
m, Ar-H), 7.41-7.34 (3H, m, Ar-H), 6.01-5.97 (2H, m, H’-5, H’-6), 5.94-5.91 (1H, 
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m, H’-4), 5.05 (1H, d, J 13.0 Hz, -CHH-O-), 4.89 (1H, d, J 13.0 Hz, -CHH-O-), 
4.65 (1H, dd, J 9.0, 3.5 Hz, H’-3), 4.52 (1H, d, J 9.0 Hz, H’-2), 3.56 (3H, s, 
-OCH3), 1.37 (6H, s, 2× C-CH3); δC (125.8 MHz, CDCl3, 298 K) 166.3 (C=O), 
132.2, 130.8, 130.1, 129.6, 128.7, 127.4, 126.9, 125.9, 123.3, 123.3 (q, 1JCF 287 
Hz, -CF3), 122.7, 105.6 (H3C-C-CH3), 84.7 (q, 2JCF 27 Hz, CCF3), 70.7, 70.5, 66.6 
(-CH2O-), 55.5 (-OCH3), 26.7 (-CCH3), 24.7 (-CCH3); δF (376.5 MHz, CDCl3, 298 
K) -71.5; νmax (film) 2968, 1754, 1452, 1372, 1171, 1122, 1017, 719, 642 cm-1; 
HRMS (+ve ESI-TOF) m/z calcd for (C20H21F3O5+Na)+, 421.1239, found 
421.1238. 
 

















Alcohol 440 (20.1 mg, 0.111 mmol, 1.0 equiv) and (2R)-3,3,3-trifluoro-2-methoxy-
2-phenylpropionate280 (60.0 mg, 0.256 mmol, 2.31 equiv, 99% e.e.) were 
dissolved in CH2Cl2 (1.2 mL) at room temperature. N,N-Dimethylaminopyridine 
(2.0 mg, 0.016 mmol, 0.15 equiv) in CH2Cl2 (0.3 mL) was added by syringe, 
followed by N,N’-diisopropylcarbodiimide (28.0 mg, 0.222 mmol, 2.00 equiv). The 
reaction mixture was stirred at rt for 17 h, then concentrated under reduced 
pressure. A 1H NMR spetrum of the crude was acquired , then purification by 
chromatography (20% EtOAc-hexane) gave 441 (–)-(2’S,3’R)-(2’,3’-
isopropylidenedioxycyclohexa-4’,6’-dienyl)methyl (2R)-3,3,3-trifluoro-2-methoxy-
2-phenylpropionate (32 mg, 72%) as a white gum; Rf 0.58 (20% EtOAc-hexane); 
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[α]D25 +10 (c 0.1, CH2Cl2); δH (400 MHz, CDCl3, 298 K) 7.57-7.52 (2H, m, Ar-H), 
7.44-7.36 (3H, m, Ar-H), 6.02-5.99 (2H, m, H’-5, H’-6), 5.95-5.92 (1H, m, H’-4), 
4.99 (1H, d, J 13.0 Hz, -CHH-O-), 4.94 (1H, d, J 13.0 Hz, -CHH-O-), 4.62 (1H, 
dd, J 9.0, 3.5 Hz, H’-3), 4.51 (1H, d, J 9.0 Hz, H’-2), 3.58 (3H, s, -OCH3), 1.37 
(3H, s, C-CH3), 1.36 (3H, s, C-CH3); δC (100.6 MHz, CDCl3, 298 K) 166.3 (C=O), 
132.3, 130.7, 129.7, 129.6, 128.8, 127.3, 126.8, 125.8 (q, 1JCF 276 Hz, -CF3), 
125.8, 123.4, 122.9, 105.6 (H3C-C-CH3), 84.7 (q, 2JCF 27 Hz, -CCF3), 70.6, 70.4, 
66.7 (-CH2O-), 55.6 (-OCH3), 26.7 (-CCH3), 24.7 (-CCH3); δF (376.5 MHz, CDCl3, 
298 K) -71.5; νmax (film) 2988, 1749, 1672, 1498, 1452, 1372, 1236, 1168, 1122, 
1018, 766, 710, 655 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C20H21F3O5+Na)+, 
421.1239, found 421.1240. 
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7.3 Compounds for Chapter 5 
 
General Experimental Procedures 
 
1. General procedure (A) for formation of cationic η5-dienyl complexes 




Acid* (TFA, HOTf, HPF6, HBF4, HBF4.OEt2) (~ 10.00 eq.) was added to a stirred 
solution of the neutral complex 383 (~ 0.10 g, 0.322 mmol, 1.00 eq.) in acetic 
anhydride (3.2 mL) at −12 °C, under nitrogen atmosp here, and stirred at this 
temperature for 1 h. To the reaction mixture, cold dried Et2O was added (60 mL) 
dropwise and light yellow precipitate was formed and filtered by suction, washed 
with cold Et2O (3 × 5 mL). After concentration and recrystalisation of resultant 
acidic solution with tBuOMe, an additional amount of products were afforded to 
give mixture of products 451 and 452. The crude cation mixture was used 
immediately in the next step. 
 






The procedure (A) for the formation of cationic products was undertaken and to a 
resultant solution of the cationic products in dry THF, MeCN or Ac2O (0.20 M) at 
0 °C was added solid sodium thiophenolate (1.374 mm ol, 4.28 eq.). The mixture 
was stirred for 1hr at this temperature, under nitrogen atmosphere. The resultant 
yellow suspension was quenched with H2O (10 mL) and extracted with CH2Cl2 (3 
× 20 mL). The organic layers were combined, dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by column chromatography 
(SiO2, 10% hexanes-ethyl acetate) to afford two products 455 and 456 (1,2- and 
2,3-additions). 
 
3. General procedure (C) for formation of cationic η5-dienyl complexes 




Tetrafluoroboric acid in diethyl ether (10.00 eq.) was added dropwise to a stirred 
solution of the neutral complex 383 (~0.20 g, 0.645 mmol, 1.00 eq.) in acetic 
anhydride (~ 6.2 mL, 0.1 M) at −12 °C for 1 h, unde r nitrogen atmosphere. The 
reaction mixture was transferred to cold Et2O (150 mL) and light yellow 
precipitate was formed and filtered by suction, washed with cold Et2O (3 × 
10mL). Recrystalization with tBuOMe afforded two products 451&452, in 83% 
overall yield. The crude cation mixture was used immediately in the next step. 
 
4. General procedure (D) for nucleophilic addition reactions of (−)-
Tricarbonyl(η5-(2S)-methyl 2-






The procedure (C) for the formation of cationic products was undertaken and to a 
resultant solution of the cationic products in dry THF or CH3CN (5 mL) at 0 °C 
was added a nucleophile (5.00 eq.). The reaction mixture was stirred at this 
temperature, under nitrogen atmosphere for 1 h, and then quenched by addition 
of H2O. The product extracted with EtOAc or Et2O (3 × 20 mL). The organic 
layers were combined, dried over MgSO4, filtered and concentrated in vacuo. 
The residue was purified by column chromatography (SiO2, hexanes-ethyl 
acetate) to afford the products. 
 
 




Method A: To a solution of anhydrous trimethylamine N-oxide (TMANO) (36.00 
eq.) in dry benzene (5 mL) was added a solution of iron complex in benzene (50 
mL), and then the solution was stirred at room temperature, under nitrogen 
atmosphere for 24 h. To the brown resultant solution was added water (80 mL) 
and extracted with diethyl ether (2 × 20 mL). The organic layer was dried 





Method B: To a solution of the relevant iron complex in wet acetone (2 mL) at 0 
°C was added a solution of ceric ammonium nitrate ( 3.00 eq.) in acetone (1 mL) 
dropwise over 5 mins. The reaction mixture was allowed to warm to room 
temperature and stirred for an additional time period (specified). Water was 
added (5 mL) and the solution was extracted with Et2O (2 × 20 mL). The 
combined organic layers were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure and purified by column chromatography. 
 






Formation of (±)-465. In accordance with the general procedure, employing 
MeCN at 0 °C to r.t. with 233 mg of 383 and with a 0.1M aqueous solution of 
NaOH as nucleophile, gave 465 as a light yellow foam (64.8 mg, 25%) Rf 0.36 
[40:60 EtOAc-Petrol]; δH (400 MHz, CDCl3); 5.61 (1H, ddd, J 6.0, 4.0, 1.5 Hz, H-
5), 5.47 (1H, t, J 5.5 Hz, H-4), 4.17 (1H, dd, J 7.0, 3.5 Hz, H-2), 3.70 (3H, s, -
COOCH3), 3.20 (1H, d, J 6.5 Hz, H-6), 3.13 (1H, ddd, J 5.0, 3.5, 1.5 Hz, H-3), 
2.71 (1H, d, J 7.0 Hz, -OH), 2.15 (3H, s, -OC(O)CH3); δC (100.6 MHz, CDCl3) 
209.9 (3 × Fe(CO)3), 170.6, 169.8, 85.2, 85.1, 84.0, 77.6, 61.1, 55.7, 53.0, 21.2; 
νmax (film) 3421, 2956, 2923, 2853, 2157, 2050, 1966, 1739, 1714, 1432, 1367, 
1333, 1270, 1236, 1205, 1136, 1101, 1069, 1049, 1025, 992, 964, 929, 909, 872, 
814, 763, 734, 705, 674 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
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(C13H12O8FeNa1)+, 374.9782; found 374.9779. Elemental analysis: C, 44.7; H, 
3.56. C13H12FeO8 requires C, 44.35; H, 3.44%. 
 





Formation of (±)-463. In accordance with the general procedure, employing THF 
at 0 °C to r.t. with 195 mg of 383, gave 463 as yellow foam, 81.4 mg (34%) Rf 
0.56 [20:80 EtOAc-Hexane]; mp: 124-126 °C; δH (250 MHz, CDCl3); 5.69 (1H, t, J 
4.5 Hz, H-5), 5.59 (1H, t, J 5.0 Hz, H-4), 3.90 (1H, d, J 3.5 Hz, H-2), 3.72 (3H, s, -
COOCH3), 3.54 (1H, d, J 6.0 Hz, H-6) 3.05 (1H, t, J 4.5 Hz, H-3), 2.15 (1H, s, 
-OC(O)CH3); δC (75.4 MHz, CDCl3) 209.4 (3 × Fe(CO)3), 170.0, 168.1, 86.9, 85.1, 
84.2, 68.0, 57.1, 55.2, 53.0, 21.3; νmax (film) 2956, 2237, 2100, 2054, 1971, 1740, 
1450, 1435, 1369, 1331, 1222, 1138, 1063, 1041, 1012, 993, 946, 915, 869, 812, 
766, 733, 716, 672, 649 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
(C13H11FeN3O7Na1)+, 399.9844; found 399.9829. Elemental analysis: C, 41.5; H, 


































Formation of 455. In accordance with the general procedure, employing THF at 
–78 °C to r.t., with 82 mg of 383 gave 455 as a beige solid (52.4 mg, 45%) Rf 
0.28 [10:90 EtOAc-Hexane]; mp: 117-118 °C; δH (250 MHz, CDCl3); 7.39-7.35 
(2H, m, o-Ar-H), 7.33-7.27 (3H, m, p+m-Ar-H), 5.64 (1H, ddd, J 6.0, 4.0, 1.5 Hz, 
H-5), 5.39 (1H, td, J 5.5, 1.0 Hz, H-4), 3.77 (1H, d, J 6.5 Hz, H-6), 3.66 (3H, s, -
COOCH3), 3.64 (1H, d, J 4.0 Hz, H-2), 3.29 (1H, ddt, J 5.0, 3.5, 1.5, H-3), 2.18 
(3H, s, -OC(O)CH3); δC (75.4 MHz, CDCl3) 210.0 (3 × Fe(CO)3), 170.2, 168.9, 
136.2, 131.0, 129.1, 127.2, 87.3, 86.6, 83.9, 61.1, 58.9, 57.6, 52.7, 21.5; νmax 
(film) 3067, 2951, 2332, 2258, 2152, 2052, 1967, 1739, 1582, 1481, 1438, 1367, 
1276, 1243, 1219, 1138, 1086, 1061, 1049, 1025, 987, 948, 909, 866, 809, 732, 
691 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C19H16FeO7S1Na1)+, 466.9863; 
found 466.9850. Elemental analysis: C, 52.1; H, 3.73. C19H16FeO7S requires C, 
51.37; H, 3.63%;  
X-ray crystal data C19H16FeO7S, M=444.23, Triclinic, P1, a = 7.3200(1)Å α = 
97.505(1)⁰ b = 10.5210(2)Å β = 103.386(1)o c = 13.3490(2)Å γ = 102.216(1)o, 
V=959.88(3) Å3, Z=2, Dc=1.537 Mg/m3, µ(Cu-Kα)=0.933 mm-1, T=150(2) K, 
18914 independent measured reflections, 3921 independent observed 









Formation of (±)-461. In accordance with the general procedure, employing 
MeCN at 0 °C to r.t. with 200 mg of 383, gave (±)-461 as a yellow foam 68.8 mg 
(31%) Rf 0.45 [20:80 EtOAc-Hexane]; mp: 89-91 °C,  δH (300 MHz, CDCl3); 5.46 
(1H, t, J 5.5 Hz, H-4), 5.35 (1H, ddd, J 6.0, 4.0, 1.0 Hz, H-5), 3.65 (3H, s, -
COOCH3), 3.16 (1H, dd, J 4.0, 2.0 Hz, H-3), 3.05 (1H, d, J 6.5 Hz, H-6), 2.71 
(1H, dd, J 16.0, 1.0 Hz, H-2), 2.07 (3H, s, -O(C(O)CH3), 1.91 (1H, dd, J 16.5, 3.5 
Hz, H-2); δC (75.4 MHz, CDCl3) 210.5 (3 × Fe(CO)3), 171.8, 170.1, 87.1, 82.3, 
81.4, 61.5, 60.4, 52.9, 39.9, 21.0; νmax (film) 2957, 2048, 1961, 1735, 1436, 1371, 
1330, 1273, 1248, 1200, 1125, 1056, 1014, 969, 947, 899, 865, 843, 810, 762, 
674, 612, 624 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C13H12FeO7Na1)+, 
358.9830; found 358.9825. Elemental analysis: C, 47.1; H, 3.92. C13H12FeO7 
requires C, 46.46; H, 3.60%; 
X-ray crystal data C13H12FeO7, M=336.08, Monoclinic, P21/n, a = 9.9550(2)Å α = 
90° b = 5.9360(1) Å β = 91.773(1)o c = 22.9660(5)Å γ = 90o, V=1356.48(5) Å3, 
Z=4, Dc=1.646 Mg/m3, µ(Cu-Kα)=1.143 mm-1, T=150(2) K, 23752 independent 
measured reflections, 2590 independent observed reflections, 209 parameters. 
 







Formation of 466. In accordance with the general procedure, employing MeCN 
at 0 °C to r.t. with 233 mg of  383 and with a 0.1M aqueous solution of NaOH as 
nucleophile, gave 466 as a yellow oil, 27.6 mg (10%), Rf 0.26 [40% EtOAc-
Petrol]; [α]D25 +190 (c 0.1, CH2Cl2); δH (250 MHz, CDCl3); 6.07 (1H, dd, J 4.5, 1.0 
Hz, H-6), 5.61 (1H, t, J 5.5 Hz, H-5), 4.66 (1H, s, H-2), 3.87 (1H, br, H-3), 3.68 
(3H, s, -COOCH3), 3.12 (1H, t, J 5.5 Hz, H-4), 2.70 (1H, d, J 3.0 Hz, -OH), 2.12 
(3H, s, -O(C(O)CH3); δC (75.4 MHz, CDCl3) 171.4, 171.4, 91.3, 83.9, 76.9, 76.6, 
61.7, 59.2, 52.1, 21.1; νmax (film) 3412, 2059, 1984, 1750, 1713, 1436, 1374, 
1271, 1237, 1100, 1034, 969, 919, 873, 775, 685 cm-1; HRMS (+ve ESI-TOF) 
m/z calcd for (C13H12O8FeNa1)+, 374.9782; found 374.9774. Elemental analysis: 
C, 43.9; H, 3.64. C13H12FeO8 requires C, 44.35; H, 3.44%. 
 
7.3.6 Synthesis of (−)-(4S)-Tricarbonyl(η4-(2S,3R)-1-methyl 2-acetoxy-





























Formation of 464. In accordance with the general procedure, employing THF at 
0 °C to r.t. with 195 mg of 383, gave 464 as light yellow oil (12.4 mg, 5%) Rf 0.43 
[20:80 EtOAc-Hexane]; [α]D25 +430 (c 0.1, CH2Cl2); δH (250 MHz, CDCl3); 6.09 
(1H, dd, J 4.5, 1.0 Hz, H-6), 5.67 (1H, t, J 5.0 Hz, H-5), 4.95 (1H, s, H-2), 3.68 
(3H, s, -COOCH3), 3.58 (1H, d, J 4.5 Hz, H-3), 3.14 (1H, td, J 5.5, 1.0 Hz, H-4), 
2.11 (3H, s, -OC(O)CH3); δC (75.4 MHz, CDCl3) 208.4 (3 × Fe(CO)3), 170.9, 
169.4, 91.7, 82.9, 73.0, 66.9, 63.6, 55.8, 52.2, 21.0; νmax (film) 2955, 2096, 2059, 
1982, 1746, 1713, 1456, 1435, 1369, 1323, 1275, 1225, 1151, 1099, 1032, 971, 
926, 872, 814, 775, 745, 611 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 
(C13H11FeN3O7 Na1)+, 399.9844; found 399.9846. Elemental analysis: C, 41.6; H, 
3.00; N, 10.7. C13H11FeN3O7 requires C, 44.41; H, 2.94; N, 11.14%.   
 





Formation of 456. In accordance with the general procedure, employing THF at 
–78 °C to rt, with 82 mg of 383 gave 456 as a yellow oil, 7.3 mg (6%). Rf 0.15 
[10:90 EtOAc-Hexane]; [α]D25 +20 (c 0.05, CH2Cl2); δH (250 MHz, CDCl3); 7.44-
7.42 (2H, m, o-Ar-H), 7.32-7.29 (3H, m, para+meta-Ar-H), 5.91 (1H, d, J 4.0 Hz, 
H-6), 5.41 (1H, t, J 5.0 Hz, H-5), 5.24 (1H, s, H-2), 3.65 (3H, s, -COOCH3), 3.30 
(1H, s, H-4), 3.26 (1H, br, H-3), 2.05 (3H, s, -OC(O)CH3); δC (75.4 MHz, CDCl3) 
208.9 (3 × Fe(CO)3), 171.0, 169.3, 134.3, 129.7, 129.0, 128.4, 90.1, 83.0, 72.8, 
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64.8, 60.8, 55.2, 52.0, 21.0; νmax (film) 2340, 2203, 2146, 2061, 1991, 1749, 
1717, 1438, 1370, 1272, 1229, 1097, 1026, 143, 693 cm-1; HRMS (+ve ESI-TOF) 
m/z calcd for (C19H16FeO7S1Na1)+, 466.9864; found 466.9861. Elemental 
analysis: C, 51.3; H, 3.64; C19H16FeO7S1 requires C, 51.37; H, 3.63. 
 





Formation of 462. In accordance with the general procedure, employing MeCN 
at 0 °C to r.t. with 200 mg of 383, gave 462 as a yellow foam, 9.5 mg (4%). Rf 
0.30 [20:80 EtOAc-Hexane]; [α]D25 +280 (c 0.1, CH2Cl2); δH (300 MHz, CDCl3); 
5.94 (1H, d, J 3.0 Hz, H-6), 5.52 (1H, t, J 5.0 Hz, H-5), 5.03 (1H, d, J 6.5 Hz, H-
2), 3.68 (3H, s, -COOCH3), 3.20 (1H, br s, H-4), 2.09 (1H, dd, J 16.0, 6.5 Hz, H-
3), 2.07 (3H, s, -OC(O)CH3), 1.58 (1H, dd, J 16.0, 3.5 Hz, H-3); δC (75.4 MHz, 
CDCl3) 209.4 (3 × Fe(CO)3), 171.7, 170.2, 90.3, 84.5, 77.4, 68.1, 58.7, 51.9, 
34.3, 21.2; νmax (film) 2952, 2850, 2055, 1972, 1737, 1713, 1583, 1435, 1368, 
1343, 1270, 1235, 1132, 1097, 1042, 1029, 991, 969, 894, 865, 802, 775, 715, 
685 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C13H12FeO7Na1)+, 358.9830; 
found 358.9834. Elemental analysis: C, 46.6; H, 3.71. C13H12FeO7 requires C, 
46.46; H, 3.60%.   
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Formation of (±)-474. Reaction of 13.8 mg of (±)-465 for 25 min gave a beige 
solid, 8.8 mg (100%). Rf 0.48 [ 50:50 EtOAc:Petrol]; δH (400 MHz, CDCl3); 6.33 
(1H, d, J 9.5 Hz, H-6), 6.17 (1H, dd, J 9.5, 5.0 Hz, H-5), 6.09 (1H, dd, J 9.5, 5.0 
Hz, H-4), 6.01 (1H, dd, J 9.5, 5.0 Hz, H-3), 4.36 (1H, dd, J 8.5, 4.5 Hz, H-2), 3.80 
(3H, s, -COOCH3), 2.05 (3H, s, -OC(O)CH3), 1.94 (1H, d, J 9.0 Hz, -OH); δC 
(100.6 MHz, CDCl3) 170.0, 169.9, 126.6, 126.5, 124.4, 124.3, 79.6, 68.6, 52.9, 
20.9; νmax (film) 3452, 2955, 2056, 1985, 1732, 1436, 1412, 1370, 1273, 1232, 
1136, 1078, 1047, 1019, 1000, 953, 920, 879, 812, 729, 796 694, 620 cm-1; 
HRMS (+ve ESI-TOF) m/z calcd for (C10H12O5Na1)+, 235.0577; found 235.0616; 
for (C20H24O10Na1)+, 447.1262; found 447.1255. 
 
 





Formation of (±)-473. Reaction of 77.3 mg of (±)-463 for 4 h gave a white solid, 
34.9 mg (64%). Rf 0.27 [10:90 EtOAc-hexane]; δH (300 MHz, CDCl3); 6.49 (1H, d 
J 9.5 Hz, H-6), 6.37 (1H, dd J 9.5, 5.5 Hz, H-4), 6.20 (1H, dd J 9.5, 5.5 Hz, H-5), 
5.90 (1H, dd J 9.0, 5.0 Hz, H-3), 3.86-3.83 (1H, m, H-2), 3.83 (3H, s, -COOCH3), 
2.02 (3H, s, -OC(O)CH3); δC (75.4 MHz, CDCl3) 169.6, 169.4, 126.8, 126.6, 
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124.7, 120.1, 77.3, 57.7, 53.3, 20.7; νmax (film) 2957, 2101, 1744, 1438, 1371, 
1272, 1235, 1075, 1021, 937, 852, 808, 746 cm-1; HRMS (+ve ESI-TOF) m/z 
calcd for (C10H11N3O4Na1)+, 260.0642; found 260.0625. 
 
 





Formation of (±)-471. Reaction of 63.8 mg of (±)-455 for 5 min gave a brown oil 
37.1 mg, (85%) Rf 0.42 [ 20:80 EtOAc-Hexane]; δH (500 MHz, CDCl3): 7.49-7.47 
(2H, m Ar-H), 7.28-7.25 (3H, m, Ar-H), 6.36 (1H, d, J 9.5 Hz, H-6), 5.99-5.91 (3H, 
m, H-3,4,5), 4.04 (1H, d, J 4.5 Hz, H-2), 3.65 (3H, s, -COOCH3), 1.99 (3H, s, 
-OC(O)CH3); δC (125.8 MHz, CDCl3): 169.6, 169.5, 134.8, 131.3, 128.3, 127.0, 
125.1, 123.2, 122.9, 79.6, 52.4, 48.6, 20.7; νmax (film) 2951, 2058, 1995, 1742, 
1581, 1473, 1438, 1368, 1268, 1229, 1131, 1074, 1012, 986, 951, 909, 752, 717, 
691, 651, 631 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C16H16S1O4Na1)+, 
327.0667; found 327.0687. 
 
 







Formation of 478. Reaction of 14.7 mg of 466 for 5 min gave a white solid, 4.7 
mg (53%). Rf 0.19 [35:65 EtOAc:hexane]; [α]D25 +400 (c 0.1, CH2Cl2); δH (500 
MHz, CDCl3); 7.26-7.25 (1H, m, H-6), 6.29-6.28 (2H, m, H-4,5), 5.89 (1H, d, J 2.5 
Hz, H-2), 4.34 (1H, s, H-3), 3.78 (3H, s, -COOMe), 2.34 (1H, d, J 6.0 Hz, OH), 
2.07 (3H, s, OAc); δC (125.8 MHz, CDCl3) 171.0, 166.2, 135.2, 133.0, 125.2, 
124.2, 70.7, 67.7, 52.2, 21.2; νmax (film) 3444, 2955, 2922, 2853, 2008, 1741, 
1714, 1651, 1587, 1438, 1407, 1371, 1230, 1121, 1082, 1020,992, 960, 917, 
876, 815, 743, 682 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C10H12O5Na1)+, 
235.0577; found 235.0616; for (C20H24O10Na1)+, 447.1262; found 447.1278. 
 
 






Formation of 477. Reaction of 26.4 mg of 464 for 3 h gave a colourless oil, 10.5 
mg (63%). Rf 0.27 [20:80 EtOAc-Hexane]; [α]D25 +840 (c 0.1, CH2Cl2); δH (400 
MHz, CDCl3); 7.30 (1H, dd, J 6.0, 0.5 Hz, H-6), 6.52 (1H, dd, J 9.5, 6.0 Hz, H-5), 
6.21 (1H, dd, J 9.5, 5.5 Hz, H-4), 5.93 (1H, dd, J 2.0, 1.0 Hz, H-2), 4.00 (1H, dd, 
J 5.5, 1.5 Hz, H-3), 3.80 (3H, s, -COOCH3), 2.04 (3H, s, -OC(O)CH3);  δC (125.8 
MHz, CDCl3) 170.0, 165.7, 135.4, 127.6, 126.5, 125.4, 66.1, 56.4, 52.3, 21.1; 
νmax (film) 2917, 2850, 2097, 1744, 1718, 1438, 1371, 1289, 1259, 1226, 1082, 
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1022, 757 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C10H11O4N3Na1)+, 
260.0642; found 260.0621. 
 
 





Formation of 475. Reaction of 3.4 mg of 456 for 5 min gave a white solid, 2.1 
mg (91%) Rf 0.35 [20:80 EtOAc-Hexane]; [α]D25 +40 (c 0.1, CH2Cl2); δH (500 MHz, 
CDCl3); 7.53-7.50 (2H, m, Ar-H), 7.31-7.30 (3H, m, Ar-H), 7.13 (1H, d, J 5.5 Hz, 
H-6), 6.28 (1H, dd, J 9.0, 5.5 Hz, H-4), 6.24 (1H, dd, J 9.0, 5.5 Hz, H-5), 6.08 
(1H, s, H-3), 4.08 (1H, d, J 5.5 Hz, H-2), 3.77 (3H, s, -COOMe), 1.98 (3H, s, 
-OC(O)CH3); δC (125.8 MHz, CDCl3) 170.3, 166.2, 135.7, 133.9, 132.2, 129.0, 
128.5, 123.8, 123.7, 67.7, 52.2, 46.4, 29.8, 21.2; νmax (film) 2924, 2854, 2064, 
2064, 2004, 1743, 1715, 1580, 1439, 1369, 1286, 1228, 1078, 1025, 991, 951, 











Methanolysis of (±)-465 to give (±)-468. To a solution of 465 (64.8 mg, 0.184 
mmol, 1.00 equiv) in MeOH (dry, 8 mL) under nitrogen atmosphere, was added 
solid sodium methoxide (118 mg, 3.68 mmol, 20.0 eq.), and stirred for 24 h at 
room temperature. The resulting reaction mixture was diluted with EtOAc (15 
mL), then washed with H2O (15 mL). The organic phase dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure and purified by 
column chromatography to afford (±)-468 as a yellow powder (20 mg, 35%). Rf 
0.35 [50:50 EtOAc-Petrol]; δH (300 MHz, CDCl3); 5.55 (1H, t, J 4.5 Hz), 5.40 (1H, 
t, J 4.5 Hz), 4.07 (1H, br s), 3.77 (3H, s, -COOCH3), 3.71 (1H, s), 3.07 (1H, br s), 
2.74 (1H, d, J 6.0 Hz); δC (75.4 MHz, CDCl3) 210.0 (3 × Fe(CO)3), 173.7, 84.8, 
84.5, 81.5, 62.0, 59.1, 53.5; νmax (film) 3426, 3361, 2059, 1983, 1708, 1274, 
1122, 1014 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C11H10O7FeNa1)+, 
332.9673; found 332.9673.  
X-ray crystal data C11H10FeO7, M=310.04, Triclinic, P1, a = 6.9380(2))Å α = 
99.162(3)o b = 7.4496(3)Å β 99.099(3)o c = 12.0918(4)Å γ = 95.993(3)o, 
V=603.82(4) Å3, Z=2, Dc=1.705 Mg/m3, µ(Cu-Kα)=1.275 mm-1, T=150(2) K, 2129 






















Formation of 460. In accordance with the general procedure, employing THF at 
–78 °C to r.t., with 82 mg of 455 gave 460 as a yellow oil, 10.8 mg (8%). Rf 0.24 [ 
10:90 EtOAc-hexane]; δH (300 MHz, CDCl3); 7.56 (2H, d, J 7.0 Hz, 2xmeta-H-Ar-
1), 7.42 (2H, d, J 7.0 Hz, 2xmeta-H-Ar-2), 7.35-7.25 (6H, m, ortho,para-H-Ar-1,2), 
6.11 (1H, d, J 4.0 Hz), 5.43 (1H, t, J 10.5, 5.0 Hz), 4.34 (1H, d, J 10.0 Hz), 4.22 
(1H, dd, J 9.5, 2.0 Hz), 3.68 (3H, s, -OMe), 3.45 (1H, d, J 5.0 Hz); δC (75.4 MHz, 
CDCl3) 170.8, 136.6, 135.8, 132.8, 132.4, 129.4, 128.9, 127.9, 127.5, 86.2, 85.9, 
65.1, 63.3, 55.0, 51.9, 49.8; νmax (film) 3064, 2950, 2057, 1984, 1713, 1582, 
1478, 1438, 1273, 1204, 1085, 1025, 743, 691, 610 cm-1; HRMS (+ve ESI-TOF) 
m/z calcd for (C23H18FeS2O5+ Na)+, 516.9843; found 516.9860. 
 
 
7.3.17 Synthesis of (−)-(4S)-Tricarbonyl(η4-(2S,3R)-1-methyl 2-acetoxy-




A solution of dimethyl malonate (87.6 µL), in THF (2 mL) was cooled to −78 °C 
and treated with n-BuLi (399 µL, 1.30 equiv), and left to stir for 15 min. Then 
reaction mixture were transferred via cannula into a solution of cationic solution 
of 383 in THF (10 mL), and left to stir for 48 h. The solution was quenched with 
NH4Cl (5 mL), and washed with EtOAc (2 × 20 mL), brnie, dried (MgSO4), and 
concentrated. Flash chromatography (40% EtOAc-hexane) gave product 467 as 
creamy foam (24 mg, 12%). Rf 0.30 [ 40:60 EtOAc-hexane]; δH (300 MHz, 
CDCl3); 5.96 (1H, d, J 3.0, H-6), 5.45 (1H, t, J 5.0, H-5), 5.02 (1H, s, H-3), 3.74 
(3H, s, -OMe), 3.72 (3H, s, -OMe), 3.66 (3H, s, -COOMe), 3.47 (1H, d, J 7.0 Hz, 
H-2), 3.29 (1H, t, H-4), 2.07 (3H, s, OAc); δC (75.4 MHz, CDCl3) 236.6 (3 × 
Fe(CO)3), 168.1, 114.7, 90.6, 83.5, 70.6, 65.5, 58.9, 56.9, 53.0, 52.8, 52.0, 47.5, 
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21.0; νmax (film) 3463, 2956, 2060, 1982, 1731, 1435, 1369, 1235, 1196, 1163, 
1101, 1029, 966, 909, 872, 802, 775, 687 cm-1; HRMS (+ve ESI-TOF) m/z calcd 
for (C18H18FeO11+ Na)+, 489.0100; found 489.0045. 
 





A solution of 461 (35 mg, 0.104 mmol, 1.00 equiv), in CH2Cl2 (1 mL) was treated 
with triphenylcarbenium tetrafluoroborate (36 mg, 0.109 mmol, 1.05 equiv), and 
left to stir for 1 h at room temperature, under nitrogen atmosphere. Then reaction 
mixture was cooled down to −12 °C, and acetic acid (5.96 µL, 0.104 mmol, 1.00 
equiv) was added, and left to stir for 1 h at 0 °C.  The solution was quenched with 
water (2 mL), and washed with CH2Cl2 (3 × 10 mL), dried (MgSO4), and 
concentrated. Flash chromatography (20% EtOAc-hexane) gave not stable 
product (±)-497 as yellow foam (11.4 mg, 27%). Rf 0.20 [ 20:80 EtOAc-hexane]; 
δH (500 MHz, CDCl3); 7.83 (2H, d, J 7.5, Ar), 7.68 (1H, t, J 14.0, 5.0 Hz, Ar-para-
H), 7.58 (2H, t, J 15.0, 7.5 Hz, Ar-H), 6.12 (1H, d, J 4.0 Hz), 5.61 (1H, t, J 10.5, 
5.0 Hz, H), 3.70 (3H, s, -OMe), 3.67 (1H, dt, J 11.0, 6.5, 3.0 Hz, H), 3.13 (1H, t, J 
8.0, 3.5 Hz, H), 2.49 (1H, dd, J 16.0, 11.5 Hz, H), 1.89 (1H, dd, J 16.0, 3.0 Hz, 
H); δC (125.5 Hz, CDCl3) 171.5, 137.9, 134.1, 129.5, 129.0, 90.0, 85.3, 64.6, 
61.0, 52.1, 51.9, 25.8; νmax (film) 2964, 2924, 2853, 2059, 1981, 1709, 1464, 
1447, 1381, 1306, 1274, 1254, 1192, 1145, 1084, 1026, 919, 886, 804, 763, 730, 
695, 669, 649, 605 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C11H8FeO5+ H)+, 





7.3.19 Synthesis of Methyl trans-5,6-Diacetoxy-1,3-cyclohexadiene-1-
carboxylate, (482) 




Acetylation of 478 to give 482. Compound 478 (4 mg, 0.018 mmol, 1.00 eq.) 
was dissolved in dry CH2Cl2 (2 mL) at 0 °C and Ac 2O (3.8 µL, 0.040 mmol, 2.0 
eq.) was added portionwise, followed by Et3N (8.4 µL, 0.060 mmol, 3.2 eq.). The 
reaction mixture was stirred at room temperature under an atmosphere of 
nitrogen for 24 h. The reaction mixture was transferred into separating funnel and 
extracted with EtOAc (4 × 10 mL), and water (10 mL) and the combined organic 
phases dried over Na2SO4, filtered and concentrated, followed by flash column 
chromatography (30% EtOAc-hexane) to give 482 as an white solid (3 mg, 63%) 
Rf 0.35 [ 30:70 EtOAc-Hexane]; [α]D25 +440 (c 0.1, CH2Cl2); δH (500 MHz, CDCl3); 
7.28 (1H, d, J 6.0 Hz, H-6), 6.37 (1H, dd, J 9.5, 6.0 Hz, H-5), 6.29 (1H, dd, J 9.5, 
6.0 Hz, H-4), 5.94 (1H, d, J 2.0 Hz, H-2), 5.29 (1H, dd, J 5.00, 2.00 Hz, H-3), 3.79 
(3H, s, -COOMe), 2.05 (6H, s, 2 × -OC(O)CH3); δC (125.8 MHz, CDCl3) 169.6, 
169.6, 165.8, 135.1, 129.1, 126.0, 125.4, 67.7, 65.9, 52.1, 21.0, 21.0; νmax (film) 
2955, 1742, 1717, 1594, 1437, 1370, 1295, 1221, 1084, 1022, 967, 749 cm-1; 
HRMS (+ve ESI-TOF) m/z calcd for (C12H14O6Na1)+, 277.0683; found 277.0773; 
for (C24H28O12Na1)+, 531.1473; found 531.1581. 
 








This was performed in accordance with a literature procedure.297  
To a mixture of furan (6.00 g, 0.088 mmol, 3.00 eq.) and methyl acrylate (2.64 
mL, 0.029 mmol, 1.00 eq.) 2 × 0.37 mL of BF3-OEt2 was added via syringe at −20 
°C with stirring. Solution was stirred at this temp erature under nitrogen overnight. 
During the reaction, the solution colour changed to pale yellow. After evaporation 
of the excess reagents, the residue was poured into CH2Cl2 and washed 
successively with water (20 mL), NaHCO3 (sat.), and brnie (20 mL), dried over 
MgSO4, and concentrated in vacuo to give crude product purified further on 
silica-gel column chromatography (Hexane-EtOAc: 1:1) to give first fraction as an 
endo-product 489, 263 mg, 6%, δH (100 MHz, CCl4); 6.35 (1H, dd, J 6.0, 1.5 Hz, 
C5-H), 6.13 (1H, dd, J 6.0, 1.5 Hz, C6-H), 5.01 (1H, br d, J 5 Hz, C1-H), 4.89 
(1H, br d, J 5 Hz, C4-H), 3.56 (3H, s), 2.96 (1H, q, J 4.5 Hz, C2-H), 2.00 (1H, 
ddd, J 11.5 10.5 Hz, C3-H), 1.50 (1H, dd, J 11.5, 4 Hz, C-H); Data in agreement 
with that previously reported.313 
 
7.3.21 Synthesis of (±)-endo-7-Oxabicyclo[2.2.1]hept-5-ene-2-




This was performed in accordance with a literature procedure.298 To racemic 
methyl ester product 489 was added 1 M NaOH (6 mL). The resulting mixture 
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was stirred at room temp. for 23 h under nitrogen, before being acidified (conc. 
HCl, to Ph = 4.0) and extracted with DCM (8 × 20 mL). The organic phase was 
dried over MgSO4, and evaporated under reduced pressure to give crystalline 
acid 486 (237.7 mg, 89%).m.p.=96−98 °C,  δH (60 MHz, CDCl3); 8.81 (COOH), 
6.45 (1H, dd, J 6.0, 2 Hz, C-H6), 6.28 (1H, dd, J 6.0, 2 Hz, C-H5), 5.06 (1H, br d, 
J 4, 2 Hz, C-H-4), 5.23 (1H, br d, J 4, 2 Hz, C-H1), 3.17 (1H, q, J 8, 4, 4 Hz, C-
H2
-exo), 2.13 (1H, m, C-H3-exo), 1.55 (1H, dd, J 10, 4 Hz, C-H3-endo);314 
Data in agreement with that previously reported.298,314 
 
 





This was performed in accordance with a literature procedure.299  
Compound 486 (211.6 mg, 1.510 mmol, 1.00 eq.) was dissolved in water (6.5 
mL) containing NaHCO3 (152.2 mg, 1.812 mmol, 1.20 eq.). Bromine (85 µL, 
1.661 mmol, 1.10 eq.) was added dropwise to this solution under vigorous 
agitation. Resultant mixture was stirred for 1 h, and precipitate was collected by 
filtration and washed with water thoroughly. Recrystalization of the crude product 
from EtOAc gave product 490 (269 mg, 81%) as prims: data in agreement with 
that previously reported.299 δH (60 MHz, DMSO-d6) 5.53 (1H, t, J 5 Hz, H-8), 4.95 
(1H, d, J 5 Hz, H-1), 4.75 (1H, m, H-6), 4.37 (1H, s, H-9), 2.69 (1H, m, H-4), 2.00-





7.3.23 Synthesis of DL-(1,3,5/2,4)-2,3-Diacetoxy-4,5-




This was performed in accordance with a literature procedure.300  
A mixture of 490 (268.7 mg, 1.227 mmol) and 33% hydrogen bromide in glacial 
acetic acid (2.5 mL) was heated in a sealed tube at 80 °C for 2 days. The cooled 
mixture was poured into ice-water, and the precipitate was collected and 
recrystallized from ethanol to give 491 (207 mg, 42%), as prims m.p.= 206-207 
°C; δH (90 MHz, CD3OD); 2.04 (3H, s, OAc), 1.96 (3H, s, OAc). 
Data in agreement with that previously reported.300 
 
 





A mixture of 491 in 20 mL of MeOH-Benzene (1:1) was treated with slow addition 
of (trimethylsilyl)diazomethane (2.0 M solution in hexanes) when a yellow colour 
persisted ( ~ 2.75 mL) at room temperature. 
The reaction mixture was stirred for 1h, and then concentrated under reduced 
pressure, dried in vacuo to give 492 (229.3 mg, 100%) as a light yellow oil, used 
immediately without purification. 1H-NMR data (90 MHz); δH 3.70 (3H, s, Me), 
Experimental Part 
 190 
2.66 (3H, s, OAc), 2.00 (3H, s, OAc). 1H−NMR in agreement with that previously 
reported.300  
 





This was performed in accordance with a literature procedure.300  
A mixture of 492 (229.3 mg, 0551 mmol, 1.00eq.), zinc powder (360.3 mg, 5.511 
mmol, 10.00 eq.) and acetic acid (20 mL) was stirred vigorously at 70 °C for 1 h, 
and then the insoluble material was removed, and the filtrate concentrated. A 
solution of the residue in EtOAc (30 mL) was washed with 1M HCl and water. 
Dried over MgSO4 and concentrated in vacuo to give crude of 493 (106.8 mg, 
81%), as a prims m.p.= 67- 68.5 °C; δH (90 MHz, CD3OD); 5.87 (1H, dt, J 3.8, 9.6 
Hz, H-4), 5.65-5.26 (3H, m, H-2,3,5), 3.67 (3H, s, Me), 2.93 (1H, dt, J 10.7, 8.6 
Hz, H-1), 2.60-2.33 (2H, m, H-6,6’), 2.03 (3H, s, OAc), 2.00 (3H, s, OAc). 
1H NMR in agreement with that previously reported.300 
 
 
















This was performed in accordance with a literature procedure.301 A mixture of 
493 (106.8 mg, 0.417 mmol, 1.00 eq.), NBS (148.3 mg, 0.833 mmol, 2.00 eq.), 
AIBN (15mg), and carbon tetrachloride (4 mL), was refluxed under nitrogen 
atmosphere for 2h. Cooled reaction mixture was concentrated, and the residue 
absorbed on silica and was purified by silica-gel column chromatography with 2-
butanone-toluene (1:20) as eluent to give three fractions, when the last one was 
desired product 494 (45 mg, 26%) as an oil, partially crystallized. No second 
column chromatography was performed. 1H-NMR data in agreement with that 
previously reported.301 m.p.= 115 − 116 °C; δH (90 MHz, CDCl3); 7.10 (1H, d, H-
6), 6.03 (1H, d, H-2), 5.49 (1H, dd, J 6.5 Hz, H-3), 4.97 (1H, t, J 4 Hz, H-5), 4.57 
(1H, dd, J 4.0, 2.7 Hz, H-4), 3.80 (3H, s, CO2Me), 2.12 (3H, s, OAc), 2.07 (3H, s, 
OAc). 





This was performed in accordance with a literature procedure.301  
To a stirred solution of 494 (45 mg, 0.109 mmol, 1.00 eq.) in acetic acid (0.6 mL) 
was added zinc powder (28.4 mg, 0.4344 matom, 4.00 eq.) at room temperature. 
After 2 h, TLC (2-butanone-toulene 1:5) showed a disappearance of 494. The 
reaction mixture was washed with water (10 mL), NaHCO3 (sat.), and brnie (10 
mL), dried over MgSO4, concentrated and purified by silica gel column 
chromatography (30:70 EtOAc-Hexane) to give 482 (17.7 mg, 64%) as a white 
foam. Rf = 0.35, m.p.= 80 − 81 °C; δH (90 MHz, CDCl3); 7.28 (1H, dd, J 4.5, 1.5 
Hz, H-2), 6.33 (2H, m, H-3 and H-4), 5.92 (1H, d, H-6), 5.27 (1H, dd, J 4.5, 1.7 
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Hz, H-5), 3.80 (3H, s, CO2Me), 2.04 (6H, s, 2×OAc). 1H−NMR data in agreement 
with that previously reported. 301 
 
 





This was performed in accordance with a literature procedure.243  
A mixture of diol acid 33 (1.03 g, 6.63 mmol, 1.00 eq.) and caesium fluoride (1.51 
g, 9.94 mmol, 1.50 eq.) in DMF (15 mL) was stirred at room temperature for 2 
min, followed by addition of ethyl iodide (0.799 mL, 9.94 mmol, 1.50 eq.). The 
reaction mixture was stirred for 23 h, then diluted with aqueous NaHCO3 (15 mL) 
and extracted with EtOAc (3 × 15 mL). The organic layer was dried over Na2SO4 
and filtered. The filtrate was concentrated under reduced pressure, then purified 
by chromatography (50:50 EtOAc-Hexane) to give 498 as a colourless oil, 846 
mg (69%). Rf 0.37 (50:50 EtOAc-Petrol); [α]D25 −140 (c 0.1, CH2Cl2); δH (500 
MHz, CDCl3): δ = 6.12 (1H, dd, J 9.5, 5.5 Hz, H-5), 5.93 (1H, dddd, J 9.5, 5.5, 
3.0, 1.0 Hz, H-4), 5.80 (1H, ddt, J 9.5, 2.5, 1.0 Hz, H-3), 5.74 (1H, dd, J 9.5, 1.0 
Hz, H-6), 4.83 (1H, d, J 5.0 Hz, H-2), 4.31 (2H, q, J 7.0 Hz, -CH2CH3), 3.67 (1H, 
s, C1-OH), 2.84 (1H, d, J 9.5 Hz, C2-OH), 1.32 (3H, t, J 7.0 Hz, -CH2CH3); δC 
(125.8 MHz, CDCl3): δ = 175.3, 132.1, 126.7, 124.9, 122.8, 73.9, 71.0, 63.0, 
14.3;  FT-IR (neat): νmax =  3448, 3049, 2983, 1727, 1446, 1408, 1369, 1246, 
1169, 1078, 1039, 1019, 914, 858, 829, 754, 724, 693, 646 cm-1; HRMS (+ve 
ESI-TOF) m/z calcd for (C9H12O4Na1)+, 207.0628; found 207.0748; for 










To ester 498 (1.79 g, 5.52 mmol, 1.0 eq.) was added nonacarbonyldiiron (3.05 g, 
8.28 mmol, 1.5 eq.). THF (200 mL) was added, and the reaction mixture was 
stirred at room temperature for 5 days. The reaction mixture was concentrated 
under reduced pressure (caution! toxic pentacarbonyliron distilled over) and 
the crude product was purified by chromatography (30:70 EtOAc-Petrol) to give 
499 as a yellow foam, 1.09 g (61%). Rf 0.60 (30:70 EtOAc-Petrol); [α]D25 -180 (c 
0.1, CH2Cl2); δH (300 MHz, CDCl3): δ = 5.38-5.33 (2H, m, H-4,5), 4.22-4.15 (2H, 
m, -CH2CH3), 3.94 (1H, s, C1-OH), 3.88 (1H, d, J 5.0 Hz, H-2), 3.26 (1H, d, J 6.5 
Hz, C2-OH), 3.21 (1H, dt, J 6.0, 2.0 Hz, H-3), 2.82 (1H, dd, J 6.0, 1.5 Hz, H-6), 
1.27 (3H, t, J 7.0 Hz, -CH2CH3); δC (75.4 MHz, CDCl3): δ = 210.2 (3 × Fe(CO)3), 
174.4, 84.5, 84.2, 77.2, 72.0, 67.6, 64.6, 62.7, 14.0;  FT-IR (neat): νmax = 3401.5, 
2991, 2905, 2051, 1960, 1720, 1574, 1446, 1377, 1297, 1233, 1175, 1133, 1063, 
1026, 936, 866, 831, 737 cm-1; HRMS (+ve ESI-TOF) m/z calcd for 





7.3.30 Synthesis of (±)-(3S)-Tricarbonyl(η4-(1S)-ethyl 1-






Tetrafluoroboric acid diethyl etherate (319 µL, 2.33 mmol 4.00 eq.) was added to 
a stirred solution of complex 499 (189 mg, 0.583 mmol, 1.00 eq.) in acetic 
anhydride (5.8 mL) at −10 °C and stirred at this te mperature for 1 h. To the 
reaction mixture, pre-cooled Et2O was added (60 mL) dropwise, giving a light 
yellow precipitate. This was filtered by suction and washed with cold Et2O (3 × 5 
mL). The crude cation mixture was redissolved in MeCN at 0 °C, and NaBH 4 
(111 mg, 2.91 mmol, 5.00 eq.) was added in one portion. The reaction mixture 
allowed to warm to room temperature and was stirred for 18 h, then quenched by 
addition of H2O. The product was extracted with CH2Cl2 (3 × 20 mL). The organic 
layers were combined, dried over Na2SO4 and filtered. The filtrate was 
concentrated under reduced pressure and the crude product was purified by 
chromatography (10:90 EtOAc-Hexane) to give (±)-502 as a yellow foam, 80.3 
mg (39%). Rf 0.25 (10:90 EtOAc-Hexane); δH (500 MHz, CDCl3): δ = 5.47 (1H, t, 
J 5.5 Hz, H-4), 5.36 (1H, t, J 5.5 Hz, H-5), 4.18-4.07 (2H, m, -CH2CH3), 3.20-3.17 
(1H, m, H-3), 3.08 (1H, d, J 6.5 Hz, H-6), 2.73 (1H, d, J 16.0 Hz, H-2), 2.09 (3H, 
s, -OC(O)CH3), 1.92 (1H, dd, J 16.0, 3.5 Hz, H-2); 1.22 (3H, t, J 7.0 Hz, -
CH2CH3); δC (125.8 MHz, CDCl3): δ = 210.6 (3 × Fe(CO)3), 171.3, 170.1, 87.1, 
82.3, 81.5, 61.8, 61.6, 60.5, 39.9, 21.0, 14.6; FT-IR (neat): νmax = 2985, 2051, 
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1969, 1740, 1427, 1370, 1251, 1196, 1097, 1054, 1014, 954, 869 cm-1; HRMS 
(+ve ESI-TOF) m/z calcd for (C14H14FeO7Na1)+, 372.9986; found 372.9996. 
Second product 503 was isolated as a yellow foam, 10.9 mg (5%). Rf 0.14 (10:90 
EtOAc- Hexane); [α]D25 +120 (c 0.1, CH2Cl2); δH (250 MHz, CDCl3): δ = 5.95 (1H, 
dd, J 4.5, 1.5 Hz,  H-6), 5.52 (1H, t, J 5.5 Hz, H-5), 5.04 (1H, d, J 6.5 Hz, H-2), 
4.24-4.02 (2H, m, -CH2CH3), 3.22-3.17 (1H, m, H-4), 2.10-2.00 (1H, m, H-3) 2.06 
(3H, s, -OC(O)CH3), 1.57 (1H, ddd, J 16.0, 4.5, 1.0 Hz, H-3), 1.24 (3H, t, J 7.0 
Hz, -CH2CH3); δC (75.4 MHz, CDCl3): δ = 209.5 (3 × Fe(CO)3), 171.2, 170.1, 
90.4, 84.4, 68.5, 68.2, 61.0, 58.6, 34.3, 21.2, 14.1;  FT-IR (neat): νmax = 2925, 
2057, 1981, 1739, 1710, 1505, 1448, 1368, 1240, 1207, 1098, 1043, 871, 752, 
715, 612 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C14H14FeO7Na1)+, 372.9986; 
found 372.9974. 
NMR data for this racemic compound is in agreement with a recent enantiopure 
Synthesis of 5.225 
 
 
7.3.31 Synthesis of (±)-tricarbonyl 1-ethyl cyclohexa-3,5-




Deacetoxylation to give cation (±)-349. Iron complex (±)-502 (51.5 mg, 0.147 
mmol) was dissolved in dry CH2Cl2 (3 mL) at −12 °C and HBF 4-eterate (30.2 µL, 
0.220 mmol, 1.50 eq.) was added portionwise. The reaction mixture was stirred 
at this temperature under an atmosphere of nitrogen for 1 h. The reaction mixture 
was added to cold Et2O (50 mL) to give a precipitate that was isolated by 
filtration, washed with Et2O and dried under vacuum affording (±)-349 as a pale 
yellow powder, 55.5 mg (100%); δH (300 MHz, CD3CN); 7.38 (1H, t, J 5.0 Hz), 
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6.57 (1H, d, J 5.5 Hz), 5.91 (1H, t, J 5.5 Hz), 4.70 (1H, t, J 6.5 Hz), 4.26 (1H, q, J 
7.0 Hz), 3.27 (1H, dd, J 15.5, 6.5 Hz), 1.96-1.86 (1H, m), 1.28 (1H, t, J 7.0 Hz); 
δC (75.4 MHz, CD3CN): 167.6, 105.1, 103.0, 91.3, 71.8, 63.9, 56.0, 24.2, 14.1; 
HRMS (+ve ESI-TOF) m/z calcd for (C12H11FeO5)+, 290.9951; found 290.9925. 
 
NMR data for this racemic compound is in agreement with a recent enantiopure 
Synthesis of 5.225 
 
 






Formation of (±)-353. To a suspension of [η5]+ complex (±)-349 (51.5 g, 0.1471 
mmol, 1.00 eq.) in dry CH2Cl2 (3 mL) and tert-butyl carbamate (34.5 mg, 0.294 
mmol, 2.00 eq.) at 0 °C was added  dropwise diisopropylethyl amine (38.5 µL, 
1.50 eq.). The reaction mixture stirred on ice for 30 min before being allowed to 
warm to room temperature. Left to stir under nitrogen for 23 h. The reaction 
mixture was further stirred for 23 h, then quenched by addition of water, 
transferred to a separating funnel and extracted with CH2Cl2 (3 × 30 mL). The 
combined organic phases were dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure and purified by column chromatography 
(20:80 EtOAc-Petrol) to give (±)-353 as a yellow oil, 48.2 mg (82%). Rf 0.59 [20% 
EtOAc-hexane]; δH (300 MHz, CDCl3); 6.20 (1H, d, J 4.0 Hz), 5.39 (1H, dd, J 6.0, 
4.5 Hz), 4.40-4.17 (2H, m), 4.21-4.03 (2H, m), 3.27 (1H, br s), 2.84 (1H, dd, J 
15.0, 11.0 Hz), 1.41 (9H, s), 1.25 (3H, t, J 7.0 Hz), 1.16 (1H, dd, J 15.0, 3.0 Hz); 
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δC (75.4 MHz, CDCl3) 171.8, 155.1, 90.0, 84.2, 79.9, 62.6, 61.0, 59.6, 49.5, 31.0, 
28.5, 14.2; Data in agreement with those previously reported.315 
 
 





Formation of (±)-354. To a solution of the iron complex (±)-353 (48.9 mg, 0.120 
mmol) in EtOH (20 mL) on an ice bath at 0 °C was ad ded aqueous hydrogen 
peroxide (30%, 8.3 mL), followed by the dropwise addition of 1M NaOH (7.23 
mL) and the reaction mixture was stirred on ice under a nitrogen atmosphere for 
5 min. The reaction was diluted with brine (50 mL) and the product extracted with 
CH2Cl2 (3 × 50 mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated, affording (±)-354 as a light yellow oil 22.6 mg (71%); δH 
(400 MHz, CDCl3); 7.04 (1H, d, J 4.0, 1.0 Hz), 6.19-6.10 (2H, m), 4.64 (1H, br s), 
4.43 (1H, br s), 4.22 (2H, q, J 14.0, 7.0 Hz), 2.76-2.62 (1H, m), 1.43 (9H, s), 1.30 
(1H, t, J 7.0 Hz); NMR data for this racemic compound is in agreement with a 
recent enantiopure synthesis of 9.315 
 
 
7.3.34 Synthesis of (±)-5-tert-Butoxycarbonylamino-cyclohexa-1,3-






Formation of (±)-278. To a suspension of 354 in methanol (2 mL) at room 
temperature was added 2 M NaOH (1 mL) and left to stir for 2 h 50 min. The 
solution was acidified with 2 M HCl, and extracted with DCM (5 × 20 mL), dried 
over MgSO4, concentrated on vacuo to give racemic (±)-278 without further 
purification as a white solid (13.5 mg, 67%); δH (300 MHz, CDCl3); 7.17 (1H, m), 
6.20 (2H, m), 4.69-4.67 (1H, br, NH), 4.47-4.45 (1H, br), 2.70 (2H, m), 1.43 (9H, 
s); HRMS (+ve ESI-TOF) m/z calcd for (C12H17FeO4Na1)+, 238.1079; found 
238.1075. 
NMR data for this racemic compound is in agreement with a recent enantiopure 
Synthesis of 5.203 
 
 






Formation of (±)-279. A solution of HCl/dioxane (2 mL, 4 N HCl) was added to 
the racemic (±)-278 (13.5 mg, 0.056 mmol) under nitrogen, cooled on an ice bath 
to 0 °C, with stirring. Allowed to warm up the reac tion mixture to room 
temperature over 1h. The reaction mixture was concentrated under high 
pressure, dried in vacuo, followed by flash column chromatography (silica: 8:3:1, 
chloroform-methanol-water) to give racemic (±)-279 as a white solid, mp=195-
199 °C (lit. 316 mp=198-200 °C), (7.5 mg, 96%); δH (400 MHz, D2O); 6.76 (1H, d, J 
5.5 Hz), 6.41 (1H, dd, J 9.5, 5.5 Hz), 6.00 (1H, dd, J 9.5, 5.0 Hz), 4.04 (1H, dd, J 
12.0, 6.0 Hz), 2.72-2.69 (2H, m); δC (100.6 MHz, D2O) 174.8, 131.8, 129.4, 
128.0, 123.4, 44.4, 27.2; HRMS (-ve ESI-TOF) m/z calcd for (C7H8NO2)+, 









Formation of (±)-504. To a suspension of [η5]+ complex (±)-349 (78.2 g, 0.2233 
mmol) and potassium phthalimide (124 mg, 0.699 mmol, 3.00 eq.) in CH2Cl2 (4.4 
mL) was cooled to 0 °C.  Di isopropylethyl amine (42.7 µL, 0.246 mmol, 1.10 eq.) 
was added dropwise and the reaction mixture was stirred at 0 °C for 30 min 
before being allowed to warm to room temperature. The reaction mixture was 
stirred for 23 h, then quenched by addition of water, transferred to a separating 
funnel and extracted with CH2Cl2 (3 × 30 mL). The combined organic phases 
were dried over MgSO4 and filtered. The filtrate was concentrated under reduced 
pressure, then purified by column chromatography (15:85 EtOAc-Petrol) to give 
(±)-504 as a yellow solid, 70.8 mg (73%). Rf 0.73 (15:85 EtOAc-Petrol); mp: 124-
125 °C; δH (400 MHz, CDCl3): 7.79 (2H, dd, J 5.5, 3.0 Hz, Ar-H), 7.69 (2H, dd, J 
5.5, 3.0 Hz, Ar-H), 6.33 (1H, d, J 4.5 Hz, H-6), 5.59 (1H, t, J 5.5 Hz, H-5), 4.90 
(1H, dt, J 11.5, 3.5 Hz, H-3), 4.24-4.08 (2H, m, -CH2CH3), 2.91 (1H, dd, J 5.0, 3.5 
Hz, H-4), 2.78 (1H, dd, J 15.0, 11.5 Hz, H-2), 1.84 (1H, dd, J 15.0, 4.0 Hz, H-2),  
1.26 (3H, t, J 7.0 Hz, -CH2CH3); δC (100.6 MHz, CDCl3): 171.6, 167.7, 134.0, 
131.7, 123.2, 89.5, 85.7, 60.8, 60.0, 58.2, 48.3, 26.3, 14.1; νmax (film) 2982, 2057, 
1982, 1774, 1708, 1468, 1382, 1354, 1327, 1270, 1249, 1117, 1083, 1042, 881, 
716, 649, 606 cm-1; HRMS (+ve ESI-TOF) m/z calcd for (C20H15FeNO7Na1)+, 











To a solution of the iron complex (±)-504 (38 mg, 0.0869 mmol, 1.00 eq.) in EtOH 
(17 mL) at 0 °C was added aqueous hydrogen peroxide  (30%, 6.0 mL), followed 
by the dropwise addition of aqueous NaOH (1.0 M, 5.2 mL). The reaction mixture 
was stirred for 5 min. The reaction was diluted with brine (50 mL) and the product 
extracted with CH2Cl2 (3 × 50 mL). The combined organic phases were dried 
over MgSO4, filtered. The filtrate was concentrated under reduced pressure, 
affording (±)-505 as a light yellow foam, mp= 124-125 °C, 19.8 mg (77 %). δH 
(400 MHz, CDCl3); 7.84 (2H, dd, J 5.5, 3.0 Hz), 7.74 (2H, dd, J 5.5, 3.0 Hz), 7.09 
(1H, m), 6.23 (1H, ddd, J 9.5, 5.5, 3.0 Hz), 6.00 (1H, dd, J 9.5, 3.0 Hz), 5.23 (1H, 
ddm, J 13.0, 10.0 Hz), 4.22 (2H, q, J 14.0, 7.0 Hz), 2.93 (1H, dt, J 17.5, 15.0, 2.5 
Hz); 2.81 (1H, dd, J 17.0, 10.0, Hz); 1.30 (3H, t, J 14.0, 7.0 Hz); δC (100.6 MHz, 
CDCl3) 167.9, 166.8, 134.5, 132.8, 131.7, 131.6, 127.8, 125.0, 123.8, 60.8, 46.1, 
26.6, 14.4; 
NMR data for this racemic compound is in agreement with previously reported.224  
 
 








To a suspension of [η5]+ complex (±)-502 (15 mg, 0.042 mmol, 1.00 eq.) in dry 
CH2Cl2 (2 mL) at −12 °C and HBF 4-etherate (8.8 µL, 0.064 mmol, 1.50 eq.) was 
added portionwise. The reaction mixture was stirred at this temperature under an 
atmosphere of nitrogen for 1 h. To this reaction mixture, cooled on an ice bath to 
0 oC, and then tert-butyl carbamate (10.0 mg) was added, The reaction mixture 
stirred on ice for 30 min before allowing it to warm to room temperature. Left to 
stir under nitrogen for 1h. The reaction mixture was transferred into separating 
funnel and extracted with water (5 mL), and CH2Cl2 (5 × 10mL) and the 
combined organic phases dried over MgSO4, filtered and concentrated, followed 
by flash column chromatography (20:80 EtOAc-Hexane) to give racemic (±)-506 
as an yellow oil 10.5 mg (80%); Rf 0.24 [20:80 EtOAc-Petrol]; (500 MHz, CDCl3); 
6.28 (1H, d, J 4.5 Hz), 5.50 (1H, t, J 5.5 Hz), 4.45 (1H, d, J 4.5 Hz), 4.22-4.08 
(2H, m, -CH2Me), 3.18 (1H, t, J 5.0 Hz), 2.82 (1H, dd, J 15.5, 10.0 Hz), 1.59 (1H, 
s), 1.37 (1H, dd, J 15.5, 2.5 Hz), 1.26 (3H, t, J 7.0 Hz, -CH2CH3); δC (125.8 MHz, 
CDCl3) 210.5 (3 × Fe(CO)3), 171.8, 90.5, 84.5, 69.9, 63.8, 61.0, 58.6, 32.8, 30.5, 
14.2; νmax (film) 2980, 2057, 1984, 1706, 1281, 1245, 1085, 1024, 609 cm-1; 
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APPENDIX  1 
 























Figure 13  
 
ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic numbering 
scheme for 383 
 
Table 6 Crystal data and structure refinement for 383. 
                                                        
 Identification code k08sel1 
 Empirical formula C11 H10 Fe O7 
 Formula weight 310.04 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Monoclinic 
 Space group P212121 
 Unit cell dimensions a = 8.0220(1)Å α = 90o 
       b = 8.1780(1)Å β = 90o 
       c = 18.1270(3)Å γ = 90o 
Appendix 1 
 217 
 Volume 1189.20(3) Å3 
 Z 4 
 Density (calculated) 1.732 Mg/m3 
 Absorption coefficient 1.295 mm-1 
 F(000) 632 
 Crystal size 0.20 x 0.30 x 0.40 mm 
 Theta range for data collection 3.56 to 29.13 o. 
 Index ranges -10<=h<=10; -11<=k<=11; -24<=l<=24 
 Reflections collected 25065 
 Independent reflections 3187 [R(int) = 0.0524] 
 Reflections observed (>2σ) 2889 
 Data Completeness 0.997 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.68 and 0.63 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 3187 / 4 / 193 
 Goodness-of-fit on F2 1.108 
 Final R indices [I>2σ(I)] R1 = 0.0259   wR2 = 0.0588 
 R indices (all data) R1 = 0.0349  wR2 = 0.0622 
 Absolute structure parameter -0.034(14) 
 Largest diff. peak and hole 0.644 and -0.856 eÅ-3 
  
 
Notes: H4-H7 located and refined at a distance of 0.98Å from the relevant parent 
atoms. Intramolecular and intermolecular hydrogen bonding present. 
 
 
Hydrogen bonds with  H..A < r(A) + 2.000 Angstroms  and  <DHA > 110 
deg. 
 
 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
 
 O4-H4A         0.840    1.994   123.58    2.556    O7  
 
 O7-H7A         0.840    1.989   156.40    2.780    O5 [ -x, y+1/2, 
-z+3/2 ] 
 
   
 Table 7 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 383. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
                                                                                  
  Atom   x   y   z  U(eq) 
                                 
Fe(1) -29(1) 9595(1) 5514(1) 16(1) 
O(1) -3424(2) 10047(2) 6086(1) 34(1) 
O(2) 92(2) 6016(2) 5503(1) 32(1) 
O(3) -921(2) 9774(2) 3946(1) 38(1) 
O(4) -608(2) 10934(2) 7404(1) 24(1) 
O(5) 2374(2) 11216(2) 8081(1) 26(1) 
O(6) 3480(2) 12350(2) 7068(1) 25(1) 
O(7) -1291(2) 13153(2) 6458(1) 23(1) 
C(1) -2097(3) 9887(2) 5875(1) 23(1) 
C(2) 28(2) 7402(2) 5502(1) 22(1) 
C(3) -549(2) 9712(2) 4549(1) 24(1) 
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C(4) 691(2) 12061(2) 5599(1) 19(1) 
C(5) 2067(2) 11041(2) 5421(1) 21(1) 
C(6) 2347(2) 9749(2) 5918(1) 20(1) 
C(7) 1213(2) 9675(2) 6522(1) 20(1) 
C(8) 775(2) 11240(2) 6938(1) 19(1) 
C(9) 410(2) 12655(2) 6381(1) 18(1) 
C(10) 2262(2) 11620(2) 7441(1) 20(1) 
C(11) 5024(3) 12640(2) 7460(1) 27(1) 
                                     
  
 Table 8 Bond lengths [Å] and angles [o] for 383. 
  
Fe(1)-C(2) 1.7942(17) Fe(1)-C(1) 1.799(2) 
Fe(1)-C(3) 1.8025(19) Fe(1)-C(6) 2.0459(18) 
Fe(1)-C(5) 2.0628(18) Fe(1)-C(7) 2.0813(17) 
Fe(1)-C(4) 2.1037(17) O(1)-C(1) 1.139(2) 
O(2)-C(2) 1.135(2) O(3)-C(3) 1.134(2) 
O(4)-C(8) 1.417(2) O(4)-H(4A) 0.8400 
O(5)-C(10) 1.210(2) O(6)-C(10) 1.329(2) 
O(6)-C(11) 1.448(3) O(7)-C(9) 1.4312(19) 
O(7)-H(7A) 0.8400 C(4)-C(5) 1.420(3) 
C(4)-C(9) 1.515(2) C(4)-H(4) 0.940(15) 
C(5)-C(6) 1.406(3) C(5)-H(5) 0.959(14) 
C(6)-C(7) 1.425(3) C(6)-H(6) 0.923(15) 
C(7)-C(8) 1.526(2) C(7)-H(7) 0.959(14) 
C(8)-C(10) 1.532(2) C(8)-C(9) 1.564(2) 
C(9)-H(9) 1.0000 C(11)-H(11A) 0.9800 
C(11)-H(11B) 0.9800 C(11)-H(11C) 0.9800 
                                           
C(2)-Fe(1)-C(1) 99.26(9) C(2)-Fe(1)-C(3) 92.67(8) 
C(1)-Fe(1)-C(3) 97.63(9) C(2)-Fe(1)-C(6) 92.44(9) 
C(1)-Fe(1)-C(6) 136.16(7) C(3)-Fe(1)-C(6) 124.02(8) 
C(2)-Fe(1)-C(5) 123.46(8) C(1)-Fe(1)-C(5) 134.85(8) 
C(3)-Fe(1)-C(5) 94.51(8) C(6)-Fe(1)-C(5) 40.01(8) 
C(2)-Fe(1)-C(7) 91.76(7) C(1)-Fe(1)-C(7) 96.80(8) 
C(3)-Fe(1)-C(7) 164.02(8) C(6)-Fe(1)-C(7) 40.39(7) 
C(5)-Fe(1)-C(7) 70.33(7) C(2)-Fe(1)-C(4) 162.22(8) 
C(1)-Fe(1)-C(4) 95.71(8) C(3)-Fe(1)-C(4) 94.81(8) 
C(6)-Fe(1)-C(4) 70.03(8) C(5)-Fe(1)-C(4) 39.85(7) 
C(7)-Fe(1)-C(4) 76.93(7) C(8)-O(4)-H(4A) 109.5 
C(10)-O(6)-C(11) 116.91(14) C(9)-O(7)-H(7A) 109.5 
O(1)-C(1)-Fe(1) 177.98(17) O(2)-C(2)-Fe(1) 178.58(18) 
O(3)-C(3)-Fe(1) 178.09(18) C(5)-C(4)-C(9) 121.11(16) 
C(5)-C(4)-Fe(1) 68.52(10) C(9)-C(4)-Fe(1) 109.58(11) 
C(5)-C(4)-H(4) 116.0(13) C(9)-C(4)-H(4) 114.1(13) 
Fe(1)-C(4)-H(4) 119.9(13) C(6)-C(5)-C(4) 114.85(16) 
C(6)-C(5)-Fe(1) 69.35(11) C(4)-C(5)-Fe(1) 71.63(10) 
C(6)-C(5)-H(5) 120.1(13) C(4)-C(5)-H(5) 123.9(12) 
Fe(1)-C(5)-H(5) 118.2(12) C(5)-C(6)-C(7) 114.93(17) 
C(5)-C(6)-Fe(1) 70.64(10) C(7)-C(6)-Fe(1) 71.14(10) 
C(5)-C(6)-H(6) 120.8(13) C(7)-C(6)-H(6) 124.2(13) 
Fe(1)-C(6)-H(6) 125.0(13) C(6)-C(7)-C(8) 119.43(16) 
C(6)-C(7)-Fe(1) 68.47(10) C(8)-C(7)-Fe(1) 110.51(11) 
C(6)-C(7)-H(7) 121.1(12) C(8)-C(7)-H(7) 112.9(11) 
Fe(1)-C(7)-H(7) 116.2(12) O(4)-C(8)-C(7) 109.07(14) 
O(4)-C(8)-C(10) 106.93(13) C(7)-C(8)-C(10) 106.56(14) 
O(4)-C(8)-C(9) 111.66(14) C(7)-C(8)-C(9) 110.12(14) 
C(10)-C(8)-C(9) 112.30(14) O(7)-C(9)-C(4) 108.94(14) 
O(7)-C(9)-C(8) 109.03(13) C(4)-C(9)-C(8) 109.79(13) 
O(7)-C(9)-H(9) 109.7 C(4)-C(9)-H(9) 109.7 
C(8)-C(9)-H(9) 109.7 O(5)-C(10)-O(6) 123.76(16) 
O(5)-C(10)-C(8) 124.91(16) O(6)-C(10)-C(8) 111.16(14) 
O(6)-C(11)-H(11A) 109.5 O(6)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 O(6)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 H(11B)-C(11)-H(11C) 109.5 
                                                    
Symmetry transformations used to generate equivalent atoms: 




 Table 9 Anisotropic displacement parameters (Å2 x 103) for 383. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
                                                                                 
  Atom  U11  U22  U33  U23  U13  U12 
                                               
Fe(1) 18(1) 14(1) 17(1) 1(1) 1(1) 0(1) 
O(1) 22(1) 43(1) 37(1) -7(1) 5(1) -3(1) 
O(2) 43(1) 17(1) 34(1) -3(1) -1(1) 0(1) 
O(3) 48(1) 46(1) 21(1) 1(1) -2(1) 10(1) 
O(4) 20(1) 28(1) 25(1) 1(1) 5(1) -4(1) 
O(5) 27(1) 29(1) 21(1) 4(1) -2(1) -8(1) 
O(6) 18(1) 32(1) 24(1) 6(1) -2(1) -7(1) 
O(7) 18(1) 19(1) 33(1) -4(1) 3(1) 5(1) 
C(1) 24(1) 22(1) 21(1) -2(1) -2(1) -1(1) 
C(2) 25(1) 20(1) 19(1) -1(1) -1(1) 0(1) 
C(3) 27(1) 22(1) 24(1) 0(1) 3(1) 4(1) 
C(4) 20(1) 15(1) 22(1) 4(1) 1(1) -1(1) 
C(5) 20(1) 19(1) 24(1) 0(1) 5(1) -3(1) 
C(6) 16(1) 19(1) 26(1) -3(1) -1(1) 3(1) 
C(7) 23(1) 16(1) 20(1) 2(1) -3(1) 0(1) 
C(8) 18(1) 18(1) 20(1) 1(1) 3(1) -2(1) 
C(9) 17(1) 15(1) 22(1) 0(1) 1(1) 2(1) 
C(10) 23(1) 15(1) 23(1) -1(1) 2(1) -2(1) 
C(11) 19(1) 32(1) 28(1) 3(1) -2(1) -2(1) 
  
 
 Table 10. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 383 
                                     
  Atom   x   y   z  U(eq) 
                                 
H(4A) -1421 11504 7266 57(9) 
H(7A) -1328 14102 6634 33(6) 
H(9) 1163 13602 6486 22 
H(11A) 5820 13183 7132 40 
H(11B) 5489 11594 7626 40 
H(11C) 4807 13338 7889 40 
H(4) 370(30) 12810(20) 5234(10) 30(6) 
H(5) 2640(20) 11060(30) 4957(8) 19(5) 
H(6) 3180(20) 8990(20) 5833(10) 18(5) 
H(7) 1130(20) 8710(20) 6823(10) 15(5) 
    
   
 Table 11 Dihedral angles [o] for 383 
                                         
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
                                                  
C(2) - Fe(1) - C(1) - O(1) -59(5) 
C(3) - Fe(1) - C(1) - O(1) 35(5) 
C(6) - Fe(1) - C(1) - O(1) -163(5) 
C(5) - Fe(1) - C(1) - O(1) 139(5) 
C(7) - Fe(1) - C(1) - O(1) -152(5) 
C(4) - Fe(1) - C(1) - O(1) 131(5) 
C(1) - Fe(1) - C(2) - O(2) -122(7) 
C(3) - Fe(1) - C(2) - O(2) 139(7) 
C(6) - Fe(1) - C(2) - O(2) 15(7) 
C(5) - Fe(1) - C(2) - O(2) 42(7) 
C(7) - Fe(1) - C(2) - O(2) -25(7) 
C(4) - Fe(1) - C(2) - O(2) 25(7) 
C(2) - Fe(1) - C(3) - O(3) 77(5) 
C(1) - Fe(1) - C(3) - O(3) -22(5) 
C(6) - Fe(1) - C(3) - O(3) 172(5) 
C(5) - Fe(1) - C(3) - O(3) -159(5) 
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C(7) - Fe(1) - C(3) - O(3) -177(100) 
C(4) - Fe(1) - C(3) - O(3) -119(5) 
C(2) - Fe(1) - C(4) - C(5) 23.2(3) 
C(1) - Fe(1) - C(4) - C(5) 170.53(11) 
C(3) - Fe(1) - C(4) - C(5) -91.29(12) 
C(6) - Fe(1) - C(4) - C(5) 33.24(10) 
C(7) - Fe(1) - C(4) - C(5) 74.86(11) 
C(2) - Fe(1) - C(4) - C(9) -93.5(2) 
C(1) - Fe(1) - C(4) - C(9) 53.83(13) 
C(3) - Fe(1) - C(4) - C(9) 152.01(13) 
C(6) - Fe(1) - C(4) - C(9) -83.47(12) 
C(5) - Fe(1) - C(4) - C(9) -116.70(17) 
C(7) - Fe(1) - C(4) - C(9) -41.85(11) 
C(9) - C(4) - C(5) - C(6) 44.8(2) 
Fe(1) - C(4) - C(5) - C(6) -55.71(14) 
C(9) - C(4) - C(5) - Fe(1) 100.55(15) 
C(2) - Fe(1) - C(5) - C(6) -44.94(13) 
C(1) - Fe(1) - C(5) - C(6) 113.41(13) 
C(3) - Fe(1) - C(5) - C(6) -141.15(11) 
C(7) - Fe(1) - C(5) - C(6) 33.68(11) 
C(4) - Fe(1) - C(5) - C(6) 126.75(15) 
C(2) - Fe(1) - C(5) - C(4) -171.69(10) 
C(1) - Fe(1) - C(5) - C(4) -13.35(16) 
C(3) - Fe(1) - C(5) - C(4) 92.10(12) 
C(6) - Fe(1) - C(5) - C(4) -126.75(15) 
C(7) - Fe(1) - C(5) - C(4) -93.07(11) 
C(4) - C(5) - C(6) - C(7) -0.3(2) 
Fe(1) - C(5) - C(6) - C(7) -57.24(14) 
C(4) - C(5) - C(6) - Fe(1) 56.93(14) 
C(2) - Fe(1) - C(6) - C(5) 143.85(11) 
C(1) - Fe(1) - C(6) - C(5) -110.08(13) 
C(3) - Fe(1) - C(6) - C(5) 48.98(14) 
C(7) - Fe(1) - C(6) - C(5) -126.30(16) 
C(4) - Fe(1) - C(6) - C(5) -33.11(10) 
C(2) - Fe(1) - C(6) - C(7) -89.84(12) 
C(1) - Fe(1) - C(6) - C(7) 16.23(15) 
C(3) - Fe(1) - C(6) - C(7) 175.28(11) 
C(5) - Fe(1) - C(6) - C(7) 126.30(16) 
C(4) - Fe(1) - C(6) - C(7) 93.20(12) 
C(5) - C(6) - C(7) - C(8) -45.1(2) 
Fe(1) - C(6) - C(7) - C(8) -102.11(15) 
C(5) - C(6) - C(7) - Fe(1) 56.97(14) 
C(2) - Fe(1) - C(7) - C(6) 91.70(12) 
C(1) - Fe(1) - C(7) - C(6) -168.76(11) 
C(3) - Fe(1) - C(7) - C(6) -14.3(3) 
C(5) - Fe(1) - C(7) - C(6) -33.39(12) 
C(4) - Fe(1) - C(7) - C(6) -74.45(12) 
C(2) - Fe(1) - C(7) - C(8) -153.69(12) 
C(1) - Fe(1) - C(7) - C(8) -54.15(13) 
C(3) - Fe(1) - C(7) - C(8) 100.3(3) 
C(6) - Fe(1) - C(7) - C(8) 114.61(17) 
C(5) - Fe(1) - C(7) - C(8) 81.22(12) 
C(4) - Fe(1) - C(7) - C(8) 40.16(11) 
C(6) - C(7) - C(8) - O(4) 167.98(15) 
Fe(1) - C(7) - C(8) - O(4) 91.80(14) 
C(6) - C(7) - C(8) - C(10) -76.92(19) 
Fe(1) - C(7) - C(8) - C(10) -153.10(11) 
C(6) - C(7) - C(8) - C(9) 45.1(2) 
Fe(1) - C(7) - C(8) - C(9) -31.06(16) 
C(5) - C(4) - C(9) - O(7) -160.29(15) 
Fe(1) - C(4) - C(9) - O(7) -84.13(14) 
C(5) - C(4) - C(9) - C(8) -41.0(2) 
Fe(1) - C(4) - C(9) - C(8) 35.21(16) 
O(4) - C(8) - C(9) - O(7) -4.99(19) 
C(7) - C(8) - C(9) - O(7) 116.34(15) 
C(10) - C(8) - C(9) - O(7) -125.08(15) 
O(4) - C(8) - C(9) - C(4) -124.27(15) 
C(7) - C(8) - C(9) - C(4) -2.94(19) 
C(10) - C(8) - C(9) - C(4) 115.64(15) 
C(11) - O(6) - C(10) - O(5) 1.0(3) 
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C(11) - O(6) - C(10) - C(8) -174.35(15) 
O(4) - C(8) - C(10) - O(5) 21.8(2) 
C(7) - C(8) - C(10) - O(5) -94.8(2) 
C(9) - C(8) - C(10) - O(5) 144.58(17) 
O(4) - C(8) - C(10) - O(6) -162.90(14) 
C(7) - C(8) - C(10) - O(6) 80.55(17) 
C(9) - C(8) - C(10) - O(6) -40.10(19) 
                                                





Figure 14 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 388 
 
      Table 12 Crystal data and structure refinement for 388 
  
 
Identification code                k10sel2 
      Empirical formula                  C14 H18 Fe O7 Si 
      Formula weight                      382.22 
      Temperature                         150(2) K 
      Wavelength                          0.71073 A 
      Crystal system, space group         Monoclinic,  P 21 
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      Unit cell dimensions            a = 11.7832(2) A   α = 90o                                      
b = 6.61340(10) A    β = 101.4370(10)o 
c = 22.3223(5) A   γ = 90o 
      Volume                              1704.97(5) Å3 
      Z, Calculated density               4,  1.489 Mg/m3 
      Absorption coefficient              0.985 mm-1 
      F(000)                              792 
      Crystal size                        0.38 x 0.15 x 0.15 mm 
      Theta range for data collection     2.99 to 27.50o 
      Limiting indices                    -15<=h<=15, -8<=k<=8, -29<=l<=28 
      Reflections collected / unique      30516 / 7382 [R(int) = 0.0607] 
      Completeness to theta = 27.50       91.8 % 
      Absorption correction               None 
      Refinement method                   Full-matrix least-squares on F2 
      Data / restraints / parameters      7382 / 1 / 447 
      Goodness-of-fit on F2              1.023 
      Final R indices [I>2sigma(I)]       R1 = 0.0366, wR2 = 0.0724 
      R indices (all data)                R1 = 0.0591, wR2 = 0.0804 
      Absolute structure parameter        -0.014(11) 
      Largest diff. peak and hole        0.340 and -0.442 e.A-3 
 
 
         Table 13 Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (A2 x 103) for 388. U(eq) is defined as one third of the trace of the 
orthogonalized  Uij tensor. 
  
          
  Atom   x   y   z  U(eq) 
                                  
Fe(1)         2997(1)       10090(1)        9472(1)        21(1) 
C(10)   3227(2)        7411(4)        9507(1)       26(1) 
O(10)         3437(2)        5723(3 9531(1)       38(1) 
C(20)         4295(3)       10827(5) 9232(1)        29(1) 
O(20)         5125(2)       11352(4)        9076(1)        42(1) 
C(30)         3600(2)       10706(4)       10255(2)        26(1) 
O(30)         3979(2)       11088(4)       10754(1)        42(1) 
O(1)           899(2)        6958(3)        8282(1)        24(1) 
O(2)           696(2)        6746(3)        9410(1)      28(1) 
O(3)         -1513(2)        8124(4) 9153(1)        43(1) 
O(4)          -917(2)       11267(3)        8996(1)        34(1) 
C(1)           862(2)        8933(4)        8538(1)        23(1) 
C(2)           537(2)        8740(4)        9179(1)       22(1) 
C(3)          1296(2)       10151(4)  9626(2)        21(1) 
C(4)          1636(2)       12060(4)        9424(1)        24(1) 
C(5)          2029(2)       12027(4)        8869(1)        25(1) 
C(6)          1986(3)       10080(5)        8588(2)        24(1) 
C(7)          -749(3)        9293(5)        9117(2)        26(1) 
C(8)         -2103(3)       11974(6)        8920(2)        45(1) 
Si(1)          152(1)        6477(1)        7578(1)        25(1) 
C(11)          874(3)        7805(6)        7022(2)        47(1) 
C(12)          163(4)        3730(5)        7498(2)        55(1) 
C(13)        -1351(3)        7447(6)        7487(2)        51(1) 
Fe(2)         2069(1)         452(1)        5531(1)        22(1) 
C(40)         1757(2)       -2209(4)        5516(1)        26(1) 
O(40)         1509(2)       -3873(3)        5497(1)        37(1) 
C(50)          793(3)        1332(4)        5768(2)        31(1) 
O(50)          -26(2)        1908(4)   5923(1)        45(1) 
C(60)         1490(3)        1043(5)        4747(2)        31(1) 
O(60)         1124(2)        1414(4)        4245(1)        48(1) 
O(5)          3945(2)       -2674(3)        6769(1)        25(1) 
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O(6)          4208(2)       -3194(3)        5638(1)       27(1) 
O(7)          6036(2)        1102(3)  5957(1)        33(1) 
O(8)          6461(2)       -2217(4)     5952(1)        42(1) 
C(21)         4135(2)        -819(4)        6488(1)        21(1) 
C(22)         4455(2)       -1193(4)        5846(1)    22(1) 
C(23)         3771(2)         226(4)   5383(2)        23(1) 
C(24)         3510(2)        2221(4)        5543(1)        24(1) 
C(25)         3117(2)        2402(4) 6098(1)        27(1) 
C(26)         3086(3)         535(5)        6414(2)       24(1) 
C(27)         5768(3)        -853(5)    5919(2)        25(1) 
C(28)         7264(3)        1563(6)        6035(2)        46(1) 
Si(2)         4793(1)       -3612(1)        7397(1)        27(1) 
C(31)         3818(3)       -4901(5)        7831(2)        47(1) 
C(32)         5624(3)       -1540(5)        7842(2)        41(1) 
C(33)         5789(3)       -5491(5)        7161(2)        41(1) 
 
 
           Table 14 Bond lengths [Å] for 388 
            
            Fe(1) -C(20)                   1.786(3)             C(13) -H(13A)                  0.9800 
            Fe(1) -C(10)                   1.791(3)             C(13) -H(13B)                  0.9800 
            Fe(1) -C(30)                   1.797(3)             C(13) -H(13C)                  0.9800 
            Fe(1) -C(5)                    2.036(3)             Fe(2) -C(50)                   1.788(3) 
            Fe(1) -C(4)                    2.053(3)             Fe(2) -C(60)                   1.791(4) 
            Fe(1) -C(6)                    2.094(3)             Fe(2) -C(40)                   1.796(3) 
            Fe(1) -C(3)                    2.100(3)             Fe(2) -C(25)                   2.042(3) 
            C(10) -O(10)                   1.142(3)             Fe(2) -C(24)                   2.058(3) 
            C(20) -O(20)                   1.156(4)             Fe(2) -C(26)                   2.095(3) 
            C(30) -O(30)                   1.143(4)             Fe(2) -C(23)                   2.102(3) 
            O(1) -C(1)                     1.430(3)             C(40) -O(40)                   1.138(3) 
            O(1) -Si(1)                     1.671(2)             C(50) -O(50)                   1.152(4) 
            O(2) -C(2)                     1.415(3)             C(60) -O(60)                   1.144(4) 
            O(2) -H(2A)                    0.73(4)             O(5) -C(21)                    1.415(3) 
            O(3)- C(7)                     1.201(4)             O(5) -Si(2)                     1.671(2) 
            O(4) -C(7)                     1.340(4)             O(6) -C(22)                    1.414(3) 
            O(4) -C(8)                     1.451(4)             O(6) -H(6A)                    0.72(4) 
            C(1) -C(6)                     1.511(4)             O(7) -C(27)                    1.330(4) 
            C(1) -C(2)                     1.558(4)             O(7) -C(28)                    1.454(4) 
            C(1)- H(1)                     1.0000             O(8) -C(27)                    1.209(4) 
            C(2) -C(3)                     1.521(4)             C(21)-C(26)                   1.509(4) 
            C(2) -C(7)                     1.538(4)             C(21) -C(22)                   1.572(4) 
            C(3) -C(4)                     1.424(4)             C(21) -H(21)                   1.0000 
            C(3) -H(3)                     0.90(3)             C(22) -C(23)                   1.507(4) 
            C(4) -C(5)                     1.407(4)             C(22) -C(27)                   1.540(4) 
            C(4) -H(4)                     0.9500             C(23) -C(24)                   1.417(4) 
            C(5) -C(6)                     1.429(4)             C(23) -H(23)                   0.91(3) 
            C(5)- H(5)                     0.9500             C(24) -C(25)                   1.411(4) 
            C(6) -H(6)                     0.90(3)             C(24) -H(24)                   0.9500 
            C(8) -H(8A)                    0.9800             C(25) -C(26)                   1.426(4) 
            C(8) -H(8B)                    0.9800             C(25) -H(25)                   0.9500 
            C(8)- H(8C)                    0.9800             C(26) -H(26)                   0.95(3) 
            Si(1) -C(12)                   1.825(4)             C(28) -H(28A)                  0.9800 
            Si(1) -C(13)                   1.857(4)             C(28) -H(28B)                  0.9800 
            Si(1) -C(11)                   1.859(4)             C(28) -H(28C)                  0.9800 
C(11) -H(11A) 0.9800             Si(2) -C(31)                   1.851(3) 
            C(11) -H(11B)                  0.9800             Si(2) -C(32)                   1.854(3) 
            C(11) -H(11C)                  0.9800             Si(2) -C(33)                   1.856(3) 
            C(12) -H(12A)                  0.9800             C(31) -H(31A)                  0.9800 
            C(12) -H(12B)                  0.9800             C(31) -H(31B)                  0.9800 
            C(12) -H(12C)               0.9800             C(31) -H(31C)                  0.9800 
C(33) -H(33A) 0.9800 C(32) -H(32A)                  0.9800 
            C(33) -H(33B)                  0.9800             C(32) -H(32B)                  0.9800 
            C(33) -H(33C)                  0.9800              C(32) -H(32C)                  0.9800 
 
 
   
           Table 15 Bond angles [deg] for 388 
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C(20)-Fe(1)-C(10)             98.73(13) C(20)-Fe(1)-C(5)              91.76(13) 
C(20)-Fe(1)-C(30)             91.86(13) C(10)-Fe(1)-C(5)             135.29(13) 
C(10)-Fe(1)-C(30)             98.91(14) H(33B)-C(33)-H(33C)          109.5 
C(30)-Fe(1)-C(5)             124.19(12) Fe(1)-C(3)-H(3)              124(2) 
C(20)-Fe(1)-C(4)             121.19(13) C(5)-C(4)-C(3)               115.3(3) 
C(10)-Fe(1)-C(4)             137.72(12) C(5)-C(4)-Fe(1)               69.24(16) 
C(30)-Fe(1)-C(4)              93.50(12) C(3)-C(4)-Fe(1)               71.73(16) 
C(5)-Fe(1)-C(4)               40.25(11) C(5)-C(4)-H(4)               122.3 
C(20)-Fe(1)-C(6)              94.53(13) C(3)-C(4)-H(4)               122.3 
C(10)-Fe(1)-C(6)              95.19(13) Fe(1)-C(4)-H(4)              128.6 
C(30)-Fe(1)-C(6)             163.45(13) C(4)-C(5)-C(6)               114.3(3) 
C(5)-Fe(1)-C(6)               40.45(12) C(4)-C(5)-Fe(1)               70.51(16) 
C(4)-Fe(1)-C(6)               70.15(12) C(6)-C(5)-Fe(1)               71.94(17) 
C(20)-Fe(1)-C(3)             161.05(13) C(4)-C(5)-H(5)               122.8 
C(10)-Fe(1)-C(3)              98.81(12) C(6)-C(5)-H(5)               122.8 
C(30)-Fe(1)-C(3)              92.44(13) Fe(1)-C(5)-H(5)              126.4 
C(5)-Fe(1)-C(3)               70.64(12) C(5)-C(6)-C(1)               116.0(3) 
C(4)-Fe(1)-C(3)               40.09(11) C(5)-C(6)-Fe(1)               67.61(17) 
C(6)-Fe(1)-C(3)               76.80(13) C(1)-C(6)-Fe(1)              113.4(2) 
O(10)-C(10)-Fe(1)            176.2(2) C(5)-C(6)-H(6)               117(2) 
O(20)-C(20)-Fe(1)            178.3(3) C(1)-C(6)-H(6)               112(2) 
O(30)-C(30)-Fe(1)            179.6(3) Fe(1)-C(6)-H(6)              124(2) 
C(1)-O(1)-Si(1)              119.82(17) O(3)-C(7)-O(4)               123.9(3) 
C(2)-O(2)-H(2A)              108(3) O(3)-C(7)-C(2)               125.3(3) 
C(7)-O(4)-C(8)               116.0(3) O(4)-C(7)-C(2)               110.7(2) 
O(1)-C(1)-C(6)               113.1(2) O(4)-C(8)-H(8A)              109.5 
O(1)-C(1)-C(2)               109.0(2) O(4)-C(8)-H(8B)              109.5 
C(6)-C(1)-C(2)               110.2(2) H(8A)-C(8)-H(8B)             109.5 
O(1)-C(1)-H(1)               108.2 O(4)-C(8)-H(8C)              109.5 
C(6)-C(1)-H(1)               108.2 H(8A)-C(8)-H(8C)             109.5 
C(2)-C(1)-H(1)               108.2 H(8B)-C(8)-H(8C)             109.5 
O(2)-C(2)-C(3)               108.3(2) O(1)-Si(1)-C(12)             105.61(15) 
O(2)-C(2)-C(7)               108.1(2) O(1)-Si(1)-C(13)            110.49(15) 
C(3)-C(2)-C(7)               110.7(2) C(12)-Si(1)-C(13)            111.0(2) 
O(2)-C(2)-C(1)               111.9(2) O(1)-Si(1)-C(11)             108.18(14) 
C(3)-C(2)-C(1)               109.5(2) C(12)-Si(1)-C(11)            113.1(2) 
C(7)-C(2)-C(1)               108.3(2) C(13)-Si(1)-C(11)            108.44(19) 
C(4)-C(3)-C(2)               120.1(3) Si(1)-C(11)-H(11A)           109.5 
C(4)-C(3)-Fe(1)               68.17(17) Si(1)-C(11)-H(11B)           109.5 
C(2)-C(3)-Fe(1)              109.7(2) H(11A)-C(11)-H(11B)         109.5 
C(4)-C(3)-H(3)               119(2) Si(1)-C(11)-H(11C)           109.5 
C(2)-C(3)-H(3)               111(2) H(11A)-C(11)-H(11C)          109.5 
C(40)-Fe(2)-C(24)            136.27(12) H(11B)-C(11)-H(11C)          109.5 
C(25)-Fe(2)-C(24)             40.24(12) Si(1)-C(12)-H(12A)           109.5 
C(50)-Fe(2)-C(26)             94.05(13) Si(1)-C(12)-H(12B)           109.5 
C(60)-Fe(2)-C(26)            161.78(13) H(12A)-C(12)-H(12B)          109.5 
C(40)-Fe(2)-C(26)             96.86(13) Si(1)-C(12)-H(12C)           109.5 
C(25)-Fe(2)-C(26)             40.32(12) H(12A)-C(12)-H(12C)          109.5 
C(24)-Fe(2)-C(26)             69.89(12) H(12B)-C(12)-H(12C)          109.5 
C(50)-Fe(2)-C(23)            162.67(13) Si(1)-C(13)-H(13A)           109.5 
C(60)-Fe(2)-C(23)             93.00(13) Si(1)-C(13)-H(13B)           109.5 
C(40)-Fe(2)-C(23)             97.24(12) H(13A)-C(13)-H(13B)          109.5 
C(25)-Fe(2)-C(23)             70.34(12) Si(1)-C(13)-H(13C)           109.5 
C(24)-Fe(2)-C(23)             39.81(11) H(13A)-C(13)-H(13C)          109.5 
C(26)-Fe(2)-C(23)             76.36(13) H(13B)-C(13)-H(13C)          109.5 
O(40)-C(40)-Fe(2)            177.0(3) C(50)-Fe(2)-C(60)             92.20(14) 
O(50)-C(50)-Fe(2)            179.6(3) C(50)-Fe(2)-C(40)             98.23(13) 
O(60)-C(60)-Fe(2)            179.7(3) C(60)-Fe(2)-C(40)             99.16(14) 
C(21)-O(5)-Si(2)             124.97(17) C(50)-Fe(2)-C(25)             92.95(13) 
C(22)-O(6)-H(6A)             110(4) C(60)-Fe(2)-C(25)            122.28(13) 
C(27)-O(7)-C(28)             115.5(3) C(40)-Fe(2)-C(25)            136.57(12) 
O(5)-C(21)-C(26)             111.4(2) C(50)-Fe(2)-C(24)            123.44(13) 
O(5)-C(21)-C(22)             110.8(2) C(60)-Fe(2)-C(24)             92.42(13) 
C(26)-C(21)-C(22)            109.4(2) O(5)-C(21)-H(21)             108.4 
C(26)-C(21)-H(21)            108.4 C(22)-C(21)-H(21)            108.4 
O(6)-C(22)-C(23)             108.1(2) O(6)-C(22)-C(27)             108.0(2) 
C(23)-C(22)-C(27)            111.8(2) O(6)-C(22)-C(21)             112.1(2) 
C(23)-C(22)-C(21)            109.6(2) C(27)-C(22)-C(21)            107.4(2) 
C(24)-C(23)-C(22)            121.3(3) C(24)-C(23)-Fe(2)             68.44(17) 
C(22)-C(23)-Fe(2)            109.5(2) C(24)-C(23)-H(23)            118.2(17) 
Appendix 1 
 225 
C(22)-C(23)-H(23)            112.8(17) Fe(2)-C(23)-H(23)            119.2(16) 
C(25)-C(24)-C(23)            115.2(3) C(25)-C(24)-Fe(2)             69.26(16) 
C(23)-C(24)-Fe(2)             71.75(16) C(25)-C(24)-H(24)            122.4 
C(23)-C(24)-H(24)            122.4 Fe(2)-C(24)-H(24)            128.5 
C(24)-C(25)-C(26)            114.0(3) C(24)-C(25)-Fe(2)             70.50(17) 
C(26)-C(25)-Fe(2)             71.83(17) C(24)-C(25)-H(25)            123.0 
C(26)-C(25)-H(25)            123.0 Fe(2)-C(25)-H(25)            126.3 
C(25)-C(26)-C(21)            117.9(3) C(25)-C(26)-Fe(2)             67.86(18) 
C(21)-C(26)-Fe(2)            113.1(2) C(25)-C(26)-H(26)            115.9(17) 
C(21)-C(26)-H(26)            117.1(18) Fe(2)-C(26)-H(26)            115.7(17) 
O(8)-C(27)-O(7)              124.9(3) O(8)-C(27)-C(22)             123.4(3) 
O(7)-C(27)-C(22)             111.7(2) O(7)-C(28)-H(28A)            109.5 
O(7)-C(28)-H(28B)            109.5 H(28A)-C(28)-H(28B)          109.5 
O(7)-C(28)-H(28C)            109.5 H(28A)-C(28)-H(28C)          109.5 
H(28B)-C(28)-H(28C)          109.5 O(5)-Si(2)-C(31)             106.28(14) 
O(5)-Si(2)-C(32)             109.79(13) C(31)-Si(2)-C(32)            112.14(18) 
O(5)-Si(2)-C(33)             108.51(14) C(31)-Si(2)-C(33)            109.49(17) 
C(32)-Si(2)-C(33)            110.48(16) Si(2)-C(31)-H(31A)           109.5 
Si(2)-C(31)-H(31B)           109.5 H(31A)-C(31)-H(31B)          109.5 
Si(2)-C(31)-H(31C)           109.5 H(31A)-C(31)-H(31C)          109.5 
H(31B)-C(31)-H(31C)          109.5 Si(2)-C(32)-H(32A)           109.5 
Si(2)-C(32)-H(32B)           109.5 H(32A)-C(32)-H(32B)          109.5 
Si(2)-C(32)-H(32C)           109.5 H(32A)-C(32)-H(32C)          109.5 
H(32B)-C(32)-H(32C)          109.5 Si(2)-C(33)-H(33A)           109.5 
Si(2)-C(33)-H(33B)           109.5 H(33A)-C(33)-H(33B)          109.5 
Si(2)-C(33)-H(33C)           109.5 H(33A)-C(33)-H(33C)          109.5 
 
 
Table 16 Anisotropic displacement parameters (A2 x 103) for 388. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ] 
  
     
  Atom  U11  U22  U33  U23  U13  U12 
                                               
Fe(1)     19(1)       21(1)       23(1)       -2(1)        4(1)       -2(1) 
C(10)     18(2)       28(2)       29(2)       -5(1)        1(1)       -3(1) 
O(10)     32(1)       23(1)       56(2)       -4(1)        1(1)        0(1) 
C(20)     29(2)       29(2)       27(2)       -6(1)        3(1)       -3(1) 
O(20)     29(1)       52(2)       49(2)       -1(1)       15(1)       -9(1) 
C(30)     19(1)       30(2)       31(2)       -4(1)        7(1)        0(1) 
O(30)     34(1)       61(2)       28(1)      -15(1)       -2(1)       3(1) 
O(1)      24(1)       22(1)       26(1)       -3(1)        2(1)       -1(1) 
O(2)      35(1)       22(1)       26(1)        3(1)        6(1)       -2(1) 
 O(3)      25(1)       55(2)       48(2)       13(1)        7(1)      -11(1) 
O(4)      20(1)       37(1)       45(2)       -4(1)       5(1)        3(1) 
C(1)      24(2)       19(1)       25(2)        0(1)        4(1)        0(1) 
C(2)      23(2)       20(1)       22(2)        2(1)        5(1)        0(1) 
C(3)      23(2)       24(2)       18(2)        1(1)        4(1)        2(1) 
 C(4)      24(2)       19(1)       29(2)        1(1)        2(1)        1(1) 
C(5)      27(2)       20(1)       26(2)        3(1)        2(1)       -5(1) 
C(6)      23(2)       29(2)       19(2)       -1(1)        4(1)       -4(1) 
C(7)      22(2)       35(2)       21(2)       -1(1)        3(1)        1(1) 
C(8)      27(2)       59(2)       48(2)       -9(2)        5(2)       17(2) 
Si(1)     25(1)       28(1)       23(1)       -2(1)       2(1)       -4(1) 
C(11)     42(2)       62(2)       34(2)        5(2)        4(2)      -11(2) 
C(12)     72(3)       33(2)       50(3)       -6(2)       -9(2)       -5(2) 
C(13)     29(2)       68(3)       51(2)       -4(2)       -3(2)        2(2) 
 Fe(2)     20(1)       20(1)       25(1)        2(1)        2(1)        1(1) 
C(40)     19(2)       30(2)       26(2)        2(1)        2(1)        1(1) 
O(40)     30(1)       24(1)       56(2)        3(1)        3(1)       -4(1) 
C(50)     31(2)       27(2)       33(2)        5(1)        2(2)       -1(1) 
O(50)     32(1)       53(2)       54(2)       -2(1)       13(1)       13(1) 
C(60)     22(2)       30(2)       42(2)        7(1)        6(2)       -1(1) 
O(60)     34(1)       71(2)       35(2)       21(1)       -5(1)       -8(1) 
O(5)      26(1)       21(1)       28(1)        7(1)        3(1)       -4(1) 
O(6)      30(1)       21(1)       28(1)       -2(1)       3(1)        1(1) 
O(7)      22(1)       36(1)       41(2)        4(1)        6(1)       -8(1) 
O(8)      26(1)       46(1)       51(2)       -9(1)        7(1)       10(1) 
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C(21)     22(2)       17(1)       22(2)        2(1)        2(1)       -1(1) 
C(22)     19(2)       21(1)       24(2)       -1(1)        3(1)       -2(1) 
C(23)     21(2)       26(2)       21(2)        0(1)        6(1)       -3(1) 
C(24)     26(2)       20(1)       24(2)        3(1)        0(1)       -4(1) 
C(25)     0(1) -1(1)        -1(1)       28(2)       21(1)       28(2)      
C(26)     24(2)       25(2)       22(2)       -2(1)        7(1)        2(1) 
C(27)     28(2)       29(2)       20(2)        2(1)        6(1)        0(1) 
C(28)     27(2)       61(2)      48(2)        7(2)        5(2)      -18(2) 
Si(2)     27(1)       26(1)       25(1)        5(1)        2(1)        0(1) 
C(31)     47(2)       48(2)       46(2)       20(2)       12(2)        3(2) 
C(32)     50(2)       40(2)       29(2)        3(1)       -2(2)       -3(2) 




    Table 17 Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2 x 
103) for 388 
  
          
  Atom   x   y   z  U(eq) 
                                  
H(2A)          600(30)       6060(60)       9151(17)       38(12) 
H(1)                                     238   9721 8267 27 
H(3)          1120(30)      10060(50)      10001(16)       28(9) 
H(4)          1599                          13271   9649   29 
H(5)                                2300   13200     8695 30 
H(6)          2270(30)       9980(50)       8246(15)       26(9) 
H(8A)                            -67 8574   11271   2585     
H(8B)        -2129                            13432   8841 67 
H(8C)       -2396                        11695   9293     67 
H(11A)                                 915   9256   7114 70 
H(11B)                                429   7593   6607   70 
H(11C)                          1659      7269    7052     70 
H(12A)                              965 3247    7572     82 
H(12B)        -228                        3355     7084    82 
H(12C)                            -242      3115 7795    82 
H(13A)                          -1747     6750   7774     76 
H(13B)       -1767                         7201    7068   76 
H(13C)      -1332                         8903   7571     76 
H(6A)         4480(40)       -3900(70)    5870(20)       61(15) 
H(21)             4799    -112                   6755   25 
H(23)         3890(20)          0(40)       4998(13)       10(7) 
H(24)                       3594       3357      5295      29 
H(25)                              2893 3654     6247    32 
H(26)         2670(20)        550(40)       6738(13)       15(7) 
H(28A)                            7679    969   6418      69 
H(28B)                            7373    3032      6046 69 
H(28C)                          69 5692    997    7566        
H(31A)              3253    -3929                 7928     71 
H(31B)              4275    -5451                  8211    71 
H(31C)             3411    -6003                  7585    71 
H(32A)              6148    -934           7602           62 
H(32B)       6075      -2083                   8224   62 
H(32C)             5087      -508                7934      62 
H(33A)              5338    -6533                 6907     62 
H(33B)                           6258 -6121      7525    62 











ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic numbering 
scheme for 396 
 
Table 18 Crystal data and structure refinement for 396 
                                                        
 Identification code k09sel1 
 Empirical formula C11 H8 Fe O7 
 Formula weight 308.02 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Triclinic 
 Space group P1 
 Unit cell dimensions a = 6.6880(3)Å α = 85.896(1)o 
       b = 6.7010(3)Å β = 85.972(2)o 
       c = 46.634(2)Å γ = 60.254(3)o 
 Volume 1808.47(15) Å3 
 Z 6 
 Density (calculated) 1.697 Mg/m3 
 Absorption coefficient 1.277 mm-1 
 F(000) 936 
 Crystal size 0.22 x 0.07 x 0.07 mm 
 Theta range for data collection 4.21 to 25.00o 
 Index ranges -7<=h<=7; -7<=k<=7; -55<=l<=55 
 Reflections collected 14425 
 Independent reflections 9757 [R(int) = 0.0357] 
 Reflections observed (>2σ) 8640 
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 Data Completeness 0.937 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.787 and 0.745 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 9757 / 27 / 1177 
 Goodness-of-fit on F2 1.023 
 Final R indices [I>2σ(I)] R1 = 0.0318   wR2 = 0.0629 
 R indices (all data) R1 = 0.0418  wR2 = 0.0662 
 Absolute structure parameter -0.017(10) 




…inserted directly into SEL manuscript – October ’09, and added to CIF file… 
 
 




 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
 
 O4-H41         0.840    2.268   113.72    2.717    O5  
 O4A-H42        0.840    2.289   110.89    2.705    O5A  
 O4B-H43        0.840    2.305   110.53    2.716    O5B  
 O4C-H44        0.840    2.290   112.24    2.721    O5C  
 O4D-H45        0.840    2.264   113.32    2.709    O5D  
 O5E-H46        0.840    2.262   113.21    2.706    O6E  
 
 Table 19 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 396. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
                                                             
  Atom   x   y   z  U(eq) 
                                 
Fe(1) 11161(1) 3236(1) 4(1) 19(1) 
Fe(1A) 10429(1) -1003(1) 2191(1) 19(1) 
Fe(1B) 4017(1) 1988(1) 3338(1) 19(1) 
Fe(1C) -175(1) 4734(1) 5523(1) 19(1) 
Fe(1D) 6066(1) 10376(1) 6669(1) 19(1) 
Fe(1E) 8903(1) 9635(1) 8858(1) 20(1) 
O(1) 7871(6) 6954(6) -376(1) 37(1) 
O(2) 11345(7) -627(7) -281(1) 41(1) 
O(3) 15506(6) 2620(7) -280(1) 41(1) 
O(4) 5309(5) 7198(5) 224(1) 25(1) 
O(5) 8010(5) 9055(5) 311(1) 27(1) 
O(6) 4351(7) 6895(7) 777(1) 64(1) 
O(7) 8044(7) 5301(7) 892(1) 52(1) 
O(1A) 6809(6) -1203(7) 2571(1) 38(1) 
O(2A) 10702(7) 2666(7) 2469(1) 36(1) 
O(3A) 14454(7) -4726(7) 2481(1) 48(1) 
O(4A) 4717(5) 817(5) 1968(1) 25(1) 
O(5A) 7435(5) -3735(5) 1887(1) 27(1) 
O(6A) 4145(7) 1902(7) 1412(1) 66(1) 
O(7A) 7906(8) -252(7) 1299(1) 52(1) 
O(1B) 7744(6) 1954(7) 2957(1) 37(1) 
O(2B) 145(7) 5937(7) 3052(1) 40(1) 
O(3B) 3379(7) -1456(7) 3054(1) 39(1) 
O(4B) 8002(5) 3652(5) 3559(1) 25(1) 
O(5B) 9848(5) -970(5) 3644(1) 26(1) 
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O(6B) 7685(7) 4386(7) 4111(1) 63(1) 
O(7B) 6105(7) 2136(7) 4227(1) 51(1) 
O(1C) -465(6) 8199(6) 5905(1) 38(1) 
O(2C) 3590(7) 667(7) 5809(1) 41(1) 
O(3C) -3810(7) 3899(7) 5806(1) 41(1) 
O(4C) 1639(5) 8864(5) 5302(1) 23(1) 
O(5C) -2943(5) 10762(5) 5216(1) 25(1) 
O(6C) 2709(7) 8941(7) 4748(1) 61(1) 
O(7C) 564(7) 7414(7) 4633(1) 52(1) 
O(1D) 6151(7) 6996(6) 6289(1) 40(1) 
O(2D) 9931(7) 10826(7) 6392(1) 39(1) 
O(3D) 2514(7) 14598(7) 6380(1) 48(1) 
O(4D) 7744(5) 4522(5) 6893(1) 25(1) 
O(5D) 3126(5) 7192(5) 6975(1) 27(1) 
O(6D) 8458(7) 3577(7) 7447(1) 67(1) 
O(7D) 6230(7) 7291(8) 7559(1) 52(1) 
O(2E) 12326(6) 6013(6) 9239(1) 37(1) 
O(3E) 4692(6) 9883(7) 9134(1) 38(1) 
O(4E) 8336(8) 13664(7) 9148(1) 49(1) 
O(5E) 12983(5) 3945(5) 8632(1) 25(1) 
O(6E) 14895(5) 6688(5) 8552(1) 27(1) 
O(7E) 13017(7) 3384(7) 8080(1) 69(1) 
O(8E) 11513(6) 7153(8) 7966(1) 55(1) 
C(1) 9134(9) 5500(9) -234(1) 26(1) 
C(2) 11314(8) 844(9) -171(1) 28(1) 
C(3) 13836(8) 2826(8) -171(1) 26(1) 
C(4) 8548(8) 3472(8) 306(1) 18(1) 
C(5) 10768(7) 2005(7) 410(1) 20(1) 
C(6) 12218(8) 2948(8) 417(1) 22(1) 
C(7) 11311(7) 5299(8) 320(1) 19(1) 
C(8) 8858(7) 6967(8) 348(1) 18(1) 
C(9) 7255(7) 5939(7) 400(1) 18(1) 
C(10) 6483(8) 6060(7) 715(1) 22(1) 
C(11) 3157(18) 7250(20) 1041(2) 42(3) 
C(12) 8130(20) 4930(20) 1192(2) 46(3) 
C(1A) 8200(9) -1093(9) 2427(1) 25(1) 
C(2A) 10595(8) 1249(9) 2363(1) 25(1) 
C(3A) 12931(9) -3276(9) 2368(1) 31(1) 
C(4A) 8012(8) 1274(8) 1889(1) 16(1) 
C(5A) 10322(7) 494(8) 1787(1) 20(1) 
C(6A) 11780(8) -1897(8) 1779(1) 22(1) 
C(7A) 10758(8) -3296(8) 1873(1) 20(1) 
C(8A) 8347(7) -2537(7) 1848(1) 17(1) 
C(9A) 6774(7) 76(7) 1796(1) 19(1) 
C(10A) 6233(8) 615(8) 1474(1) 24(1) 
C(11A) 3165(19) 2610(20) 1155(2) 47(3) 
C(12A) 8180(20) -74(19) 1007(2) 40(3) 
C(1B) 6298(9) 1968(9) 3098(1) 24(1) 
C(2B) 1621(8) 4412(9) 3159(1) 27(1) 
C(3B) 3611(8) -104(9) 3162(1) 29(1) 
C(4B) 4279(8) 4050(8) 3639(1) 19(1) 
C(5B) 2775(7) 3231(8) 3743(1) 19(1) 
C(6B) 3710(8) 813(8) 3751(1) 22(1) 
C(7B) 6086(8) -537(8) 3654(1) 20(1) 
C(8B) 7744(8) 237(8) 3682(1) 22(1) 
C(9B) 6746(7) 2805(7) 3731(1) 18(1) 
C(10B) 6864(7) 3152(8) 4050(1) 24(1) 
C(11B) 8050(20) 4930(20) 4374(2) 42(3) 
C(12B) 5790(20) 2120(20) 4527(2) 47(3) 
C(1C) -332(9) 6855(9) 5760(1) 24(1) 
C(2C) 2127(9) 2221(9) 5698(1) 29(1) 
C(3C) -2382(9) 4203(8) 5698(1) 29(1) 
C(4C) 2095(7) 5193(8) 5222(1) 18(1) 
C(5C) 1334(8) 3760(8) 5118(1) 21(1) 
C(6C) -1094(8) 4704(8) 5109(1) 23(1) 
C(7C) -2509(8) 7021(8) 5206(1) 21(1) 
C(8C) -1712(7) 8667(8) 5180(1) 19(1) 
C(9C) 912(7) 7718(7) 5128(1) 18(1) 
C(10C) 1445(7) 8043(7) 4810(1) 23(1) 
C(11C) 3430(20) 9460(20) 4486(2) 45(3) 
C(12C) 770(20) 7270(20) 4337(2) 48(3) 
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C(1D) 6124(9) 8302(9) 6430(1) 25(1) 
C(2D) 8448(9) 10643(8) 6498(1) 25(1) 
C(3D) 3888(9) 12992(9) 6492(1) 30(1) 
C(4D) 8148(8) 7769(8) 6971(1) 18(1) 
C(5D) 7297(8) 10008(8) 7073(1) 20(1) 
C(6D) 4906(8) 11443(9) 7082(1) 22(1) 
C(7D) 3568(8) 10487(8) 6985(1) 19(1) 
C(8D) 4305(7) 8067(8) 7014(1) 17(1) 
C(9D) 6904(7) 6446(7) 7066(1) 17(1) 
C(10D) 7240(7) 5693(8) 7385(1) 23(1) 
C(11D) 9030(20) 2434(18) 7705(2) 48(3) 
C(12D) 6244(18) 7360(20) 7854(2) 39(3) 
C(1E) 10990(9) 7401(9) 9095(1) 24(1) 
C(2E) 6334(9) 9795(8) 9027(1) 28(1) 
C(3E) 8523(8) 12132(9) 9036(1) 31(1) 
C(4E) 9326(7) 7239(8) 8556(1) 18(1) 
C(5E) 7910(8) 9538(8) 8450(1) 20(1) 
C(6E) 8870(8) 11000(8) 8445(1) 21(1) 
C(7E) 11177(8) 9985(8) 8541(1) 22(1) 
C(8E) 12830(7) 7564(7) 8514(1) 18(1) 
C(9E) 11851(7) 5997(7) 8462(1) 19(1) 
C(10E) 12151(7) 5460(8) 8140(1) 25(1) 
C(11E) 13580(20) 2381(19) 7825(2) 46(3) 
C(12E) 11380(20) 7430(20) 7664(2) 44(3) 
                                        
    
 Table 20 Bond lengths [Å] and angles [o] for 396. 
  
Fe(1)-C(2) 1.805(6) Fe(1)-C(3) 1.811(5) 
Fe(1)-C(1) 1.816(5) Fe(1)-C(6) 2.058(4) 
Fe(1)-C(5) 2.064(4) Fe(1)-C(4) 2.114(5) 
Fe(1)-C(7) 2.132(4) Fe(1A)-C(2A) 1.811(5) 
Fe(1A)-C(3A) 1.812(5) Fe(1A)-C(1A) 1.813(6) 
Fe(1A)-C(5A) 2.060(4) Fe(1A)-C(6A) 2.062(5) 
Fe(1A)-C(4A) 2.121(5) Fe(1A)-C(7A) 2.133(5) 
Fe(1B)-C(3B) 1.813(6) Fe(1B)-C(2B) 1.820(5) 
Fe(1B)-C(1B) 1.822(6) Fe(1B)-C(6B) 2.066(5) 
Fe(1B)-C(5B) 2.067(4) Fe(1B)-C(4B) 2.114(5) 
Fe(1B)-C(7B) 2.135(5) Fe(1C)-C(2C) 1.810(5) 
Fe(1C)-C(3C) 1.811(6) Fe(1C)-C(1C) 1.818(6) 
Fe(1C)-C(5C) 2.068(5) Fe(1C)-C(6C) 2.074(4) 
Fe(1C)-C(4C) 2.115(5) Fe(1C)-C(7C) 2.145(4) 
Fe(1D)-C(2D) 1.814(6) Fe(1D)-C(3D) 1.819(5) 
Fe(1D)-C(1D) 1.827(6) Fe(1D)-C(5D) 2.059(4) 
Fe(1D)-C(6D) 2.064(5) Fe(1D)-C(4D) 2.117(5) 
Fe(1D)-C(7D) 2.123(5) Fe(1E)-C(2E) 1.796(6) 
Fe(1E)-C(3E) 1.817(6) Fe(1E)-C(1E) 1.823(5) 
Fe(1E)-C(6E) 2.066(5) Fe(1E)-C(5E) 2.072(4) 
Fe(1E)-C(4E) 2.111(5) Fe(1E)-C(7E) 2.130(5) 
O(1)-C(1) 1.128(6) O(2)-C(2) 1.134(6) 
O(3)-C(3) 1.142(6) O(4)-C(9) 1.428(5) 
O(4)-H(41) 0.8400 O(5)-C(8) 1.226(5) 
O(6)-C(10) 1.266(5) O(6)-C(11) 1.387(10) 
O(7)-C(10) 1.250(5) O(7)-C(12) 1.404(10) 
O(1A)-C(1A) 1.137(6) O(2A)-C(2A) 1.138(6) 
O(3A)-C(3A) 1.130(6) O(4A)-C(9A) 1.416(5) 
O(4A)-H(42) 0.8400 O(5A)-C(8A) 1.225(5) 
O(6A)-C(10A) 1.265(5) O(6A)-C(11A) 1.348(10) 
O(7A)-C(10A) 1.243(6) O(7A)-C(12A) 1.366(9) 
O(1B)-C(1B) 1.126(6) O(2B)-C(2B) 1.124(6) 
O(3B)-C(3B) 1.145(6) O(4B)-C(9B) 1.410(5) 
O(4B)-H(43) 0.8400 O(5B)-C(8B) 1.234(5) 
O(6B)-C(10B) 1.254(5) O(6B)-C(11B) 1.378(9) 
O(7B)-C(10B) 1.268(6) O(7B)-C(12B) 1.403(10) 
O(1C)-C(1C) 1.131(6) O(2C)-C(2C) 1.138(6) 
O(3C)-C(3C) 1.147(6) O(4C)-C(9C) 1.416(5) 
O(4C)-H(44) 0.8400 O(5C)-C(8C) 1.242(5) 
O(6C)-C(10C) 1.267(5) O(6C)-C(11C) 1.368(10) 
O(7C)-C(10C) 1.253(5) O(7C)-C(12C) 1.385(10) 
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O(1D)-C(1D) 1.126(6) O(2D)-C(2D) 1.134(6) 
O(3D)-C(3D) 1.131(6) O(4D)-C(9D) 1.415(5) 
O(4D)-H(45) 0.8400 O(5D)-C(8D) 1.222(5) 
O(6D)-C(10D) 1.259(5) O(6D)-C(11D) 1.353(10) 
O(7D)-C(10D) 1.261(6) O(7D)-C(12D) 1.383(10) 
O(2E)-C(1E) 1.132(6) O(3E)-C(2E) 1.149(6) 
O(4E)-C(3E) 1.134(6) O(5E)-C(9E) 1.411(5) 
O(5E)-H(46) 0.8400 O(6E)-C(8E) 1.224(5) 
O(7E)-C(10E) 1.258(5) O(7E)-C(11E) 1.346(11) 
O(8E)-C(10E) 1.250(6) O(8E)-C(12E) 1.412(10) 
C(4)-C(5) 1.412(6) C(4)-C(9) 1.519(6) 
C(4)-H(4) 0.979(5) C(5)-C(6) 1.398(6) 
C(5)-H(5) 0.979(5) C(6)-C(7) 1.428(6) 
C(6)-H(6) 0.980(5) C(7)-C(8) 1.459(6) 
C(7)-H(7) 0.980(5) C(8)-C(9) 1.535(6) 
C(9)-C(10) 1.519(6) C(11)-H(11A) 0.9800 
C(11)-H(11B) 0.9800 C(11)-H(11C) 0.9800 
C(12)-H(12A) 0.9800 C(12)-H(12B) 0.9800 
C(12)-H(12C) 0.9800 C(4A)-C(5A) 1.420(6) 
C(4A)-C(9A) 1.508(6) C(4A)-H(4A) 0.979(5) 
C(5A)-C(6A) 1.404(6) C(5A)-H(5A) 0.979(5) 
C(6A)-C(7A) 1.440(6) C(6A)-H(6A) 0.980(5) 
C(7A)-C(8A) 1.441(6) C(7A)-H(7A) 0.980(5) 
C(8A)-C(9A) 1.542(6) C(9A)-C(10A) 1.547(6) 
C(11A)-H(11D) 0.9800 C(11A)-H(11E) 0.9800 
C(11A)-H(11F) 0.9800 C(12A)-H(12D) 0.9800 
C(12A)-H(12E) 0.9800 C(12A)-H(12F) 0.9800 
C(4B)-C(5B) 1.410(6) C(4B)-C(9B) 1.512(6) 
C(4B)-H(4B) 0.980(5) C(5B)-C(6B) 1.417(6) 
C(5B)-H(5B) 0.979(5) C(6B)-C(7B) 1.442(6) 
C(6B)-H(6B) 0.979(5) C(7B)-C(8B) 1.455(6) 
C(7B)-H(7B) 0.979(5) C(8B)-C(9B) 1.534(6) 
C(9B)-C(10B) 1.532(6) C(11B)-H(11G) 0.9800 
C(11B)-H(11H) 0.9800 C(11B)-H(11I) 0.9800 
C(12B)-H(12G) 0.9800 C(12B)-H(12H) 0.9800 
C(12B)-H(12I) 0.9800 C(4C)-C(5C) 1.416(6) 
C(4C)-C(9C) 1.515(6) C(4C)-H(4C) 0.980(3) 
C(5C)-C(6C) 1.423(6) C(5C)-H(5C) 0.980(3) 
C(6C)-C(7C) 1.448(7) C(6C)-H(6C) 0.980(3) 
C(7C)-C(8C) 1.439(6) C(7C)-H(7C) 0.980(3) 
C(8C)-C(9C) 1.548(6) C(9C)-C(10C) 1.526(6) 
C(11C)-H(11J) 0.9800 C(11C)-H(11K) 0.9800 
C(11C)-H(11L) 0.9800 C(12C)-H(12J) 0.9800 
C(12C)-H(12K) 0.9800 C(12C)-H(12L) 0.9800 
C(4D)-C(5D) 1.421(6) C(4D)-C(9D) 1.516(6) 
C(4D)-H(4D) 0.91(6) C(5D)-C(6D) 1.398(6) 
C(5D)-H(5D) 0.93(6) C(6D)-C(7D) 1.444(6) 
C(6D)-H(6D) 0.97(6) C(7D)-C(8D) 1.441(6) 
C(7D)-H(7D) 0.95(7) C(8D)-C(9D) 1.552(6) 
C(9D)-C(10D) 1.529(6) C(11D)-H(11M) 0.9800 
C(11D)-H(11N) 0.9800 C(11D)-H(11O) 0.9800 
C(12D)-H(12M) 0.9800 C(12D)-H(12N) 0.9800 
C(12D)-H(12O) 0.9800 C(4E)-C(5E) 1.422(6) 
C(4E)-C(9E) 1.513(6) C(4E)-H(4E) 0.98(7) 
C(5E)-C(6E) 1.411(6) C(5E)-H(5E) 0.93(6) 
C(6E)-C(7E) 1.434(6) C(6E)-H(6E) 0.98(6) 
C(7E)-C(8E) 1.449(6) C(7E)-H(7E) 0.89(7) 
C(8E)-C(9E) 1.526(6) C(9E)-C(10E) 1.546(6) 
C(11E)-H(11P) 0.9800 C(11E)-H(11Q) 0.9800 
C(11E)-H(11R) 0.9800 C(12E)-H(12P) 0.9800 
C(12E)-H(12Q) 0.9800 C(12E)-H(12R) 0.9800 
                                             
C(2)-Fe(1)-C(3) 92.6(2) C(2)-Fe(1)-C(1) 97.1(2) 
C(3)-Fe(1)-C(1) 99.4(2) C(2)-Fe(1)-C(6) 122.5(2) 
C(3)-Fe(1)-C(6) 95.3(2) C(1)-Fe(1)-C(6) 137.0(2) 
C(2)-Fe(1)-C(5) 93.4(2) C(3)-Fe(1)-C(5) 126.45(19) 
C(1)-Fe(1)-C(5) 132.4(2) C(6)-Fe(1)-C(5) 39.66(17) 
C(2)-Fe(1)-C(4) 93.6(2) C(3)-Fe(1)-C(4) 165.00(19) 
C(1)-Fe(1)-C(4) 93.4(2) C(6)-Fe(1)-C(4) 69.88(18) 
C(5)-Fe(1)-C(4) 39.49(17) C(2)-Fe(1)-C(7) 162.1(2) 
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C(3)-Fe(1)-C(7) 91.78(19) C(1)-Fe(1)-C(7) 99.3(2) 
C(6)-Fe(1)-C(7) 39.82(17) C(5)-Fe(1)-C(7) 70.21(18) 
C(4)-Fe(1)-C(7) 78.36(17) C(2A)-Fe(1A)-C(3A) 93.2(2) 
C(2A)-Fe(1A)-C(1A) 98.0(2) C(3A)-Fe(1A)-C(1A) 98.7(2) 
C(2A)-Fe(1A)-C(5A) 92.5(2) C(3A)-Fe(1A)-C(5A) 127.6(2) 
C(1A)-Fe(1A)-C(5A) 131.8(2) C(2A)-Fe(1A)-C(6A) 120.6(2) 
C(3A)-Fe(1A)-C(6A) 95.2(2) C(1A)-Fe(1A)-C(6A) 138.0(2) 
C(5A)-Fe(1A)-C(6A) 39.83(17) C(2A)-Fe(1A)-C(4A) 94.44(19) 
C(3A)-Fe(1A)-C(4A) 165.4(2) C(1A)-Fe(1A)-C(4A) 92.5(2) 
C(5A)-Fe(1A)-C(4A) 39.68(17) C(6A)-Fe(1A)-C(4A) 70.21(18) 
C(2A)-Fe(1A)-C(7A) 160.7(2) C(3A)-Fe(1A)-C(7A) 90.7(2) 
C(1A)-Fe(1A)-C(7A) 100.1(2) C(5A)-Fe(1A)-C(7A) 70.30(18) 
C(6A)-Fe(1A)-C(7A) 40.11(18) C(4A)-Fe(1A)-C(7A) 78.14(17) 
C(3B)-Fe(1B)-C(2B) 92.9(2) C(3B)-Fe(1B)-C(1B) 98.6(2) 
C(2B)-Fe(1B)-C(1B) 96.7(2) C(3B)-Fe(1B)-C(6B) 95.3(2) 
C(2B)-Fe(1B)-C(6B) 122.7(2) C(1B)-Fe(1B)-C(6B) 137.4(2) 
C(3B)-Fe(1B)-C(5B) 127.0(2) C(2B)-Fe(1B)-C(5B) 93.3(2) 
C(1B)-Fe(1B)-C(5B) 132.7(2) C(6B)-Fe(1B)-C(5B) 40.09(18) 
C(3B)-Fe(1B)-C(4B) 165.2(2) C(2B)-Fe(1B)-C(4B) 93.8(2) 
C(1B)-Fe(1B)-C(4B) 93.8(2) C(6B)-Fe(1B)-C(4B) 70.02(18) 
C(5B)-Fe(1B)-C(4B) 39.40(17) C(3B)-Fe(1B)-C(7B) 91.5(2) 
C(2B)-Fe(1B)-C(7B) 162.6(2) C(1B)-Fe(1B)-C(7B) 99.2(2) 
C(6B)-Fe(1B)-C(7B) 40.09(18) C(5B)-Fe(1B)-C(7B) 70.74(18) 
C(4B)-Fe(1B)-C(7B) 78.37(17) C(2C)-Fe(1C)-C(3C) 92.9(2) 
C(2C)-Fe(1C)-C(1C) 97.4(2) C(3C)-Fe(1C)-C(1C) 99.5(2) 
C(2C)-Fe(1C)-C(5C) 92.9(2) C(3C)-Fe(1C)-C(5C) 126.57(19) 
C(1C)-Fe(1C)-C(5C) 132.2(2) C(2C)-Fe(1C)-C(6C) 122.2(2) 
C(3C)-Fe(1C)-C(6C) 94.9(2) C(1C)-Fe(1C)-C(6C) 137.0(2) 
C(5C)-Fe(1C)-C(6C) 40.18(17) C(2C)-Fe(1C)-C(4C) 93.5(2) 
C(3C)-Fe(1C)-C(4C) 165.0(2) C(1C)-Fe(1C)-C(4C) 93.1(2) 
C(5C)-Fe(1C)-C(4C) 39.53(17) C(6C)-Fe(1C)-C(4C) 70.24(18) 
C(2C)-Fe(1C)-C(7C) 162.2(2) C(3C)-Fe(1C)-C(7C) 91.5(2) 
C(1C)-Fe(1C)-C(7C) 99.0(2) C(5C)-Fe(1C)-C(7C) 70.79(18) 
C(6C)-Fe(1C)-C(7C) 40.09(18) C(4C)-Fe(1C)-C(7C) 78.47(18) 
C(2D)-Fe(1D)-C(3D) 93.7(2) C(2D)-Fe(1D)-C(1D) 97.9(2) 
C(3D)-Fe(1D)-C(1D) 98.3(2) C(2D)-Fe(1D)-C(5D) 92.4(2) 
C(3D)-Fe(1D)-C(5D) 127.6(2) C(1D)-Fe(1D)-C(5D) 132.2(2) 
C(2D)-Fe(1D)-C(6D) 120.6(2) C(3D)-Fe(1D)-C(6D) 95.4(2) 
C(1D)-Fe(1D)-C(6D) 138.1(2) C(5D)-Fe(1D)-C(6D) 39.64(18) 
C(2D)-Fe(1D)-C(4D) 94.2(2) C(3D)-Fe(1D)-C(4D) 165.5(2) 
C(1D)-Fe(1D)-C(4D) 92.8(2) C(5D)-Fe(1D)-C(4D) 39.74(17) 
C(6D)-Fe(1D)-C(4D) 70.03(19) C(2D)-Fe(1D)-C(7D) 160.9(2) 
C(3D)-Fe(1D)-C(7D) 90.5(2) C(1D)-Fe(1D)-C(7D) 100.0(2) 
C(5D)-Fe(1D)-C(7D) 70.47(19) C(6D)-Fe(1D)-C(7D) 40.31(18) 
C(4D)-Fe(1D)-C(7D) 78.24(18) C(2E)-Fe(1E)-C(3E) 93.2(2) 
C(2E)-Fe(1E)-C(1E) 98.2(2) C(3E)-Fe(1E)-C(1E) 98.4(2) 
C(2E)-Fe(1E)-C(6E) 120.7(2) C(3E)-Fe(1E)-C(6E) 95.1(2) 
C(1E)-Fe(1E)-C(6E) 137.8(2) C(2E)-Fe(1E)-C(5E) 92.6(2) 
C(3E)-Fe(1E)-C(5E) 127.6(2) C(1E)-Fe(1E)-C(5E) 132.0(2) 
C(6E)-Fe(1E)-C(5E) 39.86(17) C(2E)-Fe(1E)-C(4E) 94.6(2) 
C(3E)-Fe(1E)-C(4E) 165.4(2) C(1E)-Fe(1E)-C(4E) 92.63(19) 
C(6E)-Fe(1E)-C(4E) 70.27(19) C(5E)-Fe(1E)-C(4E) 39.72(17) 
C(2E)-Fe(1E)-C(7E) 160.6(2) C(3E)-Fe(1E)-C(7E) 90.5(2) 
C(1E)-Fe(1E)-C(7E) 100.1(2) C(6E)-Fe(1E)-C(7E) 39.93(17) 
C(5E)-Fe(1E)-C(7E) 70.21(19) C(4E)-Fe(1E)-C(7E) 78.20(18) 
C(9)-O(4)-H(41) 109.5 C(10)-O(6)-C(11) 130.9(6) 
C(10)-O(7)-C(12) 135.0(7) C(9A)-O(4A)-H(42) 109.5 
C(10A)-O(6A)-C(11A) 130.5(7) C(10A)-O(7A)-C(12A) 134.5(6) 
C(9B)-O(4B)-H(43) 109.5 C(10B)-O(6B)-C(11B) 130.3(6) 
C(10B)-O(7B)-C(12B) 133.0(7) C(9C)-O(4C)-H(44) 109.5 
C(10C)-O(6C)-C(11C) 130.4(7) C(10C)-O(7C)-C(12C) 133.7(7) 
C(9D)-O(4D)-H(45) 109.5 C(10D)-O(6D)-C(11D) 130.5(7) 
C(10D)-O(7D)-C(12D) 133.3(6) C(9E)-O(5E)-H(46) 109.5 
C(10E)-O(7E)-C(11E) 130.8(7) C(10E)-O(8E)-C(12E) 134.0(7) 
O(1)-C(1)-Fe(1) 177.9(5) O(2)-C(2)-Fe(1) 178.1(4) 
O(3)-C(3)-Fe(1) 178.4(5) C(5)-C(4)-C(9) 118.2(4) 
C(5)-C(4)-Fe(1) 68.4(3) C(9)-C(4)-Fe(1) 106.7(3) 
C(5)-C(4)-H(4) 124(4) C(9)-C(4)-H(4) 111(4) 
Fe(1)-C(4)-H(4) 123(4) C(6)-C(5)-C(4) 116.5(4) 
C(6)-C(5)-Fe(1) 70.0(3) C(4)-C(5)-Fe(1) 72.1(3) 
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C(6)-C(5)-H(5) 120(4) C(4)-C(5)-H(5) 123(4) 
Fe(1)-C(5)-H(5) 120(4) C(5)-C(6)-C(7) 117.2(4) 
C(5)-C(6)-Fe(1) 70.4(2) C(7)-C(6)-Fe(1) 72.9(3) 
C(5)-C(6)-H(6) 126(4) C(7)-C(6)-H(6) 116(4) 
Fe(1)-C(6)-H(6) 123(4) C(6)-C(7)-C(8) 121.9(4) 
C(6)-C(7)-Fe(1) 67.3(2) C(8)-C(7)-Fe(1) 98.6(3) 
C(6)-C(7)-H(7) 118(4) C(8)-C(7)-H(7) 118(4) 
Fe(1)-C(7)-H(7) 120(4) O(5)-C(8)-C(7) 125.2(4) 
O(5)-C(8)-C(9) 119.0(4) C(7)-C(8)-C(9) 115.5(4) 
O(4)-C(9)-C(10) 110.4(3) O(4)-C(9)-C(4) 108.0(3) 
C(10)-C(9)-C(4) 111.4(3) O(4)-C(9)-C(8) 108.8(3) 
C(10)-C(9)-C(8) 109.9(3) C(4)-C(9)-C(8) 108.2(3) 
O(7)-C(10)-O(6) 125.8(5) O(7)-C(10)-C(9) 116.1(4) 
O(6)-C(10)-C(9) 118.1(4) O(6)-C(11)-H(11A) 109.5 
O(6)-C(11)-H(11B) 109.5 O(6)-C(11)-H(11C) 109.5 
O(7)-C(12)-H(12A) 109.5 O(7)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 O(7)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 H(12B)-C(12)-H(12C) 109.5 
O(1A)-C(1A)-Fe(1A) 177.9(5) O(2A)-C(2A)-Fe(1A) 179.7(5) 
O(3A)-C(3A)-Fe(1A) 177.9(5) C(5A)-C(4A)-C(9A) 118.8(4) 
C(5A)-C(4A)-Fe(1A) 67.9(3) C(9A)-C(4A)-Fe(1A) 106.4(3) 
C(5A)-C(4A)-H(4A) 121(4) C(9A)-C(4A)-H(4A) 113(4) 
Fe(1A)-C(4A)-H(4A) 122(4) C(6A)-C(5A)-C(4A) 116.8(4) 
C(6A)-C(5A)-Fe(1A) 70.1(3) C(4A)-C(5A)-Fe(1A) 72.4(3) 
C(6A)-C(5A)-H(5A) 116(4) C(4A)-C(5A)-H(5A) 127(4) 
Fe(1A)-C(5A)-H(5A) 120(4) C(5A)-C(6A)-C(7A) 116.2(4) 
C(5A)-C(6A)-Fe(1A) 70.0(3) C(7A)-C(6A)-Fe(1A) 72.6(3) 
C(5A)-C(6A)-H(6A) 123(4) C(7A)-C(6A)-H(6A) 121(4) 
Fe(1A)-C(6A)-H(6A) 124(4) C(6A)-C(7A)-C(8A) 123.0(4) 
C(6A)-C(7A)-Fe(1A) 67.3(3) C(8A)-C(7A)-Fe(1A) 98.5(3) 
C(6A)-C(7A)-H(7A) 122(4) C(8A)-C(7A)-H(7A) 113(4) 
Fe(1A)-C(7A)-H(7A) 121(4) O(5A)-C(8A)-C(7A) 126.1(4) 
O(5A)-C(8A)-C(9A) 117.9(4) C(7A)-C(8A)-C(9A) 115.7(4) 
O(4A)-C(9A)-C(4A) 108.4(4) O(4A)-C(9A)-C(8A) 109.5(3) 
C(4A)-C(9A)-C(8A) 108.2(3) O(4A)-C(9A)-C(10A) 110.6(3) 
C(4A)-C(9A)-C(10A) 110.7(4) C(8A)-C(9A)-C(10A) 109.4(3) 
O(7A)-C(10A)-O(6A) 126.2(5) O(7A)-C(10A)-C(9A) 116.5(4) 
O(6A)-C(10A)-C(9A) 117.3(4) O(6A)-C(11A)-H(11D) 109.5 
O(6A)-C(11A)-H(11E) 109.5 H(11D)-C(11A)-H(11E) 109.5 
O(6A)-C(11A)-H(11F) 109.5 H(11D)-C(11A)-H(11F) 109.5 
H(11E)-C(11A)-H(11F) 109.5 O(7A)-C(12A)-H(12D) 109.5 
O(7A)-C(12A)-H(12E) 109.5 O(7A)-C(12A)-H(12F) 109.5 
O(1B)-C(1B)-Fe(1B) 177.8(5) O(2B)-C(2B)-Fe(1B) 178.7(5) 
O(3B)-C(3B)-Fe(1B) 178.8(5) C(5B)-C(4B)-C(9B) 119.4(4) 
C(5B)-C(4B)-Fe(1B) 68.5(3) C(9B)-C(4B)-Fe(1B) 106.8(3) 
C(5B)-C(4B)-H(4B) 121(4) C(9B)-C(4B)-H(4B) 113(4) 
Fe(1B)-C(4B)-H(4B) 121(4) C(4B)-C(5B)-C(6B) 116.1(4) 
C(4B)-C(5B)-Fe(1B) 72.1(3) C(6B)-C(5B)-Fe(1B) 69.9(3) 
C(4B)-C(5B)-H(5B) 119(4) C(6B)-C(5B)-H(5B) 125(4) 
Fe(1B)-C(5B)-H(5B) 127(4) C(5B)-C(6B)-C(7B) 116.7(4) 
C(5B)-C(6B)-Fe(1B) 70.0(3) C(7B)-C(6B)-Fe(1B) 72.6(3) 
C(5B)-C(6B)-H(6B) 127(4) C(7B)-C(6B)-H(6B) 115(4) 
Fe(1B)-C(6B)-H(6B) 117(4) C(6B)-C(7B)-C(8B) 121.6(4) 
C(6B)-C(7B)-Fe(1B) 67.3(2) C(8B)-C(7B)-Fe(1B) 98.2(3) 
C(6B)-C(7B)-H(7B) 118(4) C(8B)-C(7B)-H(7B) 117(4) 
Fe(1B)-C(7B)-H(7B) 124(4) O(5B)-C(8B)-C(7B) 124.6(4) 
O(5B)-C(8B)-C(9B) 118.6(4) C(7B)-C(8B)-C(9B) 116.5(4) 
O(4B)-C(9B)-C(4B) 108.6(3) O(4B)-C(9B)-C(10B) 110.2(3) 
C(4B)-C(9B)-C(10B) 110.9(3) O(4B)-C(9B)-C(8B) 109.5(3) 
C(4B)-C(9B)-C(8B) 107.8(3) C(10B)-C(9B)-C(8B) 109.8(4) 
O(6B)-C(10B)-O(7B) 126.4(5) O(6B)-C(10B)-C(9B) 118.1(4) 
O(7B)-C(10B)-C(9B) 115.5(4) O(6B)-C(11B)-H(11G) 109.5 
O(6B)-C(11B)-H(11H) 109.5 H(11G)-C(11B)-H(11H) 109.5 
O(6B)-C(11B)-H(11I) 109.5 H(11G)-C(11B)-H(11I) 109.5 
H(11H)-C(11B)-H(11I) 109.5 O(7B)-C(12B)-H(12G) 109.5 
O(7B)-C(12B)-H(12H) 109.5 O(7B)-C(12B)-H(12I) 109.5 
O(1C)-C(1C)-Fe(1C) 178.9(5) O(2C)-C(2C)-Fe(1C) 178.7(5) 
O(3C)-C(3C)-Fe(1C) 178.8(5) C(5C)-C(4C)-C(9C) 119.2(4) 
C(5C)-C(4C)-Fe(1C) 68.4(3) C(9C)-C(4C)-Fe(1C) 107.1(3) 
C(5C)-C(4C)-H(4C) 120(4) C(9C)-C(4C)-H(4C) 113(4) 
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Fe(1C)-C(4C)-H(4C) 122(4) C(4C)-C(5C)-C(6C) 116.2(4) 
C(4C)-C(5C)-Fe(1C) 72.0(3) C(6C)-C(5C)-Fe(1C) 70.1(2) 
C(4C)-C(5C)-H(5C) 122(4) C(6C)-C(5C)-H(5C) 121(4) 
Fe(1C)-C(5C)-H(5C) 120(4) C(5C)-C(6C)-C(7C) 116.5(4) 
C(5C)-C(6C)-Fe(1C) 69.7(2) C(7C)-C(6C)-Fe(1C) 72.6(3) 
C(5C)-C(6C)-H(6C) 123(3) C(7C)-C(6C)-H(6C) 119(4) 
Fe(1C)-C(6C)-H(6C) 115(4) C(8C)-C(7C)-C(6C) 121.6(4) 
C(8C)-C(7C)-Fe(1C) 97.8(3) C(6C)-C(7C)-Fe(1C) 67.3(2) 
C(8C)-C(7C)-H(7C) 121(4) C(6C)-C(7C)-H(7C) 115(4) 
Fe(1C)-C(7C)-H(7C) 116(4) O(5C)-C(8C)-C(7C) 124.9(4) 
O(5C)-C(8C)-C(9C) 117.7(4) C(7C)-C(8C)-C(9C) 117.2(4) 
O(4C)-C(9C)-C(4C) 108.4(3) O(4C)-C(9C)-C(10C) 111.1(3) 
C(4C)-C(9C)-C(10C) 111.2(3) O(4C)-C(9C)-C(8C) 109.3(3) 
C(4C)-C(9C)-C(8C) 107.0(3) C(10C)-C(9C)-C(8C) 109.7(3) 
O(7C)-C(10C)-O(6C) 125.8(5) O(7C)-C(10C)-C(9C) 116.6(4) 
O(6C)-C(10C)-C(9C) 117.6(4) O(6C)-C(11C)-H(11J) 109.5 
O(6C)-C(11C)-H(11K) 109.5 O(6C)-C(11C)-H(11L) 109.5 
O(7C)-C(12C)-H(12J) 109.5 O(7C)-C(12C)-H(12K) 109.5 
H(12J)-C(12C)-H(12K) 109.5 O(7C)-C(12C)-H(12L) 109.5 
H(12J)-C(12C)-H(12L) 109.5 H(12K)-C(12C)-H(12L) 109.5 
O(1D)-C(1D)-Fe(1D) 178.3(5) O(2D)-C(2D)-Fe(1D) 179.4(5) 
O(3D)-C(3D)-Fe(1D) 178.7(5) C(5D)-C(4D)-C(9D) 118.9(4) 
C(5D)-C(4D)-Fe(1D) 67.9(3) C(9D)-C(4D)-Fe(1D) 107.0(3) 
C(5D)-C(4D)-H(4D) 127(4) C(9D)-C(4D)-H(4D) 108(4) 
Fe(1D)-C(4D)-H(4D) 122(4) C(6D)-C(5D)-C(4D) 116.7(4) 
C(6D)-C(5D)-Fe(1D) 70.4(3) C(4D)-C(5D)-Fe(1D) 72.4(3) 
C(6D)-C(5D)-H(5D) 121(4) C(4D)-C(5D)-H(5D) 123(4) 
Fe(1D)-C(5D)-H(5D) 127(4) C(5D)-C(6D)-C(7D) 116.2(4) 
C(5D)-C(6D)-Fe(1D) 70.0(3) C(7D)-C(6D)-Fe(1D) 72.1(3) 
C(5D)-C(6D)-H(6D) 126(4) C(7D)-C(6D)-H(6D) 118(4) 
Fe(1D)-C(6D)-H(6D) 122(4) C(8D)-C(7D)-C(6D) 122.6(4) 
C(8D)-C(7D)-Fe(1D) 99.0(3) C(6D)-C(7D)-Fe(1D) 67.6(3) 
C(8D)-C(7D)-H(7D) 113(4) C(6D)-C(7D)-H(7D) 122(4) 
Fe(1D)-C(7D)-H(7D) 119(4) O(5D)-C(8D)-C(7D) 125.8(4) 
O(5D)-C(8D)-C(9D) 118.0(4) C(7D)-C(8D)-C(9D) 115.8(4) 
O(4D)-C(9D)-C(4D) 108.4(3) O(4D)-C(9D)-C(10D) 110.9(3) 
C(4D)-C(9D)-C(10D) 111.2(3) O(4D)-C(9D)-C(8D) 109.0(3) 
C(4D)-C(9D)-C(8D) 107.3(3) C(10D)-C(9D)-C(8D) 109.9(3) 
O(6D)-C(10D)-O(7D) 126.9(5) O(6D)-C(10D)-C(9D) 117.6(4) 
O(7D)-C(10D)-C(9D) 115.4(4) O(6D)-C(11D)-H(11M) 109.5 
O(6D)-C(11D)-H(11N) 109.5 O(6D)-C(11D)-H(11O) 109.5 
O(7D)-C(12D)-H(12M) 109.5 O(7D)-C(12D)-H(12N) 109.5 
H(12M)-C(12D)-H(12N) 109.5 O(7D)-C(12D)-H(12O) 109.5 
H(12M)-C(12D)-H(12O) 109.5 H(12N)-C(12D)-H(12O) 109.5 
O(2E)-C(1E)-Fe(1E) 178.4(5) O(3E)-C(2E)-Fe(1E) 179.5(5) 
O(4E)-C(3E)-Fe(1E) 178.5(5) C(5E)-C(4E)-C(9E) 118.7(4) 
C(5E)-C(4E)-Fe(1E) 68.7(3) C(9E)-C(4E)-Fe(1E) 106.8(3) 
C(5E)-C(4E)-H(4E) 117(4) C(9E)-C(4E)-H(4E) 114(4) 
Fe(1E)-C(4E)-H(4E) 124(4) C(6E)-C(5E)-C(4E) 116.2(4) 
C(6E)-C(5E)-Fe(1E) 69.8(3) C(4E)-C(5E)-Fe(1E) 71.6(3) 
C(6E)-C(5E)-H(5E) 122(4) C(4E)-C(5E)-H(5E) 122(4) 
Fe(1E)-C(5E)-H(5E) 122(4) C(5E)-C(6E)-C(7E) 116.4(4) 
C(5E)-C(6E)-Fe(1E) 70.3(3) C(7E)-C(6E)-Fe(1E) 72.4(3) 
C(5E)-C(6E)-H(6E) 127(4) C(7E)-C(6E)-H(6E) 117(4) 
Fe(1E)-C(6E)-H(6E) 124(4) C(6E)-C(7E)-C(8E) 122.3(4) 
C(6E)-C(7E)-Fe(1E) 67.6(3) C(8E)-C(7E)-Fe(1E) 98.1(3) 
C(6E)-C(7E)-H(7E) 120(4) C(8E)-C(7E)-H(7E) 116(4) 
Fe(1E)-C(7E)-H(7E) 117(5) O(6E)-C(8E)-C(7E) 124.6(4) 
O(6E)-C(8E)-C(9E) 118.6(4) C(7E)-C(8E)-C(9E) 116.5(4) 
O(5E)-C(9E)-C(4E) 108.6(3) O(5E)-C(9E)-C(8E) 109.6(3) 
C(4E)-C(9E)-C(8E) 107.6(3) O(5E)-C(9E)-C(10E) 110.4(4) 
C(4E)-C(9E)-C(10E) 110.7(3) C(8E)-C(9E)-C(10E) 110.0(4) 
O(8E)-C(10E)-O(7E) 127.0(5) O(8E)-C(10E)-C(9E) 116.0(4) 
O(7E)-C(10E)-C(9E) 117.1(4) O(7E)-C(11E)-H(11P) 109.5 
O(7E)-C(11E)-H(11Q) 109.5 O(7E)-C(11E)-H(11R) 109.5 
O(8E)-C(12E)-H(12P) 109.5 O(8E)-C(12E)-H(12Q) 109.5 
H(12P)-C(12E)-H(12Q) 109.5 O(8E)-C(12E)-H(12R) 109.5 
H(12P)-C(12E)-H(12R) 109.5 H(12Q)-C(12E)-H(12R) 109.5 
                                                      




 Table 21 Anisotropic displacement parameters (Å2 x 103) for 396. The anisotropic 
displacement  factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
                                                                                 
  Atom  U11  U22  U33  U23  U13  U12 
                                                
Fe(1) 19(1) 16(1) 19(1) -1(1) 0(1) -6(1) 
Fe(1A) 18(1) 22(1) 19(1) -1(1) -2(1) -11(1) 
Fe(1B) 19(1) 22(1) 19(1) -1(1) -2(1) -10(1) 
Fe(1C) 21(1) 18(1) 18(1) 0(1) -1(1) -10(1) 
Fe(1D) 22(1) 19(1) 19(1) 0(1) -1(1) -11(1) 
Fe(1E) 18(1) 20(1) 19(1) -2(1) 0(1) -7(1) 
O(1) 36(2) 37(2) 25(2) 6(2) -8(2) -9(2) 
O(2) 56(3) 33(2) 37(3) -16(2) 0(2) -23(2) 
O(3) 29(2) 46(3) 39(3) 4(2) 8(2) -14(2) 
O(4) 18(2) 20(2) 34(2) 7(2) -9(1) -7(1) 
O(5) 27(2) 13(2) 40(2) -3(2) 2(2) -8(2) 
O(6) 54(3) 58(3) 73(3) -15(2) 43(2) -27(2) 
O(7) 84(3) 45(3) 25(2) -1(2) -11(2) -29(2) 
O(1A) 38(2) 61(3) 26(2) -1(2) 6(2) -34(2) 
O(2A) 47(3) 44(2) 33(2) -15(2) 6(2) -33(2) 
O(3A) 39(2) 46(3) 50(3) 10(2) -23(2) -12(2) 
O(4A) 15(2) 22(2) 39(2) -2(2) 4(1) -10(2) 
O(5A) 28(2) 21(2) 39(2) 0(2) -7(2) -17(2) 
O(6A) 60(3) 63(3) 75(3) 31(2) -50(2) -28(2) 
O(7A) 81(3) 63(3) 28(2) -10(2) 14(2) -49(3) 
O(1B) 34(2) 60(3) 21(2) -7(2) 11(2) -28(2) 
O(2B) 30(2) 36(2) 38(3) 12(2) -18(2) -4(2) 
O(3B) 54(3) 42(2) 40(3) -14(2) 3(2) -36(2) 
O(4B) 18(2) 23(2) 36(2) -3(2) 4(2) -12(2) 
O(5B) 15(2) 22(2) 35(2) -3(2) -4(2) -5(2) 
O(6B) 60(3) 73(3) 68(3) -33(2) -13(2) -37(2) 
O(7B) 45(2) 64(3) 22(2) 6(2) 1(2) -12(2) 
O(1C) 59(3) 38(2) 25(2) -13(2) 6(2) -30(2) 
O(2C) 41(2) 29(2) 40(3) 13(2) -14(2) -8(2) 
O(3C) 44(2) 55(3) 41(3) -6(2) 13(2) -39(2) 
O(4C) 24(2) 16(2) 33(2) -6(2) 1(2) -12(2) 
O(5C) 21(2) 15(2) 33(2) -3(2) 5(1) -5(2) 
O(6C) 62(3) 54(3) 64(3) 8(2) 31(2) -33(2) 
O(7C) 70(3) 47(3) 24(2) -8(2) -10(2) -17(2) 
O(1D) 65(3) 41(2) 27(2) -10(2) -2(2) -35(2) 
O(2D) 46(3) 52(3) 33(2) -6(2) 10(2) -35(2) 
O(3D) 47(3) 38(2) 45(3) 21(2) -18(2) -13(2) 
O(4D) 21(2) 16(2) 37(2) -7(1) -3(2) -8(1) 
O(5D) 23(2) 27(2) 38(2) 4(2) -7(2) -18(2) 
O(6D) 69(3) 50(3) 78(3) 49(2) -39(2) -29(2) 
O(7D) 68(3) 88(3) 23(2) -7(2) 6(2) -57(3) 
O(2E) 31(2) 38(2) 27(2) 9(2) -13(2) -6(2) 
O(3E) 25(2) 51(3) 33(2) 8(2) 4(2) -16(2) 
O(4E) 63(3) 38(3) 48(3) -25(2) 7(2) -24(2) 
O(5E) 18(2) 16(2) 38(2) 3(1) -8(2) -5(1) 
O(6E) 13(2) 25(2) 39(2) -6(2) -2(1) -6(2) 
O(7E) 60(3) 63(3) 83(3) -59(3) 15(2) -26(2) 
O(8E) 48(2) 88(3) 23(2) 11(2) -6(2) -32(2) 
C(1) 35(3) 23(3) 21(3) -6(2) 0(2) -15(3) 
C(2) 19(3) 30(3) 29(3) 3(3) 0(2) -8(2) 
C(3) 23(3) 25(3) 25(3) 1(2) -3(2) -9(2) 
C(4) 20(3) 16(3) 16(2) 0(2) 1(2) -8(2) 
C(5) 20(2) 11(2) 20(2) 2(2) 0(2) -3(2) 
C(6) 19(3) 18(3) 24(3) -4(2) -2(2) -5(2) 
C(7) 15(2) 18(3) 23(3) -8(2) 5(2) -8(2) 
C(8) 23(2) 17(3) 14(2) -6(2) 2(2) -8(2) 
C(9) 13(2) 13(2) 23(2) 1(2) -2(2) -4(2) 
C(10) 24(3) 12(2) 26(3) -2(2) 5(2) -7(2) 
C(11) 40(6) 55(8) 23(6) -4(5) 13(5) -19(6) 
C(12) 79(9) 45(7) 23(6) 8(5) 2(6) -40(7) 
C(1A) 30(3) 25(3) 20(3) 1(2) -5(2) -13(2) 
C(2A) 19(3) 36(3) 19(3) -1(2) 4(2) -15(2) 
C(3A) 31(3) 38(3) 28(3) 3(2) -8(2) -20(3) 
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C(4A) 17(2) 15(2) 18(2) -1(2) 1(2) -9(2) 
C(5A) 19(3) 30(3) 17(2) -1(2) -1(2) -16(2) 
C(6A) 15(2) 32(3) 18(2) -4(2) 3(2) -12(2) 
C(7A) 16(3) 20(3) 23(3) -3(2) -2(2) -7(2) 
C(8A) 21(3) 15(2) 16(2) -4(2) -1(2) -8(2) 
C(9A) 14(2) 21(3) 20(2) 1(2) 2(2) -9(2) 
C(10A) 28(3) 22(3) 29(3) 3(2) -10(2) -18(2) 
C(11A) 44(7) 67(8) 39(7) 28(6) -28(6) -35(6) 
C(12A) 76(8) 51(7) 3(5) 2(5) 1(5) -40(7) 
C(1B) 28(3) 22(3) 21(3) 1(2) -9(2) -10(2) 
C(2B) 29(3) 38(3) 21(3) -4(2) 1(2) -21(3) 
C(3B) 21(3) 37(3) 28(3) -2(2) 4(2) -14(2) 
C(4B) 17(2) 16(3) 21(3) -1(2) 3(2) -7(2) 
C(5B) 16(2) 21(3) 17(2) -2(2) -2(2) -7(2) 
C(6B) 25(3) 33(3) 15(2) 5(2) -6(2) -20(2) 
C(7B) 15(2) 18(3) 26(3) -2(2) -3(2) -7(2) 
C(8B) 24(3) 25(3) 14(2) 4(2) -6(2) -11(2) 
C(9B) 18(2) 17(2) 22(2) -4(2) 1(2) -12(2) 
C(10B) 15(2) 22(3) 25(3) -2(2) -4(2) -2(2) 
C(11B) 48(7) 71(8) 24(6) -24(6) -1(5) -41(6) 
C(12B) 56(8) 51(8) 22(6) -14(5) 5(5) -16(6) 
C(1C) 27(3) 32(3) 14(3) 2(2) -2(2) -16(3) 
C(2C) 37(3) 29(3) 29(3) 2(2) -2(2) -22(3) 
C(3C) 30(3) 24(3) 31(3) -8(2) -3(2) -10(2) 
C(4C) 14(2) 20(3) 19(3) -2(2) 3(2) -8(2) 
C(5C) 22(3) 16(3) 22(3) -2(2) 2(2) -7(2) 
C(6C) 32(3) 26(3) 13(2) 6(2) -7(2) -18(2) 
C(7C) 23(3) 17(3) 24(3) 4(2) -6(2) -11(2) 
C(8C) 23(2) 20(3) 11(2) 2(2) -3(2) -8(2) 
C(9C) 15(2) 12(2) 23(2) -4(2) 1(2) -5(2) 
C(10C) 21(2) 10(2) 27(3) 2(2) 5(2) -1(2) 
C(11C) 79(8) 48(7) 25(6) 7(5) 20(6) -47(7) 
C(12C) 58(8) 52(8) 16(6) -1(5) 2(5) -14(6) 
C(1D) 27(3) 29(3) 21(3) 11(2) -2(2) -16(3) 
C(2D) 36(3) 24(3) 20(3) -3(2) -2(2) -18(3) 
C(3D) 31(3) 33(3) 29(3) -1(2) 1(2) -18(3) 
C(4D) 17(2) 22(3) 18(2) -1(2) -3(2) -11(2) 
C(5D) 28(3) 21(3) 18(2) -2(2) -2(2) -18(2) 
C(6D) 27(3) 19(3) 19(3) -4(2) 2(2) -10(2) 
C(7D) 16(3) 17(3) 21(3) -2(2) 5(2) -7(2) 
C(8D) 17(2) 27(3) 10(2) 1(2) 3(2) -13(2) 
C(9D) 17(2) 12(2) 22(2) -1(2) -1(2) -8(2) 
C(10D) 21(2) 26(3) 26(3) 4(2) -4(2) -16(2) 
C(11D) 75(9) 36(7) 26(6) 20(5) -19(6) -22(6) 
C(12D) 41(6) 66(8) 18(6) 2(5) -9(5) -32(6) 
C(1E) 17(3) 30(3) 19(3) -11(2) 5(2) -8(2) 
C(2E) 25(3) 27(3) 27(3) 4(2) -6(2) -11(2) 
C(3E) 26(3) 35(3) 31(3) -2(3) 3(2) -15(3) 
C(4E) 17(2) 16(3) 22(2) 1(2) -2(2) -8(2) 
C(5E) 16(2) 24(3) 15(2) -2(2) 2(2) -6(2) 
C(6E) 21(3) 16(3) 20(2) -2(2) 3(2) -5(2) 
C(7E) 27(3) 16(3) 23(3) -1(2) 2(2) -10(2) 
C(8E) 15(2) 25(3) 16(2) -1(2) -1(2) -10(2) 
C(9E) 15(2) 13(2) 23(2) -2(2) -3(2) -3(2) 
C(10E) 14(2) 29(3) 32(3) -6(2) -1(2) -11(2) 
C(11E) 64(8) 45(7) 24(6) -13(5) -3(6) -21(6) 
C(12E) 52(7) 71(8) 17(6) -3(5) 6(5) -36(7) 
  
 
 Table 22 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 396 
                                     
  Atom   x   y   z  U(eq) 
                                 
H(41) 5052 8556 196 34(16) 
H(42) 4326 -199 1976 22(14) 
H(43) 9405 2651 3553 47(18) 
H(44) 591 10238 5317 48(18) 
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H(45) 6681 4231 6870 22(14) 
H(46) 14335 3649 8658 16(13) 
H(11A) 4038 5951 1175 64 
H(11B) 1651 7387 1016 64 
H(11C) 2938 8671 1119 64 
H(12A) 6784 6203 1284 69 
H(12B) 9540 4839 1257 69 
H(12C) 8141 3483 1245 69 
H(11D) 3630 3675 1058 70 
H(11E) 1484 3404 1183 70 
H(11F) 3668 1283 1037 70 
H(12D) 7206 -527 915 60 
H(12E) 9800 -1088 949 60 
H(12F) 7742 1520 948 60 
H(11G) 6624 5529 4494 63 
H(11H) 8530 6097 4347 63 
H(11I) 9263 3545 4470 63 
H(12G) 7232 1757 4615 70 
H(12H) 5354 964 4591 70 
H(12I) 4571 3643 4585 70 
H(11J) 4639 8047 4401 68 
H(11K) 4050 10493 4511 68 
H(11L) 2130 10227 4359 68 
H(12J) 648 8688 4247 73 
H(12K) -470 7050 4271 73 
H(12L) 2263 5958 4282 73 
H(11M) 9511 3235 7828 73 
H(11N) 10304 866 7678 73 
H(11O) 7696 2373 7796 73 
H(12M) 6197 6027 7946 59 
H(12N) 4894 8778 7920 59 
H(12O) 7651 7343 7905 59 
H(11P) 12178 2762 7728 69 
H(11Q) 14506 708 7856 69 
H(11R) 14482 2942 7705 69 
H(12P) 12699 6108 7575 66 
H(12Q) 11411 8842 7599 66 
H(12R) 9946 7539 7607 66 
H(4) 7470(80) 2950(100) 266(14) 80 
H(5) 11380(100) 350(20) 447(14) 80 
H(6) 13840(30) 2120(90) 465(13) 80 
H(7) 12390(80) 5890(100) 291(14) 80 
H(4A) 6970(80) 2900(30) 1928(14) 80 
H(5A) 11060(90) 1430(90) 1745(14) 80 
H(6A) 13430(30) -2610(90) 1726(13) 80 
H(7A) 11700(90) -4964(19) 1907(14) 80 
H(4B) 3700(100) 5700(30) 3598(14) 80 
H(5B) 1190(40) 4350(80) 3798(13) 80 
H(6B) 2860(90) -30(90) 3778(14) 80 
H(7B) 6710(90) -2200(20) 3640(14) 80 
H(4C) 3730(30) 4570(100) 5259(14) 80 
H(5C) 2390(80) 2140(30) 5081(14) 80 
H(6C) -1820(90) 3770(80) 5085(14) 80 
H(7C) -4140(30) 7500(100) 5245(14) 80 
H(4D) 9640(110) 6730(110) 6929(15) 80 
H(5D) 8270(110) 10530(100) 7130(14) 80 
H(6D) 4090(100) 13060(110) 7126(14) 80 
H(7D) 1980(110) 11410(110) 6948(15) 80 
H(4E) 8630(100) 6240(110) 8579(14) 80 
H(5E) 6370(110) 10100(100) 8410(14) 80 
H(6E) 8100(100) 12650(110) 8395(14) 80 




Table 23 Dihedral angles [o] for 396 
                                         
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
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C(2) - Fe(1) - C(1) - O(1) 173(100) 
C(3) - Fe(1) - C(1) - O(1) -93(15) 
C(6) - Fe(1) - C(1) - O(1) 15(15) 
C(5) - Fe(1) - C(1) - O(1) 72(15) 
C(4) - Fe(1) - C(1) - O(1) 79(15) 
C(7) - Fe(1) - C(1) - O(1) 0(15) 
C(3) - Fe(1) - C(2) - O(2) -148(14) 
C(1) - Fe(1) - C(2) - O(2) -48(14) 
C(6) - Fe(1) - C(2) - O(2) 115(14) 
C(5) - Fe(1) - C(2) - O(2) 86(14) 
C(4) - Fe(1) - C(2) - O(2) 46(14) 
C(7) - Fe(1) - C(2) - O(2) 109(14) 
C(2) - Fe(1) - C(3) - O(3) 157(100) 
C(1) - Fe(1) - C(3) - O(3) 59(16) 
C(6) - Fe(1) - C(3) - O(3) -80(16) 
C(5) - Fe(1) - C(3) - O(3) -107(16) 
C(4) - Fe(1) - C(3) - O(3) -89(16) 
C(7) - Fe(1) - C(3) - O(3) -40(16) 
C(2) - Fe(1) - C(4) - C(5) 91.0(3) 
C(3) - Fe(1) - C(4) - C(5) -23.2(9) 
C(1) - Fe(1) - C(4) - C(5) -171.7(3) 
C(6) - Fe(1) - C(4) - C(5) -32.4(3) 
C(7) - Fe(1) - C(4) - C(5) -72.9(3) 
C(2) - Fe(1) - C(4) - C(9) -154.8(3) 
C(3) - Fe(1) - C(4) - C(9) 91.0(8) 
C(1) - Fe(1) - C(4) - C(9) -57.4(3) 
C(6) - Fe(1) - C(4) - C(9) 81.9(3) 
C(5) - Fe(1) - C(4) - C(9) 114.3(4) 
C(7) - Fe(1) - C(4) - C(9) 41.3(3) 
C(9) - C(4) - C(5) - C(6) -42.2(6) 
Fe(1) - C(4) - C(5) - C(6) 55.8(4) 
C(9) - C(4) - C(5) - Fe(1) -98.0(4) 
C(2) - Fe(1) - C(5) - C(6) 140.4(3) 
C(3) - Fe(1) - C(5) - C(6) 44.7(3) 
C(1) - Fe(1) - C(5) - C(6) -116.8(3) 
C(4) - Fe(1) - C(5) - C(6) -128.0(4) 
C(7) - Fe(1) - C(5) - C(6) -32.3(3) 
C(2) - Fe(1) - C(5) - C(4) -91.5(3) 
C(3) - Fe(1) - C(5) - C(4) 172.7(3) 
C(1) - Fe(1) - C(5) - C(4) 11.2(4) 
C(6) - Fe(1) - C(5) - C(4) 128.0(4) 
C(7) - Fe(1) - C(5) - C(4) 95.7(3) 
C(4) - C(5) - C(6) - C(7) 0.7(6) 
Fe(1) - C(5) - C(6) - C(7) 57.6(4) 
C(4) - C(5) - C(6) - Fe(1) -56.9(4) 
C(2) - Fe(1) - C(6) - C(5) -48.9(3) 
C(3) - Fe(1) - C(6) - C(5) -145.4(3) 
C(1) - Fe(1) - C(6) - C(5) 104.8(4) 
C(4) - Fe(1) - C(6) - C(5) 32.2(3) 
C(7) - Fe(1) - C(6) - C(5) 128.2(4) 
C(2) - Fe(1) - C(6) - C(7) -177.1(3) 
C(3) - Fe(1) - C(6) - C(7) 86.4(3) 
C(1) - Fe(1) - C(6) - C(7) -23.4(4) 
C(5) - Fe(1) - C(6) - C(7) -128.2(4) 
C(4) - Fe(1) - C(6) - C(7) -96.0(3) 
C(5) - C(6) - C(7) - C(8) 29.7(6) 
Fe(1) - C(6) - C(7) - C(8) 86.0(4) 
C(5) - C(6) - C(7) - Fe(1) -56.4(4) 
C(2) - Fe(1) - C(7) - C(6) 7.9(7) 
C(3) - Fe(1) - C(7) - C(6) -96.2(3) 
C(1) - Fe(1) - C(7) - C(6) 164.1(3) 
C(5) - Fe(1) - C(7) - C(6) 32.2(3) 
C(4) - Fe(1) - C(7) - C(6) 72.5(3) 
C(2) - Fe(1) - C(7) - C(8) -113.2(6) 
C(3) - Fe(1) - C(7) - C(8) 142.7(3) 
C(1) - Fe(1) - C(7) - C(8) 42.9(3) 
C(6) - Fe(1) - C(7) - C(8) -121.1(4) 
C(5) - Fe(1) - C(7) - C(8) -88.9(3) 
C(4) - Fe(1) - C(7) - C(8) -48.7(3) 
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C(6) - C(7) - C(8) - O(5) 168.6(4) 
Fe(1) - C(7) - C(8) - O(5) -122.8(4) 
C(6) - C(7) - C(8) - C(9) -17.7(6) 
Fe(1) - C(7) - C(8) - C(9) 50.9(4) 
C(5) - C(4) - C(9) - O(4) 168.2(4) 
Fe(1) - C(4) - C(9) - O(4) 94.2(3) 
C(5) - C(4) - C(9) - C(10) -70.5(5) 
Fe(1) - C(4) - C(9) - C(10) -144.4(3) 
C(5) - C(4) - C(9) - C(8) 50.5(5) 
Fe(1) - C(4) - C(9) - C(8) -23.5(4) 
O(5) - C(8) - C(9) - O(4) 37.3(5) 
C(7) - C(8) - C(9) - O(4) -136.8(4) 
O(5) - C(8) - C(9) - C(10) -83.7(5) 
C(7) - C(8) - C(9) - C(10) 102.2(4) 
O(5) - C(8) - C(9) - C(4) 154.4(4) 
C(7) - C(8) - C(9) - C(4) -19.7(5) 
C(12) - O(7) - C(10) - O(6) 5.2(10) 
C(12) - O(7) - C(10) - C(9) -174.4(7) 
C(11) - O(6) - C(10) - O(7) 1.6(10) 
C(11) - O(6) - C(10) - C(9) -178.8(8) 
O(4) - C(9) - C(10) - O(7) -170.2(4) 
C(4) - C(9) - C(10) - O(7) 69.8(5) 
C(8) - C(9) - C(10) - O(7) -50.2(5) 
O(4) - C(9) - C(10) - O(6) 10.2(5) 
C(4) - C(9) - C(10) - O(6) -109.8(4) 
C(8) - C(9) - C(10) - O(6) 130.2(4) 
C(2A) - Fe(1A) - C(1A) - O(1A) -178(100) 
C(3A) - Fe(1A) - C(1A) - O(1A) -83(14) 
C(5A) - Fe(1A) - C(1A) - O(1A) 82(14) 
C(6A) - Fe(1A) - C(1A) - O(1A) 25(15) 
C(4A) - Fe(1A) - C(1A) - O(1A) 88(14) 
C(7A) - Fe(1A) - C(1A) - O(1A) 9(14) 
C(3A) - Fe(1A) - C(2A) - O(2A) 109(100) 
C(1A) - Fe(1A) - C(2A) - O(2A) -152(100) 
C(5A) - Fe(1A) - C(2A) - O(2A) -19(100) 
C(6A) - Fe(1A) - C(2A) - O(2A) 11(100) 
C(4A) - Fe(1A) - C(2A) - O(2A) -59(100) 
C(7A) - Fe(1A) - C(2A) - O(2A) 8(100) 
C(2A) - Fe(1A) - C(3A) - O(3A) 132(14) 
C(1A) - Fe(1A) - C(3A) - O(3A) 33(14) 
C(5A) - Fe(1A) - C(3A) - O(3A) -132(14) 
C(6A) - Fe(1A) - C(3A) - O(3A) -107(14) 
C(4A) - Fe(1A) - C(3A) - O(3A) -107(14) 
C(7A) - Fe(1A) - C(3A) - O(3A) -67(14) 
C(2A) - Fe(1A) - C(4A) - C(5A) 88.6(3) 
C(3A) - Fe(1A) - C(4A) - C(5A) -32.7(9) 
C(1A) - Fe(1A) - C(4A) - C(5A) -173.2(3) 
C(6A) - Fe(1A) - C(4A) - C(5A) -32.4(3) 
C(7A) - Fe(1A) - C(4A) - C(5A) -73.4(3) 
C(2A) - Fe(1A) - C(4A) - C(9A) -156.4(3) 
C(3A) - Fe(1A) - C(4A) - C(9A) 82.3(9) 
C(1A) - Fe(1A) - C(4A) - C(9A) -58.2(3) 
C(5A) - Fe(1A) - C(4A) - C(9A) 115.0(4) 
C(6A) - Fe(1A) - C(4A) - C(9A) 82.6(3) 
C(7A) - Fe(1A) - C(4A) - C(9A) 41.6(3) 
C(9A) - C(4A) - C(5A) - C(6A) -41.2(6) 
Fe(1A) - C(4A) - C(5A) - C(6A) 56.0(3) 
C(9A) - C(4A) - C(5A) - Fe(1A) -97.2(4) 
C(2A) - Fe(1A) - C(5A) - C(6A) 138.0(3) 
C(3A) - Fe(1A) - C(5A) - C(6A) 42.0(3) 
C(1A) - Fe(1A) - C(5A) - C(6A) -119.0(3) 
C(4A) - Fe(1A) - C(5A) - C(6A) -128.1(4) 
C(7A) - Fe(1A) - C(5A) - C(6A) -33.0(2) 
C(2A) - Fe(1A) - C(5A) - C(4A) -93.9(3) 
C(3A) - Fe(1A) - C(5A) - C(4A) 170.1(3) 
C(1A) - Fe(1A) - C(5A) - C(4A) 9.2(4) 
C(6A) - Fe(1A) - C(5A) - C(4A) 128.1(4) 
C(7A) - Fe(1A) - C(5A) - C(4A) 95.1(3) 
C(4A) - C(5A) - C(6A) - C(7A) 0.6(6) 
Fe(1A) - C(5A) - C(6A) - C(7A) 57.8(4) 
C(4A) - C(5A) - C(6A) - Fe(1A) -57.2(4) 
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C(2A) - Fe(1A) - C(6A) - C(5A) -51.0(3) 
C(3A) - Fe(1A) - C(6A) - C(5A) -147.8(3) 
C(1A) - Fe(1A) - C(6A) - C(5A) 102.9(4) 
C(4A) - Fe(1A) - C(6A) - C(5A) 32.3(2) 
C(7A) - Fe(1A) - C(6A) - C(5A) 127.3(4) 
C(2A) - Fe(1A) - C(6A) - C(7A) -178.3(3) 
C(3A) - Fe(1A) - C(6A) - C(7A) 84.9(3) 
C(1A) - Fe(1A) - C(6A) - C(7A) -24.4(4) 
C(5A) - Fe(1A) - C(6A) - C(7A) -127.3(4) 
C(4A) - Fe(1A) - C(6A) - C(7A) -95.1(3) 
C(5A) - C(6A) - C(7A) - C(8A) 28.9(6) 
Fe(1A) - C(6A) - C(7A) - C(8A) 85.3(4) 
C(5A) - C(6A) - C(7A) - Fe(1A) -56.4(3) 
C(2A) - Fe(1A) - C(7A) - C(6A) 4.4(7) 
C(3A) - Fe(1A) - C(7A) - C(6A) -97.3(3) 
C(1A) - Fe(1A) - C(7A) - C(6A) 163.7(3) 
C(5A) - Fe(1A) - C(7A) - C(6A) 32.8(3) 
C(4A) - Fe(1A) - C(7A) - C(6A) 73.3(3) 
C(2A) - Fe(1A) - C(7A) - C(8A) -117.9(6) 
C(3A) - Fe(1A) - C(7A) - C(8A) 140.4(3) 
C(1A) - Fe(1A) - C(7A) - C(8A) 41.4(3) 
C(5A) - Fe(1A) - C(7A) - C(8A) -89.5(3) 
C(6A) - Fe(1A) - C(7A) - C(8A) -122.3(4) 
C(4A) - Fe(1A) - C(7A) - C(8A) -49.0(3) 
C(6A) - C(7A) - C(8A) - O(5A) 169.7(5) 
Fe(1A) - C(7A) - C(8A) - O(5A) -122.0(4) 
C(6A) - C(7A) - C(8A) - C(9A) -17.2(6) 
Fe(1A) - C(7A) - C(8A) - C(9A) 51.2(4) 
C(5A) - C(4A) - C(9A) - O(4A) 168.2(4) 
Fe(1A) - C(4A) - C(9A) - O(4A) 94.8(3) 
C(5A) - C(4A) - C(9A) - C(8A) 49.5(5) 
Fe(1A) - C(4A) - C(9A) - C(8A) -23.8(4) 
C(5A) - C(4A) - C(9A) - C(10A) -70.4(5) 
Fe(1A) - C(4A) - C(9A) - C(10A) -143.7(3) 
O(5A) - C(8A) - C(9A) - O(4A) 36.1(5) 
C(7A) - C(8A) - C(9A) - O(4A) -137.6(4) 
O(5A) - C(8A) - C(9A) - C(4A) 154.1(4) 
C(7A) - C(8A) - C(9A) - C(4A) -19.7(5) 
O(5A) - C(8A) - C(9A) - C(10A) -85.2(5) 
C(7A) - C(8A) - C(9A) - C(10A) 101.0(4) 
C(12A) - O(7A) - C(10A) - O(6A) 5.1(10) 
C(12A) - O(7A) - C(10A) - C(9A) -174.4(7) 
C(11A) - O(6A) - C(10A) - O(7A) 2.2(10) 
C(11A) - O(6A) - C(10A) - C(9A) -178.3(8) 
O(4A) - C(9A) - C(10A) - O(7A) -169.7(4) 
C(4A) - C(9A) - C(10A) - O(7A) 70.1(5) 
C(8A) - C(9A) - C(10A) - O(7A) -49.1(5) 
O(4A) - C(9A) - C(10A) - O(6A) 10.7(5) 
C(4A) - C(9A) - C(10A) - O(6A) -109.5(4) 
C(8A) - C(9A) - C(10A) - O(6A) 131.4(4) 
C(3B) - Fe(1B) - C(1B) - O(1B) -135(12) 
C(2B) - Fe(1B) - C(1B) - O(1B) 131(12) 
C(6B) - Fe(1B) - C(1B) - O(1B) -28(13) 
C(5B) - Fe(1B) - C(1B) - O(1B) 30(13) 
C(4B) - Fe(1B) - C(1B) - O(1B) 37(12) 
C(7B) - Fe(1B) - C(1B) - O(1B) -42(13) 
C(3B) - Fe(1B) - C(2B) - O(2B) 173(100) 
C(1B) - Fe(1B) - C(2B) - O(2B) -88(26) 
C(6B) - Fe(1B) - C(2B) - O(2B) 75(26) 
C(5B) - Fe(1B) - C(2B) - O(2B) 46(26) 
C(4B) - Fe(1B) - C(2B) - O(2B) 7(26) 
C(7B) - Fe(1B) - C(2B) - O(2B) 69(26) 
C(2B) - Fe(1B) - C(3B) - O(3B) -164(100) 
C(1B) - Fe(1B) - C(3B) - O(3B) 99(26) 
C(6B) - Fe(1B) - C(3B) - O(3B) -41(26) 
C(5B) - Fe(1B) - C(3B) - O(3B) -67(26) 
C(4B) - Fe(1B) - C(3B) - O(3B) -47(26) 
C(7B) - Fe(1B) - C(3B) - O(3B) -1(26) 
C(3B) - Fe(1B) - C(4B) - C(5B) -25.9(9) 
C(2B) - Fe(1B) - C(4B) - C(5B) 90.6(3) 
C(1B) - Fe(1B) - C(4B) - C(5B) -172.4(3) 
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C(6B) - Fe(1B) - C(4B) - C(5B) -32.9(3) 
C(7B) - Fe(1B) - C(4B) - C(5B) -73.7(3) 
C(3B) - Fe(1B) - C(4B) - C(9B) 89.7(8) 
C(2B) - Fe(1B) - C(4B) - C(9B) -153.8(3) 
C(1B) - Fe(1B) - C(4B) - C(9B) -56.8(3) 
C(6B) - Fe(1B) - C(4B) - C(9B) 82.7(3) 
C(5B) - Fe(1B) - C(4B) - C(9B) 115.6(4) 
C(7B) - Fe(1B) - C(4B) - C(9B) 41.8(3) 
C(9B) - C(4B) - C(5B) - C(6B) -41.9(6) 
Fe(1B) - C(4B) - C(5B) - C(6B) 55.9(3) 
C(9B) - C(4B) - C(5B) - Fe(1B) -97.8(4) 
C(3B) - Fe(1B) - C(5B) - C(4B) 172.0(3) 
C(2B) - Fe(1B) - C(5B) - C(4B) -91.9(3) 
C(1B) - Fe(1B) - C(5B) - C(4B) 10.3(4) 
C(6B) - Fe(1B) - C(5B) - C(4B) 127.6(4) 
C(7B) - Fe(1B) - C(5B) - C(4B) 95.1(3) 
C(3B) - Fe(1B) - C(5B) - C(6B) 44.4(3) 
C(2B) - Fe(1B) - C(5B) - C(6B) 140.5(3) 
C(1B) - Fe(1B) - C(5B) - C(6B) -117.3(3) 
C(4B) - Fe(1B) - C(5B) - C(6B) -127.6(4) 
C(7B) - Fe(1B) - C(5B) - C(6B) -32.5(3) 
C(4B) - C(5B) - C(6B) - C(7B) 0.3(6) 
Fe(1B) - C(5B) - C(6B) - C(7B) 57.3(4) 
C(4B) - C(5B) - C(6B) - Fe(1B) -57.1(4) 
C(3B) - Fe(1B) - C(6B) - C(5B) -145.9(3) 
C(2B) - Fe(1B) - C(6B) - C(5B) -49.0(3) 
C(1B) - Fe(1B) - C(6B) - C(5B) 105.4(4) 
C(4B) - Fe(1B) - C(6B) - C(5B) 32.3(2) 
C(7B) - Fe(1B) - C(6B) - C(5B) 128.0(4) 
C(3B) - Fe(1B) - C(6B) - C(7B) 86.1(3) 
C(2B) - Fe(1B) - C(6B) - C(7B) -177.0(3) 
C(1B) - Fe(1B) - C(6B) - C(7B) -22.6(4) 
C(5B) - Fe(1B) - C(6B) - C(7B) -128.0(4) 
C(4B) - Fe(1B) - C(6B) - C(7B) -95.7(3) 
C(5B) - C(6B) - C(7B) - C(8B) 29.7(6) 
Fe(1B) - C(6B) - C(7B) - C(8B) 85.7(4) 
C(5B) - C(6B) - C(7B) - Fe(1B) -56.0(3) 
C(3B) - Fe(1B) - C(7B) - C(6B) -96.4(3) 
C(2B) - Fe(1B) - C(7B) - C(6B) 8.4(8) 
C(1B) - Fe(1B) - C(7B) - C(6B) 164.7(3) 
C(5B) - Fe(1B) - C(7B) - C(6B) 32.5(3) 
C(4B) - Fe(1B) - C(7B) - C(6B) 72.7(3) 
C(3B) - Fe(1B) - C(7B) - C(8B) 142.8(3) 
C(2B) - Fe(1B) - C(7B) - C(8B) -112.4(7) 
C(1B) - Fe(1B) - C(7B) - C(8B) 43.8(3) 
C(6B) - Fe(1B) - C(7B) - C(8B) -120.9(4) 
C(5B) - Fe(1B) - C(7B) - C(8B) -88.4(3) 
C(4B) - Fe(1B) - C(7B) - C(8B) -48.2(3) 
C(6B) - C(7B) - C(8B) - O(5B) 168.6(4) 
Fe(1B) - C(7B) - C(8B) - O(5B) -123.0(4) 
C(6B) - C(7B) - C(8B) - C(9B) -18.1(6) 
Fe(1B) - C(7B) - C(8B) - C(9B) 50.3(4) 
C(5B) - C(4B) - C(9B) - O(4B) 168.6(4) 
Fe(1B) - C(4B) - C(9B) - O(4B) 94.2(3) 
C(5B) - C(4B) - C(9B) - C(10B) -70.1(5) 
Fe(1B) - C(4B) - C(9B) - C(10B) -144.5(3) 
C(5B) - C(4B) - C(9B) - C(8B) 50.1(5) 
Fe(1B) - C(4B) - C(9B) - C(8B) -24.3(4) 
O(5B) - C(8B) - C(9B) - O(4B) 36.8(5) 
C(7B) - C(8B) - C(9B) - O(4B) -136.9(4) 
O(5B) - C(8B) - C(9B) - C(4B) 154.8(4) 
C(7B) - C(8B) - C(9B) - C(4B) -18.9(5) 
O(5B) - C(8B) - C(9B) - C(10B) -84.3(5) 
C(7B) - C(8B) - C(9B) - C(10B) 102.0(4) 
C(11B) - O(6B) - C(10B) - O(7B) 2.0(10) 
C(11B) - O(6B) - C(10B) - C(9B) -177.9(7) 
C(12B) - O(7B) - C(10B) - O(6B) 4.3(10) 
C(12B) - O(7B) - C(10B) - C(9B) -175.7(7) 
O(4B) - C(9B) - C(10B) - O(6B) 10.6(5) 
C(4B) - C(9B) - C(10B) - O(6B) -109.8(4) 
C(8B) - C(9B) - C(10B) - O(6B) 131.3(4) 
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O(4B) - C(9B) - C(10B) - O(7B) -169.4(4) 
C(4B) - C(9B) - C(10B) - O(7B) 70.3(5) 
C(8B) - C(9B) - C(10B) - O(7B) -48.7(5) 
C(2C) - Fe(1C) - C(1C) - O(1C) -159(100) 
C(3C) - Fe(1C) - C(1C) - O(1C) -65(27) 
C(5C) - Fe(1C) - C(1C) - O(1C) 101(27) 
C(6C) - Fe(1C) - C(1C) - O(1C) 43(27) 
C(4C) - Fe(1C) - C(1C) - O(1C) 107(27) 
C(7C) - Fe(1C) - C(1C) - O(1C) 28(27) 
C(3C) - Fe(1C) - C(2C) - O(2C) -129(25) 
C(1C) - Fe(1C) - C(2C) - O(2C) -29(25) 
C(5C) - Fe(1C) - C(2C) - O(2C) 104(25) 
C(6C) - Fe(1C) - C(2C) - O(2C) 133(25) 
C(4C) - Fe(1C) - C(2C) - O(2C) 64(25) 
C(7C) - Fe(1C) - C(2C) - O(2C) 127(24) 
C(2C) - Fe(1C) - C(3C) - O(3C) -180(100) 
C(1C) - Fe(1C) - C(3C) - O(3C) 82(25) 
C(5C) - Fe(1C) - C(3C) - O(3C) -84(25) 
C(6C) - Fe(1C) - C(3C) - O(3C) -57(25) 
C(4C) - Fe(1C) - C(3C) - O(3C) -65(25) 
C(7C) - Fe(1C) - C(3C) - O(3C) -17(25) 
C(2C) - Fe(1C) - C(4C) - C(5C) 90.2(3) 
C(3C) - Fe(1C) - C(4C) - C(5C) -25.0(9) 
C(1C) - Fe(1C) - C(4C) - C(5C) -172.2(3) 
C(6C) - Fe(1C) - C(4C) - C(5C) -32.8(3) 
C(7C) - Fe(1C) - C(4C) - C(5C) -73.7(3) 
C(2C) - Fe(1C) - C(4C) - C(9C) -154.5(3) 
C(3C) - Fe(1C) - C(4C) - C(9C) 90.2(8) 
C(1C) - Fe(1C) - C(4C) - C(9C) -57.0(3) 
C(5C) - Fe(1C) - C(4C) - C(9C) 115.3(4) 
C(6C) - Fe(1C) - C(4C) - C(9C) 82.4(3) 
C(7C) - Fe(1C) - C(4C) - C(9C) 41.6(3) 
C(9C) - C(4C) - C(5C) - C(6C) -42.1(6) 
Fe(1C) - C(4C) - C(5C) - C(6C) 56.1(3) 
C(9C) - C(4C) - C(5C) - Fe(1C) -98.1(4) 
C(2C) - Fe(1C) - C(5C) - C(4C) -92.1(3) 
C(3C) - Fe(1C) - C(5C) - C(4C) 172.2(3) 
C(1C) - Fe(1C) - C(5C) - C(4C) 10.5(4) 
C(6C) - Fe(1C) - C(5C) - C(4C) 127.7(4) 
C(7C) - Fe(1C) - C(5C) - C(4C) 95.2(3) 
C(2C) - Fe(1C) - C(5C) - C(6C) 140.2(3) 
C(3C) - Fe(1C) - C(5C) - C(6C) 44.5(4) 
C(1C) - Fe(1C) - C(5C) - C(6C) -117.2(3) 
C(4C) - Fe(1C) - C(5C) - C(6C) -127.7(4) 
C(7C) - Fe(1C) - C(5C) - C(6C) -32.5(3) 
C(4C) - C(5C) - C(6C) - C(7C) 0.2(6) 
Fe(1C) - C(5C) - C(6C) - C(7C) 57.2(4) 
C(4C) - C(5C) - C(6C) - Fe(1C) -57.0(4) 
C(2C) - Fe(1C) - C(6C) - C(5C) -49.1(3) 
C(3C) - Fe(1C) - C(6C) - C(5C) -145.6(3) 
C(1C) - Fe(1C) - C(6C) - C(5C) 104.8(4) 
C(4C) - Fe(1C) - C(6C) - C(5C) 32.4(3) 
C(7C) - Fe(1C) - C(6C) - C(5C) 127.9(4) 
C(2C) - Fe(1C) - C(6C) - C(7C) -177.0(3) 
C(3C) - Fe(1C) - C(6C) - C(7C) 86.4(3) 
C(1C) - Fe(1C) - C(6C) - C(7C) -23.1(4) 
C(5C) - Fe(1C) - C(6C) - C(7C) -127.9(4) 
C(4C) - Fe(1C) - C(6C) - C(7C) -95.6(3) 
C(5C) - C(6C) - C(7C) - C(8C) 29.4(6) 
Fe(1C) - C(6C) - C(7C) - C(8C) 85.1(4) 
C(5C) - C(6C) - C(7C) - Fe(1C) -55.7(3) 
C(2C) - Fe(1C) - C(7C) - C(8C) -112.9(6) 
C(3C) - Fe(1C) - C(7C) - C(8C) 143.0(3) 
C(1C) - Fe(1C) - C(7C) - C(8C) 43.2(3) 
C(5C) - Fe(1C) - C(7C) - C(8C) -88.5(3) 
C(6C) - Fe(1C) - C(7C) - C(8C) -121.1(4) 
C(4C) - Fe(1C) - C(7C) - C(8C) -48.2(3) 
C(2C) - Fe(1C) - C(7C) - C(6C) 8.2(8) 
C(3C) - Fe(1C) - C(7C) - C(6C) -95.9(3) 
C(1C) - Fe(1C) - C(7C) - C(6C) 164.3(3) 
C(5C) - Fe(1C) - C(7C) - C(6C) 32.6(3) 
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C(4C) - Fe(1C) - C(7C) - C(6C) 72.9(3) 
C(6C) - C(7C) - C(8C) - O(5C) 168.0(4) 
Fe(1C) - C(7C) - C(8C) - O(5C) -123.8(4) 
C(6C) - C(7C) - C(8C) - C(9C) -17.3(6) 
Fe(1C) - C(7C) - C(8C) - C(9C) 50.8(4) 
C(5C) - C(4C) - C(9C) - O(4C) 168.3(4) 
Fe(1C) - C(4C) - C(9C) - O(4C) 93.9(3) 
C(5C) - C(4C) - C(9C) - C(10C) -69.3(5) 
Fe(1C) - C(4C) - C(9C) - C(10C) -143.7(3) 
C(5C) - C(4C) - C(9C) - C(8C) 50.5(5) 
Fe(1C) - C(4C) - C(9C) - C(8C) -23.9(4) 
O(5C) - C(8C) - C(9C) - O(4C) 38.0(5) 
C(7C) - C(8C) - C(9C) - O(4C) -137.0(4) 
O(5C) - C(8C) - C(9C) - C(4C) 155.2(4) 
C(7C) - C(8C) - C(9C) - C(4C) -19.8(5) 
O(5C) - C(8C) - C(9C) - C(10C) -84.0(5) 
C(7C) - C(8C) - C(9C) - C(10C) 100.9(4) 
C(12C) - O(7C) - C(10C) - O(6C) 6.4(10) 
C(12C) - O(7C) - C(10C) - C(9C) -174.4(8) 
C(11C) - O(6C) - C(10C) - O(7C) 0.2(10) 
C(11C) - O(6C) - C(10C) - C(9C) -179.0(8) 
O(4C) - C(9C) - C(10C) - O(7C) -169.2(4) 
C(4C) - C(9C) - C(10C) - O(7C) 69.9(5) 
C(8C) - C(9C) - C(10C) - O(7C) -48.3(5) 
O(4C) - C(9C) - C(10C) - O(6C) 10.0(5) 
C(4C) - C(9C) - C(10C) - O(6C) -110.9(4) 
C(8C) - C(9C) - C(10C) - O(6C) 131.0(4) 
C(2D) - Fe(1D) - C(1D) - O(1D) 138(17) 
C(3D) - Fe(1D) - C(1D) - O(1D) -127(17) 
C(5D) - Fe(1D) - C(1D) - O(1D) 38(17) 
C(6D) - Fe(1D) - C(1D) - O(1D) -19(17) 
C(4D) - Fe(1D) - C(1D) - O(1D) 43(17) 
C(7D) - Fe(1D) - C(1D) - O(1D) -35(17) 
C(3D) - Fe(1D) - C(2D) - O(2D) 65(54) 
C(1D) - Fe(1D) - C(2D) - O(2D) 164(100) 
C(5D) - Fe(1D) - C(2D) - O(2D) -63(54) 
C(6D) - Fe(1D) - C(2D) - O(2D) -34(54) 
C(4D) - Fe(1D) - C(2D) - O(2D) -103(100) 
C(7D) - Fe(1D) - C(2D) - O(2D) -38(54) 
C(2D) - Fe(1D) - C(3D) - O(3D) 133(24) 
C(1D) - Fe(1D) - C(3D) - O(3D) 34(24) 
C(5D) - Fe(1D) - C(3D) - O(3D) -131(24) 
C(6D) - Fe(1D) - C(3D) - O(3D) -106(24) 
C(4D) - Fe(1D) - C(3D) - O(3D) -105(24) 
C(7D) - Fe(1D) - C(3D) - O(3D) -66(24) 
C(2D) - Fe(1D) - C(4D) - C(5D) 88.8(3) 
C(3D) - Fe(1D) - C(4D) - C(5D) -33.5(9) 
C(1D) - Fe(1D) - C(4D) - C(5D) -173.1(3) 
C(6D) - Fe(1D) - C(4D) - C(5D) -32.4(3) 
C(7D) - Fe(1D) - C(4D) - C(5D) -73.5(3) 
C(2D) - Fe(1D) - C(4D) - C(9D) -156.3(3) 
C(3D) - Fe(1D) - C(4D) - C(9D) 81.4(9) 
C(1D) - Fe(1D) - C(4D) - C(9D) -58.2(3) 
C(5D) - Fe(1D) - C(4D) - C(9D) 115.0(4) 
C(6D) - Fe(1D) - C(4D) - C(9D) 82.6(3) 
C(7D) - Fe(1D) - C(4D) - C(9D) 41.4(3) 
C(9D) - C(4D) - C(5D) - C(6D) -41.5(6) 
Fe(1D) - C(4D) - C(5D) - C(6D) 56.3(4) 
C(9D) - C(4D) - C(5D) - Fe(1D) -97.8(4) 
C(2D) - Fe(1D) - C(5D) - C(6D) 138.5(3) 
C(3D) - Fe(1D) - C(5D) - C(6D) 42.0(4) 
C(1D) - Fe(1D) - C(5D) - C(6D) -118.7(3) 
C(4D) - Fe(1D) - C(5D) - C(6D) -127.9(4) 
C(7D) - Fe(1D) - C(5D) - C(6D) -32.9(3) 
C(2D) - Fe(1D) - C(5D) - C(4D) -93.6(3) 
C(3D) - Fe(1D) - C(5D) - C(4D) 169.9(3) 
C(1D) - Fe(1D) - C(5D) - C(4D) 9.3(4) 
C(6D) - Fe(1D) - C(5D) - C(4D) 127.9(4) 
C(7D) - Fe(1D) - C(5D) - C(4D) 95.1(3) 
C(4D) - C(5D) - C(6D) - C(7D) -0.4(6) 
Fe(1D) - C(5D) - C(6D) - C(7D) 57.0(4) 
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C(4D) - C(5D) - C(6D) - Fe(1D) -57.3(4) 
C(2D) - Fe(1D) - C(6D) - C(5D) -50.3(4) 
C(3D) - Fe(1D) - C(6D) - C(5D) -147.8(3) 
C(1D) - Fe(1D) - C(6D) - C(5D) 103.4(4) 
C(4D) - Fe(1D) - C(6D) - C(5D) 32.5(3) 
C(7D) - Fe(1D) - C(6D) - C(5D) 127.8(4) 
C(2D) - Fe(1D) - C(6D) - C(7D) -178.1(3) 
C(3D) - Fe(1D) - C(6D) - C(7D) 84.4(3) 
C(1D) - Fe(1D) - C(6D) - C(7D) -24.4(4) 
C(5D) - Fe(1D) - C(6D) - C(7D) -127.8(4) 
C(4D) - Fe(1D) - C(6D) - C(7D) -95.3(3) 
C(5D) - C(6D) - C(7D) - C(8D) 30.6(6) 
Fe(1D) - C(6D) - C(7D) - C(8D) 86.4(4) 
C(5D) - C(6D) - C(7D) - Fe(1D) -55.9(4) 
C(2D) - Fe(1D) - C(7D) - C(8D) -116.7(6) 
C(3D) - Fe(1D) - C(7D) - C(8D) 140.5(3) 
C(1D) - Fe(1D) - C(7D) - C(8D) 42.0(3) 
C(5D) - Fe(1D) - C(7D) - C(8D) -89.3(3) 
C(6D) - Fe(1D) - C(7D) - C(8D) -121.7(4) 
C(4D) - Fe(1D) - C(7D) - C(8D) -48.8(3) 
C(2D) - Fe(1D) - C(7D) - C(6D) 4.9(7) 
C(3D) - Fe(1D) - C(7D) - C(6D) -97.8(3) 
C(1D) - Fe(1D) - C(7D) - C(6D) 163.7(3) 
C(5D) - Fe(1D) - C(7D) - C(6D) 32.3(3) 
C(4D) - Fe(1D) - C(7D) - C(6D) 72.9(3) 
C(6D) - C(7D) - C(8D) - O(5D) 168.7(4) 
Fe(1D) - C(7D) - C(8D) - O(5D) -122.2(4) 
C(6D) - C(7D) - C(8D) - C(9D) -18.2(6) 
Fe(1D) - C(7D) - C(8D) - C(9D) 51.0(4) 
C(5D) - C(4D) - C(9D) - O(4D) 167.7(4) 
Fe(1D) - C(4D) - C(9D) - O(4D) 94.0(3) 
C(5D) - C(4D) - C(9D) - C(10D) -70.2(5) 
Fe(1D) - C(4D) - C(9D) - C(10D) -143.9(3) 
C(5D) - C(4D) - C(9D) - C(8D) 50.1(5) 
Fe(1D) - C(4D) - C(9D) - C(8D) -23.6(4) 
O(5D) - C(8D) - C(9D) - O(4D) 37.0(5) 
C(7D) - C(8D) - C(9D) - O(4D) -136.7(4) 
O(5D) - C(8D) - C(9D) - C(4D) 154.2(4) 
C(7D) - C(8D) - C(9D) - C(4D) -19.5(5) 
O(5D) - C(8D) - C(9D) - C(10D) -84.7(4) 
C(7D) - C(8D) - C(9D) - C(10D) 101.6(4) 
C(11D) - O(6D) - C(10D) - O(7D) -0.3(11) 
C(11D) - O(6D) - C(10D) - C(9D) -179.6(8) 
C(12D) - O(7D) - C(10D) - O(6D) 6.8(10) 
C(12D) - O(7D) - C(10D) - C(9D) -173.9(7) 
O(4D) - C(9D) - C(10D) - O(6D) 9.9(5) 
C(4D) - C(9D) - C(10D) - O(6D) -110.8(4) 
C(8D) - C(9D) - C(10D) - O(6D) 130.5(4) 
O(4D) - C(9D) - C(10D) - O(7D) -169.4(4) 
C(4D) - C(9D) - C(10D) - O(7D) 69.9(5) 
C(8D) - C(9D) - C(10D) - O(7D) -48.8(5) 
C(2E) - Fe(1E) - C(1E) - O(2E) 173(100) 
C(3E) - Fe(1E) - C(1E) - O(2E) -92(18) 
C(6E) - Fe(1E) - C(1E) - O(2E) 15(19) 
C(5E) - Fe(1E) - C(1E) - O(2E) 72(19) 
C(4E) - Fe(1E) - C(1E) - O(2E) 78(18) 
C(7E) - Fe(1E) - C(1E) - O(2E) 0(19) 
C(3E) - Fe(1E) - C(2E) - O(3E) 176(100) 
C(1E) - Fe(1E) - C(2E) - O(3E) -85(61) 
C(6E) - Fe(1E) - C(2E) - O(3E) 78(61) 
C(5E) - Fe(1E) - C(2E) - O(3E) 48(61) 
C(4E) - Fe(1E) - C(2E) - O(3E) 9(61) 
C(7E) - Fe(1E) - C(2E) - O(3E) 76(61) 
C(2E) - Fe(1E) - C(3E) - O(4E) 134(20) 
C(1E) - Fe(1E) - C(3E) - O(4E) 35(20) 
C(6E) - Fe(1E) - C(3E) - O(4E) -105(20) 
C(5E) - Fe(1E) - C(3E) - O(4E) -130(20) 
C(4E) - Fe(1E) - C(3E) - O(4E) -104(20) 
C(7E) - Fe(1E) - C(3E) - O(4E) -65(20) 
C(2E) - Fe(1E) - C(4E) - C(5E) 88.6(3) 
C(3E) - Fe(1E) - C(4E) - C(5E) -33.4(9) 
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C(1E) - Fe(1E) - C(4E) - C(5E) -172.9(3) 
C(6E) - Fe(1E) - C(4E) - C(5E) -32.4(3) 
C(7E) - Fe(1E) - C(4E) - C(5E) -73.2(3) 
C(2E) - Fe(1E) - C(4E) - C(9E) -156.5(3) 
C(3E) - Fe(1E) - C(4E) - C(9E) 81.5(8) 
C(1E) - Fe(1E) - C(4E) - C(9E) -58.1(3) 
C(6E) - Fe(1E) - C(4E) - C(9E) 82.5(3) 
C(5E) - Fe(1E) - C(4E) - C(9E) 114.9(4) 
C(7E) - Fe(1E) - C(4E) - C(9E) 41.7(3) 
C(9E) - C(4E) - C(5E) - C(6E) -42.7(6) 
Fe(1E) - C(4E) - C(5E) - C(6E) 55.4(4) 
C(9E) - C(4E) - C(5E) - Fe(1E) -98.1(4) 
C(2E) - Fe(1E) - C(5E) - C(6E) 137.9(3) 
C(3E) - Fe(1E) - C(5E) - C(6E) 41.8(4) 
C(1E) - Fe(1E) - C(5E) - C(6E) -118.6(3) 
C(4E) - Fe(1E) - C(5E) - C(6E) -128.1(4) 
C(7E) - Fe(1E) - C(5E) - C(6E) -32.8(3) 
C(2E) - Fe(1E) - C(5E) - C(4E) -94.0(3) 
C(3E) - Fe(1E) - C(5E) - C(4E) 169.9(3) 
C(1E) - Fe(1E) - C(5E) - C(4E) 9.5(4) 
C(6E) - Fe(1E) - C(5E) - C(4E) 128.1(4) 
C(7E) - Fe(1E) - C(5E) - C(4E) 95.3(3) 
C(4E) - C(5E) - C(6E) - C(7E) 1.4(6) 
Fe(1E) - C(5E) - C(6E) - C(7E) 57.6(4) 
C(4E) - C(5E) - C(6E) - Fe(1E) -56.3(4) 
C(2E) - Fe(1E) - C(6E) - C(5E) -51.1(4) 
C(3E) - Fe(1E) - C(6E) - C(5E) -148.0(3) 
C(1E) - Fe(1E) - C(6E) - C(5E) 103.4(4) 
C(4E) - Fe(1E) - C(6E) - C(5E) 32.3(3) 
C(7E) - Fe(1E) - C(6E) - C(5E) 127.4(4) 
C(2E) - Fe(1E) - C(6E) - C(7E) -178.6(3) 
C(3E) - Fe(1E) - C(6E) - C(7E) 84.6(3) 
C(1E) - Fe(1E) - C(6E) - C(7E) -24.0(4) 
C(5E) - Fe(1E) - C(6E) - C(7E) -127.4(4) 
C(4E) - Fe(1E) - C(6E) - C(7E) -95.2(3) 
C(5E) - C(6E) - C(7E) - C(8E) 28.9(6) 
Fe(1E) - C(6E) - C(7E) - C(8E) 85.4(4) 
C(5E) - C(6E) - C(7E) - Fe(1E) -56.5(4) 
C(2E) - Fe(1E) - C(7E) - C(6E) 3.7(8) 
C(3E) - Fe(1E) - C(7E) - C(6E) -97.4(3) 
C(1E) - Fe(1E) - C(7E) - C(6E) 163.9(3) 
C(5E) - Fe(1E) - C(7E) - C(6E) 32.7(3) 
C(4E) - Fe(1E) - C(7E) - C(6E) 73.3(3) 
C(2E) - Fe(1E) - C(7E) - C(8E) -118.0(6) 
C(3E) - Fe(1E) - C(7E) - C(8E) 140.8(3) 
C(1E) - Fe(1E) - C(7E) - C(8E) 42.2(3) 
C(6E) - Fe(1E) - C(7E) - C(8E) -121.7(4) 
C(5E) - Fe(1E) - C(7E) - C(8E) -89.0(3) 
C(4E) - Fe(1E) - C(7E) - C(8E) -48.4(3) 
C(6E) - C(7E) - C(8E) - O(6E) 168.7(4) 
Fe(1E) - C(7E) - C(8E) - O(6E) -122.7(4) 
C(6E) - C(7E) - C(8E) - C(9E) -17.6(6) 
Fe(1E) - C(7E) - C(8E) - C(9E) 51.1(4) 
C(5E) - C(4E) - C(9E) - O(5E) 169.2(4) 
Fe(1E) - C(4E) - C(9E) - O(5E) 94.7(3) 
C(5E) - C(4E) - C(9E) - C(8E) 50.6(5) 
Fe(1E) - C(4E) - C(9E) - C(8E) -23.9(4) 
C(5E) - C(4E) - C(9E) - C(10E) -69.5(5) 
Fe(1E) - C(4E) - C(9E) - C(10E) -144.0(3) 
O(6E) - C(8E) - C(9E) - O(5E) 36.6(5) 
C(7E) - C(8E) - C(9E) - O(5E) -137.6(4) 
O(6E) - C(8E) - C(9E) - C(4E) 154.5(4) 
C(7E) - C(8E) - C(9E) - C(4E) -19.7(5) 
O(6E) - C(8E) - C(9E) - C(10E) -84.9(5) 
C(7E) - C(8E) - C(9E) - C(10E) 100.9(4) 
C(12E) - O(8E) - C(10E) - O(7E) 4.1(10) 
C(12E) - O(8E) - C(10E) - C(9E) -176.4(7) 
C(11E) - O(7E) - C(10E) - O(8E) 3.0(11) 
C(11E) - O(7E) - C(10E) - C(9E) -176.5(8) 
O(5E) - C(9E) - C(10E) - O(8E) -169.9(4) 
C(4E) - C(9E) - C(10E) - O(8E) 69.9(5) 
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C(8E) - C(9E) - C(10E) - O(8E) -48.8(5) 
O(5E) - C(9E) - C(10E) - O(7E) 9.7(5) 
C(4E) - C(9E) - C(10E) - O(7E) -110.5(4) 
C(8E) - C(9E) - C(10E) - O(7E) 130.8(4) 
                                                  





Figure 29 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for (±)-468 
 
 
Table 24 Crystal data and structure refinement (±)-468 
                                                        
 Identification code p09sel4 
 Empirical formula C11 H10 Fe O7 
 Formula weight 310.04 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Triclinic 
Appendix 1 
 247 
 Space group P-1 
 Unit cell dimensions a = 6.9380(2)Å α = 99.162(3)o 
       b = 7.4496(3)Å β = 99.099(3)o 
       c = 12.0918(4)Å γ = 95.993(3)o 
 Volume 603.82(4) Å3 
 Z 2 
 Density (calculated) 1.705 Mg/m3 
 Absorption coefficient 1.275 mm-1 
 F(000) 316 
 Crystal size 0.14 x 0.09 x 0.02 mm 
 Theta range for data collection 3.00 to 25.01o 
 Index ranges -8<=h<=8; -8<=k<=8; -14<=l<=14 
 Reflections collected 8848 
 Independent reflections 2129 [R(int) = 0.0716] 
 Reflections observed (>2σ) 1672 
 Data Completeness 0.999 
 Absorption correction Analytical 
 Max. and min. transmission 0.835 and 0.494 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 2129 / 10 / 193 
 Goodness-of-fit on F2 0.926 
 Final R indices [I>2σ(I)] R1 = 0.0292   wR2 = 0.0579 
 R indices (all data) R1 = 0.0449  wR2 = 0.0604 
 Largest diff. peak and hole 0.356 and -0.318 eÅ-3 
  
Notes:   
 
Crystal quality was moderate, and given the diffracting ability of the sample, data were 
truncated to a max Bragg angle of 25o. 
 
H4-H7 were located and refined at a distance of 0.98Å from the relevant parent atoms. 
 
Hydrogen bonding gives rise to 1-D polymers in the lattice. 
 
 
Hydrogen bonds with  H..A < r(A) + 2.000 Angstroms  and  <DHA > 110 
deg. 
 
 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
 O4-H4A         0.840    1.977   178.01    2.816    O5 [ -x+1, -y+2, 
-z+2 ] 
 O5-H5A         0.840    1.979   173.31    2.815    O6 [ -x+2, -y+2, 
-z+2 ] 
 
   
 Table 25 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) (±)-468. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
                                                                                     
  Atom   x   y   z  U(eq) 
                                 
Fe(1) 7218(1) 6250(1) 6939(1) 12(1) 
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O(1) 8505(3) 7524(3) 4965(2) 43(1) 
O(2) 7213(3) 2338(3) 6067(2) 38(1) 
O(3) 3025(3) 6622(3) 6449(2) 32(1) 
O(4) 4317(2) 6642(2) 9191(1) 12(1) 
O(5) 7573(2) 10556(2) 9764(1) 12(1) 
O(6) 9165(2) 7467(2) 10819(1) 15(1) 
O(7) 6212(2) 7797(2) 11281(1) 13(1) 
C(1) 7993(4) 7008(4) 5720(2) 22(1) 
C(2) 7218(4) 3875(4) 6386(2) 20(1) 
C(3) 4665(4) 6451(3) 6641(2) 18(1) 
C(4) 7224(3) 5759(3) 8601(2) 12(1) 
C(5) 9161(3) 6156(3) 8389(2) 13(1) 
C(6) 9564(3) 7831(3) 8031(2) 13(1) 
C(7) 7951(3) 8851(3) 7927(2) 12(1) 
C(8) 6705(3) 9067(3) 8847(2) 9(1) 
C(9) 6358(3) 7228(3) 9296(2) 9(1) 
C(10) 7417(3) 7505(3) 10544(2) 10(1) 
C(11) 7085(4) 7964(4) 12472(2) 19(1) 
                                     
   
 Table 26 Bond lengths [Å] and angles [o] for (±)-468 
  
Fe(1)-C(3) 1.778(3) Fe(1)-C(2) 1.789(3) 
Fe(1)-C(1) 1.798(3) Fe(1)-C(6) 2.051(2) 
Fe(1)-C(5) 2.051(2) Fe(1)-C(7) 2.075(2) 
Fe(1)-C(4) 2.098(2) O(1)-C(1) 1.137(3) 
O(2)-C(2) 1.148(3) O(3)-C(3) 1.149(3) 
O(4)-C(9) 1.416(3) O(4)-H(4A) 0.8400 
O(5)-C(8) 1.443(3) O(5)-H(5A) 0.8400 
O(6)-C(10) 1.210(3) O(7)-C(10) 1.323(3) 
O(7)-C(11) 1.452(3) C(4)-C(5) 1.417(3) 
C(4)-C(9) 1.506(3) C(4)-H(4) 0.977(5) 
C(5)-C(6) 1.400(3) C(5)-H(5) 0.978(5) 
C(6)-C(7) 1.417(3) C(6)-H(6) 0.978(5) 
C(7)-C(8) 1.512(3) C(7)-H(7) 0.979(5) 
C(8)-C(9) 1.562(3) C(8)-H(8) 1.0000 
C(9)-C(10) 1.542(3) C(11)-H(11A) 0.9800 
C(11)-H(11B) 0.9800 C(11)-H(11C) 0.9800 
                                           
C(3)-Fe(1)-C(2) 101.33(11) C(3)-Fe(1)-C(1) 99.99(11) 
C(2)-Fe(1)-C(1) 93.81(12) C(3)-Fe(1)-C(6) 133.09(10) 
C(2)-Fe(1)-C(6) 122.98(11) C(1)-Fe(1)-C(6) 92.24(11) 
C(3)-Fe(1)-C(5) 134.19(10) C(2)-Fe(1)-C(5) 92.66(10) 
C(1)-Fe(1)-C(5) 122.55(11) C(6)-Fe(1)-C(5) 39.91(10) 
C(3)-Fe(1)-C(7) 93.79(10) C(2)-Fe(1)-C(7) 162.29(10) 
C(1)-Fe(1)-C(7) 92.57(11) C(6)-Fe(1)-C(7) 40.17(9) 
C(5)-Fe(1)-C(7) 70.04(9) C(3)-Fe(1)-C(4) 95.54(10) 
C(2)-Fe(1)-C(4) 92.56(10) C(1)-Fe(1)-C(4) 161.71(10) 
C(6)-Fe(1)-C(4) 69.97(9) C(5)-Fe(1)-C(4) 39.92(9) 
C(7)-Fe(1)-C(4) 76.72(9) C(9)-O(4)-H(4A) 109.5 
C(8)-O(5)-H(5A) 109.5 C(10)-O(7)-C(11) 115.90(18) 
O(1)-C(1)-Fe(1) 178.4(3) O(2)-C(2)-Fe(1) 177.7(2) 
O(3)-C(3)-Fe(1) 178.5(2) C(5)-C(4)-C(9) 118.9(2) 
C(5)-C(4)-Fe(1) 68.24(13) C(9)-C(4)-Fe(1) 111.38(15) 
C(5)-C(4)-H(4) 116.4(14) C(9)-C(4)-H(4) 115.6(14) 
Fe(1)-C(4)-H(4) 117.8(15) C(6)-C(5)-C(4) 115.3(2) 
C(6)-C(5)-Fe(1) 70.02(13) C(4)-C(5)-Fe(1) 71.84(13) 
C(6)-C(5)-H(5) 121.7(13) C(4)-C(5)-H(5) 122.8(13) 
Fe(1)-C(5)-H(5) 122.6(13) C(5)-C(6)-C(7) 114.4(2) 
C(5)-C(6)-Fe(1) 70.06(14) C(7)-C(6)-Fe(1) 70.85(13) 
C(5)-C(6)-H(6) 120.6(13) C(7)-C(6)-H(6) 124.6(13) 
Fe(1)-C(6)-H(6) 122.0(13) C(6)-C(7)-C(8) 120.5(2) 
C(6)-C(7)-Fe(1) 68.98(14) C(8)-C(7)-Fe(1) 109.90(15) 
C(6)-C(7)-H(7) 122.6(15) C(8)-C(7)-H(7) 108.4(15) 
Fe(1)-C(7)-H(7) 121.1(16) O(5)-C(8)-C(7) 111.56(18) 
O(5)-C(8)-C(9) 111.12(18) C(7)-C(8)-C(9) 110.23(18) 
O(5)-C(8)-H(8) 107.9 C(7)-C(8)-H(8) 107.9 
C(9)-C(8)-H(8) 107.9 O(4)-C(9)-C(4) 107.95(19) 
O(4)-C(9)-C(10) 111.40(18) C(4)-C(9)-C(10) 108.49(17) 
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O(4)-C(9)-C(8) 110.71(17) C(4)-C(9)-C(8) 109.46(18) 
C(10)-C(9)-C(8) 108.79(18) O(6)-C(10)-O(7) 123.6(2) 
O(6)-C(10)-C(9) 123.6(2) O(7)-C(10)-C(9) 112.82(18) 
O(7)-C(11)-H(11A) 109.5 O(7)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 O(7)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 H(11B)-C(11)-H(11C) 109.5 
                                                    
Symmetry transformations used to generate equivalent atoms: 
                                                            
 Table 27 Anisotropic displacement parameters (Å2 x 103) for (±)-468. The anisotropic 
displacement actor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
                                                                                 
  Atom  U11  U22  U33  U23  U13  U12 
                                               
Fe(1) 15(1) 12(1) 10(1) 0(1) 4(1) 1(1) 
O(1) 55(1) 56(2) 18(1) 13(1) 12(1) -8(1) 
O(2) 63(2) 18(1) 34(1) -1(1) 17(1) 7(1) 
O(3) 18(1) 52(1) 24(1) -2(1) -2(1) 10(1) 
O(4) 9(1) 11(1) 16(1) -2(1) 5(1) -1(1) 
O(5) 13(1) 9(1) 13(1) -1(1) 4(1) -2(1) 
O(6) 10(1) 17(1) 18(1) 6(1) 0(1) 0(1) 
O(7) 15(1) 16(1) 10(1) 3(1) 5(1) 3(1) 
C(1) 25(2) 23(2) 14(2) 0(1) 1(1) -2(1) 
C(2) 26(2) 22(2) 14(1) 3(1) 8(1) 4(1) 
C(3) 25(2) 16(1) 9(1) -4(1) 0(1) 2(1) 
C(4) 15(1) 8(1) 12(1) 3(1) 1(1) 2(1) 
C(5) 12(1) 16(1) 12(1) 2(1) 1(1) 7(1) 
C(6) 10(1) 19(1) 9(1) -2(1) 4(1) -2(1) 
C(7) 17(1) 7(1) 10(1) 0(1) 2(1) -2(1) 
C(8) 9(1) 7(1) 9(1) 0(1) 0(1) 1(1) 
C(9) 7(1) 9(1) 12(1) 2(1) 3(1) 2(1) 
C(10) 12(1) 5(1) 14(1) 4(1) 4(1) -1(1) 
C(11) 24(2) 23(2) 12(1) 6(1) 3(1) 0(1) 
 
 Table 28 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for (±)-468. 
                                     
  Atom   x   y   z  U(eq) 
                                 
H(4A) 3780 7495 9506 34(9) 
H(5A) 8602 11081 9607 28(8) 
H(8) 5394 9361 8500 11 
H(11A) 7469 6782 12615 29 
H(11B) 6124 8331 12948 29 
H(11C) 8251 8894 12656 29 
H(4) 6830(30) 4503(14) 8700(20) 19(7) 
H(5) 10110(20) 5280(20) 8414(18) 9(6) 
H(6) 10816(16) 8160(30) 7790(17) 4(6) 
H(7) 7970(40) 9950(20) 7580(20) 28(7) 
    
   
 Table 29 Dihedral angles [o] for (±)-468. 
                                         
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
                                                  
C(3) - Fe(1) - C(1) - O(1) 110(9) 
C(2) - Fe(1) - C(1) - O(1) -148(9) 
C(6) - Fe(1) - C(1) - O(1) -25(9) 
C(5) - Fe(1) - C(1) - O(1) -53(9) 
C(7) - Fe(1) - C(1) - O(1) 15(9) 
C(4) - Fe(1) - C(1) - O(1) -38(9) 
C(3) - Fe(1) - C(2) - O(2) -92(6) 
C(1) - Fe(1) - C(2) - O(2) 167(6) 
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C(6) - Fe(1) - C(2) - O(2) 72(6) 
C(5) - Fe(1) - C(2) - O(2) 45(6) 
C(7) - Fe(1) - C(2) - O(2) 57(6) 
C(4) - Fe(1) - C(2) - O(2) 5(6) 
C(2) - Fe(1) - C(3) - O(3) -156(8) 
C(1) - Fe(1) - C(3) - O(3) -60(8) 
C(6) - Fe(1) - C(3) - O(3) 42(8) 
C(5) - Fe(1) - C(3) - O(3) 99(8) 
C(7) - Fe(1) - C(3) - O(3) 33(8) 
C(4) - Fe(1) - C(3) - O(3) 110(8) 
C(3) - Fe(1) - C(4) - C(5) -167.27(15) 
C(2) - Fe(1) - C(4) - C(5) 91.08(15) 
C(1) - Fe(1) - C(4) - C(5) -19.2(4) 
C(6) - Fe(1) - C(4) - C(5) -33.22(14) 
C(7) - Fe(1) - C(4) - C(5) -74.67(14) 
C(3) - Fe(1) - C(4) - C(9) -53.51(18) 
C(2) - Fe(1) - C(4) - C(9) -155.16(17) 
C(1) - Fe(1) - C(4) - C(9) 94.5(4) 
C(6) - Fe(1) - C(4) - C(9) 80.54(17) 
C(5) - Fe(1) - C(4) - C(9) 113.8(2) 
C(7) - Fe(1) - C(4) - C(9) 39.09(16) 
C(9) - C(4) - C(5) - C(6) -46.7(3) 
Fe(1) - C(4) - C(5) - C(6) 56.48(18) 
C(9) - C(4) - C(5) - Fe(1) -103.18(19) 
C(3) - Fe(1) - C(5) - C(6) -108.84(18) 
C(2) - Fe(1) - C(5) - C(6) 142.53(15) 
C(1) - Fe(1) - C(5) - C(6) 46.31(18) 
C(7) - Fe(1) - C(5) - C(6) -33.61(14) 
C(4) - Fe(1) - C(5) - C(6) -126.7(2) 
C(3) - Fe(1) - C(5) - C(4) 17.8(2) 
C(2) - Fe(1) - C(5) - C(4) -90.81(15) 
C(1) - Fe(1) - C(5) - C(4) 172.96(15) 
C(6) - Fe(1) - C(5) - C(4) 126.7(2) 
C(7) - Fe(1) - C(5) - C(4) 93.04(14) 
C(4) - C(5) - C(6) - C(7) -0.7(3) 
Fe(1) - C(5) - C(6) - C(7) 56.78(18) 
C(4) - C(5) - C(6) - Fe(1) -57.44(18) 
C(3) - Fe(1) - C(6) - C(5) 111.67(17) 
C(2) - Fe(1) - C(6) - C(5) -46.41(18) 
C(1) - Fe(1) - C(6) - C(5) -142.41(15) 
C(7) - Fe(1) - C(6) - C(5) 126.2(2) 
C(4) - Fe(1) - C(6) - C(5) 33.23(13) 
C(3) - Fe(1) - C(6) - C(7) -14.6(2) 
C(2) - Fe(1) - C(6) - C(7) -172.66(15) 
C(1) - Fe(1) - C(6) - C(7) 91.34(15) 
C(5) - Fe(1) - C(6) - C(7) -126.2(2) 
C(4) - Fe(1) - C(6) - C(7) -93.02(14) 
C(5) - C(6) - C(7) - C(8) 45.0(3) 
Fe(1) - C(6) - C(7) - C(8) 101.4(2) 
C(5) - C(6) - C(7) - Fe(1) -56.36(19) 
C(3) - Fe(1) - C(7) - C(6) 169.39(15) 
C(2) - Fe(1) - C(7) - C(6) 20.6(4) 
C(1) - Fe(1) - C(7) - C(6) -90.42(15) 
C(5) - Fe(1) - C(7) - C(6) 33.41(14) 
C(4) - Fe(1) - C(7) - C(6) 74.59(14) 
C(3) - Fe(1) - C(7) - C(8) 53.39(17) 
C(2) - Fe(1) - C(7) - C(8) -95.4(4) 
C(1) - Fe(1) - C(7) - C(8) 153.58(17) 
C(6) - Fe(1) - C(7) - C(8) -116.0(2) 
C(5) - Fe(1) - C(7) - C(8) -82.60(16) 
C(4) - Fe(1) - C(7) - C(8) -41.42(15) 
C(6) - C(7) - C(8) - O(5) 83.9(3) 
Fe(1) - C(7) - C(8) - O(5) 160.63(14) 
C(6) - C(7) - C(8) - C(9) -40.0(3) 
Fe(1) - C(7) - C(8) - C(9) 36.7(2) 
C(5) - C(4) - C(9) - O(4) 168.19(19) 
Fe(1) - C(4) - C(9) - O(4) 91.99(18) 
C(5) - C(4) - C(9) - C(10) -71.0(3) 
Fe(1) - C(4) - C(9) - C(10) -147.16(15) 
C(5) - C(4) - C(9) - C(8) 47.6(3) 
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Fe(1) - C(4) - C(9) - C(8) -28.6(2) 
O(5) - C(8) - C(9) - O(4) 111.96(19) 
C(7) - C(8) - C(9) - O(4) -123.84(19) 
O(5) - C(8) - C(9) - C(4) -129.15(19) 
C(7) - C(8) - C(9) - C(4) -5.0(2) 
O(5) - C(8) - C(9) - C(10) -10.8(2) 
C(7) - C(8) - C(9) - C(10) 113.4(2) 
C(11) - O(7) - C(10) - O(6) -3.7(3) 
C(11) - O(7) - C(10) - C(9) 176.57(18) 
O(4) - C(9) - C(10) - O(6) 157.5(2) 
C(4) - C(9) - C(10) - O(6) 38.8(3) 
C(8) - C(9) - C(10) - O(6) -80.2(3) 







Figure 16 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 414 
 
Table 30 Crystal data and structure refinement for 414 
                                                        
 Identification code k10sel1 
 Empirical formula C14 H14 Fe O7 
 Formula weight 350.10 
 Temperature 150(2) K 
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 Wavelength 0.71073 Å 
 Crystal system Monoclinic 
 Space group C2 
 Unit cell dimensions a = 20.7320(4)Å α = 90o 
       b = 6.2630(1)Å β = 110.174(1)o 
       c = 12.1540(3)Å γ = 90o 
 Volume 1481.31(5) Å3 
 Z 4 
 Density (calculated) 1.570 Mg/m3 
 Absorption coefficient 1.050 mm-1 
 F(000) 720 
 Crystal size 0.30 x 0.20 x 0.15 mm 
 Theta range for data collection 3.57 to 27.48o 
 Index ranges -26<=h<=26; -8<=k<=8; -15<=l<=15 
 Reflections collected 12804 
 Independent reflections 3350 [R(int) = 0.1159] 
 Reflections observed (>2σ) 3232 
 Data Completeness 0.995 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.750 and 0.155 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 3350 / 5 / 219 
 Goodness-of-fit on F2 1.023 
 Final R indices [I>2σ(I)] R1 = 0.0398   wR2 = 0.0975 
 R indices (all data) R1 = 0.0438  wR2 = 0.0992 
 Absolute structure parameter -0.009(16) 




H4-H7 located and refine at 0.98Å from the relevant parent atoms. 
   
 Table 31 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 414. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
                                                                               
  Atom   x   y   z  U(eq) 
                                 
Fe(1) 3048(1) 470(1) 2711(1) 19(1) 
O(1) 4438(1) -1348(4) 3628(2) 39(1) 
O(2) 3601(1) 4600(4) 2320(2) 40(1) 
O(3) 2626(1) -1181(4) 301(2) 39(1) 
O(4) 1466(1) -2575(3) 3448(2) 24(1) 
O(5) 1019(1) 640(4) 2734(2) 24(1) 
O(6) 1103(1) -976(3) 224(2) 35(1) 
O(7) 1050(1) 2505(3) 618(2) 30(1) 
C(1) 3895(2) -662(4) 3266(2) 25(1) 
C(2) 3385(2) 2991(4) 2462(3) 26(1) 
C(3) 2775(2) -528(4) 1233(2) 25(1) 
C(4) 2124(2) 1879(4) 2707(2) 20(1) 
C(5) 2607(2) 1656(4) 3872(3) 21(1) 
C(6) 2854(2) -438(5) 4196(2) 21(1) 
C(7) 2579(1) -2022(4) 3316(2) 20(1) 
C(8) 1815(1) -1994(4) 2651(2) 19(1) 
C(9) 1551(1) 275(5) 2241(2) 19(1) 
C(10) 845(1) -1372(4) 3124(2) 25(1) 
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C(11) 659(2) -962(5) 4200(3) 36(1) 
C(12) 280(2) -2513(5) 2158(3) 35(1) 
C(13) 1218(1) 452(6) 909(2) 22(1) 
C(14) 709(2) 2955(5) -611(3) 35(1) 
                                   
  
Table 32 Bond lengths [Å] and angles [o] for 414. 
  
Fe(1)-C(2) 1.795(3) Fe(1)-C(1) 1.795(3) 
Fe(1)-C(3) 1.799(3) Fe(1)-C(6) 2.060(3) 
Fe(1)-C(5) 2.066(3) Fe(1)-C(7) 2.101(2) 
Fe(1)-C(4) 2.107(3) O(1)-C(1) 1.143(4) 
O(2)-C(2) 1.139(4) O(3)-C(3) 1.142(4) 
O(4)-C(10) 1.426(3) O(4)-C(8) 1.442(3) 
O(5)-C(10) 1.436(3) O(5)-C(9) 1.443(3) 
O(6)-C(13) 1.189(4) O(7)-C(13) 1.347(4) 
O(7)-C(14) 1.443(4) C(4)-C(5) 1.431(4) 
C(4)-C(9) 1.509(4) C(4)-H(4) 0.980(5) 
C(5)-C(6) 1.414(4) C(5)-H(5) 0.979(5) 
C(6)-C(7) 1.426(4) C(6)-H(6) 0.979(5) 
C(7)-C(8) 1.509(4) C(7)-H(7) 0.982(5) 
C(8)-C(9) 1.543(4) C(8)-H(8) 1.0000 
C(9)-C(13) 1.530(3) C(10)-C(11) 1.508(4) 
C(10)-C(12) 1.521(4) C(11)-H(11A) 0.9800 
C(11)-H(11B) 0.9800 C(11)-H(11C) 0.9800 
C(12)-H(12A) 0.9800 C(12)-H(12B) 0.9800 
C(12)-H(12C) 0.9800 C(14)-H(14A) 0.9800 
C(14)-H(14B) 0.9800 C(14)-H(14C) 0.9800 
                                           
C(2)-Fe(1)-C(1) 91.32(13) C(2)-Fe(1)-C(3) 98.29(13) 
C(1)-Fe(1)-C(3) 99.69(13) C(2)-Fe(1)-C(6) 126.54(12) 
C(1)-Fe(1)-C(6) 91.28(12) C(3)-Fe(1)-C(6) 133.65(12) 
C(2)-Fe(1)-C(5) 95.09(12) C(1)-Fe(1)-C(5) 119.39(12) 
C(3)-Fe(1)-C(5) 138.26(12) C(6)-Fe(1)-C(5) 40.07(10) 
C(2)-Fe(1)-C(7) 165.20(11) C(1)-Fe(1)-C(7) 94.92(11) 
C(3)-Fe(1)-C(7) 93.89(11) C(6)-Fe(1)-C(7) 40.06(10) 
C(5)-Fe(1)-C(7) 70.16(10) C(2)-Fe(1)-C(4) 92.18(12) 
C(1)-Fe(1)-C(4) 159.44(12) C(3)-Fe(1)-C(4) 99.84(12) 
C(6)-Fe(1)-C(4) 70.48(11) C(5)-Fe(1)-C(4) 40.09(11) 
C(7)-Fe(1)-C(4) 77.40(10) C(10)-O(4)-C(8) 107.26(19) 
C(10)-O(5)-C(9) 108.3(2) C(13)-O(7)-C(14) 116.6(2) 
O(1)-C(1)-Fe(1) 178.8(3) O(2)-C(2)-Fe(1) 179.0(3) 
O(3)-C(3)-Fe(1) 177.5(3) C(5)-C(4)-C(9) 119.8(2) 
C(5)-C(4)-Fe(1) 68.41(15) C(9)-C(4)-Fe(1) 108.59(16) 
C(5)-C(4)-H(4) 118(2) C(9)-C(4)-H(4) 114(2) 
Fe(1)-C(4)-H(4) 121(2) C(6)-C(5)-C(4) 115.4(2) 
C(6)-C(5)-Fe(1) 69.72(17) C(4)-C(5)-Fe(1) 71.50(15) 
C(6)-C(5)-H(5) 123(2) C(4)-C(5)-H(5) 121(2) 
Fe(1)-C(5)-H(5) 121(2) C(5)-C(6)-C(7) 115.0(2) 
C(5)-C(6)-Fe(1) 70.21(17) C(7)-C(6)-Fe(1) 71.54(15) 
C(5)-C(6)-H(6) 122.4(18) C(7)-C(6)-H(6) 121.9(18) 
Fe(1)-C(6)-H(6) 120.0(19) C(6)-C(7)-C(8) 118.0(2) 
C(6)-C(7)-Fe(1) 68.40(14) C(8)-C(7)-Fe(1) 109.29(16) 
C(6)-C(7)-H(7) 119(2) C(8)-C(7)-H(7) 113(2) 
Fe(1)-C(7)-H(7) 122(2) O(4)-C(8)-C(7) 108.3(2) 
O(4)-C(8)-C(9) 104.16(19) C(7)-C(8)-C(9) 111.9(2) 
O(4)-C(8)-H(8) 110.8 C(7)-C(8)-H(8) 110.8 
C(9)-C(8)-H(8) 110.8 O(5)-C(9)-C(4) 110.7(2) 
O(5)-C(9)-C(13) 107.25(19) C(4)-C(9)-C(13) 111.0(2) 
O(5)-C(9)-C(8) 104.4(2) C(4)-C(9)-C(8) 110.3(2) 
C(13)-C(9)-C(8) 112.9(2) O(4)-C(10)-O(5) 104.3(2) 
O(4)-C(10)-C(11) 109.1(2) O(5)-C(10)-C(11) 107.8(2) 
O(4)-C(10)-C(12) 110.3(2) O(5)-C(10)-C(12) 111.9(2) 
C(11)-C(10)-C(12) 113.0(3) C(10)-C(11)-H(11A) 109.5 
C(10)-C(11)-H(11B) 109.5 H(11A)-C(11)-H(11B) 109.5 
C(10)-C(11)-H(11C) 109.5 H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 C(10)-C(12)-H(12A) 109.5 
C(10)-C(12)-H(12B) 109.5 H(12A)-C(12)-H(12B) 109.5 
C(10)-C(12)-H(12C) 109.5 H(12A)-C(12)-H(12C) 109.5 
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H(12B)-C(12)-H(12C) 109.5 O(6)-C(13)-O(7) 124.3(2) 
O(6)-C(13)-C(9) 126.5(3) O(7)-C(13)-C(9) 109.2(3) 
O(7)-C(14)-H(14A) 109.5 O(7)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 O(7)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 H(14B)-C(14)-H(14C) 109.5 
                                                    
Symmetry transformations used to generate equivalent atoms: 
                                                            
   
 Table 33 Anisotropic displacement parameters (Å2 x 103) for 414. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
                                                                                 
  Atom  U11  U22  U33  U23  U13  U12 
                                               
Fe(1) 18(1) 16(1) 20(1) -1(1) 6(1) 0(1) 
O(1) 25(1) 42(1) 45(1) 0(1) 8(1) 6(1) 
O(2) 50(2) 23(1) 56(2) -3(1) 32(1) -9(1) 
O(3) 42(1) 47(1) 26(1) -13(1) 9(1) 2(1) 
O(4) 19(1) 25(1) 28(1) 8(1) 6(1) -1(1) 
O(5) 20(1) 24(1) 27(1) 7(1) 9(1) 3(1) 
O(6) 42(1) 32(1) 25(1) -1(1) 1(1) -2(1) 
O(7) 35(1) 27(1) 24(1) 10(1) 6(1) 10(1) 
C(1) 23(2) 25(1) 26(1) 1(1) 8(1) -3(1) 
C(2) 27(2) 26(1) 28(1) -1(1) 14(1) 1(1) 
C(3) 20(1) 26(1) 28(2) -1(1) 7(1) 1(1) 
C(4) 20(1) 15(1) 24(1) 1(1) 7(1) 3(1) 
C(5) 17(1) 23(1) 22(1) -6(1) 7(1) -1(1) 
C(6) 15(1) 26(1) 22(1) 1(1) 6(1) -1(1) 
C(7) 18(1) 18(1) 25(1) 1(1) 7(1) 1(1) 
C(8) 20(1) 16(1) 18(1) 2(1) 3(1) 0(1) 
C(9) 17(1) 18(1) 20(1) 1(1) 4(1) -1(1) 
C(10) 18(1) 28(1) 26(1) 8(1) 5(1) -1(1) 
C(11) 30(2) 47(2) 33(2) 10(1) 15(1) 4(1) 
C(12) 21(2) 43(2) 34(2) 9(1) 0(1) -9(1) 
C(13) 17(1) 24(1) 24(1) 8(1) 6(1) 2(1) 
C(14) 33(2) 43(2) 26(1) 16(1) 5(1) 10(1) 
  
   
 Table 34 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 414 
                                     
  Atom   x   y   z  U(eq) 
                                 
H(8) 1694 -3001 1971 23 
H(11A) 1037 -209 4787 54 
H(11B) 576 -2325 4525 54 
H(11C) 242 -86 3988 54 
H(12A) -143 -1664 1939 53 
H(12B) 197 -3917 2440 53 
H(12C) 421 -2693 1473 53 
H(14A) 966 2298 -1064 53 
H(14B) 688 4503 -735 53 
H(14C) 242 2370 -867 53 
H(6) 3236(11) -740(50) 4921(15) 21(8) 
H(7) 2772(17) -3470(20) 3450(30) 26(8) 
H(5) 2801(18) 2910(40) 4350(30) 31(9) 
H(4) 1998(19) 3320(30) 2400(30) 43(13) 
  
  
 Table 35 Dihedral angles [o] for 414. 
                                         
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
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C(2) - Fe(1) - C(1) - O(1) 35(13) 
C(3) - Fe(1) - C(1) - O(1) 134(13) 
C(6) - Fe(1) - C(1) - O(1) -91(13) 
C(5) - Fe(1) - C(1) - O(1) -61(13) 
C(7) - Fe(1) - C(1) - O(1) -131(13) 
C(4) - Fe(1) - C(1) - O(1) -65(13) 
C(1) - Fe(1) - C(2) - O(2) -88(18) 
C(3) - Fe(1) - C(2) - O(2) 172(100) 
C(6) - Fe(1) - C(2) - O(2) 5(18) 
C(5) - Fe(1) - C(2) - O(2) 32(18) 
C(7) - Fe(1) - C(2) - O(2) 27(18) 
C(4) - Fe(1) - C(2) - O(2) 72(18) 
C(2) - Fe(1) - C(3) - O(3) 79(6) 
C(1) - Fe(1) - C(3) - O(3) -14(6) 
C(6) - Fe(1) - C(3) - O(3) -115(6) 
C(5) - Fe(1) - C(3) - O(3) -174(6) 
C(7) - Fe(1) - C(3) - O(3) -109(6) 
C(4) - Fe(1) - C(3) - O(3) 173(6) 
C(2) - Fe(1) - C(4) - C(5) -95.31(17) 
C(1) - Fe(1) - C(4) - C(5) 4.3(4) 
C(3) - Fe(1) - C(4) - C(5) 165.89(16) 
C(6) - Fe(1) - C(4) - C(5) 32.91(15) 
C(7) - Fe(1) - C(4) - C(5) 74.07(16) 
C(2) - Fe(1) - C(4) - C(9) 149.13(19) 
C(1) - Fe(1) - C(4) - C(9) -111.3(3) 
C(3) - Fe(1) - C(4) - C(9) 50.3(2) 
C(6) - Fe(1) - C(4) - C(9) -82.65(18) 
C(5) - Fe(1) - C(4) - C(9) -115.6(2) 
C(7) - Fe(1) - C(4) - C(9) -41.49(17) 
C(9) - C(4) - C(5) - C(6) 44.0(4) 
Fe(1) - C(4) - C(5) - C(6) -55.7(2) 
C(9) - C(4) - C(5) - Fe(1) 99.7(2) 
C(2) - Fe(1) - C(5) - C(6) -145.36(17) 
C(1) - Fe(1) - C(5) - C(6) -50.97(19) 
C(3) - Fe(1) - C(5) - C(6) 106.2(2) 
C(7) - Fe(1) - C(5) - C(6) 33.38(16) 
C(4) - Fe(1) - C(5) - C(6) 127.3(2) 
C(2) - Fe(1) - C(5) - C(4) 87.34(17) 
C(1) - Fe(1) - C(5) - C(4) -178.27(16) 
C(3) - Fe(1) - C(5) - C(4) -21.1(2) 
C(6) - Fe(1) - C(5) - C(4) -127.3(2) 
C(7) - Fe(1) - C(5) - C(4) -93.92(16) 
C(4) - C(5) - C(6) - C(7) -0.7(4) 
Fe(1) - C(5) - C(6) - C(7) -57.3(2) 
C(4) - C(5) - C(6) - Fe(1) 56.6(2) 
C(2) - Fe(1) - C(6) - C(5) 44.8(2) 
C(1) - Fe(1) - C(6) - C(5) 137.39(17) 
C(3) - Fe(1) - C(6) - C(5) -117.89(19) 
C(7) - Fe(1) - C(6) - C(5) -126.5(2) 
C(4) - Fe(1) - C(6) - C(5) -32.92(15) 
C(2) - Fe(1) - C(6) - C(7) 171.28(17) 
C(1) - Fe(1) - C(6) - C(7) -96.13(17) 
C(3) - Fe(1) - C(6) - C(7) 8.6(2) 
C(5) - Fe(1) - C(6) - C(7) 126.5(2) 
C(4) - Fe(1) - C(6) - C(7) 93.55(17) 
C(5) - C(6) - C(7) - C(8) -44.4(3) 
Fe(1) - C(6) - C(7) - C(8) -101.1(2) 
C(5) - C(6) - C(7) - Fe(1) 56.6(2) 
C(2) - Fe(1) - C(7) - C(6) -28.5(6) 
C(1) - Fe(1) - C(7) - C(6) 86.13(18) 
C(3) - Fe(1) - C(7) - C(6) -173.79(18) 
C(5) - Fe(1) - C(7) - C(6) -33.38(16) 
C(4) - Fe(1) - C(7) - C(6) -74.56(17) 
C(2) - Fe(1) - C(7) - C(8) 84.9(5) 
C(1) - Fe(1) - C(7) - C(8) -160.55(18) 
C(3) - Fe(1) - C(7) - C(8) -60.46(18) 
C(6) - Fe(1) - C(7) - C(8) 113.3(2) 
C(5) - Fe(1) - C(7) - C(8) 79.94(18) 
C(4) - Fe(1) - C(7) - C(8) 38.76(17) 
C(10) - O(4) - C(8) - C(7) 144.9(2) 
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C(10) - O(4) - C(8) - C(9) 25.7(3) 
C(6) - C(7) - C(8) - O(4) -68.2(3) 
Fe(1) - C(7) - C(8) - O(4) -143.37(16) 
C(6) - C(7) - C(8) - C(9) 46.1(3) 
Fe(1) - C(7) - C(8) - C(9) -29.1(2) 
C(10) - O(5) - C(9) - C(4) -133.0(2) 
C(10) - O(5) - C(9) - C(13) 105.8(3) 
C(10) - O(5) - C(9) - C(8) -14.3(3) 
C(5) - C(4) - C(9) - O(5) 75.9(3) 
Fe(1) - C(4) - C(9) - O(5) 151.17(16) 
C(5) - C(4) - C(9) - C(13) -165.1(2) 
Fe(1) - C(4) - C(9) - C(13) -89.8(2) 
C(5) - C(4) - C(9) - C(8) -39.2(3) 
Fe(1) - C(4) - C(9) - C(8) 36.1(2) 
O(4) - C(8) - C(9) - O(5) -6.8(2) 
C(7) - C(8) - C(9) - O(5) -123.6(2) 
O(4) - C(8) - C(9) - C(4) 112.2(2) 
C(7) - C(8) - C(9) - C(4) -4.6(3) 
O(4) - C(8) - C(9) - C(13) -122.9(2) 
C(7) - C(8) - C(9) - C(13) 120.3(2) 
C(8) - O(4) - C(10) - O(5) -34.9(3) 
C(8) - O(4) - C(10) - C(11) -149.9(2) 
C(8) - O(4) - C(10) - C(12) 85.4(2) 
C(9) - O(5) - C(10) - O(4) 30.3(3) 
C(9) - O(5) - C(10) - C(11) 146.3(2) 
C(9) - O(5) - C(10) - C(12) -88.9(3) 
C(14) - O(7) - C(13) - O(6) 0.1(4) 
C(14) - O(7) - C(13) - C(9) -178.2(2) 
O(5) - C(9) - C(13) - O(6) -108.0(3) 
C(4) - C(9) - C(13) - O(6) 130.9(3) 
C(8) - C(9) - C(13) - O(6) 6.4(4) 
O(5) - C(9) - C(13) - O(7) 70.3(3) 
C(4) - C(9) - C(13) - O(7) -50.8(3) 
C(8) - C(9) - C(13) - O(7) -175.3(2) 
                                     






Figure 17 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 415. 
 
 
Table 36 Crystal data and structure refinement for 415 
 
Identification code  h09sel5 
Empirical formula  C14 H14 Fe O7 
Formula weight  350.10 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 10.1710(4) Å 
 b = 7.2170(4) Å 
 c = 10.6320(6) Å 
Volume 731.36(6) Å3 
Z 2 
Density (calculated) 1.590 Mg/m3 




Crystal size 0.22 x 0.17 x 0.13 mm3 
Theta range for data collection 8.57 to 30.69°. 
Index ranges -14<=h<=14, -10<=k<=10, -15<=l<=15 
Reflections collected 7011 
Independent reflections 3709 [R(int) = 0.0767] 
Completeness to theta = 30.69° 92.9 %  
Absorption correction None 
Max. and min. transmission 0.8742 and 0.7998 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3709 / 1 / 203 
Goodness-of-fit on F2 1.055 
Final R indices [I>2sigma(I)] R1 = 0.0380, wR2 = 0.1013 
R indices (all data) R1 = 0.0402, wR2 = 0.1034 
Absolute structure parameter -0.005(16) 
Extinction coefficient 0.030(11) 
Largest diff. peak and hole 0.427 and -0.616 e.Å-3 
 
Table 37 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 415.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 














O(1) 812(2) -1126(3) -6360(2) 38(1)   
O(2) -49(3) 4784(3)  6992(3) 42(1)   
O(3) -584(2) 1747(4)  10470(2) 45(1)   
O(4) -2697(2) -3871(3) -9759(2) 28(1)   
O(5) -2932(2) -1314(3) -11032(2) 26(1)   
O(6) -4070(2) -727(3) -6166(2) 26(1)   
O(7) -4310(2) -2720(2) -7867(2) 21(1)   
C(1) -47(3) -209(4) -7048(3) 24(1)   
C(2) -589(3) 3439(4) -7459(3) 27(1)   
C(3) -933(2) 1517(5) -9585(3) 29(1)   
C(11) -2875(2) -917(3) -8810(2) 18(1)   
C(12) -3521(2) 868(3) -9167(2) 19(1)   
C(13) -3357(2) 2090(3) -8080(2) 22(1)   
C(14) -2559(2) 1389(4) -6780(2) 21(1)   
C(15) -2771(2) -571(3) -6412(2) 19(1)   
C(16) -2951(2) -1911(3) -7589(2) 19(1)   
C(17) -2816(2) -2208(3) -9881(2) 19(1)   
C(18) -2958(3) -2485(4) -12142(3) 28(1)   
C(19) -4665(2) -2481(3) -6692(2) 21(1)   
C(20) -6244(3) -2359(4) -7107(3) 33(1)   
C(21) -4039(3) -4034(4) -5700(2) 30(1)   
 
Table 38 Bond lengths [Å] and angles [°] for 415 
 
Fe(1)- C(1) 1.794(3) C(12)-C(11)-C(16) 119.87(19) 
Fe(1)- C(2 1.796(3) C(17)-C(11)-C(16) 112.85(19) 
Fe(1) -C(3) 1.824(3) C(12)-C(11)-Fe(1) 68.08(12) 
Fe(1) -C(12) 2.066(2) C(17)-C(11)-Fe(1) 122.02(16) 
Fe(1)- C(13) 2.070(2) C(16)-C(11)-Fe(1) 106.54(14) 
Fe(1)- C(14) 2.109(2) C(13)-C(12)-C(11) 115.50(19) 
Fe(1)- C(11) 2.116(2) C(13)-C(12)-Fe(1) 70.11(12) 
O(1) -C(1) 1.136(3) C(11)-C(12)-Fe(1) 71.79(12) 
O(2) -C(2) 1.140(4) C(13)-C(12)-H(12) 122.2 
O(3)- C(3) 1.129(3) C(11)-C(12)-H(12) 122.2 
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O(4) -C(17) 1.209(3) Fe(1)-C(12)-H(12) 127.7 
O(5)-C(17) 1.351(3) C(12)-C(13)-C(14) 115.7(2) 
O(5) -C(18) 1.445(3) C(12)-C(13)-Fe(1) 69.84(13) 
O(6)- C(19) 1.430(3) C(14)-C(13)-Fe(1) 71.50(13) 
O(6) -C(15) 1.438(3) C(12)-C(13)-H(13) 122.2 
O(7)- C(19) 1.426(3) C(14)-C(13)-H(13) 122.2 
O(7)- C(16) 1.434(3) Fe(1)-C(13)-H(13) 128.5 
C(11)- C(12) 1.436(3) C(13)-C(14)-C(15) 120.0(2) 
C(11)- C(17) 1.489(3) C(13)-C(14)-Fe(1) 68.52(13) 
C(11)- C(16) 1.509(3) C(15)-C(14)-Fe(1) 107.15(16) 
C(1)-Fe(1)-C(2) 97.23(12) C(13)-C(14)-H(14) 120.0 
C(1)-Fe(1)-C(3) 102.31(12) C(15)-C(14)-H(14) 120.0 
C(2)-Fe(1)-C(3) 90.42(13) Fe(1)-C(14)-H(14) 94.1 
C(1)-Fe(1)-C(12) 133.62(10) O(6)-C(15)-C(14) 110.21(19) 
C(2)-Fe(1)-C(12) 125.92(11) O(6)-C(15)-C(16) 104.00(17) 
C(3)-Fe(1)-C(12) 94.30(10) C(14)-C(15)-C(16) 111.49(18) 
C(1)-Fe(1)-C(13) 134.54(10) O(6)-C(15)-H(15) 110.3 
C(2)-Fe(1)-C(13) 93.90(11) C(14)-C(15)-H(15) 110.3 
C(3)-Fe(1)-C(13) 121.59(11) C(16)-C(15)-H(15) 110.3 
C(12)-Fe(1)-C(13 40.05(9) O(7)-C(16)-C(11) 110.60(17) 
C(1)-Fe(1)-C(14) 95.86(11) O(7)-C(16)-C(15) 104.84(17) 
C(2)-Fe(1)-C(14) 90.44(12) C(11)-C(16)-C(15) 111.89(19) 
C(3)-Fe(1)-C(14) 161.55(11) O(7)-C(16)-H(16) 109.8 
C(12)-Fe(1)-C(14) 70.46(8) C(11)-C(16)-H(16) 109.8 
C(13)-Fe(1)-C(14) 39.98(9) C(15)-C(16)-H(16) 109.8 
C(1)-Fe(1)-C(11) 94.41(10) O(4)-C(17)-O(5) 123.1(2) 
C(2)-Fe(1)-C(11) 164.26(11) O(4)-C(17)-C(11) 124.6(2) 
C(3)-Fe(1)-C(11) 97.43(11) O(5)-C(17)-C(11) 112.29(19) 
C(12)-Fe(1)-C(11) 40.14(8) O(5)-C(18)-H(18A) 109.5 
C(13)-Fe(1)-C(11) 70.37(9) O(5)-C(18)-H(18B) 109.5 
C(14)-Fe(1)-C(11) 77.83(9) H(18A)-C(18)-H(18B) 109.5 
C(17)-O(5)-C(18) 115.5(2) O(5)-C(18)-H(18C) 109.5 
C(19)-O(6)-C(15) 106.77(17) H(18A)-C(18)-H(18C) 109.5 
C(19)-O(7)-C(16) 106.91(16) H(18B)-C(18)-H(18C) 109.5 
O(1)-C(1)-Fe(1) 178.4(3) O(7)-C(19)-O(6) 104.33(18) 
O(2)-C(2)-Fe(1) 176.5(3) O(7)-C(19)-C(20) 108.6(2) 
O(3)-C(3)-Fe(1) 176.2(3) O(6)-C(19)-C(20) 108.90(19) 
C(12)-C(11)-C(17) 119.77(19) O(7)-C(19)-C(21) 110.3(2) 
H(20B)-C(20)-H(20C) 109.5 O(6)-C(19)-C(21) 111.3(2) 
C(19)-C(21)-H(21A) 109.5 C(20)-C(19)-C(21) 113.0(2) 
C(19)-C(21)-H(21B) 109.5 C(19)-C(20)-H(20A) 109.5 
H(21A)-C(21)-H(21B) 109.5 C(19)-C(20)-H(20B) 109.5 
C(19)-C(21)-H(21C) 109.5 H(20A)-C(20)-H(20B) 109.5 
H(21A)-C(21)-H(21C) 109.5 C(19)-C(20)-H(20C) 109.5 
H(21B)-C(21)-H(21C) 109.5 H(20A)-C(20)-H(20C) 109.5 
Symmetry transformations used to generate equivalent atoms:  
 
Table 39Anisotropic displacement parameters (Å2x 103)for 415.  The anisotropic 
displacement factor exponent takes the form: -2pi2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
   
ATOM U1  U22 U33  U23 U13  U12 
Fe(1) 18(1)  17(1) 19(1)  0(1) 4(1)  -1(1) 
O(1) 27(1)  33(1) 44(1)  9(1) -1(1)  4(1) 
O(2) 40(1)  24(1) 52(1)  -5(1) 4(1)  -8(1) 
O(3) 38(1)  67(2) 33(1)  1(1) 15(1)  -13(1) 
O(4) 43(1)  18(1) 25(1)  -1(1) 15(1)  2(1) 
O(5) 40(1)  19(1) 18(1)  -3(1) 12(1)  0(1) 
O(6) 28(1)  24(1) 30(1)  -12(1) 16(1)  -7(1) 
O(7) 24(1)  22(1) 16(1)  -3(1) 6(1)  -6(1) 
C(1) 20(1)  23(1) 29(1)  -2(1) 7(1)  -4(1) 
C(2) 26(1)  23(1) 30(1)  1(1) 7(1)  -1(1) 
C(3) 21(1)  35(2) 28(1)  0(1) 7(1)  -5(1) 
C(11) 19(1)  16(1) 16(1)  -2(1) 4(1)  -2(1) 
C(12) 19(1)  19(1) 19(1)  0(1) 5(1)  0(1) 
C(13) 22(1)  17(1) 25(1)  -2(1) 6(1)  1(1) 
C(14) 22(1)  21(1) 20(1)  -3(1) 6(1)  -3(1) 
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C(15) 19(1)  22(1) 16(1)  -3(1) 5(1)  -1(1) 
C(16) 19(1)  18(1) 18(1)  -1(1) 4(1)  0(1) 
C(17) 19(1)  20(1) 18(1)  -1(1) 6(1)  1(1) 
C(18) 43(1)  24(1) 22(1)  -6(1) 15(1)  0(1) 
C(19) 24(1)  20(1) 22(1)  -5(1) 10(1)  -2(1) 
C(20) 25(1)  24(1) 51(2)  -11(1) 17(1)  -2(1) 








Figure 27 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 455 
 
Table 40 Crystal data and structure refinement 455 
                                                        
 Identification code k09sel4 
 Empirical formula C19 H16 Fe O7 S 
 Formula weight 444.23 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Triclinic 
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 Space group P-1 
 Unit cell dimensions a = 7.3200(1)Å α = 97.505(1)o 
       b = 10.5210(2)Å β = 103.386(1)o 
       c = 13.3490(2)Å γ = 102.216(1)o 
 Volume 959.88(3) Å3 
 Z 2 
 Density (calculated) 1.537 Mg/m3 
 Absorption coefficient 0.933 mm-1 
 F(000) 456 
 Crystal size 0.5 x 0.25 x 0.15 mm 
 Theta range for data collection 3.70 to 27.50o 
 Index ranges -9<=h<=9; -13<=k<=13; -17<=l<=17 
 Reflections collected 18914 
 Independent reflections 4407 [R(int) = 0.0373] 
 Reflections observed (>2σ) 3921 
 Data Completeness 0.996 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.760 and 0.721 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 4407 / 4 / 272 
 Goodness-of-fit on F2 1.062 
 Final R indices [I>2σ(I)] R1 = 0.0285   wR2 = 0.0690 
 R indices (all data) R1 = 0.0358  wR2 = 0.0723 




H4-7 located and refined at 0.98Å from the relevant parent atoms. Structure is a 
racemic mixture. 
 
   
 Table 41 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 455. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
                                                             
  Atom   x   y   z  U(eq) 
                                 
Fe(1) 3416(1) -2586(1) 1502(1) 20(1) 
S(1) 3860(1) 1828(1) 1522(1) 21(1) 
O(1) 942(2) -5270(1) 1201(1) 49(1) 
O(2) 6391(2) -3497(1) 659(1) 34(1) 
O(3) 5220(2) -2322(1) 3752(1) 34(1) 
O(4) 2642(2) -388(1) 3468(1) 18(1) 
O(5) -453(2) -1195(1) 3485(1) 31(1) 
O(6) 925(2) 1507(1) 2991(1) 24(1) 
O(7) -776(2) 287(1) 1403(1) 29(1) 
C(1) 1919(3) -4231(2) 1304(1) 30(1) 
C(2) 5233(2) -3147(2) 988(1) 25(1) 
C(3) 4544(2) -2404(2) 2875(1) 24(1) 
C(4) 1192(2) -1702(2) 1692(1) 21(1) 
C(5) 1239(2) -1907(2) 621(1) 24(1) 
C(6) 3020(2) -1351(2) 438(1) 23(1) 
C(7) 4480(2) -629(2) 1358(1) 20(1) 
C(8) 3937(2) 338(1) 2112(1) 18(1) 
C(9) 2029(2) -331(1) 2359(1) 17(1) 
C(10) 5296(2) 3157(1) 2552(1) 21(1) 
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C(11) 6422(2) 4213(2) 2256(1) 28(1) 
C(12) 7576(3) 5299(2) 3010(2) 37(1) 
C(13) 7646(3) 5328(2) 4055(2) 39(1) 
C(14) 6542(3) 4279(2) 4352(1) 34(1) 
C(15) 5339(2) 3196(2) 3603(1) 26(1) 
C(16) 1246(2) -871(2) 3932(1) 23(1) 
C(17) 2126(3) -935(2) 5046(1) 34(1) 
C(18) 531(2) 498(2) 2183(1) 21(1) 
C(19) -248(3) 2445(2) 2814(2) 36(1) 
                                    
    
 Table 42Bond lengths [Å] and angles [o] for 455 
  
Fe(1)-C(1) 1.7921(17) Fe(1)-C(3) 1.7941(17) 
Fe(1)-C(2) 1.7993(17) Fe(1)-C(6) 2.0584(15) 
Fe(1)-C(5) 2.0650(15) Fe(1)-C(4) 2.0855(15) 
Fe(1)-C(7) 2.0920(15) S(1)-C(10) 1.7767(16) 
S(1)-C(8) 1.8490(14) O(1)-C(1) 1.144(2) 
O(2)-C(2) 1.143(2) O(3)-C(3) 1.145(2) 
O(4)-C(16) 1.3562(18) O(4)-C(9) 1.4586(17) 
O(5)-C(16) 1.201(2) O(6)-C(18) 1.3413(19) 
O(6)-C(19) 1.4466(19) O(7)-C(18) 1.1988(19) 
C(4)-C(5) 1.426(2) C(4)-C(9) 1.512(2) 
C(4)-H(4) 0.978(5) C(5)-C(6) 1.401(2) 
C(5)-H(5) 0.978(5) C(6)-C(7) 1.425(2) 
C(6)-H(6) 0.978(5) C(7)-C(8) 1.514(2) 
C(7)-H(7) 0.977(5) C(8)-C(9) 1.5527(19) 
C(8)-H(8) 1.0000 C(9)-C(18) 1.535(2) 
C(10)-C(15) 1.390(2) C(10)-C(11) 1.396(2) 
C(11)-C(12) 1.389(2) C(11)-H(11) 0.9500 
C(12)-C(13) 1.380(3) C(12)-H(12) 0.9500 
C(13)-C(14) 1.384(3) C(13)-H(13) 0.9500 
C(14)-C(15) 1.395(2) C(14)-H(14) 0.9500 
C(15)-H(15) 0.9500 C(16)-C(17) 1.494(2) 
C(17)-H(17A) 0.9800 C(17)-H(17B) 0.9800 
C(17)-H(17C) 0.9800 C(19)-H(19A) 0.9800 
C(19)-H(19B) 0.9800 C(19)-H(19C) 0.9800 
                                           
C(1)-Fe(1)-C(3) 97.79(7) C(1)-Fe(1)-C(2) 93.07(8) 
C(3)-Fe(1)-C(2) 98.88(7) C(1)-Fe(1)-C(6) 123.13(7) 
C(3)-Fe(1)-C(6) 136.73(7) C(2)-Fe(1)-C(6) 92.83(7) 
C(1)-Fe(1)-C(5) 93.64(7) C(3)-Fe(1)-C(5) 135.30(7) 
C(2)-Fe(1)-C(5) 123.55(7) C(6)-Fe(1)-C(5) 39.74(6) 
C(1)-Fe(1)-C(4) 93.37(7) C(3)-Fe(1)-C(4) 95.89(7) 
C(2)-Fe(1)-C(4) 162.93(7) C(6)-Fe(1)-C(4) 70.46(6) 
C(5)-Fe(1)-C(4) 40.19(6) C(1)-Fe(1)-C(7) 162.64(7) 
C(3)-Fe(1)-C(7) 97.46(7) C(2)-Fe(1)-C(7) 92.73(6) 
C(6)-Fe(1)-C(7) 40.16(6) C(5)-Fe(1)-C(7) 69.59(6) 
C(4)-Fe(1)-C(7) 76.85(6) C(10)-S(1)-C(8) 103.92(7) 
C(16)-O(4)-C(9) 117.51(11) C(18)-O(6)-C(19) 114.41(13) 
O(1)-C(1)-Fe(1) 178.03(17) O(2)-C(2)-Fe(1) 179.59(15) 
O(3)-C(3)-Fe(1) 177.85(15) C(5)-C(4)-C(9) 119.30(13) 
C(5)-C(4)-Fe(1) 69.13(9) C(9)-C(4)-Fe(1) 110.22(10) 
C(5)-C(4)-H(4) 117.4(11) C(9)-C(4)-H(4) 113.6(11) 
Fe(1)-C(4)-H(4) 120.0(10) C(6)-C(5)-C(4) 115.44(14) 
C(6)-C(5)-Fe(1) 69.88(9) C(4)-C(5)-Fe(1) 70.68(9) 
C(6)-C(5)-H(5) 121.6(11) C(4)-C(5)-H(5) 122.3(11) 
Fe(1)-C(5)-H(5) 121.3(12) C(5)-C(6)-C(7) 114.09(14) 
C(5)-C(6)-Fe(1) 70.38(9) C(7)-C(6)-Fe(1) 71.18(8) 
C(5)-C(6)-H(6) 121.3(11) C(7)-C(6)-H(6) 124.3(11) 
Fe(1)-C(6)-H(6) 121.8(11) C(6)-C(7)-C(8) 118.16(13) 
C(6)-C(7)-Fe(1) 68.65(8) C(8)-C(7)-Fe(1) 111.36(10) 
C(6)-C(7)-H(7) 119.7(11) C(8)-C(7)-H(7) 112.0(11) 
Fe(1)-C(7)-H(7) 120.5(11) C(7)-C(8)-C(9) 110.31(12) 
C(7)-C(8)-S(1) 106.79(10) C(9)-C(8)-S(1) 115.14(10) 
C(7)-C(8)-H(8) 108.1 C(9)-C(8)-H(8) 108.1 
S(1)-C(8)-H(8) 108.1 O(4)-C(9)-C(4) 111.35(11) 
O(4)-C(9)-C(18) 109.79(11) C(4)-C(9)-C(18) 110.18(12) 
O(4)-C(9)-C(8) 103.73(11) C(4)-C(9)-C(8) 109.89(12) 
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C(18)-C(9)-C(8) 111.76(11) C(15)-C(10)-C(11) 119.78(15) 
C(15)-C(10)-S(1) 124.13(12) C(11)-C(10)-S(1) 116.09(12) 
C(12)-C(11)-C(10) 119.95(17) C(12)-C(11)-H(11) 120.0 
C(10)-C(11)-H(11) 120.0 C(13)-C(12)-C(11) 120.30(17) 
C(13)-C(12)-H(12) 119.8 C(11)-C(12)-H(12) 119.8 
C(12)-C(13)-C(14) 119.89(17) C(12)-C(13)-H(13) 120.1 
C(14)-C(13)-H(13) 120.1 C(13)-C(14)-C(15) 120.53(17) 
C(13)-C(14)-H(14) 119.7 C(15)-C(14)-H(14) 119.7 
C(10)-C(15)-C(14) 119.52(16) C(10)-C(15)-H(15) 120.2 
C(14)-C(15)-H(15) 120.2 O(5)-C(16)-O(4) 123.20(14) 
O(5)-C(16)-C(17) 126.16(15) O(4)-C(16)-C(17) 110.64(14) 
C(16)-C(17)-H(17A) 109.5 C(16)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B) 109.5 C(16)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C) 109.5 H(17B)-C(17)-H(17C) 109.5 
O(7)-C(18)-O(6) 124.98(14) O(7)-C(18)-C(9) 123.65(14) 
O(6)-C(18)-C(9) 111.32(12) O(6)-C(19)-H(19A) 109.5 
O(6)-C(19)-H(19B) 109.5 H(19A)-C(19)-H(19B) 109.5 
O(6)-C(19)-H(19C) 109.5 H(19A)-C(19)-H(19C) 109.5 
H(19B)-C(19)-H(19C) 109.5   
 
Symmetry transformations used to generate equivalent atoms: 
                                                            
 Table 43 Anisotropic displacement parameters (Å2 x 103) for 455. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
                                                                                 
  Atom  U11  U22  U33  U23  U13  U12 
                                               
Fe(1) 23(1) 16(1) 19(1) 4(1) 5(1) 4(1) 
S(1) 24(1) 17(1) 21(1) 8(1) 7(1) 4(1) 
O(1) 67(1) 24(1) 45(1) 5(1) 13(1) -12(1) 
O(2) 39(1) 33(1) 37(1) 9(1) 18(1) 17(1) 
O(3) 43(1) 38(1) 23(1) 7(1) 4(1) 20(1) 
O(4) 20(1) 21(1) 17(1) 7(1) 6(1) 6(1) 
O(5) 26(1) 35(1) 34(1) 8(1) 15(1) 3(1) 
O(6) 26(1) 24(1) 29(1) 9(1) 11(1) 14(1) 
O(7) 20(1) 37(1) 30(1) 13(1) 3(1) 9(1) 
C(1) 39(1) 26(1) 24(1) 5(1) 8(1) 5(1) 
C(2) 33(1) 18(1) 24(1) 7(1) 5(1) 5(1) 
C(3) 27(1) 18(1) 29(1) 7(1) 9(1) 9(1) 
C(4) 17(1) 20(1) 23(1) 5(1) 5(1) 1(1) 
C(5) 24(1) 24(1) 21(1) 4(1) 0(1) 7(1) 
C(6) 31(1) 22(1) 21(1) 10(1) 10(1) 12(1) 
C(7) 21(1) 18(1) 26(1) 10(1) 10(1) 6(1) 
C(8) 17(1) 16(1) 21(1) 7(1) 6(1) 3(1) 
C(9) 16(1) 19(1) 17(1) 6(1) 4(1) 4(1) 
C(10) 20(1) 17(1) 28(1) 5(1) 7(1) 8(1) 
C(11) 32(1) 19(1) 33(1) 9(1) 8(1) 5(1) 
C(12) 39(1) 19(1) 47(1) 10(1) 5(1) 0(1) 
C(13) 43(1) 23(1) 42(1) -3(1) -2(1) 6(1) 
C(14) 38(1) 33(1) 29(1) 0(1) 5(1) 13(1) 
C(15) 26(1) 25(1) 29(1) 6(1) 9(1) 8(1) 
C(16) 29(1) 19(1) 25(1) 7(1) 14(1) 8(1) 
C(17) 47(1) 39(1) 24(1) 12(1) 16(1) 14(1) 
C(18) 17(1) 25(1) 25(1) 11(1) 9(1) 6(1) 
C(19) 43(1) 37(1) 43(1) 18(1) 21(1) 28(1) 
  
   
 Table 44 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 455. 
                                     
  Atom   x   y   z  U(eq) 
                                 
H(8) 4996 597 2781 21 
H(11) 6400 4188 1539 33 
H(12) 8320 6026 2805 44 
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H(13) 8451 6067 4569 47 
H(14) 6604 4297 5073 40 
H(15) 4554 2490 3808 31 
H(17A) 2342 -69 5490 51 
H(17B) 3367 -1170 5104 51 
H(17C) 1245 -1605 5274 51 
H(19A) -80 2809 2193 54 
H(19B) 156 3165 3426 54 
H(19C) -1616 1996 2703 54 
H(4) 57(16) -2206(15) 1862(14) 23(4) 
H(5) 175(19) -2508(15) 67(11) 31(5) 
H(6) 3240(30) -1539(19) -254(7) 31(5) 
H(7) 5815(12) -317(17) 1323(15) 27(5) 
   
 Table 45 Dihedral angles [o] for 455 
                                         
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
                                                  
C(3) - Fe(1) - C(1) - O(1) 54(5) 
C(2) - Fe(1) - C(1) - O(1) 154(5) 
C(6) - Fe(1) - C(1) - O(1) -111(5) 
C(5) - Fe(1) - C(1) - O(1) -82(5) 
C(4) - Fe(1) - C(1) - O(1) -42(5) 
C(7) - Fe(1) - C(1) - O(1) -97(5) 
C(1) - Fe(1) - C(2) - O(2) 151(100) 
C(3) - Fe(1) - C(2) - O(2) -110(26) 
C(6) - Fe(1) - C(2) - O(2) 28(26) 
C(5) - Fe(1) - C(2) - O(2) 55(26) 
C(4) - Fe(1) - C(2) - O(2) 39(26) 
C(7) - Fe(1) - C(2) - O(2) -12(26) 
C(1) - Fe(1) - C(3) - O(3) -14(4) 
C(2) - Fe(1) - C(3) - O(3) -108(4) 
C(6) - Fe(1) - C(3) - O(3) 148(4) 
C(5) - Fe(1) - C(3) - O(3) 89(4) 
C(4) - Fe(1) - C(3) - O(3) 80(4) 
C(7) - Fe(1) - C(3) - O(3) 158(4) 
C(1) - Fe(1) - C(4) - C(5) -91.66(10) 
C(3) - Fe(1) - C(4) - C(5) 170.15(10) 
C(2) - Fe(1) - C(4) - C(5) 20.3(3) 
C(6) - Fe(1) - C(4) - C(5) 32.41(9) 
C(7) - Fe(1) - C(4) - C(5) 73.83(9) 
C(1) - Fe(1) - C(4) - C(9) 153.66(11) 
C(3) - Fe(1) - C(4) - C(9) 55.46(11) 
C(2) - Fe(1) - C(4) - C(9) -94.4(2) 
C(6) - Fe(1) - C(4) - C(9) -82.28(11) 
C(5) - Fe(1) - C(4) - C(9) -114.69(14) 
C(7) - Fe(1) - C(4) - C(9) -40.85(10) 
C(9) - C(4) - C(5) - C(6) 46.9(2) 
Fe(1) - C(4) - C(5) - C(6) -55.22(12) 
C(9) - C(4) - C(5) - Fe(1) 102.14(13) 
C(1) - Fe(1) - C(5) - C(6) -141.27(10) 
C(3) - Fe(1) - C(5) - C(6) 113.81(12) 
C(2) - Fe(1) - C(5) - C(6) -45.16(12) 
C(4) - Fe(1) - C(5) - C(6) 127.82(13) 
C(7) - Fe(1) - C(5) - C(6) 34.13(9) 
C(1) - Fe(1) - C(5) - C(4) 90.91(10) 
C(3) - Fe(1) - C(5) - C(4) -14.01(14) 
C(2) - Fe(1) - C(5) - C(4) -172.97(9) 
C(6) - Fe(1) - C(5) - C(4) -127.82(13) 
C(7) - Fe(1) - C(5) - C(4) -93.69(10) 
C(4) - C(5) - C(6) - C(7) -2.1(2) 
Fe(1) - C(5) - C(6) - C(7) -57.70(11) 
C(4) - C(5) - C(6) - Fe(1) 55.64(12) 
C(1) - Fe(1) - C(6) - C(5) 48.21(12) 
C(3) - Fe(1) - C(6) - C(5) -110.14(12) 
C(2) - Fe(1) - C(6) - C(5) 143.73(10) 
C(4) - Fe(1) - C(6) - C(5) -32.75(9) 
C(7) - Fe(1) - C(6) - C(5) -125.40(13) 
C(1) - Fe(1) - C(6) - C(7) 173.60(10) 
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C(3) - Fe(1) - C(6) - C(7) 15.26(14) 
C(2) - Fe(1) - C(6) - C(7) -90.88(10) 
C(5) - Fe(1) - C(6) - C(7) 125.40(13) 
C(4) - Fe(1) - C(6) - C(7) 92.65(9) 
C(5) - C(6) - C(7) - C(8) -46.29(19) 
Fe(1) - C(6) - C(7) - C(8) -103.55(12) 
C(5) - C(6) - C(7) - Fe(1) 57.26(12) 
C(1) - Fe(1) - C(7) - C(6) -18.2(3) 
C(3) - Fe(1) - C(7) - C(6) -169.52(10) 
C(2) - Fe(1) - C(7) - C(6) 91.16(10) 
C(5) - Fe(1) - C(7) - C(6) -33.78(9) 
C(4) - Fe(1) - C(7) - C(6) -75.18(9) 
C(1) - Fe(1) - C(7) - C(8) 94.8(3) 
C(3) - Fe(1) - C(7) - C(8) -56.49(11) 
C(2) - Fe(1) - C(7) - C(8) -155.81(11) 
C(6) - Fe(1) - C(7) - C(8) 113.03(14) 
C(5) - Fe(1) - C(7) - C(8) 79.25(11) 
C(4) - Fe(1) - C(7) - C(8) 37.85(10) 
C(6) - C(7) - C(8) - C(9) 48.82(17) 
Fe(1) - C(7) - C(8) - C(9) -27.65(14) 
C(6) - C(7) - C(8) - S(1) -76.97(14) 
Fe(1) - C(7) - C(8) - S(1) -153.43(7) 
C(10) - S(1) - C(8) - C(7) -130.01(10) 
C(10) - S(1) - C(8) - C(9) 107.17(11) 
C(16) - O(4) - C(9) - C(4) -65.21(15) 
C(16) - O(4) - C(9) - C(18) 57.08(16) 
C(16) - O(4) - C(9) - C(8) 176.66(11) 
C(5) - C(4) - C(9) - O(4) -154.89(13) 
Fe(1) - C(4) - C(9) - O(4) -78.10(12) 
C(5) - C(4) - C(9) - C(18) 83.05(16) 
Fe(1) - C(4) - C(9) - C(18) 159.83(9) 
C(5) - C(4) - C(9) - C(8) -40.53(18) 
Fe(1) - C(4) - C(9) - C(8) 36.26(14) 
C(7) - C(8) - C(9) - O(4) 113.74(12) 
S(1) - C(8) - C(9) - O(4) -125.34(10) 
C(7) - C(8) - C(9) - C(4) -5.40(16) 
S(1) - C(8) - C(9) - C(4) 115.52(12) 
C(7) - C(8) - C(9) - C(18) -128.04(13) 
S(1) - C(8) - C(9) - C(18) -7.12(16) 
C(8) - S(1) - C(10) - C(15) -36.68(15) 
C(8) - S(1) - C(10) - C(11) 143.69(12) 
C(15) - C(10) - C(11) - C(12) -0.2(2) 
S(1) - C(10) - C(11) - C(12) 179.43(13) 
C(10) - C(11) - C(12) - C(13) 1.4(3) 
C(11) - C(12) - C(13) - C(14) -0.9(3) 
C(12) - C(13) - C(14) - C(15) -0.7(3) 
C(11) - C(10) - C(15) - C(14) -1.4(2) 
S(1) - C(10) - C(15) - C(14) 179.00(12) 
C(13) - C(14) - C(15) - C(10) 1.9(3) 
C(9) - O(4) - C(16) - O(5) -3.3(2) 
C(9) - O(4) - C(16) - C(17) 176.75(13) 
C(19) - O(6) - C(18) - O(7) -6.3(2) 
C(19) - O(6) - C(18) - C(9) 171.21(13) 
O(4) - C(9) - C(18) - O(7) -147.12(14) 
C(4) - C(9) - C(18) - O(7) -24.1(2) 
C(8) - C(9) - C(18) - O(7) 98.34(17) 
O(4) - C(9) - C(18) - O(6) 35.38(16) 
C(4) - C(9) - C(18) - O(6) 158.36(12) 
C(8) - C(9) - C(18) - O(6) -79.16(15) 
                                      
                                      








Figure 28 ORTEP diagram (50% probability factor for thermal ellipsoid) with atomic 
numbering scheme for 461 
 
Table 46 Crystal data and structure refinement for 461 
                                                    
 Identification code k09sel5 
 Empirical formula C13 H12 Fe O7 
 Formula weight 336.08 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Monoclinic 
 Space group P21/n 
 Unit cell dimensions a = 9.9550(2)Å α = 90o 
       b = 5.9360(1)Å β = 91.773(1)o 
       c = 22.9660(5)Å γ = 90o 
 Volume 1356.48(5) Å3 
 Z 4 
 Density (calculated) 1.646 Mg/m3 
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 Absorption coefficient 1.143 mm-1 
 F(000) 688 
 Crystal size 0.25 x 0.20 x 0.20 mm 
 Theta range for data collection 3.55 to 27.48o 
 Index ranges -12<=h<=12; -7<=k<=7; -29<=l<=29 
 Reflections collected 23752 
 Independent reflections 3095 [R(int) = 0.0469] 
 Reflections observed (>2σ) 2590 
 Data Completeness 0.996 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.801 and 0.750 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 3095 / 4 / 209 
 Goodness-of-fit on F2 1.092 
 Final R indices [I>2σ(I)] R1 = 0.0293   wR2 = 0.0685 
 R indices (all data) R1 = 0.0420  wR2 = 0.0734 




H4-7 located and refined at distances of 0.98Å from the relevant carbon parent. 
 
This structure is a racemate. 
 
 Table 47 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 461. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
                                                                            
  Atom   x   y   z  U(eq) 
                                 
Fe(1) 8212(1) -80(1) 1054(1) 19(1) 
O(1) 6545(1) 1514(2) 63(1) 36(1) 
O(2) 10159(2) -2547(2) 357(1) 40(1) 
O(3) 10160(1) 3616(2) 1182(1) 33(1) 
O(4) 4918(1) 2004(2) 1166(1) 21(1) 
O(5) 2897(1) 342(2) 1244(1) 28(1) 
O(6) 4343(1) 2488(2) 2262(1) 27(1) 
O(7) 4780(1) -1146(2) 2480(1) 29(1) 
C(1) 7201(2) 906(3) 448(1) 25(1) 
C(2) 9409(2) -1644(3) 642(1) 26(1) 
C(3) 9404(2) 2184(3) 1137(1) 24(1) 
C(4) 6937(2) 1173(3) 1682(1) 19(1) 
C(5) 7912(2) -338(3) 1931(1) 20(1) 
C(6) 7918(2) -2500(3) 1679(1) 22(1) 
C(7) 6937(2) -2827(3) 1222(1) 22(1) 
C(8) 5513(2) -2010(3) 1296(1) 22(1) 
C(9) 5506(2) 350(3) 1565(1) 19(1) 
C(10) 3585(2) 1795(3) 1039(1) 23(1) 
C(11) 3128(2) 3600(3) 625(1) 31(1) 
C(12) 4804(2) 425(3) 2150(1) 21(1) 
C(13) 3625(2) 2794(4) 2797(1) 34(1) 
                                    
  Table 48 Bond lengths [Å] and angles [o] for 461 
  
Fe(1)-C(1) 1.7889(18) Fe(1)-C(3) 1.7990(18) 
Fe(1)-C(2) 1.8025(18) Fe(1)-C(5) 2.0527(16) 
Fe(1)-C(6) 2.0594(16) Fe(1)-C(4) 2.0872(16) 
Fe(1)-C(7) 2.1096(16) O(1)-C(1) 1.143(2) 
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O(2)-C(2) 1.141(2) O(3)-C(3) 1.138(2) 
O(4)-C(10) 1.356(2) O(4)-C(9) 1.4535(19) 
O(5)-C(10) 1.206(2) O(6)-C(12) 1.336(2) 
O(6)-C(13) 1.453(2) O(7)-C(12) 1.203(2) 
C(4)-C(5) 1.429(2) C(4)-C(9) 1.522(2) 
C(4)-H(4) 0.979(5) C(5)-C(6) 1.408(2) 
C(5)-H(5) 0.979(5) C(6)-C(7) 1.425(2) 
C(6)-H(6) 0.976(5) C(7)-C(8) 1.513(2) 
C(7)-H(7) 0.980(5) C(8)-C(9) 1.532(2) 
C(8)-H(8A) 0.9900 C(8)-H(8B) 0.9900 
C(9)-C(12) 1.534(2) C(10)-C(11) 1.495(2) 
C(11)-H(11A) 0.9800 C(11)-H(11B) 0.9800 
C(11)-H(11C) 0.9800 C(13)-H(13A) 0.9800 
C(13)-H(13B) 0.9800 C(13)-H(13C) 0.9800 
                                           
C(1)-Fe(1)-C(3) 101.05(8) C(1)-Fe(1)-C(2) 97.21(8) 
C(3)-Fe(1)-C(2) 89.75(8) C(1)-Fe(1)-C(5) 133.80(7) 
C(3)-Fe(1)-C(5) 93.85(7) C(2)-Fe(1)-C(5) 126.57(7) 
C(1)-Fe(1)-C(6) 132.97(7) C(3)-Fe(1)-C(6) 123.68(7) 
C(2)-Fe(1)-C(6) 96.75(7) C(5)-Fe(1)-C(6) 40.05(7) 
C(1)-Fe(1)-C(4) 94.65(7) C(3)-Fe(1)-C(4) 94.25(7) 
C(2)-Fe(1)-C(4) 166.53(7) C(5)-Fe(1)-C(4) 40.37(6) 
C(6)-Fe(1)-C(4) 70.36(6) C(1)-Fe(1)-C(7) 93.90(7) 
C(3)-Fe(1)-C(7) 163.07(7) C(2)-Fe(1)-C(7) 96.27(7) 
C(5)-Fe(1)-C(7) 69.86(7) C(6)-Fe(1)-C(7) 39.96(7) 
C(4)-Fe(1)-C(7) 76.51(6) C(10)-O(4)-C(9) 116.52(12) 
C(12)-O(6)-C(13) 117.25(14) O(1)-C(1)-Fe(1) 179.17(17) 
O(2)-C(2)-Fe(1) 176.20(16) O(3)-C(3)-Fe(1) 179.10(15) 
C(5)-C(4)-C(9) 119.31(14) C(5)-C(4)-Fe(1) 68.51(9) 
C(9)-C(4)-Fe(1) 110.48(11) C(5)-C(4)-H(4) 116.1(10) 
C(9)-C(4)-H(4) 113.8(10) Fe(1)-C(4)-H(4) 121.4(10) 
C(6)-C(5)-C(4) 114.73(15) C(6)-C(5)-Fe(1) 70.24(10) 
C(4)-C(5)-Fe(1) 71.11(9) C(6)-C(5)-H(5) 120.6(11) 
C(4)-C(5)-H(5) 124.2(10) Fe(1)-C(5)-H(5) 121.7(12) 
C(5)-C(6)-C(7) 114.57(15) C(5)-C(6)-Fe(1) 69.72(9) 
C(7)-C(6)-Fe(1) 71.92(10) C(5)-C(6)-H(6) 120.7(11) 
C(7)-C(6)-H(6) 124.3(11) Fe(1)-C(6)-H(6) 120.8(11) 
C(6)-C(7)-C(8) 119.81(15) C(6)-C(7)-Fe(1) 68.13(9) 
C(8)-C(7)-Fe(1) 110.12(11) C(6)-C(7)-H(7) 116.0(11) 
C(8)-C(7)-H(7) 116.1(11) Fe(1)-C(7)-H(7) 117.8(11) 
C(7)-C(8)-C(9) 110.73(13) C(7)-C(8)-H(8A) 109.5 
C(9)-C(8)-H(8A) 109.5 C(7)-C(8)-H(8B) 109.5 
C(9)-C(8)-H(8B) 109.5 H(8A)-C(8)-H(8B) 108.1 
O(4)-C(9)-C(4) 104.50(12) O(4)-C(9)-C(8) 111.73(13) 
C(4)-C(9)-C(8) 110.44(13) O(4)-C(9)-C(12) 110.27(13) 
C(4)-C(9)-C(12) 106.63(13) C(8)-C(9)-C(12) 112.83(13) 
O(5)-C(10)-O(4) 123.06(15) O(5)-C(10)-C(11) 126.56(16) 
O(4)-C(10)-C(11) 110.38(14) C(10)-C(11)-H(11A) 109.5 
C(10)-C(11)-H(11B) 109.5 H(11A)-C(11)-H(11B) 109.5 
C(10)-C(11)-H(11C) 109.5 H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 O(7)-C(12)-O(6) 125.18(16) 
O(7)-C(12)-C(9) 123.26(15) O(6)-C(12)-C(9) 111.30(14) 
O(6)-C(13)-H(13A) 109.5 O(6)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 O(6)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 H(13B)-C(13)-H(13C) 109.5 
                                                    
Symmetry transformations used to generate equivalent atoms: 
                                                            
 
 Table 49 Anisotropic displacement parameters (Å2 x 103) for 461. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U 
                                                                                 
  Atom  U11  U22  U33  U23  U13  U12 
                                               
Fe(1) 21(1) 18(1) 17(1) 1(1) 2(1) 1(1) 
O(1) 40(1) 46(1) 23(1) 7(1) -3(1) 8(1) 
O(2) 48(1) 36(1) 37(1) 1(1) 18(1) 13(1) 
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O(3) 33(1) 30(1) 36(1) -3(1) 8(1) -7(1) 
O(4) 19(1) 21(1) 22(1) 3(1) -1(1) 1(1) 
O(5) 21(1) 35(1) 29(1) 5(1) 1(1) -3(1) 
O(6) 28(1) 31(1) 21(1) -3(1) 3(1) 8(1) 
O(7) 34(1) 31(1) 24(1) 5(1) 4(1) -2(1) 
C(1) 28(1) 24(1) 24(1) 0(1) 7(1) 1(1) 
C(2) 30(1) 23(1) 25(1) 5(1) 4(1) 0(1) 
C(3) 26(1) 25(1) 21(1) 1(1) 6(1) 6(1) 
C(4) 19(1) 19(1) 19(1) -1(1) 2(1) 0(1) 
C(5) 19(1) 25(1) 16(1) 3(1) 2(1) -1(1) 
C(6) 23(1) 22(1) 21(1) 5(1) 3(1) 3(1) 
C(7) 27(1) 17(1) 21(1) 1(1) 2(1) 1(1) 
C(8) 25(1) 18(1) 22(1) -1(1) 1(1) -2(1) 
C(9) 19(1) 20(1) 18(1) 3(1) -1(1) 1(1) 
C(10) 21(1) 28(1) 21(1) -1(1) 0(1) 3(1) 
C(11) 25(1) 35(1) 32(1) 8(1) -5(1) 3(1) 
C(12) 15(1) 27(1) 21(1) -1(1) -2(1) -2(1) 
C(13) 25(1) 50(1) 26(1) -8(1) 4(1) 10(1) 
 
 Table 50 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 461. 
                                     
  Atom   x   y   z  U(eq) 
                                 
H(8A) 5033 -3068 1550 26 
H(8B) 5034 -1977 911 26 
H(11A) 2274 3155 435 46 
H(11B) 3806 3820 330 46 
H(11C) 3004 5010 839 46 
H(13A) 2688 2321 2736 50 
H(13B) 3652 4386 2910 50 
H(13C) 4049 1881 3107 50 
H(4) 6994(17) 2740(12) 1813(7) 16(4) 
H(5) 8607(14) 100(30) 2220(7) 22(5) 
H(6) 8625(13) -3580(20) 1783(8) 24(5) 
H(7) 7038(19) -4190(20) 987(7) 26(5) 
  
 Table 51 Dihedral angles [o] for 461 
                                          
  Atom1  -  Atom2  -  Atom3  -  Atom4  Dihedral 
                                                  
C(3) - Fe(1) - C(1) - O(1) -171(100) 
C(2) - Fe(1) - C(1) - O(1) 97(12) 
C(5) - Fe(1) - C(1) - O(1) -65(12) 
C(6) - Fe(1) - C(1) - O(1) -9(12) 
C(4) - Fe(1) - C(1) - O(1) -76(12) 
C(7) - Fe(1) - C(1) - O(1) 1(12) 
C(1) - Fe(1) - C(2) - O(2) 34(3) 
C(3) - Fe(1) - C(2) - O(2) -67(3) 
C(5) - Fe(1) - C(2) - O(2) -162(3) 
C(6) - Fe(1) - C(2) - O(2) 169(3) 
C(4) - Fe(1) - C(2) - O(2) -175(2) 
C(7) - Fe(1) - C(2) - O(2) 129(3) 
C(1) - Fe(1) - C(3) - O(3) -42(10) 
C(2) - Fe(1) - C(3) - O(3) 55(10) 
C(5) - Fe(1) - C(3) - O(3) -178(100) 
C(6) - Fe(1) - C(3) - O(3) 153(10) 
C(4) - Fe(1) - C(3) - O(3) -138(10) 
C(7) - Fe(1) - C(3) - O(3) 166(10) 
C(1) - Fe(1) - C(4) - C(5) 167.57(10) 
C(3) - Fe(1) - C(4) - C(5) -90.95(10) 
C(2) - Fe(1) - C(4) - C(5) 16.0(3) 
C(6) - Fe(1) - C(4) - C(5) 33.38(10) 
C(7) - Fe(1) - C(4) - C(5) 74.67(10) 
C(1) - Fe(1) - C(4) - C(9) 53.08(12) 
C(3) - Fe(1) - C(4) - C(9) 154.56(11) 
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C(2) - Fe(1) - C(4) - C(9) -98.5(3) 
C(5) - Fe(1) - C(4) - C(9) -114.49(15) 
C(6) - Fe(1) - C(4) - C(9) -81.11(11) 
C(7) - Fe(1) - C(4) - C(9) -39.82(11) 
C(9) - C(4) - C(5) - C(6) 45.6(2) 
Fe(1) - C(4) - C(5) - C(6) -56.56(13) 
C(9) - C(4) - C(5) - Fe(1) 102.13(14) 
C(1) - Fe(1) - C(5) - C(6) 109.07(12) 
C(3) - Fe(1) - C(5) - C(6) -141.62(11) 
C(2) - Fe(1) - C(5) - C(6) -49.07(13) 
C(4) - Fe(1) - C(5) - C(6) 126.36(14) 
C(7) - Fe(1) - C(5) - C(6) 33.63(10) 
C(1) - Fe(1) - C(5) - C(4) -17.29(14) 
C(3) - Fe(1) - C(5) - C(4) 92.03(10) 
C(2) - Fe(1) - C(5) - C(4) -175.42(10) 
C(6) - Fe(1) - C(5) - C(4) -126.36(14) 
C(7) - Fe(1) - C(5) - C(4) -92.73(10) 
C(4) - C(5) - C(6) - C(7) -0.8(2) 
Fe(1) - C(5) - C(6) - C(7) -57.80(13) 
C(4) - C(5) - C(6) - Fe(1) 57.03(12) 
C(1) - Fe(1) - C(6) - C(5) -111.22(12) 
C(3) - Fe(1) - C(6) - C(5) 48.12(13) 
C(2) - Fe(1) - C(6) - C(5) 142.34(11) 
C(4) - Fe(1) - C(6) - C(5) -33.64(10) 
C(7) - Fe(1) - C(6) - C(5) -125.94(14) 
C(1) - Fe(1) - C(6) - C(7) 14.72(14) 
C(3) - Fe(1) - C(6) - C(7) 174.06(10) 
C(2) - Fe(1) - C(6) - C(7) -91.72(11) 
C(5) - Fe(1) - C(6) - C(7) 125.94(14) 
C(4) - Fe(1) - C(6) - C(7) 92.31(10) 
C(5) - C(6) - C(7) - C(8) -44.8(2) 
Fe(1) - C(6) - C(7) - C(8) -101.38(14) 
C(5) - C(6) - C(7) - Fe(1) 56.61(13) 
C(1) - Fe(1) - C(7) - C(6) -169.26(10) 
C(3) - Fe(1) - C(7) - C(6) -17.2(3) 
C(2) - Fe(1) - C(7) - C(6) 93.04(11) 
C(5) - Fe(1) - C(7) - C(6) -33.70(10) 
C(4) - Fe(1) - C(7) - C(6) -75.41(10) 
C(1) - Fe(1) - C(7) - C(8) -54.21(12) 
C(3) - Fe(1) - C(7) - C(8) 97.9(3) 
C(2) - Fe(1) - C(7) - C(8) -151.92(12) 
C(5) - Fe(1) - C(7) - C(8) 81.35(12) 
C(6) - Fe(1) - C(7) - C(8) 115.05(16) 
C(4) - Fe(1) - C(7) - C(8) 39.64(11) 
C(6) - C(7) - C(8) - C(9) 43.7(2) 
Fe(1) - C(7) - C(8) - C(9) -32.00(16) 
C(10) - O(4) - C(9) - C(4) -173.19(13) 
C(10) - O(4) - C(9) - C(8) 67.37(18) 
C(10) - O(4) - C(9) - C(12) -58.95(17) 
C(5) - C(4) - C(9) - O(4) -163.64(14) 
Fe(1) - C(4) - C(9) - O(4) -87.45(12) 
C(5) - C(4) - C(9) - C(8) -43.3(2) 
Fe(1) - C(4) - C(9) - C(8) 32.84(15) 
C(5) - C(4) - C(9) - C(12) 79.58(18) 
Fe(1) - C(4) - C(9) - C(12) 155.76(10) 
C(7) - C(8) - C(9) - O(4) 115.63(15) 
C(7) - C(8) - C(9) - C(4) -0.23(18) 
C(7) - C(8) - C(9) - C(12) -119.46(15) 
C(9) - O(4) - C(10) - O(5) 0.7(2) 
C(9) - O(4) - C(10) - C(11) -179.80(14) 
C(13) - O(6) - C(12) - O(7) -7.1(2) 
C(13) - O(6) - C(12) - C(9) 178.59(13) 
O(4) - C(9) - C(12) - O(7) 155.84(15) 
C(4) - C(9) - C(12) - O(7) -91.28(18) 
C(8) - C(9) - C(12) - O(7) 30.1(2) 
O(4) - C(9) - C(12) - O(6) -29.76(18) 
C(4) - C(9) - C(12) - O(6) 83.12(16) 
C(8) - C(9) - C(12) - O(6) -155.46(13) 
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